000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|ţpakki||N05AX08|01.04.2000||R|||0|0|0|0|JAS|0|1|0|100|SEK|1613|3185|lyfalmen|V0045|1588||20|0|2,0000|Vistor hf|Janssen-Cilag AB|Risperídón||1613||1613|3185| 000018|G01AF0501|Pevaryl|krem/sti|||15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|||0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa||||15|0|4,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||| 000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|31882|41894|lyfsjukr||||2|0|24,0000|Icepharma hf|Roche|Epóetín||31882||31882|41894| 000145|B03XA0103|NeoRecormon|stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|47896|61992|lyfsjukr||||2|0|36,0000|Icepharma hf|Roche|Epóetín||47896||47896|61992| 000153|A02BC0102|Losec|sh-tfl|20|mg|7|stk|1|ţpakki||A02BC01|01.09.2009||L|||0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa||||7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||| 000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|||0|0|0|0|ELD|0|1|0|100|XEU|10122|14825|lyfalmen|V0457|4820||28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||10122||10122|14825| 000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|||0|0|0|0|ELD|0|1|0|100|XEU|29502|39570|lyfalmen|V0475|18913||28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||29502||29502|39570| 000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|ţpakki||N05AH03|01.12.2003||R|||0|0|0|0|ELD|0|1|0|100|XEU|38368|50697|lyfalmen|V0540|30249||28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||38368||38368|50697| 000198|N05AH0302|Zyprexa Velotab|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|||0|0|0|0|ELD|0|1|0|100|XEU|20638|28446|lyfalmen|V0456|9397||28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||20638||20638|28446| 000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|||0|1|0|1|FER|0|0|0|100|DKK|4797|6923|lyfsjukr||||1|0|0,0400|Vistor hf|Ferring|Atosíban||4797||4797|6923| 000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|||0|0|0|0|BOI|0|0|0|100|DKK|7256|14105|vetalmen||||100|0||Vistor hf|Boehringer Ingelheim|||7256||7256|14105| 000237|G02CX0101|Tractocile|irţ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|||0|1|0|1|FER|0|0|0|100|DKK|12848|18007|lyfsjukr||||5|0|0,2300|Vistor hf|Ferring|Atosíban||12848||12848|18007| 000290|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.02.2002||R|||0|1|E|0|ORG|0|0|0|100|DKK|19324|26797|lyfalmen||||0|0|4,0000|Vistor hf|N.V. Organon|Follitrópín beta||19324||19324|26797| 000316|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.02.2002||R|||0|1|E|0|ORG|0|0|0|100|DKK|37508|49618|lyfalmen||||1|0|8,0000|Vistor hf|N.V. Organon|Follitrópín beta||37508||37508|49618| 000373|N02CC0402|Maxalt Smelt|munnltfl|10|mg|6|stk|1|ţpakki||N02CC04|01.03.1999||R|||0|0|E|0|MSD|0|0|0|100|DKK|5099|7954|lyfalmen||||6|0|6,0000|Vistor hf|M.S.D.|Rizatriptan||5099||5099|7954| 000390|J01CR0202|Augmentin|sts|600|mg/hgl|10|hgl|1|pakki|500+100 mg|J01CR02|01.01.2000||R|||0|0|0|1|GSK|0|0|0|100|IKR|2534|3657|lyfsjukr||||10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2534||2534|3657| 000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|||0|0|0|1|GSK|0|0|0|100|IKR|2175|3139|lyfsjukr||||5|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2175||2175|3139| 000448|D07AC1301|Elocon|húđlausn|0,1|%|100|ml|1|glas||D07AC13|01.03.2009||R|||0|0|B|0|SPL|0|0|1|100|DKK|3131|5262|lyfalmen||||100|0||Vistor hf|Schering-Plough Europe|Mómetasón||||3131|5262| 000530|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|20|spr|án nála|J07BF03|01.06.2005||R|||0|0|0|0|SPM|0|0|0|100|XEU|26730|36091|lyfalmen||||10|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||26730||26730|36091| 000548|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.07.2001||R|||0|0|E|0|LTH|0|0|0|100|SEK|1815|3462|lyfalmen||||5|0||Vistor hf|Laboratoires THEA|Ketotifen||1815||1815|3462| 000552|G04BE0105|Caverject Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|||0|0|0|0|PER|0|0|0|100|DKK|4662|7356|lyfalmen||||2|0|2,0000|Icepharma hf|Pfizer ApS|Alprostadíl||4662||4662|7356| 000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|||0|0|E|0|JAS|0|0|0|100|SEK|3697|6036|lyfalmen||||60|0|3,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||3697||3697|6036| 000565|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.07.2001||L|||0|0|0|0|LTH|0|0|0|100|IKR|||lyflausa||||8|0||Vistor hf|Laboratoires THEA|Ketotifen|||||| 000573|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.07.2001||R|||0|0|E|0|LTH|0|0|0|100|SEK|5391|8354|lyfalmen||||24|0||Vistor hf|Laboratoires THEA|Ketotifen||5391||5391|8354| 000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|fl||B05BA02|01.04.2004||R|||0|0|0|1|FRP|0|0|0|100|DKK|6790|9800|lyfsjukr||||1000|0||Icepharma hf|Fresenius Kabi|Fitusambönd||6790||6790|9800| 000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|ţpakki||C08CA01|01.01.1992||R|||0|0|B|0|PER|0|0|0|100|DKK|2939|4999|lyfalmen||||30|0|60,0000|Icepharma hf|Pfizer ApS|Amlódipín||2939||2939|4999| 000784|G04BE0105|Caverject Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|||0|0|0|0|PER|0|0|0|100|DKK|3618|5928|lyfalmen||||2|0|1,0000|Icepharma hf|Pfizer ApS|Alprostadíl||3618||3618|5928| 000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||125|0|1,7500|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||| 000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||125|0|0,8750|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||| 000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|||0|1|0|1|MSE|0|0|0|100|SEK|170290|215596|lyfsjukr||||6|0|122,7907|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||170290||170290|215596| 000957|H01AC0101|Genotropin|sts|5|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.05.2001||R|||0|1|0|1|PER|0|0|0|100|DKK|21436|28785|lyfsjukr||||1|0|7,5000|Icepharma hf|Pfizer ApS|Sómatrópín||21436||21436|28785| 001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|||0|1|0|1|ORG|0|0|0|100|DKK|5470|7895|lyfsjukr||||0|0|1,0000|Vistor hf|N.V. Organon|Ganirelix||5470||5470|7895| 001194|M01AH0101|Celebra|hylki|200|mg|10|stk|1|ţpakki||M01AH01|01.03.2003||R|||0|0|E|0|PER|0|0|1|100|DKK|1396|2889|lyfalmen|V0037|2332||10|0|10,0000|Icepharma hf|Pfizer ApS|Celekoxíb||1396||1396|2889| 001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|ţpakki||C10AA05|01.06.2002||R|||0|0|0|0|PER|0|0|0|100|DKK|6098|9321|lyfalmen||||30|0|120,0000|Icepharma hf|Pfizer ApS|Atorvastatín||6098||6098|9321| 001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|ţpakki||C10AA05|01.06.2002||R|||0|0|0|0|PER|0|0|0|100|DKK|20176|27866|lyfalmen|V0115|13292||100|0|400,0000|Icepharma hf|Pfizer ApS|Atorvastatín||20176||20176|27866| 001291|C07AB0206|Seloken ZOC|forđatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|||0|0|B|0|AZD|0|0|0|100|SEK|2363|4211|lyfalmen|V0050|2322||100|0|15,8300|Vistor hf|AstraZeneca A/S DK|Metóprólól||2363||2363|4211| 001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|||0|1|0|1|ORG|0|0|0|100|DKK|27350|36207|lyfsjukr||||2|0|5,0000|Vistor hf|N.V. Organon|Ganirelix||27350||27350|36207| 001437|N05AH0308|Lazapix|filmhtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|||0|0|*|0|POF|0|1|0|100|XEU|2459|1816|lyfalmen|V0278|1816||28|0|7,0000|Portfarma ehf|Portfarma|Olanzapín||612||612|1816| 001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|||0|0|*|0|NAS|0|0|0|100|DKK|5856|8990|lyfalmen||||15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5856||5856|8990| 001512|C04AD0301|Trental|forđatfl|400|mg|100|stk|1|ţpakki||C04AD03|01.05.2002||R|||0|0|E|0|SNO|0|0|0|100|NOK|4225|6758|lyfalmen||||100|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||4225||4225|6758| 001517|N06AB0308|Fluoxetin Actavis|hylki|20|mg|30|stk|1|ţpakki||N06AB03|01.03.2000||R|||0|0|0|0|ACA|0|1|0|100|IKR|883|2187|lyfalmen||||30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||883||883|2187| 001528|N06AB0308|Fluoxetin Actavis|hylki|20|mg|100|stk|1|ţpakki||N06AB03|01.03.2000||R|||0|0|B|0|ACA|0|1|0|100|IKR|2456|4339|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||2456||2456|4339| 001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|||0|0|0|1|FRP|0|0|0|100|DKK|21078|28335|lyfsjukr||||4104|0||Icepharma hf|Fresenius Kabi|Blöndur||21078||21078|28335| 001599|B03AC0201|Venofer|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.07.2005||R|||0|0|E|0|VIF|0|0|1|100|CHF|14646|20926|lyfalmen|V0034|18573||25|0|5,0000|Vistor hf|Vifor France SA|Járnoxíđ (sykurflétta)||14646||14646|20926| 001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|||0|0|0|1|FRP|0|0|0|100|DKK|30714|40429|lyfsjukr||||6160|0||Icepharma hf|Fresenius Kabi|Blöndur||30714||30714|40429| 001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|||0|0|0|1|NOH|0|0|0|100|DKK|2324|3354|lyfsjukr||||10|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||2324||2324|3354| 001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|||0|0|*|0|ALC|0|0|0|100|USD|4096|6582|lyfalmen|V0444|6582||15|0|75,0000|K.Pétursson hf|Alcon|Brinzólamíđ||4096||4096|6582| 001889|A02BC0501|Nexium|sh-tfl|20|mg|7|stk|1|veski||A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|848|2139|lyfalmen|V0004|424||7|0|4,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||848||848|2139| 001954|N05AX0802|Rison|töflur|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|||0|0|*|0|ACA|0|1|0|100|IKR|1946|3373|lyfalmen|V0291|3373||60|0|12,0000|Actavis Group hf|Actavis hf|Risperídón||1750||1750|3373| 001957|N05AX0802|Rison|töflur|4|mg|60|stk|1|glas||N05AX08|01.05.2000||R|||0|0|*|0|ACA|0|1|0|100|IKR|6936|10467|lyfalmen|V0294|10467||60|0|48,0000|Actavis Group hf|Actavis hf|Risperídón||6936||6936|10467| 001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|||0|0|0|0|BIG|0|0|1|100|SEK|4348|6927|lyfalmen||||45|0||Icepharma hf|Bioglan AB|Capsaicin||4348||4348|6927| 001965|N05AX0802|Rison|töflur|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|||0|0|*|0|ACA|0|1|0|100|IKR|3353|5566|lyfalmen|V0292|5566||60|0|24,0000|Actavis Group hf|Actavis hf|Risperídón||3353||3353|5566| 001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|4419|7024|lyfalmen|V0004|1696||28|0|18,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4419||4419|7024| 001986|N05AX0802|Rison|töflur|3|mg|60|stk|1|glas||N05AX08|01.05.2000||R|||0|0|*|0|ACA|0|1|0|100|IKR|5263|8178|lyfalmen|V0293|8178||60|0|36,0000|Actavis Group hf|Actavis hf|Risperídón||5263||5263|8178| 001991|A02BC0501|Nexium|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|8774|12981|lyfalmen|V0011|2864||56|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||8774||8774|12981| 002011|A02BC0501|Nexium|sh-tfl|40|mg|7|stk|1|veski||A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|1393|2884|lyfalmen|V0005|449||7|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1393||1393|2884| 002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|6184|9438|lyfalmen|V0005|1797||28|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||6184||6184|9438| 002071|A07EC0204|Asacol|sh-tfl|400|mg|100|stk|1|ţpakki||A07EC02|01.01.2000||R|||0|0|B|0|TIL|0|0|0|100|SEK|5395|8359|lyfalmen||||100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||5395||5395|8359| 002180|A02BC0501|Nexium|sh-tfl|20|mg|50|stk|1|ţpakki|stakskammtar|A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|5415|8386|lyfalmen|V0011|2557||50|0|33,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5415||5415|8386| 002194|B05BA1010|Kabiven Peripheral|irl|1000|kcal|1440|ml|4|pokar|fleyti|B05BA10|01.02.2002||R|||0|0|0|1|FRP|0|0|0|100|DKK|24813|33023|lyfsjukr||||5760|0||Icepharma hf|Fresenius Kabi|Blöndur||24813||24813|33023| 002197|A02BC0501|Nexium|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|13449|7262|lyfalmen|V0011|5114||100|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4593||4593|7262| 002205|A02BC0501|Nexium|sh-tfl|40|mg|50|stk|1|veski|stakskammtar|A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|9863|14471|lyfalmen|V0012|2557||50|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||9863||9863|14471| 002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|||0|0|*|0|NAS|0|0|0|100|DKK|2999|5081|lyfalmen||||10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||2999||2999|5081| 002219|A02BC0501|Nexium|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|17883|24988|lyfalmen|V0012|5114||100|0|133,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||17883||17883|24988| 002312|D01AE1501|Lamisil|hlaup|10|mg/g|15|g|1|túpa||D01AE15|01.04.2003|31.08.2012|L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||15|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||| 002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.08.2002||R|||0|0|B|0|MSD|0|0|0|100|DKK|16454|23195|lyfalmen|V0492|18943||98|0|39,2000|Vistor hf|M.S.D.|Montelúkast||16454||16454|23195| 002342|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|||0|0|0|1|BAY|0|0|0|100|SEK|101734|129559|lyfsjukr||||1|0|2,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||101734|129559| 002356|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|||0|0|0|1|BAY|0|0|0|100|SEK|51855|66961|lyfsjukr||||1|0|1,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||51855|66961| 002367|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|||0|0|0|1|BAY|0|0|0|100|SEK|26847|35575|lyfsjukr||||1|0|0,5000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||26847|35575| 002391|G03AA1201|Yasmin|töflur|||63|stk|1|ţpakki|3+0,03 mg|G03AA12|01.02.2001||R|||0|0|0|0|BYP|0|0|0|100|SEK|3244|5417|lyfalmen||||63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrógen||||3244|5417| 002413|G03AA1204|Yasmin 28|töflur|||84|stk|1|ţpakki|3+0,03 mg|G03AA12|01.10.2007||R|||0|0|0|0|BYP|0|0|0|100|SEK|3244|5417|lyfalmen||||84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrógen||3244||3244|5417| 002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.10.2000||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||10|0|10,0000|Actavis Group hf|Actavis hf|Lóratadín|||||| 002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.10.2000||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||30|0|30,0000|Actavis Group hf|Actavis hf|Lóratadín|||||| 002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.10.2000||L|||0|0|E|0|ACA|0|0|1|100|IKR|||lyfalmen|V0362|2202||100|0|100,0000|Actavis Group hf|Actavis hf|Lóratadín|||||2202| 002616|S01LA0101|Visudyne|irs|15|mg/hgl|1|hgl|1|pakki||S01LA01|01.12.2000|31.07.2012|R|||0|1|0|1|NOO|0|0|0|100|DKK|218235|275767|lyfsjukr||||1|0||Vistor hf|Novartis Ophthalmics Europe Ltd.|Verteporfin||218235||218235|275767| 002659|QP52AA0101|Droncit vet.|sts|57|mg/ml|10|ml|1|hgl|lausn|QP52AA01|01.03.2009||R|||0|0|0|0|BAN|0|0|0|100|SEK|3508|6120|vetorma||||10|0||Icepharma hf|Bayer Animal Health GmbH|||3508||3508|6120| 002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|6,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|||0|0|*|0|SAO|0|0|0|100|XEU|1210|2634|lyfalmen||||5|0|28,0000|Icepharma hf|Santen Oy|Tímólól||1210||1210|2634| 002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|||0|1|0|1|ALL|0|0|0|100|SEK|30821|40563|lyfsjukr||||1|0||Vistor hf|Allergan|Clostridium botulinum toxín-A||30821||30821|40563| 003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.06.2007||R|||0|0|0|0|MSD|0|0|0|100|DKK|13599|14797|lyfalmen|V0089|2686||98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||10101||10101|14797| 003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|||0|0|0|0|UCB|0|0|0|100|DKK|10052|14730|lyfalmen|V0515|4973||100|0|16,6700|Vistor hf|U.C.B|Levetíracetam||10052||10052|14730| 003099|L01DB0104|Myocet|irl|50|mg|2|sett|1|pakki||L01DB01|01.07.2006||R|||0|1|0|1|ZEP|0|0|0|100|DKK|236442|298617|lyfsjukr||||2|0||Icepharma hf|Zeneus Pharma Limited-|Doxórúbicín||236442||236442|298617| 003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|||0|0|0|0|UCB|0|0|0|100|DKK|17355|24326|lyfalmen|V0253|7520||100|0|33,3300|Vistor hf|U.C.B|Levetíracetam||17355||17355|24326| 003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|||0|0|0|0|UCB|0|0|0|100|DKK|33721|44865|lyfalmen|V0516|14515||100|0|66,6700|Vistor hf|U.C.B|Levetíracetam||33721||33721|44865| 003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|||0|1|*|0|PFP|0|0|0|100|SEK|10441|15262|lyfalmen||||1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||10441||10441|15262| 003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|||0|1|*|0|PFP|0|0|0|100|SEK|15521|22024|lyfalmen||||1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||15521||15521|22024| 003298|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.04.2007||R|||0|0|0|1|BYP|0|0|0|100|SEK|192811|243860|lyfsjukr||||150|0||Icepharma hf|Bayer Pharma AG|Gadóbútról||192811||192811|243860| 003310|R03AK0701|Symbicort Turbuhaler|innúđadu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|||0|0|0|0|AZD|0|0|0|100|SEK|9438|13890|lyfalmen|V0356|12692||120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9438||9438|13890| 003325|R03AK0702|Symbicort mite Turbuhaler|innúđadu|84,5|mcg/sk|120|skammtar|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|||0|0|0|0|AZD|0|0|0|100|SEK|8748|12946|lyfalmen||||120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||8748||8748|12946| 003353|L04AA1001|Rapamune|töflur|1|mg|100|stk|1|ţpakki||L04AA10|01.04.2004||R|||0|1|*|0|WTE|0|0|0|100|DKK|57129|74242|lyfalmen|V0567|74242||100|0|33,3300|Icepharma hf|Wyeth Europe|Sirolimus||57129||57129|74242| 003423|A10BG0301|Actos|töflur|15|mg|28|stk|1|ţpakki||A10BG03|01.12.2000||R|||0|0|*|0|TKE|0|0|0|100|SEK|4451|7068|lyfalmen||||28|0|14,0000|Icepharma hf|Takeda Europe -|Píóglítazón||4451||4451|7068| 003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|ţpakki||A02BB01|01.08.2002||R|||0|0|E|0|PER|0|0|0|100|DKK|3108|5230|lyfalmen||||60|0|15,0000|Icepharma hf|Pfizer ApS|Mísóprostól||3108||3108|5230| 003800|A10BG0301|Actos|töflur|15|mg|98|stk|1|ţpakki||A10BG03|01.12.2000||R|||0|0|*|0|TKE|0|0|0|100|SEK|15379|21846|lyfalmen|V0572|18098||98|0|49,0000|Icepharma hf|Takeda Europe -|Píóglítazón||15379||15379|21846| 003809|A10BG0301|Actos|töflur|30|mg|28|stk|1|ţpakki||A10BG03|01.12.2000||R|||0|0|*|0|TKE|0|0|0|100|SEK|6732|10188|lyfalmen||||28|0|28,0000|Icepharma hf|Takeda Europe -|Píóglítazón||6732||6732|10188| 003831|A10BG0301|Actos|töflur|30|mg|98|stk|1|ţpakki||A10BG03|01.12.2000||R|||0|0|*|0|TKE|0|0|0|100|SEK|22978|31383|lyfalmen|V0573|26601||98|0|98,0000|Icepharma hf|Takeda Europe -|Píóglítazón||22978||22978|31383| 003869|R01BA5202|Clarinase|forđatfl|10|mg|10|stk|1|pakki|ţp 10+240 mg|R01BA52|01.09.1998||R|||0|0|E|0|SCP|0|0|1|100|DKK|843|2132|lyfalmen||||10|0|10,0000|Vistor hf|Schering-Plough|Pseudóefedrín í blöndum||843||843|2132| 003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|glas||N06AB06|01.11.2000||R|||0|0|B|0|ACA|0|1|0|100|IKR|1017|1972|lyfalmen|V0151|1972||28|0|28,0000|Actavis Group hf|Actavis hf|Sertralín||726||726|1972| 003939|M01AB0505|Voltaren|sh-tfl|50|mg|20|stk|1|ţpakki||M01AB05|01.03.1984||R|||0|0|E|0|NOH|0|0|1|100|DKK|567|1755|lyfalmen||||20|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||567||567|1755| 003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|ţpakki||N06AB06|01.11.2000||R|||0|0|B|0|ACA|0|1|0|100|IKR|2389|4247|lyfalmen|V0322|4247||98|0|98,0000|Actavis Group hf|Actavis hf|Sertralín||2389||2389|4247| 003974|J05AE0601|Kaletra|mixtúra|100|mg/ml|60|ml|5|glös|80 + 20 mg/ml|J05AE06|01.08.2003||R|||0|1|0|1|ABL|0|0|0|100|DKK|70232|90024|lyfsjukr||||300|0|30,0000|Vistor hf|Abbott Laboratories A/S|Lopinavír||70232||70232|90024| 003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|ţpakki||M01AB05|01.03.1984||R|||0|0|E|0|NOH|0|0|1|100|DKK|2055|3790|lyfalmen|V0469|2422||100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||2055||2055|3790| 004002|L04AD0101|Sandimmun|irţ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|||0|0|0|1|NOH|0|0|0|100|DKK|21070|28325|lyfsjukr||||50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||21070||21070|28325| 004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|||0|0|E|0|NOH|0|0|0|100|DKK|7648|11441|lyfalmen||||250|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||7648||7648|11441| 004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990||L|||0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa||||100|0|2,0000|Vistor hf|McNeil Sweden AB|Lóperamíđ|||||| 004050|R03AK0601|Seretide|innúđal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|||0|0|B|0|GSK|0|0|0|100|GBP|4194|6716|lyfalmen||||120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4194||4194|6716| 004086|N06AB0601|Zoloft|töflur|25|mg|7|stk|1|ţpakki||N06AB06|01.05.2003||R|||0|0|0|0|PER|0|1|0|100|DKK|572|1761|lyfalmen||||7|0|3,5000|Icepharma hf|Pfizer ApS|Sertralín||572||572|1761| 004111|N05CD0102|Dalmadorm medium|hylki|15|mg|30|stk|1|ţpakki||N05CD01|01.12.2000||R|||0|0|0|0|MAB|0|0|1|100|DKK|1024|2380|lyfalmen||||30|0|15,0000|Vistor hf|Meda AB|Flúrazepam||1024||1024|2380| 004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|ţpakki|hart hylki|N05AE04|01.03.2003||R|||0|0|0|0|PER|0|1|0|100|DKK|5289|8214|lyfalmen||||14|0|7,0000|Icepharma hf|Pfizer ApS|Ziprasidon||5289||5289|8214| 004282|R03AK0601|Seretide|innúđal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|||0|0|0|0|GSK|0|0|0|100|GBP|7748|11578|lyfalmen||||120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||7748||7748|11578| 004293|R03AK0601|Seretide|innúđal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|||0|0|0|0|GSK|0|0|0|100|GBP|10884|15868|lyfalmen||||120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||10884||10884|15868| 004298|R06AX2701|Aerius|töflur|5|mg|10|stk|1|ţpakki||R06AX27|01.05.2001||R|||0|0|E|0|SCP|0|0|1|100|DKK|613|1817|lyfalmen|V0366|755||10|0|10,0000|Vistor hf|Schering-Plough|Deslóratadín||613||613|1817| 004301|N06AX1101|Remeron|mixtúra|15|mg/ml|66|ml|1|fl|lausn|N06AX11|01.01.2003||R|||0|0|0|0|ORG|0|1|0|100|DKK|5728|8815|lyfalmen||||66|0|33,0000|Vistor hf|N.V. Organon|Mirtazapín||5728||5728|8815| 004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|||0|0|0|1|PER|0|0|0|100|DKK|20356|27429|lyfsjukr||||1|0|0,5000|Icepharma hf|Pfizer ApS|Voricónazól||20356||20356|27429| 004370|R06AX2701|Aerius|töflur|5|mg|30|stk|1|ţpakki||R06AX27|01.05.2001||R|||0|0|E|0|SCP|0|0|1|100|DKK|1599|3166|lyfalmen|V0366|2266||30|0|30,0000|Vistor hf|Schering-Plough|Deslóratadín||1599||1599|3166| 004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|glas||A04AA01|01.01.2009||R|||0|0|E|0|GSK|0|0|0|100|GBP|7239|5032|lyfalmen|V0381|5032||10|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||2963||2963|5032| 004378|R06AX2701|Aerius|töflur|5|mg|100|stk|1|ţpakki||R06AX27|01.05.2001||R|||0|0|E|0|SCP|0|0|1|100|DKK|4476|7102|lyfalmen|V0458|5423||100|0|100,0000|Vistor hf|Schering-Plough|Deslóratadín||4476||4476|7102| 004388|QJ51RC2501|Benestermycin, vet.|spenalyf|||5|ml|20|spr||QJ51RC25|01.12.1978||R|||0|0|0|0|BOI|0|0|0|100|DKK|4634|9071|vetalmen||||100|0||Vistor hf|Boehringer Ingelheim|||4634||4634|9071| 004455|N02AX0208|Zytram|forđatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|||0|0|E|0|NOP|0|0|1|100|DKK|3138|5272|lyfalmen||||56|0|14,0000|Icepharma hf|Norpharma |Tramadól||3138||3138|5272| 004465|C01DA0801|Sorbangil|töflur|5|mg|100|stk|1|ţpakki||C01DA08|01.06.1980||R|||0|0|B|0|REP|0|0|0|100|SEK|650|1868|lyfalmen||||100|0|8,3333|Vistor hf|Recip AB|Ísósorbíđ dínítrat||650||650|1868| 004478|N02AX0208|Zytram|forđatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|||0|0|E|0|NOP|0|0|1|100|DKK|4185|6704|lyfalmen|V0226|2682||56|0|18,6667|Icepharma hf|Norpharma |Tramadól||4185||4185|6704| 004489|N02AX0208|Zytram|forđatfl|150|mg|56|stk|1|glas||N02AX02|01.01.2001||R|||0|0|E|0|NOP|0|0|1|100|DKK|5911|9065|lyfalmen|V0227|4084||56|0|28,0000|Icepharma hf|Norpharma |Tramadól||5911||5911|9065| 004500|N02AX0208|Zytram|forđatfl|200|mg|56|stk|1|glas||N02AX02|01.01.2001||R|||0|0|E|0|NOP|0|0|1|100|DKK|7867|11741|lyfalmen|V0228|5256||56|0|37,3333|Icepharma hf|Norpharma |Tramadól||7867||7867|11741| 004502|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|0,5|ml|1|dćla|einnota dćla|J07BC01|01.01.1990||R|||0|0|0|0|GSK|0|0|0|100|GBP|2223|4020|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsađir mótefnavakar||2223||2223|4020| 004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|ţpakki||A10BB12|01.06.2005||R|||0|0|*|0|AVP|0|0|0|100|NOK|3552|3159|lyfalmen|V0494|3050||90|0|180,0000|Vistor hf|Aventis Pharma |Glímepíríđ||1594||1594|3159| 004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|||0|0|B|0|ACA|0|1|0|100|IKR|2556|3615|lyfalmen|V0318|3542||100|0|100,0000|Actavis Group hf|Actavis hf|Cítalópram||1927||1927|3615| 004611|H01AC0104|Saizen|sts|8|mg/hgl|1|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|||0|1|0|1|EMA|0|0|0|100|SEK|36507|47699|lyfsjukr||||1|0|12,0000|Icepharma hf|E. Merck AB|Sómatrópín||36507||36507|47699| 004612|D06BX0105|Metronidazol Actavis|krem|10|mg/g|25|g|1|túpa||D06BX01|01.07.1987||R|||0|0|0|0|AGT|0|0|1|100|DKK|1370|2853|lyfalmen||||25|0||Actavis Group hf|Actavis Group hf|Metrónídazól||1370||1370|2853| 004613|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|1|ml|1|dćla|einnotadćl|J07BC01|01.01.1990||R|||0|0|0|0|GSK|0|0|0|100|GBP|3281|5467|lyfalmen||||1|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsađir mótefnavakar||3281||3281|5467| 004625|N06AB0402|Oropram|töflur|40|mg|28|stk|1|glas||N06AB04|01.01.2001||R|||0|0|0|0|ACA|0|1|0|100|IKR|1836|2164|lyfalmen|V0071|2164||28|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||866||866|2164| 004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|||0|0|B|0|ACA|0|1|0|100|IKR|5614|6407|lyfalmen|V0320|6150||100|0|200,0000|Actavis Group hf|Actavis hf|Cítalópram||3968||3968|6407| 004656|N06AB0402|Oropram|töflur|10|mg|28|stk|1|glas||N06AB04|01.01.2001||R|||0|0|B|0|ACA|0|1|0|100|IKR|776|1817|lyfalmen|V0062|1746||28|0|14,0000|Actavis Group hf|Actavis hf|Cítalópram||613||613|1817| 004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|||0|0|B|0|ACA|0|1|0|100|IKR|2703|3823|lyfalmen|V0317|3542||100|0|50,0000|Actavis Group hf|Actavis hf|Cítalópram||2079||2079|3823| 004678|N06AB0402|Oropram|töflur|20|mg|28|stk|1|glas||N06AB04|01.01.2001||R|||0|0|B|0|ACA|0|1|0|100|IKR|926|1709|lyfalmen|V0067|1654||28|0|28,0000|Actavis Group hf|Actavis hf|Cítalópram||534||534|1709| 004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|||0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen||||100|0|16,6700|Vistor hf|Medic Team|Magnesíum hýdroxíđ|||||1735| 004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|||0|1|0|1|BIA|0|0|0|100|DKK|36828|48102|lyfsjukr||||5|0|7,0000|Vistor hf|Biovitrum AB (publ)|Anakinra||36828||36828|48102| 004691|N06AB0402|Oropram|töflur|20|mg|56|stk|1|glas||N06AB04|01.01.2001||R|||0|0|B|0|ACA|0|1|0|100|IKR|1778|3411|lyfalmen|V0318|1984||56|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||1778||1778|3411| 004696|R05DA0901|Dexomet|mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||150|0|5,0000|Actavis Group hf|Actavis hf|Dextrómetorfan|||||| 004733|H01AC0104|Saizen|sts|8|mg/hgl|5|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|||0|1|0|1|EMA|0|0|0|100|SEK|182534|230963|lyfsjukr||||5|0|60,0000|Icepharma hf|E. Merck AB|Sómatrópín||182534||182534|230963| 004746|A10AE0405|Lantus [Clikstar]|stl|100|ein/ml|3|ml|5|rörlyk|rörlykjur fyrir Clikstar penna|A10AE04|01.06.2004||R|||0|0|*|0|SDE|0|0|0|100|NOK|10538|15394|lyfalmen||||15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||10538||10538|15394| 004834|N03AX1201|Neurontin|hylki|300|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|||0|0|E|0|PER|0|0|0|100|DKK|6650|7229|lyfalmen|V0250|4493||100|0|16,6667|Icepharma hf|Pfizer ApS|Gabapentín||4569||4569|7229| 004845|N03AX1201|Neurontin|hylki|400|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|||0|0|E|0|PER|0|0|0|100|DKK|8593|3868|lyfalmen|V0251|3868||100|0|22,2222|Icepharma hf|Pfizer ApS|Gabapentín||2112||2112|3868| 004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|ţpakki||P01AB01|01.12.1972||R|||0|0|0|0|AGT|0|0|1|100|DKK|627|1837|lyfalmen||||24|0|3,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||627||627|1837| 004874|N05AH0308|Lazapix|filmhtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.09.2011||R|||0|0|*|0|POF|0|1|0|100|XEU|14391|6957|lyfalmen|V0282|6691||56|0|56,0000|Portfarma ehf|Portfarma|Olanzapín||4370||4370|6957| 004880|J01FA1001|Zitromax|irs|500|mg/hgl|1|hgl|1|pakki||J01FA10|01.05.2003||R|||0|0|0|1|PER|0|0|0|100|DKK|5234|7554|lyfsjukr||||1|0|1,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||5234||5234|7554| 004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|||0|0|0|0|AGT|0|0|1|100|DKK|361|1473|lyfalmen||||8|0|2,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||361||361|1473| 004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|||0|0|0|0|AGT|0|0|1|100|DKK|634|1846|lyfalmen||||14|0|3,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||634||634|1846| 004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|||0|0|0|0|AGT|0|0|1|100|DKK|1199|2619|lyfalmen||||30|0|7,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||1199||1199|2619| 005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||36|0|2,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 005085|J07AJ5205|Boostrix|stl|||0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|||0|0|0|0|GSK|0|0|0|100|GBP|1801|3443|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum međ öđrum toxóíđum||1801||1801|3443| 005089|J07AL0103|Pneumovax|stl|||0,5|ml|1|hgl|lausn|J07AL01|01.11.2008||R|||0|0|0|0|SPM|0|0|0|100|XEU|2240|4043|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar||||2240|4043| 005108|G04CA0201|Omnic|forđahlk|0,4|mg|90|stk|1|ţpakki||G04CA02|01.08.1998||R|||0|0|E|0|ASP|0|0|0|100|XEU|8479|6883|lyfalmen|V0148|3942||90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4316||4316|6883| 005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|ţpakki||J01CF01|01.05.2001||R|||0|0|0|0|ACA|0|0|1|100|DKK|2141|3908|lyfalmen||||30|0|3,7500|Actavis Group hf|Actavis hf|Díkloxacillín||2141||2141|3908| 005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|ţpakki||J01CF01|01.05.2001||R|||0|0|0|0|ACA|0|0|1|100|DKK|2466|4352|lyfalmen||||20|0|5,0000|Actavis Group hf|Actavis hf|Díkloxacillín||2466||2466|4352| 005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|ţpakki||J01CF01|01.05.2001||R|||0|0|0|0|ACA|0|0|1|100|DKK|3372|5592|lyfalmen||||30|0|7,5000|Actavis Group hf|Actavis hf|Díkloxacillín||3372||3372|5592| 005241|R03AK0701|Symbicort Turbuhaler|innúđadu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|||0|0|0|0|AZD|0|0|0|100|SEK|28313|38078|lyfalmen|V0356|38077||360|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||28313||28313|38078| 005296|N05AH0401|Seroquel|filmhtfl|300|mg|100|stk|1|ţpakki||N05AH04|01.12.2002||R|||0|0|0|0|AZA|0|1|0|100|SEK|52019|67829|lyfalmen|V0287|56533||100|0|75,0000|Vistor hf|AstraZeneca AB|Quetíapín||52019||52019|67829| 005303|N02CC0303|Zomig Nasal|nefúđi|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|||0|0|E|0|ASZ|0|0|0|100|SEK|3411|5645|lyfalmen||||10|0|4,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||3411||3411|5645| 005330|D08AG0201|Betadine|áburđur|100|mg/ml|500|ml|1|fl|sprittl.|D08AG02|01.09.1982||L|||0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa||||500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||| 005336|R01AA0704|Otrivin ukonserveret|nefúđi|0,5|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.07.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 005355|S01AA1301|Fucithalmic|augndr|10|mg/g|0,2|g|12|sk-hyl|2 mg/sk|S01AA13|01.04.1992||R|||0|0|E|0|LEP|0|0|1|100|DKK|1088|2467|lyfalmen||||2|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||1088||1088|2467| 005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|stk|1|áf.spr|+ dćla|L02AE03|01.04.1996||R|||0|1|*|0|AZA|0|0|0|100|SEK|62917|81506|lyfalmen|V0451|78401||1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||62917||62917|81506| 005390|R03BB0101|Atrovent|innúđal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|||0|0|B|0|BOI|0|0|0|100|DKK|1436|2943|lyfalmen||||200|0|33,3300|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíđ||1436||1436|2943| 005503|N05AH0301|Zyprexa|húđuđtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|||0|0|*|0|ELD|0|1|0|100|XEU|28582|17893|lyfalmen|V0283|8176||28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||12229||12229|17893| 005526|N05AH0301|Zyprexa|húđuđtfl|20|mg|28|stk|1|ţpakki||N05AH03|01.12.2003||R|||0|0|0|0|ELD|0|1|0|100|XEU|36351|48166|lyfalmen||||28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||36351||36351|48166| 005538|G03AA0702|Microgyn|töflur|||63|stk|1|ţpakki||G03AA07|01.06.1977||R|||0|0|0|0|BAP|0|0|0|100|SEK|1259|2701|lyfalmen|V0545|2700||63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1259||1259|2701| 005576|R05CA0301|Tussol|mixtúra|||150|ml|1|glas||R05CA03|01.10.2001||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||150|0||Actavis Group hf|Actavis hf|Slímlosandi lyf nema slímţynnir (mucolytica)- guaifenesin|||||| 005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|||0|0|0|0|BII|0|0|0|100|DKK|6046|9250|lyfalmen||||30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíđ||6046||6046|9250| 005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|||0|0|0|0|BII|0|0|0|100|DKK|6372|9695|lyfalmen||||30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíđ||||6372|9695| 005606|J07AH0703|NeisVac-C|bóluefni|||0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.09.2001||R|||0|0|0|0|BAX|0|0|0|100|USD|4117|6611|lyfalmen||||0|0||Icepharma hf|Baxter|Hreinsuđ meningókokka C, poly­sakkaríđ mótefnavakar||4117||4117|6611| 005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|ţpakki||A10BB09|01.04.2002||R|||0|0|*|0|LLS|0|0|0|100|DKK|1543|3090|lyfalmen||||30|0|15,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||1543||1543|3090| 005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|ţpakki||A10BB09|01.04.2002||R|||0|0|*|0|LLS|0|0|0|100|DKK|2690|4659|lyfalmen|V0020|3583||60|0|30,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||2690||2690|4659| 005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|ţpakki||A10BB09|01.04.2002||R|||0|0|*|0|LLS|0|0|0|100|DKK|7143|10750|lyfalmen|V0020|10750||180|0|90,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||7143||7143|10750| 005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|ţpakki||A10BB09|01.04.2002||R|||0|0|*|0|LLS|0|0|0|100|DKK|3925|6348|lyfalmen|V0020|5375||90|0|45,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||3925||3925|6348| 005689|B01AC0601|Hjartamagnyl|töflur|75|mg|100|stk|1|plglas||B01AC06|01.06.2007||L|||0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa||||100|0|100,0000|Actavis Group hf|Actavis hf|Asetýlsalicýlsýra|||||| 005757|N06AB1001|Cipralex|töflur|5|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|1727|3341|lyfalmen||||28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||1727||1727|3341| 005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|6419|8805|lyfalmen|V0324|2519||100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5721||5721|8805| 005812|N06AB1001|Cipralex|töflur|10|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|3044|4824|lyfalmen|V0035|3551||28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||2811||2811|4824| 005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|||0|0|0|0|MEF|0|0|0|100|XEU|17355|30275|vetorma||||5|0||Vistor hf|Merial (MSD)|Ivermectinum||17355||17355|30275| 005823|N06AB1001|Cipralex|töflur|10|mg|56|stk|1|ţpakki||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|6051|9256|lyfalmen|V0325|2578||56|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||6051||6051|9256| 005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|10208|13757|lyfalmen|V0325|4604||100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||9341||9341|13757| 005867|N06AB1001|Cipralex|töflur|15|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|4889|7261|lyfalmen||||28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||4592||4592|7261| 005872|C09DA0701|MicardisPlus|töflur|52,5|mg|28|stk|1|ţpakki|40 + 12,5 mg|C09DA07|01.02.2008|31.07.2012|R|||0|0|0|0|BII|0|0|0|100|DKK|3036|5132|lyfalmen||||28|0|28,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||3036||3036|5132| 005884|P01BC0201|Lariam|töflur|250|mg|8|stk|1|ţpakki||P01BC02|01.01.1993||R|||0|0|0|0|ROC|0|0|0|100|DKK|3376|5597|lyfalmen||||8|0|2,0000|Icepharma hf|Roche|Meflókvín||3376||3376|5597| 005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|||0|0|*|0|ELD|0|1|0|100|XEU|853|2146|lyfalmen||||1|0|1,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||853||853|2146| 005894|C09DA0701|MicardisPlus|töflur|52,5|mg|98|stk|1|ţpakki|40 + 12,5 mg|C09DA07|01.02.2008|31.07.2012|R|||0|0|0|0|BII|0|0|0|100|DKK|10408|15217|lyfalmen||||98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||10408||10408|15217| 005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|15804|20246|lyfalmen|V0326|4470||100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||14104||14104|20246| 005910|C09CA0301|Diovan|töflur|80|mg|28|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.01.2001||R|||0|0|0|0|NOH|0|0|0|100|DKK|3448|5696|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||3448||3448|5696| 005922|N06AB1001|Cipralex|töflur|20|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|6245|8500|lyfalmen|V0246|4395||28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5498||5498|8500| 005932|C09CA0301|Diovan|töflur|80|mg|98|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.01.2001||R|||0|0|0|0|NOH|0|0|0|100|DKK|9121|12104|lyfalmen|V0072|2651||98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||8133||8133|12104| 005933|N06AB1001|Cipralex|töflur|20|mg|56|stk|1|ţpakki||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|12237|17903|lyfalmen|V0327|2503||56|0|112,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||12237||12237|17903| 005954|C09CA0301|Diovan|töflur|160|mg|28|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.01.2001||R|||0|0|0|0|NOH|0|0|0|100|DKK|4531|7177|lyfalmen||||28|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||4531||4531|7177| 005976|C09CA0301|Diovan|töflur|160|mg|98|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.01.2001||R|||0|0|0|0|NOH|0|0|0|100|DKK|12397|17077|lyfalmen|V0073|2723||98|0|196,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||11768||11768|17077| 006000|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.1995||R|||0|1|0|1|NYC|0|0|0|100|DKK|81297|103910|lyfsjukr||||2|0|0,7500|Vistor hf|Nycomed Danmark A/S|Náttúrulegir fosfólípíđar||81297||81297|103910| 006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|||0|0|*|0|NAS|0|0|0|100|DKK|5585|8619|lyfalmen||||15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5585||5585|8619| 006079|J02AX0403|Cancidas|irţ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|||0|1|0|1|MSD|0|0|0|100|DKK|100827|128420|lyfsjukr||||1|0|1,4000|Vistor hf|M.S.D.|Caspofungin||100827||100827|128420| 006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|||0|0|*|0|NAS|0|0|0|100|DKK|5418|8390|lyfalmen||||15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5418||5418|8390| 006111|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.1995||R|||0|1|0|1|NYC|0|0|0|100|DKK|151389|191876|lyfsjukr||||3|0|1,5000|Vistor hf|Nycomed Danmark A/S|Náttúrulegir fosfólípíđar||151389||151389|191876| 006115|J02AX0403|Cancidas|irţ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|||0|1|0|1|MSD|0|0|0|100|DKK|77001|98519|lyfsjukr||||1|0|1,0000|Vistor hf|M.S.D.|Caspofungin||77001||77001|98519| 006239|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1995||R|||0|0|0|0|REP|0|0|1|100|SEK|2610|4549|lyfalmen||||30|0|7,5000|Vistor hf|Recip AB|Flúkloxacillín||2610||2610|4549| 006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|||0|0|0|0|BOI|1|0|0|100|DKK|8516|16525|vetalmen||||50|0||Vistor hf|Boehringer Ingelheim|||8516||8516|16525| 006547|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|10|spr|áfyllt sprauta|B01AX05|01.07.2012||R|||0|0|E|0|GGL|0|0|0|100|GBP|6645|10069|lyfalmen||||5|0|10,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||6645||6645|10069| 006558|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|20|spr|áfyllt sprauta|B01AX05|01.03.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|13221|19137|lyfalmen||||10|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||13221||13221|19137| 006579|D05AX5201|Daivobet|smyrsli|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|||0|0|B|0|LEP|0|0|0|100|DKK|6746|10207|lyfalmen||||60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||6746||6746|10207| 006681|N02BE0109|Panodil Hot|skammtar|500|mg|10|skammtar|1|pakki||N02BE01|01.05.2003||L|||0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa||||10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||| 006732|A16AB0401|Fabrazyme|irţ|5|mg/ml|35|mg|1|hgl|lausn|A16AB04|01.05.2012||R|||0|1|0|1|GZE|0|0|0|100|XEU|523218|658521|lyfsjukr||||35|0|35,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||523218||523218|658521| 006785|G03AD0101|NorLevo|töflur|750|mcg|2|stk|1|ţpakki||G03AD01|01.01.2005||L|||0|0|0|0|LAR|0|0|0|100|IKR|||lyflausa||||2|0|1,0000|Vistor hf|Laboratoire HRA Pharma|Levonorgestrel|||||| 006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|ţpakki||C09CA01|01.05.2002||R|||0|0|0|0|MSD|0|0|0|100|DKK|14146|20298|lyfalmen||||98|0|196,0000|Vistor hf|M.S.D.|Lósartan||14146||14146|20298| 007099|C10AA0701|Crestor|filmhtfl|10|mg|28|stk|1|ţpakki||C10AA07|01.06.2003||R|||0|0|0|0|AZD|0|0|0|100|SEK|4612|7288|lyfalmen||||28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||4612||4612|7288| 007104|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|glas||N05AA02|01.10.1995|30.09.2012|R|||0|0|0|0|SNO|0|1|0|100|NOK|690|1923|lyfalmen||||100|0|1,6667|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||690||690|1923| 007126|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|20|hgl|1|pakki|+ leysir|QJ01CE90|01.12.2002||R|||0|0|0|0|BID|0|0|0|100|DKK|24545|47303|vetalmen||||20|0||Vistor hf|Boehringer Ingelheim Danmark|||24545||24545|47303| 007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA07|01.07.2003||R|||0|0|0|0|AZD|0|0|0|100|SEK|13944|20045|lyfalmen|V0117|20045||98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||13944||13944|20045| 007138|N05AA0201|Nozinan|töflur|25|mg|100|stk|1|glas||N05AA02|01.10.1995||R|||0|0|*|0|SNO|0|1|0|100|NOK|2093|3842|lyfalmen||||100|0|8,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||2093||2093|3842| 007144|C10AA0701|Crestor|filmhtfl|20|mg|28|stk|1|ţpakki||C10AA07|01.06.2003||R|||0|0|0|0|AZD|0|0|0|100|SEK|6955|10493|lyfalmen||||28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||6955||6955|10493| 007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA07|01.06.2003||R|||0|0|0|0|AZD|0|0|0|100|SEK|21048|28960|lyfalmen|V0118|28960||98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||21048||21048|28960| 007161|N05AA0201|Nozinan|töflur|100|mg|100|stk|1|glas||N05AA02|01.10.1995||R|||0|0|*|0|SNO|0|1|0|100|NOK|5314|8248|lyfalmen||||100|0|33,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||5314||5314|8248| 007166|C10AA0701|Crestor|filmhtfl|40|mg|28|stk|1|ţpakki||C10AA07|01.07.2003||R|||0|0|0|0|AZD|0|0|0|100|SEK|8741|12936|lyfalmen||||28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||8741||8741|12936| 007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|ţpakki||C10AA07|01.07.2003||R|||0|0|0|0|AZD|0|0|0|100|SEK|26331|35591|lyfalmen||||98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||26331||26331|35591| 007223|B01AD1201|Ceprotin|sts|500|ae/hgl|1|hgl|1|pakki|+ 5 ml leysir|B01AD12|01.02.2002||R|||0|1|0|1|BAX|0|0|0|100|SEK|170637|216032|lyfsjukr||||1|0||Icepharma hf|Baxter|Prótein C||170637||170637|216032| 007268|B01AD1201|Ceprotin|sts|1000|ae/hgl|1|hgl|1|pakki|+ 10 ml leysir|B01AD12|01.02.2002||R|||0|1|0|1|BAX|0|0|0|100|SEK|325629|410547|lyfsjukr||||1|0||Icepharma hf|Baxter|Prótein C||325629||325629|410547| 007292|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|1|glös||S01EE03|01.04.2005||R|||0|0|*|0|ALL|0|0|0|100|SEK|3050|5151|lyfalmen|V0377|4421||3|0|30,0000|Vistor hf|Allergan|Bimatóprost||3050||3050|5151| 007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.04.2002||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.04.2002||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|||0|1|0|1|PER|0|0|0|100|DKK|94926|121015|lyfsjukr||||3000|0|5,0000|Icepharma hf|Pfizer ApS|Linezolíd||94926||94926|121015| 007385|A02BA0205|Zantac|töflur|150|mg|20|stk|1|ţpakki||A02BA02|01.09.1983||L|||0|0|0|0|GSK|0|0|0|100|IKR|||lyflausa||||20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín|||||| 007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|ţpakki||J01XX08|01.12.2001||R|||0|1|0|1|PER|0|0|0|100|DKK|271382|342467|lyfsjukr||||30|0|15,0000|Icepharma hf|Pfizer ApS|Linezolíd||271382||271382|342467| 007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|||0|0|*|0|PER|0|0|0|100|DKK|3120|5247|lyfalmen|V0374|4210||2|0|25,0000|Icepharma hf|Pfizer ApS|Tímólól í blöndum||3120||3120|5247| 007448|B05XC04|Cernevit|sts|||5|ml|10|hgl||B05XC|01.05.2002||R|||0|0|0|1|CPS|0|0|0|100|SEK|8766|12652|lyfsjukr||||50|0||Icepharma hf|Clintec parenteral SA|Vítamín||8766||8766|12652| 007449|V03AB3401|Fomepizole OPi|irţ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|||0|0|0|1|OPO|0|0|0|100|XEU|114398|145452|lyfsjukr||||100|0||Swedish Orphan International AB|OPi Orphan Pharma international (S)|Fómepízól||114398||114398|145452| 007462|N01AB0801|Sevorane|innönd.l|||250|ml|1|plastf||N01AB08|01.03.2002||R|||0|0|0|1|ABS|0|0|0|100|DKK|22582|30223|lyfsjukr||||250|0||Vistor hf|Abbott Scandinavia AB|Sevóflúran||22582||22582|30223| 007494|QP52AA0101|Droncit vet.|hlaup|9|%|6,67|g|1|dćla|til inntöku|QP52AA01|01.04.2002||L|||0|0|0|0|BAN|0|0|0|100|DKK|1902|3318|vetorma||||7|0||Icepharma hf|Bayer Animal Health GmbH|||||1902|3318| 007505|G04BD0702|Detrusitol Retard|forđahlk|1,4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|||0|0|E|0|PER|0|0|0|100|DKK|6033|9232|lyfalmen||||30|0|10,5000|Icepharma hf|Pfizer ApS|Tólteródín||6033||6033|9232| 007534|C09CA0601|Atacand|töflur|16|mg|28|stk|1|ţpakki||C09CA06|01.02.1998||R|||0|0|0|0|AZD|0|0|0|100|SEK|3709|6053|lyfalmen|V0079|6053||28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||3709||3709|6053| 007538|R03BA0701|Asmanex Twisthaler|innúđadu|400|mcg|30|skammtar|1|pakki||R03BA07|01.04.2003||R|||0|0|B|0|SPL|0|0|0|100|DKK|4789|7530|lyfalmen||||30|0|30,0000|Vistor hf|Schering-Plough Europe|Mometasón||4789||4789|7530| 007540|N02BE0111|Perfalgan|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.08.2003||R|||0|0|0|1|BRS|0|0|0|100|DKK|4340|6264|lyfsjukr||||1200|0|4,0000|Vistor hf|Bristol-Myers Squibb|Paracetamól||4340||4340|6264| 007541|J07BL0101|Stamaril|bóluefni|||0,5|ml|10|lykjur|+leysir|J07BL01|01.01.1996|30.09.2012|R|||0|0|0|0|SPM|0|0|0|100|XEU|20064|27725|lyfalmen||||5|0||Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluđ veira||20064||20064|27725| 007549|R03BA0701|Asmanex Twisthaler|innúđadu|400|mcg|60|skammtar|1|pakki||R03BA07|01.03.2003||R|||0|0|B|0|SPL|0|0|0|100|DKK|9333|13746|lyfalmen||||60|0|60,0000|Vistor hf|Schering-Plough Europe|Mometasón||9333||9333|13746| 007760|G04BD0702|Detrusitol Retard|forđahlk|2,8|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|||0|0|E|0|PER|0|0|0|100|DKK|6194|9452|lyfalmen||||30|0|21,0000|Icepharma hf|Pfizer ApS|Tólteródín||6194||6194|9452| 007769|G04BD0702|Detrusitol Retard|forđahlk|2,8|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|||0|0|E|0|PER|0|0|0|100|DKK|21028|28935|lyfalmen||||100|0|70,0000|Icepharma hf|Pfizer ApS|Tólteródín||21028||21028|28935| 007778|N05AX0802|Rison|töflur|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|||0|0|*|0|ACA|0|1|0|100|IKR|1728|3099|lyfalmen|V0290|3099||60|0|6,0000|Actavis Group hf|Actavis hf|Risperídón||1550||1550|3099| 007852|G02BB0101|NuvaRing|sk-hring|||3|stk|1|pakki|međ forđaverkun|G02BB01|01.11.2002||R|||0|0|0|0|ORG|0|0|0|100|DKK|3865|6266|lyfalmen||||3|0|84,0000|Vistor hf|N.V. Organon|Skeiđarinnleg međ progestógeni og östrógeni||3865||3865|6266| 007878|V07AB0001|Sterilt vatten Baxter Viaflo|leysir|||50|ml|50|pokar|leysir f.stungulyf|V07AB00|01.08.2005||L|||0|0|0|0|BAM|0|0|0|100|IKR|||lyflausa||||2500|0||Icepharma hf|Baxter Medical AB|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 007889|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|||100|ml|50|pokar|leysir f.stungulyf|V07AB00|01.02.2006||L|||0|0|0|0|BAX|0|0|0|100|IKR|||lyflausa||||5000|0||Icepharma hf|Baxter|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|||0|0|0|0|ALC|0|0|0|100|USD|1308|2768|lyfalmen||||5|0||K.Pétursson hf|Alcon|Ólópatadín||1308||1308|2768| 007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|||0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa||||15|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||| 007995|R07AX0101|INOmax|innö.gas|400|ppm|10|l|1|gashyl||R07AX01|01.01.2004||R|||0|1|0|1|AGA|0|0|0|100|XEU|19840|26782|lyfsjukr||||10|0||Ísaga ehf|AGA AB|Nituroxíđ||19840||19840|26782| 007997|H02AB0104|Betapred|lausnart|0,5|mg|30|stk|1|glas||H02AB01|01.09.1998||R|||0|0|0|0|LOL|0|0|1|100|IKR|729|1976|lyfalmen||||30|1|10,0000|Lyfjaver ehf|Lyfjaver- óskráđ|Betametasón||729||729|1976| 008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|ţpakki||A10BA02|01.01.2002||R|||0|0|*|0|MCK|0|0|0|100|SEK|617|1823|lyfalmen||||30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||617||617|1823| 008058|B05BA1011|Oliclinomel N4 550E|irl|||1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|24175|32222|lyfsjukr||||6000|0||Icepharma hf|Baxter Medical AB|Blöndur||24175||24175|32222| 008069|B05BA1011|Oliclinomel N4 550E|irl|||2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|29994|39525|lyfsjukr||||8000|0||Icepharma hf|Baxter Medical AB|Blöndur||29994||29994|39525| 008097|N02CC0402|Maxalt Smelt|munnltfl|5|mg|6|stk|1|ţpakki||N02CC04|01.03.2003||R|||0|0|E|0|MSD|0|0|0|100|DKK|5319|8255|lyfalmen||||6|0|3,0000|Vistor hf|M.S.D.|Rizatriptan||5319||5319|8255| 008101|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|||0|1|0|1|SCP|0|0|0|100|DKK|53339|68823|lyfsjukr||||4|0|26,6700|Vistor hf|Schering-Plough|Peginterferón alfa 2b||53339||53339|68823| 008108|L03AB1001|PegIntron|sts|100|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|||0|1|0|1|SCP|0|0|0|100|DKK|106678|135763|lyfsjukr||||4|0|53,3300|Vistor hf|Schering-Plough|Peginterferón alfa 2b||106678||106678|135763| 008131|L03AB1001|PegIntron|sts|80|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|||0|1|0|1|SCP|0|0|0|100|DKK|85010|108570|lyfsjukr||||4|0|42,6700|Vistor hf|Schering-Plough|Peginterferón alfa 2b||85010||85010|108570| 008134|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|||0|1|0|1|SCP|0|0|0|100|DKK|125757|159708|lyfsjukr||||4|0|64,0000|Vistor hf|Schering-Plough|Peginterferón alfa 2b||125757||125757|159708| 008145|L03AB1001|PegIntron|sts|150|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|||0|1|0|1|SCP|0|0|0|100|DKK|147728|187281|lyfsjukr||||4|0|80,0000|Vistor hf|Schering-Plough|Peginterferón alfa 2b||147728||147728|187281| 008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|||0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa||||30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||| 008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|||0|0|B|0|ASP|0|0|1|100|XEU|1476|2998|lyfalmen||||100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón||1476||1476|2998| 008219|D07AC0101|Betnovat|húđfl|1|mg/ml|20|ml|1|plglas||D07AC01|01.12.1980||R|||0|0|B|0|GSK|0|0|1|100|GBP|292|1378|lyfalmen||||20|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||292||292|1378| 008223|B05BA1013|Oliclinomel N6 900E|irl|||1000|ml|6|plpok|fleyti|B05BA10|01.06.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|37403|48823|lyfsjukr||||6000|0||Icepharma hf|Baxter Medical AB|Blöndur||37403||37403|48823| 008234|B05BA1013|Oliclinomel N6 900E|irl|||1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|29288|38639|lyfsjukr||||6000|0||Icepharma hf|Baxter Medical AB|Blöndur||29288||29288|38639| 008243|D07AC0101|Betnovat|húđlausn|1|mg/g|30|ml|1|plglas|í hársvörđ|D07AC01|01.01.1985||R|||0|0|B|0|GSK|0|0|1|100|GBP|571|1760|lyfalmen||||30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||571||571|1760| 008245|B05BA1013|Oliclinomel N6 900E|irl|||2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|34221|44830|lyfsjukr||||8000|0||Icepharma hf|Baxter Medical AB|Blöndur||34221||34221|44830| 008301|N02AX0209|Tramol-L|forđatfl|100|mg|20|stk|1|ţpakki||N02AX02|01.04.2002||R|||0|0|E|0|ACA|0|0|1|100|XEU|862|2012|lyfalmen||||20|0|6,6700|Actavis Group hf|Actavis hf|Tramadól||755||755|2012| 008326|D07AC0101|Betnovat|húđlausn|1|mg/g|100|ml|1|plglas|í hársvörđ|D07AC01|01.07.1988||R|||0|0|B|0|GSK|0|0|1|100|GBP|1287|2739|lyfalmen||||100|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||1287||1287|2739| 008338|N02AX0209|Tramol-L|forđatfl|100|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|||0|0|E|0|ACA|0|0|1|100|XEU|2785|4789|lyfalmen|V0226|4789||100|0|33,3300|Actavis Group hf|Actavis hf|Tramadól||2785||2785|4789| 008360|N02AX0209|Tramol-L|forđatfl|150|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|||0|0|E|0|ACA|0|0|1|100|XEU|4616|7293|lyfalmen|V0227|7293||100|0|50,0000|Actavis Group hf|Actavis hf|Tramadól||4616||4616|7293| 008368|N02AX0209|Tramol-L|forđatfl|200|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|||0|0|E|0|ACA|0|0|1|100|XEU|6229|9385|lyfalmen|V0228|9385||100|0|66,6700|Actavis Group hf|Actavis hf|Tramadól||6145||6145|9385| 008370|V04CJ0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|V04CJ01|01.01.2006||R|||0|1|0|1|GEZ|0|0|0|100|XEU|148705|188507|lyfsjukr||||2|0||Vistor hf|Genzyme BV|Thýrótrópín||148705||148705|188507| 008396|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|ţpakki||H03AA01|01.05.2002||R|||0|0|B|0|MKA|0|0|0|100|SEK|837|2124|lyfalmen|V0153|2103||100|0|33,3300|Icepharma hf|Merck KgaA|Levótýroxínnatríum||837||837|2124| 008435|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|ţpakki||H03AA01|01.05.2002||R|||0|0|B|0|MKA|0|0|0|100|SEK|727|1973|lyfalmen|V0154|1973||100|0|66,6700|Icepharma hf|Merck KgaA|Levótýroxínnatríum||727||727|1973| 008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|||0|0|0|0|CHP|0|0|0|100|USD|5044|8799|vetorma||||1000|0||Icepharma hf|Chanelle Pharmaceuticals |||5044||5044|8799| 008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|||0|0|0|0|CHP|1|0|0|100|XEU|12280|23752|vetalmen||||50|0||Icepharma hf|Chanelle Pharmaceuticals |||12280||12280|23752| 008498|R06AX2201|Kestine|töflur|10|mg|10|stk|1|ţpakki||R06AX22|01.04.1998||L|||0|0|0|0|APS|0|0|1|100|IKR|||lyflausa||||10|0|10,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||| 008519|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|100|stk|1|ţpakki||R06AE07|01.09.2012||R|||0|0|E|0|RGM|0|0|1|100|XEU|2224|3274|lyfalmen|V0575|3274||100|0|100,0000|Medical ehf|ratiopharm GmbH|Cetirizín||1678||1678|3274| 008534|R06AX2201|Kestine|töflur|10|mg|30|stk|1|ţpakki||R06AX22|01.04.1998||L|||0|0|0|0|APS|0|0|1|100|IKR|||lyflausa||||30|0|30,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||| 008545|G03FB0506|NovoFem|filmhtfl|||84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|||0|0|E|0|NAS|0|0|0|100|DKK|2791|4797|lyfalmen||||84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2791||2791|4797| 008673|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|10|stk|1|ţpakki||R06AE07|01.09.2012||L|||0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa||||10|0|10,0000|Medical ehf|ratiopharm GmbH|Cetirizín|||||| 008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|||0|1|0|1|RRL|0|0|0|100|DKK|105426|134192|lyfsjukr||||2|0|20,7700|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||105426||105426|134192| 008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|||0|1|0|1|RRL|0|0|0|100|DKK|111213|141455|lyfsjukr||||2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||111213||111213|141455| 008831|D11AH0201|Elidel|krem|1|%|15|g|1|túpa||D11AH02|01.11.2002|31.08.2012|R|||0|0|E|0|MAB|0|0|1|100|DKK|3044|5143|lyfalmen||||15|0||Vistor hf|Meda AB|Pímekrólímus||3044||3044|5143| 008904|D10AF0101|Dalacin|lausn|10|mg/ml|60|ml|1|glas|Áburđur, lausn|D10AF01|01.01.1994||R|||0|0|0|0|PER|0|0|0|100|DKK|1870|3537|lyfalmen||||60|0||Icepharma hf|Pfizer ApS|Klindamýcín||1870||1870|3537| 008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|ţpakki||G04BE08|01.02.2003||R|||0|0|0|0|LIL|0|0|0|100|XEU|5842|8970|lyfalmen|V0145|8362||4|0|8,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||5842|8970| 008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|ţpakki||G04BE08|01.02.2003||R|||0|0|0|0|LIL|0|0|0|100|XEU|11509|16723|lyfalmen|V0145|16723||8|0|16,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||11509|16723| 009065|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.11.2002|31.08.2012|R|||0|0|E|0|MAB|0|0|1|100|DKK|5136|8005|lyfalmen||||30|0||Vistor hf|Meda AB|Pímekrólímus||5136||5136|8005| 009113|B05DB0005|Balance|kviđ.sk|1,5|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|||0|0|0|1|FMC|0|0|0|100|XEU|8476|12233|lyfsjukr||||10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8476||8476|12233| 009213|B05DB0005|Balance|kviđ.sk|2,3|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|||0|0|0|1|FMC|0|0|0|100|XEU|8476|12233|lyfsjukr||||10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8476||8476|12233| 009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|||0|0|0|0|IPI|0|0|1|100|DKK|13809|19875|lyfalmen||||10|0|10,0000|Icepharma hf|Pfizer Limited|Parekoxíb||13809||13809|19875| 009216|B05DB0005|Balance|kviđ.sk|4,25|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|||0|0|0|1|FMC|0|0|0|100|XEU|8476|12233|lyfsjukr||||10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8476||8476|12233| 009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|ţpakki||J02AC03|01.11.2002||R|||0|0|0|1|PER|0|0|0|100|DKK|50375|65103|lyfsjukr||||30|0|3,7500|Icepharma hf|Pfizer ApS|Voricónazól||50375||50375|65103| 009282|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|||0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen||||400|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||1783| 009285|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.07.2003||R|||0|0|E|0|ASP|0|0|1|100|XEU|5267|8184|lyfalmen||||30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||5267||5267|8184| 009340|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||20|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||400|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 009409|G03CA0316|Vivelle Dot|forđapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|||0|0|E|0|NOH|0|0|0|100|DKK|1102|2486|lyfalmen||||8|0|21,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1102||1102|2486| 009443|G03CA0316|Vivelle Dot|forđapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|||0|0|E|0|NOH|0|0|0|100|DKK|1215|2641|lyfalmen|V0130|1681||8|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1215||1215|2641| 009465|G03CA0316|Vivelle Dot|forđapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|||0|0|E|0|NOH|0|0|0|100|DKK|1406|2902|lyfalmen|V0131|2463||8|0|42,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1406||1406|2902| 009489|G03CA0316|Vivelle Dot|forđapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|||0|0|E|0|NOH|0|0|0|100|DKK|1761|3388|lyfalmen|V0132|2734||8|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1761||1761|3388| 009525|B05DB0005|Balance|kviđ.sk|1,5|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|||0|0|0|1|FMC|0|0|0|100|XEU|7168|10345|lyfsjukr||||8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7168||7168|10345| 009560|B05DB0005|Balance|kviđ.sk|4,25|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|||0|0|0|1|FMC|0|0|0|100|XEU|7168|10345|lyfsjukr||||8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7168||7168|10345| 009591|B05DB0005|Balance|kviđ.sk|2,3|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|||0|0|0|1|FMC|0|0|0|100|XEU|7168|10345|lyfsjukr||||8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7168||7168|10345| 009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|ţpakki||J02AC03|01.11.2002||R|||0|0|0|1|PER|0|0|0|100|DKK|192299|243218|lyfsjukr||||30|0|15,0000|Icepharma hf|Pfizer ApS|Voricónazól||192299||192299|243218| 009649|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.07.2003||R|||0|0|E|0|ASP|0|0|1|100|XEU|5101|7957|lyfalmen||||30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||5101||5101|7957| 009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|||0|1|0|1|GIS|0|0|0|100|DKK|57544|74100|lyfsjukr||||30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl||57544||57544|74100| 009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|||0|0|0|0|DPL|0|0|1|100|XEU|8422|12500|lyfalmen||||180|0||Vistor hf|Dentsply Limited|Mepívakaín||8422||8422|12500| 009905|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|||0|0|0|0|DPL|0|0|1|100|XEU|7927|11823|lyfalmen||||180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||7927||7927|11823| 009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|||0|0|0|0|DPL|0|0|1|100|XEU|7778|11619|lyfalmen||||180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||7778||7778|11619| 009942|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|||0|0|0|0|DPL|0|0|1|100|XEU|9116|13449|lyfalmen||||180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||9116||9116|13449| 009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|||0|0|0|0|DPL|0|0|1|100|XEU|7941|11842|lyfalmen||||180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||7941||7941|11842| 009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|||0|0|0|0|DPL|0|0|1|100|XEU|7805|11656|lyfalmen||||180|0||Vistor hf|Dentsply Limited|Mepívakaín||7805||7805|11656| 010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|||0|0|0|0|ORG|0|1|0|100|DKK|2099|3850|lyfalmen|V0329|2422||30|0|15,0000|Vistor hf|N.V. Organon|Mirtazapín||2099||2099|3850| 010035|N06AX1102|Remeron Smelt|munndr.t|30|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|||0|0|0|0|ORG|0|1|0|100|DKK|3995|6444|lyfalmen|V0330|2783||30|0|30,0000|Vistor hf|N.V. Organon|Mirtazapín||3995||3995|6444| 010057|N06AX1102|Remeron Smelt|munndr.t|45|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|||0|0|0|0|ORG|0|1|0|100|DKK|5709|8789|lyfalmen||||30|0|45,0000|Vistor hf|N.V. Organon|Mirtazapín||5709||5709|8789| 010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|||0|0|0|1|ROA|0|0|0|100|DKK|218782|276454|lyfsjukr||||60|0|30,0000|Icepharma hf|Roche A.S.|Valgancíklóvír||218782||218782|276454| 010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|||0|1|0|1|MSD|0|0|0|100|DKK|7016|10126|lyfsjukr||||1|0|1,0000|Vistor hf|M.S.D.|Ertapenem||7016||7016|10126| 010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|ţpakki||N06AX11|01.05.2003||R|||0|0|0|0|ORG|0|1|0|100|DKK|12400|18107|lyfalmen|V0331|5085||96|0|96,0000|Vistor hf|N.V. Organon|Mirtazapín||12400||12400|18107| 010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|ţpakki||N06AX11|01.05.2003||R|||0|0|0|0|ORG|0|1|0|100|DKK|17484|24488|lyfalmen|V0332|8332||96|0|144,0000|Vistor hf|N.V. Organon|Mirtazapín||17484||17484|24488| 010290|N06DX0101|Ebixa|dropar|10|mg/g|50|g|1|fl||N06DX01|01.08.2010||R|||0|0|E|0|LBK|0|0|0|100|DKK|13820|19889|lyfalmen||||50|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||13820|19889| 010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|ţpakki||N06DX01|01.10.2002||R|||0|0|E|0|LBK|0|0|0|100|DKK|22404|30662|lyfalmen||||100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||22404||22404|30662| 010339|C09DA0701|MicardisPlus|töflur|92,5|mg|28|stk|1|ţpakki|80 + 12,5 mg|C09DA07|01.02.2008|31.07.2012|R|||0|0|0|0|BII|0|0|0|100|DKK|3760|6122|lyfalmen||||28|0|28,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||3760||3760|6122| 010348|J07BB0203|Vaxigrip|bóluefni|||0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1995||R|||0|0|0|0|SPM|0|0|0|100|XEU|7132|10735|lyfalmen||||5|0||Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsađir mótefnavakar||7132||7132|10735| 010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|ţpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|||0|0|0|0|BII|0|0|0|100|DKK|12121|17757|lyfalmen||||98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||12121||12121|17757| 010437|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.09.2008||R|||0|0|0|0|ELA|0|0|0|100|DKK|71522|124767|vetorma||||1000|0||Icepharma hf|Elanco Animal Health A/S|Óvirkar bakteríur í bóluefnum||71522||71522|124767| 010446|A07EC0204|Asacol|sh-tfl|800|mg|60|stk|1|ţpakki||A07EC02|01.01.2003||R|||0|0|B|0|TIL|0|0|0|100|SEK|6972|10516|lyfalmen||||60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||6972||6972|10516| 010464|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|7388|10663|lyfsjukr||||2500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||7388||7388|10663| 010534|B05BA0108|Vaminolac|irl|||100|ml|10|fl||B05BA01|01.03.2004||R|||0|0|0|1|FRP|0|0|0|100|DKK|8900|12845|lyfsjukr||||1000|0||Icepharma hf|Fresenius Kabi|Amínósýrur||8900||8900|12845| 010573|S01AX1901|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AX19|01.08.2002||R|||0|0|0|0|SAO|0|0|1|100|XEU|1148|2549|lyfalmen||||5|0||Icepharma hf|Santen Oy|Levófloxacín||1148||1148|2549| 010591|M05BA0702|Optinate Septimum|filmhtfl|35|mg|4|stk|1|ţpakki||M05BA07|01.12.2002|30.09.2012|R|||0|0|0|0|SNO|0|0|0|100|NOK|5438|8418|lyfalmen||||4|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||5438||5438|8418| 010669|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|6063|8750|lyfsjukr||||7500|0||Icepharma hf|Baxter Medical AB|Kolvetni||6063||6063|8750| 010672|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|9324|13457|lyfsjukr||||5000|0||Icepharma hf|Baxter Medical AB|Kolvetni||9324||9324|13457| 010683|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|4125|5953|lyfsjukr||||10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||4125||4125|5953| 010691|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|2364|3412|lyfsjukr||||10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||2364||2364|3412| 010705|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.02.2012||L|||0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa||||28|0|28,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||| 010706|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|3|glös||S01EE03|01.04.2005||R|||0|0|*|0|ALL|0|0|0|100|SEK|8979|13262|lyfalmen|V0377|13262||9|0|90,0000|Vistor hf|Allergan|Bimatóprost||8979||8979|13262| 010707|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|9312|13440|lyfsjukr||||5000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||9312||9312|13440| 010716|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|56|stk|1|glas|hart|A02BC01|01.02.2012||R|||0|0|E|0|RAT|0|0|0|100|XEU|2373|2904|lyfalmen|V0006|2362||56|0|56,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||1407||1407|2904| 010729|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|6685|9648|lyfsjukr||||7500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||6685||6685|9648| 010740|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|4058|5857|lyfsjukr||||10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||4058||4058|5857| 010746|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.12.2002||R|||0|0|0|0|SNO|0|0|0|100|NOK|14564|5887|lyfalmen|V0207|3103||12|0|84,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||3588||3588|5887| 010760|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|2184|3152|lyfsjukr||||10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||2184||2184|3152| 010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|ţpakki||C02KX01|01.11.2003||R|||0|1|0|1|ACT|0|0|0|100|DKK|341625|430622|lyfsjukr||||56|0|14,0000|Lyfjaver ehf|Actelion Registration Ltd.|Bósentan||341625||341625|430622| 010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|ţpakki||C02KX01|01.11.2003||R|||0|1|0|1|ACL|0|0|0|100|DKK|341625|430622|lyfsjukr||||56|0|28,0000|Actelion Registration Ltd|Actelion Registration Ltd.|Bósentan||341625||341625|430622| 010890|A02BC0107|Lomex-T|sh-tfl|20|mg|28|stk|1|glas||A02BC01|01.06.2002||R|||0|0|E|0|ACA|0|0|0|100|IKR|1269|1470|lyfalmen||||28|0|28,0000|Actavis Group hf|Actavis hf|Ómeprazól||359||359|1470| 010900|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.07.1986||L|||0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa||||300|0|20,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín|||||| 010912|A02BC0107|Lomex-T|sh-tfl|20|mg|100|stk|1|glas||A02BC01|01.06.2002||R|||0|0|E|0|ACA|0|0|0|100|IKR|4614|4385|lyfalmen|V0006|4217||100|0|100,0000|Actavis Group hf|Actavis hf|Ómeprazól||2490||2490|4385| 010923|A02BC0107|Lomex-T|sh-tfl|20|mg|56|stk|1|glas||A02BC01|01.06.2002||R|||0|0|E|0|ACA|0|0|0|100|IKR|2975|2842|lyfalmen|V0006|2362||56|0|56,0000|Actavis Group hf|Actavis hf|Ómeprazól||1362||1362|2842| 010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|||0|1|0|1|BAM|0|0|0|100|SEK|49804|64387|lyfsjukr||||10|0||Icepharma hf|Baxter Medical AB|Bleómýcín||49804||49804|64387| 010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|||0|0|0|1|REP|0|0|0|100|SEK|3225|4654|lyfsjukr||||10|0|5,0000|Vistor hf|Recip AB|Kloxacillín||3225||3225|4654| 010938|A02BC0304|Lanzo Melt|munndr.t|15|mg|28|stk|1|ţpakki||A02BC03|01.01.2004||R|||0|0|0|0|PER|0|0|0|100|DKK|2869|4904|lyfalmen||||28|0|14,0000|Icepharma hf|Pfizer ApS|Lansóprazól||2869||2869|4904| 010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|ţpakki||N05AX12|01.01.2005||R|||0|0|0|0|OTS|0|1|0|100|DKK|19564|27098|lyfalmen||||28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||19564||19564|27098| 010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|ţpakki||N05AX12|01.01.2005||R|||0|0|0|0|OTS|0|1|0|100|DKK|19336|26812|lyfalmen||||28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||19336||19336|26812| 010959|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.09.1982||L|||0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa||||50|0|16,6667|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín|||||| 011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|ţpakki||N05AX12|01.01.2005||R|||0|0|0|0|OTS|0|1|0|100|DKK|33311|44350|lyfalmen||||56|0|37,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||33311||33311|44350| 011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|ţpakki||N05AX12|01.01.2005||R|||0|0|0|0|OTS|0|1|0|100|DKK|33084|44066|lyfalmen||||56|0|56,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||33084||33084|44066| 011163|A07EA0601|Entocort|forđahlk|3|mg|100|stk|1|glas||A07EA06|01.10.1996||R|||0|0|B|0|AZD|0|0|0|100|SEK|19423|26921|lyfalmen||||100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||19423||19423|26921| 011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|ţpakki||M01AH05|01.10.2002||R|||0|0|E|0|MSD|0|0|1|100|DKK|4370|6957|lyfalmen||||28|0|28,0000|Vistor hf|M.S.D.|Etoríkoxíb||4370||4370|6957| 011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|ţpakki||M01AH05|01.10.2002||R|||0|0|E|0|MSD|0|0|1|100|DKK|4541|7191|lyfalmen||||28|0|42,0000|Vistor hf|M.S.D.|Etoríkoxíb||4541||4541|7191| 011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|19660|25696|lyfalmen|V0327|4470||100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||18447||18447|25696| 011326|M01AH0501|Arcoxia|filmhtfl|120|mg|7|stk|1|ţpakki||M01AH05|01.01.2010||R|||0|0|E|0|MSD|0|0|1|100|DKK|1159|2564|lyfalmen||||7|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||1159||1159|2564| 011335|C09CA0102|Lopress|töflur|12,5|mg|28|stk|1|glas||C09CA01|01.11.2002|31.08.2012|R|||0|0|0|0|ACA|0|0|0|100|XEU|761|2020|lyfalmen||||28|0|7,0000|Actavis Group hf|Actavis hf|Lósartan||761||761|2020| 011336|N05AH0309|Kozylex|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|||0|0|*|0|POF|0|1|0|100|XEU|7180|4820|lyfalmen|V0457|4820||28|0|14,0000|Portfarma ehf|Portfarma|Olanzapín||2808||2808|4820| 011353|N05AF0502|Cisordinol Depot|stl|500|mg/ml|1|ml|5|lykjur||N05AF05|01.10.1988||R|||0|0|*|0|LBK|0|1|0|100|DKK|11793|17111|lyfalmen||||5|0|166,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||11793||11793|17111| 011369|C09CA0102|Lopress|töflur|50|mg|28|stk|1|glas||C09CA01|01.11.2002||R|||0|0|0|0|ACA|0|0|0|100|XEU|1030|2388|lyfalmen||||28|0|28,0000|Actavis Group hf|Actavis hf|Lósartan||1030||1030|2388| 011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|||0|0|B|0|ACA|0|0|0|100|XEU|2840|2408|lyfalmen|V0069|2381||98|0|98,0000|Actavis Group hf|Actavis hf|Lósartan||1045||1045|2408| 011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|||0|0|0|0|AZD|0|0|0|100|SEK|9464|13925|lyfalmen|V0357|12726||60|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9464||9464|13925| 011489|N06BA0402|Concerta|forđatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|||1|0|0|0|JAS|0|0|0|100|SEK|7306|10973|lyfalmen||||30|0|18,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||7306||7306|10973| 011532|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.11.2007|31.08.2012|R|||0|0|0|1|BAM|0|0|0|100|SEK|9205|13285|lyfsjukr||||10000|0||Icepharma hf|Baxter Medical AB|Mannitól||9205||9205|13285| 011540|N01AX1401|S-Ketamin "Pfizer"|stl|5|mg/ml|5|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|||1|0|0|1|PER|0|0|0|100|DKK|2355|3399|lyfsjukr||||50|0||Icepharma hf|Pfizer ApS|Esketamín||2355||2355|3399| 011555|N06BA0402|Concerta|forđatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|||1|0|0|0|JAS|0|0|0|100|SEK|9590|14098|lyfalmen||||30|0|36,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||9590||9590|14098| 011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|||0|0|0|0|CHP|1|0|0|100|XEU|1869|3718|vetalmen||||25|0||Icepharma hf|Chanelle Pharmaceuticals |||1869||1869|3718| 011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|||1|0|0|1|PER|0|0|0|100|DKK|4801|6929|lyfsjukr||||20|0||Icepharma hf|Pfizer ApS|Esketamín||4801||4801|6929| 011620|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|skammtar|1|fl|međ skammtadćlu|G03CA03|01.03.2000||R|||0|0|E|0|OYL|0|0|0|100|SEK|1631|3210|lyfalmen||||64|0||Vistor hf|Oy Leiras Finland Ab|Estradíól||1631||1631|3210| 011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|||0|1|0|1|ROA|0|0|0|100|DKK|85560|109260|lyfsjukr||||168|0|33,6000|Icepharma hf|Roche A.S.|Ribavirin||85560||85560|109260| 011718|QJ01CE0101|Geepenil, vet.|sts|24|g|1|hgl|1|pakki|+ leysir, lausn|QJ01CE01|01.09.2012||R|||0|0|0|0|OCO|0|0|0|100|SEK|2875|5693|vetalmen||||1|0||Icepharma hf|Orion Corporation (I)|Benzylpenicillín sodíum||2875||2875|5693| 011810|D11AH0201|Elidel|krem|1|%|60|g|1|túpa||D11AH02|01.11.2002|31.08.2012|R|||0|0|E|0|MAB|0|0|1|100|DKK|10218|14957|lyfalmen||||60|0||Vistor hf|Meda AB|Pímekrólímus||10218||10218|14957| 011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|ţpakki||N06AB06|01.10.2005||R|||0|0|B|0|ACA|0|1|0|100|IKR|1486|1972|lyfalmen|V0152|1972||28|0|56,0000|Actavis Group hf|Actavis hf|Sertralín||726||726|1972| 011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|ţpakki||N06AB06|01.10.2005||R|||0|0|B|0|ACA|0|1|0|100|IKR|4738|6307|lyfalmen|V0323|6307||98|0|196,0000|Actavis Group hf|Actavis hf|Sertralín||3895||3895|6307| 011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|||0|0|0|1|AZD|0|0|0|100|SEK|4507|6505|lyfsjukr||||20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||4507||4507|6505| 011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|||0|0|0|1|AZD|0|0|0|100|SEK|2607|3763|lyfsjukr||||20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||2607||2607|3763| 011985|N06DX0101|Ebixa|filmhtfl|10|mg|28|stk|1|ţpakki||N06DX01|01.06.2009||R|||0|0|E|0|LBK|0|0|0|100|DKK|7740|11567|lyfalmen||||28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||7740|11567| 012030|J05AG0301|Stocrin|töflur|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|||0|1|0|1|MSD|0|0|0|100|DKK|39344|51259|lyfsjukr||||30|0|30,0000|Vistor hf|M.S.D.|Efavirenz||39344||39344|51259| 012113|J02AC0104|Fluconazol ratiopharm|hylki|50|mg|7|stk|1|ţpakki||J02AC01|01.10.2012||R|||0|0|0|0|RGM|0|0|1|100|XEU|1272|2439|lyfalmen|V0551|2439||7|0|1,7500|Medical ehf|ratiopharm GmbH|Flúkónazól||1067||1067|2439| 012209|G04CB0201|Avodart|hylki|0,5|mg|90|stk|1|pakki|mjúk hylki|G04CB02|01.05.2003|31.08.2012|R|||0|0|E|0|GSK|0|0|0|100|GBP|13574|19581|lyfalmen||||90|0|90,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ||13574||13574|19581| 012243|G04CB0201|Avodart|hylki|0,5|mg|30|stk|1|ţpakki|hylki mjúk|G04CB02|01.03.2012||R|||0|0|E|0|GSK|0|0|0|100|GBP|4630|7313|lyfalmen||||30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ||4630||4630|7313| 012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|ţpakki||G04BE08|01.02.2003||R|||0|0|0|0|LIL|0|0|0|100|XEU|5822|8943|lyfalmen||||4|0|4,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||5822||5822|8943| 012278|N07BA0106|Nicotinell|forđapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||7|0|3,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012290|J02AC0104|Fluconazol ratiopharm|hylki|150|mg|4|stk|1|ţpakki||J02AC01|01.10.2012||R|||0|0|0|0|RGM|0|0|1|100|XEU|1810|3187|lyfalmen|V0556|3187||4|0|3,0000|Medical ehf|ratiopharm GmbH|Flúkónazól||1614||1614|3187| 012326|N06BA0402|Concerta|forđatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|||1|0|0|0|JAS|0|0|0|100|SEK|12218|17879|lyfalmen||||30|0|54,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||12218||12218|17879| 012347|J02AC0104|Fluconazol ratiopharm|hylki|50|mg|28|stk|1|ţpakki||J02AC01|01.10.2012||R|||0|0|0|0|RGM|0|0|1|100|XEU|3816|5998|lyfalmen|V0552|5998||28|0|7,0000|Medical ehf|ratiopharm GmbH|Flúkónazól||3669||3669|5998| 012461|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012716|N07BA0106|Nicotinell|forđapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||7|0|7,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012738|M05BC0101|InductOs|ígr.sett|12|mg|1|stk|1|pakki||M05BC01|01.09.2003||R|||0|1|0|1|WTE|0|0|0|100|DKK|433232|545589|lyfsjukr||||1|0||Icepharma hf|Wyeth Europe|Díbótermín alfa||433232||433232|545589| 012799|N07BA0106|Nicotinell|forđapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||7|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|||0|0|0|0|GSK|0|0|1|100|IKR|718|1961|lyfalmen||||80|0|4,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||718||718|1961| 012921|G03AA1301|Evra|forđapl|||9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|||0|0|0|0|JCI|0|0|0|100|SEK|4781|7519|lyfalmen||||9|0||Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og östrógen||4781||4781|7519| 012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|||0|0|E|0|LBI|0|0|0|100|SEK|6919|10444|lyfalmen||||30|0|30,0000|Icepharma hf|Laboratoires Besins International|Testósterón||6919||6919|10444| 012966|N03AX1208|Gabapentin ratiopharm|hylki|300|mg|100|stk|1|ţpakki||N03AX12|01.03.2012||R|||0|0|E|0|RGM|0|0|0|100|XEU|3254|4516|lyfalmen|V0250|4493||100|0|16,6667|Medical ehf|ratiopharm GmbH|Gabapentín||2586||2586|4516| 012988|N03AX1208|Gabapentin ratiopharm|hylki|400|mg|100|stk|1|ţpakki||N03AX12|01.03.2012||R|||0|0|E|0|RGM|0|0|0|100|XEU|3543|4687|lyfalmen|V0251|3868||100|0|22,2200|Medical ehf|ratiopharm GmbH|Gabapentín||2711||2711|4687| 013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|||1|0|0|0|NOH|0|0|0|100|DKK|5977|9155|lyfalmen||||30|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||5977||5977|9155| 013070|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|||0|0|0|0|PAL|0|0|0|100|DKK|6750|13134|vetalmen||||100|0||Icepharma hf|Pfizer Oy Animal Health|||6750||6750|13134| 013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|||1|0|0|0|NOH|0|0|0|100|DKK|9023|13322|lyfalmen||||30|0|40,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||9023||9023|13322| 013082|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|||0|0|0|0|PAL|0|0|0|100|DKK|1699|3380|vetalmen||||20|0||Icepharma hf|Pfizer Oy Animal Health|||1699||1699|3380| 013100|R07AX0101|INOmax|innö.gas|400|ppm|2|l|1|gashyl||R07AX01|01.01.2004||R|||0|1|0|1|AGA|0|0|0|100|XEU|21501|28866|lyfsjukr||||2|0||Ísaga ehf|AGA AB|Nituroxíđ||21501||21501|28866| 013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|||0|0|0|1|ZLB|0|0|0|100|SEK|7167|10344|lyfsjukr||||2|0||Icepharma hf|ZLB GmbH|And-D(rh) immúnóglóbúlín||7167||7167|10344| 013259|B02BD0901|BeneFIX|sts|||250|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|||0|1|0|1|WTE|0|0|0|100|DKK|28639|37824|lyfsjukr||||250|0|0,5600|Icepharma hf|Wyeth Europe|Storkuţáttur IX||28639||28639|37824| 013270|B02BD0901|BeneFIX|sts|||500|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|||0|1|0|1|WTE|0|0|0|100|DKK|48474|62717|lyfsjukr||||500|0|1,1100|Icepharma hf|Wyeth Europe|Storkuţáttur IX||48474||48474|62717| 013302|C02CA0405|Cardosin Retard|forđatfl|4|mg|100|stk|1|ţpakki||C02CA04|01.09.2009||R|||0|0|E|0|ANO|0|0|0|100|XEU|3268|4579|lyfalmen|V0042|4579||100|0|100,0000|Actavis Group PTC hf|Actavis Nordic A/S|Doxazósín||2632||2632|4579| 013308|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|||0|0|0|0|PAL|0|0|0|100|DKK|4433|8685|vetalmen||||100|0||Icepharma hf|Pfizer Oy Animal Health|||4433||4433|8685| 013317|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|||0|0|0|0|PAL|0|0|0|100|DKK|10345|20037|vetalmen||||100|0||Icepharma hf|Pfizer Oy Animal Health|||10345||10345|20037| 013328|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|||0|0|0|0|PAL|0|0|0|100|DKK|1085|2158|vetalmen||||20|0||Icepharma hf|Pfizer Oy Animal Health|||1085||1085|2158| 013341|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|||0|0|0|1|BAL|0|0|0|100|SEK|152602|193398|lyfsjukr||||1|0|3,0000|Lyfjaver ehf|Baxter Medical AB (L)|Storkuţáttur VIII||||152602|193398| 013347|L01XE0201|Iressa|töflur|250|mg|30|stk|1|ţpakki||L01XE02|01.03.2010||R|||0|1|0|1|AZD|0|0|0|100|SEK|416010|462628|lyfsjukr||||30|0||Vistor hf|AstraZeneca A/S DK|Gefitiníb||367128||367128|462628| 013362|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|||0|0|0|1|BER|0|0|0|100|SEK|26841|35568|lyfsjukr||||1|0|0,5000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||26841|35568| 013365|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|||0|0|0|1|BER|0|0|0|100|SEK|101734|129559|lyfsjukr||||1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||101734|129559| 013373|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|||0|0|0|1|BER|0|0|0|100|SEK|51855|66961|lyfsjukr||||1|0|1,0000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||51855|66961| 013386|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|ţpakki||C10AX09|01.01.2010||R|||0|0|0|0|MSD|0|0|0|100|DKK|5253|8165|lyfalmen||||28|0||Vistor hf|M.S.D.|Ezetimíb||5253||5253|8165| 013485|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|ţpakki||C10AX09|01.05.2003||R|||0|0|0|0|MSD|0|0|0|100|DKK|17885|24991|lyfalmen||||98|0|98,0000|Vistor hf|M.S.D.|Ezetimíb||17885||17885|24991| 013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|||1|0|0|0|NOP|0|0|0|100|DKK|1275|2723|lyfalmen||||5|0|1,6700|Icepharma hf|Norpharma|Oxýcódon||1275||1275|2723| 013593|A01AA3001|Xerodent|munnstfl|||90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|||0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen||||90|0||Actavis Group hf|Actavis Group hf|Blöndur|||||1510| 013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|||1|0|0|0|NOP|0|0|0|100|DKK|2437|4313|lyfalmen||||10|0|3,3300|Icepharma hf|Norpharma|Oxýcódon||2437||2437|4313| 013672|N03AG0101|Depakine|mixtúra|200|mg/ml|40|ml|1|glas||N03AG01|01.12.1978||R|||0|0|E|0|SNO|0|0|0|100|NOK|1448|2880|lyfalmen||||40|0|5,3333|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||1390||1390|2880| 013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|||0|0|0|0|AZD|0|0|1|100|SEK|417|1549|lyfalmen||||30|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||417||417|1549| 013718|M05BA0801|Zometa|irţ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.05.2004||R|||0|1|0|1|NOE|0|0|0|100|DKK|36250|47376|lyfsjukr||||5|0|1,0000|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||36250||36250|47376| 013756|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|28|stk|1|ţpakki||C09DA03|01.04.2005||R|||0|0|0|0|NOH|0|0|0|100|DKK|4550|7203|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||4550||4550|7203| 013802|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|lykja||H02AB01|01.08.2009||R|||0|0|B|0|SPL|0|0|1|100|DKK|935|2258|lyfalmen||||1|0|4,6700|Vistor hf|Schering-Plough Europe|Betametasón||||935|2258| 013861|J01CR0202|Augmentin|töflur|625|mg|20|stk|1|ţpakki|500+125 mg|J01CR02|01.01.2003||R|||0|0|0|0|GSK|0|0|1|100|IKR|1215|2641|lyfalmen|V0168|2641||20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1215||1215|2641| 013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|||0|0|*|0|NAS|0|0|0|100|DKK|6012|9203|lyfalmen||||15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||6012||6012|9203| 013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|||0|0|*|0|NAS|0|0|0|100|DKK|2504|4404|lyfalmen||||10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2504||2504|4404| 013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|||0|0|*|0|NAS|0|0|0|100|DKK|4491|7122|lyfalmen||||15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||4491||4491|7122| 013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|ţpakki||L01XE01|01.06.2012||R|||0|1|0|1|NOE|0|0|0|100|DKK|172133|217909|lyfsjukr||||60|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||172133||172133|217909| 013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|ţpakki||L01XE01|01.05.2004||R|||0|1|0|1|NOE|0|0|0|100|DKK|365907|461096|lyfsjukr||||30|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||365907||365907|461096| 014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|||0|0|*|0|NAS|0|0|0|100|DKK|2423|4293|lyfalmen||||10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2423||2423|4293| 014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|||0|0|0|1|AZD|0|0|0|100|SEK|9219|13305|lyfsjukr||||50|0|13,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||9219||9219|13305| 014081|N03AX1401|Keppra|mixtúra|100|mg/ml|300|ml|1|glas||N03AX14|01.12.2006||R|||0|0|0|0|UCB|0|0|0|100|DKK|17581|24609|lyfalmen||||300|0|20,0000|Vistor hf|U.C.B|Levetíracetam||17581||17581|24609| 014094|H05AA0202|Forsteo|stl|250|mcg/ml|3|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|||0|0|0|0|ELD|0|0|0|100|XEU|55474|72165|lyfalmen||||3|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Teriparatíđ||55474||55474|72165| 014138|B05BA1020|StructoKabiven elektrolyfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|||0|0|0|1|FRP|0|0|0|100|DKK|28861|38103|lyfsjukr||||5908|0||Icepharma hf|Fresenius Kabi|Blöndur||28861||28861|38103| 014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|180|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.08.2009||R|||0|0|0|0|AZD|0|0|0|100|SEK|28392|38177|lyfalmen|V0357|38177||180|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||28392||28392|38177| 014261|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.04.2005||R|||0|0|0|0|IGB|0|0|0|100|SEK|1577|3136|lyfalmen||||30|0||Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1577||1577|3136| 014290|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.10.1991||L|||0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa||||4|0||Vistor hf|McNeil Sweden AB|Levókabastín|||||| 014352|B05BA1015|StructoKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|||0|0|0|1|FRP|0|0|0|100|DKK|19171|25942|lyfsjukr||||3944|0||Icepharma hf|Fresenius Kabi|Blöndur||19171||19171|25942| 014361|B05BA1015|StructoKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|||0|0|0|1|FRP|0|0|0|100|DKK|25096|33378|lyfsjukr||||5908|0||Icepharma hf|Fresenius Kabi|Blöndur||25096||25096|33378| 014415|P01AB0106|Flagyl|mixtúra|40|mg/ml|100|ml|1|fl||P01AB01|01.08.2009||R|||0|0|0|0|PCO|0|0|1|100|NOK|2606|4544|lyfalmen||||100|1||Distica|Distica - óskráđ lyf|Metrónídazól||2606||2606|4544| 014435|QM01AE03|Dolovet vet.|duft|2,4|g|15|g|3|pokar||QM01AE03|01.06.2009||R|||0|0|0|0|VET|0|0|0|100|XEU|2222|4420|vetalmen||||45|0||Dýraheilsa ehf|Vetcare Ltd.|||||2222|4420| 014453|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.04.1994||R|||0|0|0|0|BOY|0|0|0|100|SEK|18812|26154|lyfalmen||||1|0||Icepharma hf|Bayer OY|Plast lyfjalykkja (IUD) međ prógestógen||18812||18812|26154| 014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|||0|1|0|1|GIS|0|0|0|100|DKK|80170|102496|lyfsjukr||||30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Adefovír||||80170|102496| 014541|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dćlu|24|dćlur|1|pakki||QA02BX12|01.04.2005||R|||0|0|0|0|PAL|0|0|0|100|XEU|5523|10778|vetalmen||||24|0||Icepharma hf|Pfizer Oy Animal Health|||5523||5523|10778| 014583|J05AX0701|Fuzeon|sts|90|mg/ml|60|hgl|1|pakki|+ leysir|J05AX07|01.12.2003||R|||0|1|0|1|RRL|0|0|0|100|DKK|233611|295064|lyfsjukr||||60|0|36,0000|Icepharma hf|Roche Registration Limited|Enfúvirtíđ||233611||233611|295064| 014679|N02AA0501|Oxycontin|forđatfl|5|mg|28|stk|1|ţpakki||N02AA05|01.12.2005||R|||1|0|E|0|NOP|0|0|0|100|DKK|2227|4025|lyfalmen||||28|0|1,8600|Icepharma hf|Norpharma |Oxýcódon||2227||2227|4025| 014696|C03EA0111|Miloride|töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.02.2010||R|||0|0|E|0|MYL|0|0|0|100|SEK|1366|2848|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Hýdróklórtíazíđ og kalíumsparandi lyf||1366||1366|2848| 014728|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|||0|1|0|1|AEU|0|0|0|100|DKK|61058|78510|lyfsjukr||||2|0|4,2900|Vistor hf|Amgen Europe B.V.|Fílgrastím||61058||61058|78510| 014739|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|||0|1|0|1|AEU|0|0|0|100|DKK|97691|124485|lyfsjukr||||2|0|6,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||97691||97691|124485| 014795|C03EA0112|Miloride mite|töflur|27,5|mg|100|stk|1|glas|2,5+25 mg|C03EA01|01.11.2009||R|||0|0|E|0|MYL|0|0|0|100|SEK|898|2207|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Hýdróklórtíazíđ og kalíumsparandi lyf||||898|2207| 014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|||0|1|*|0|NOH|0|0|0|100|DKK|18709|26025|lyfalmen||||60|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||18709||18709|26025| 014852|A06AD6502|Movicol|mixtduft|13,8|g|20|pokar|1|pakki|lausn|A06AD65|01.09.2011||L|||0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa||||20|0|10,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||| 014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|||0|1|*|0|NOH|0|0|0|100|DKK|56454|73395|lyfalmen||||60|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||56454||56454|73395| 014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|||0|1|*|0|NOH|0|0|0|100|DKK|37578|49706|lyfalmen||||60|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||37578||37578|49706| 015037|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|90|stk|1|glas||M01AX05|01.10.2006||L|||0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa||||90|0|30,5400|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||| 015230|R01AC0301|Lastin|nefúđi|1|mg/ml|10|ml|1|glas||R01AC03|01.06.1998||R|||0|0|E|0|MAB|0|0|1|100|SEK|785|2053|lyfalmen||||10|0|17,8571|Vistor hf|Meda AB|Azelastínum||785||785|2053| 015301|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|270|stk|1|glas||M01AX05|01.10.2006||L|||0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa||||270|0|91,6200|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||| 015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|||0|0|B|0|ACA|0|1|0|100|XEU|3097|5215|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis hf|Mirtazapín||3097||3097|5215| 015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|||0|0|*|0|NAS|0|0|0|100|DKK|8336|12382|lyfalmen||||15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||8336||8336|12382| 015344|N06AX1103|Miron|filmhtfl|30|mg|30|stk|1|ţpakki||N06AX11|01.07.2003||R|||0|0|0|0|ACA|0|1|0|100|XEU|1072|2422|lyfalmen||||30|0|30,0000|Actavis Group hf|Actavis hf|Mirtazapín||1055||1055|2422| 015381|H02AB0104|Betapred|lausnart|0,5|mg|100|stk|1|glas||H02AB01|01.01.1998||R|||0|0|0|0|LOL|0|0|1|100|IKR|2760|4754|lyfalmen||||100|1|33,3333|Lyfjaver ehf|Lyfjaver- óskráđ|Betametasón||2760||2760|4754| 015419|G03CA0316|Vivelle Dot|forđapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|||0|0|E|0|NOH|0|0|0|100|DKK|1056|2423|lyfalmen|V0129|1701||8|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1056||1056|2423| 015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|ţpakki||N02CC01|01.10.2005||R|||0|0|E|0|GSK|0|0|0|100|GBP|1960|2579|lyfalmen|V0234|2246||6|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1170||1170|2579| 015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|ţpakki||N02CC01|01.10.2005||R|||0|0|E|0|GSK|0|0|0|100|GBP|2799|2964|lyfalmen|V0233|2741||12|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1451||1451|2964| 015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|||0|0|*|0|NAS|0|0|0|100|DKK|9932|14565|lyfalmen||||15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||9932||9932|14565| 015532|L01CX0101|Yondelis|irţ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|||0|1|0|1|PAM|0|0|0|100|DKK|335011|422321|lyfsjukr||||1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||335011||335011|422321| 015598|L01CX0101|Yondelis|irţ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|||0|1|0|1|PAM|0|0|0|100|DKK|89044|113633|lyfsjukr||||1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||89044||89044|113633| 015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|||0|0|E|0|ORC|0|0|0|100|DKK|5150|8024|lyfalmen||||30|0|3,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5150||5150|8024| 015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|||0|0|E|0|ORC|0|0|0|100|DKK|13092|18976|lyfalmen||||100|0|11,1100|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||13092||13092|18976| 015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|||0|0|E|0|ORC|0|0|0|100|DKK|5150|8024|lyfalmen||||30|0|10,0000|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5150||5150|8024| 015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|||0|0|E|0|ORC|0|0|0|100|DKK|14153|20307|lyfalmen||||100|0|33,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14153||14153|20307| 015679|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|ţpakki||J05AE08|01.04.2005||R|||0|1|0|1|BRS|0|0|0|100|DKK|68304|87604|lyfsjukr||||60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||68304||68304|87604| 015695|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|ţpakki||J05AE08|01.04.2005||R|||0|1|0|1|BRS|0|0|0|100|DKK|68304|87604|lyfsjukr||||60|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||68304||68304|87604| 015699|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|||0|1|0|1|BRS|0|0|0|100|DKK|59395|76423|lyfsjukr||||60|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||59395||59395|76423| 015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|||0|0|E|0|ORC|0|0|0|100|DKK|5150|8024|lyfalmen||||30|0|6,6700|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5150||5150|8024| 015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|||0|0|E|0|ORC|0|0|0|100|DKK|12954|18802|lyfalmen||||100|0|22,2200|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||12954||12954|18802| 015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|||0|1|0|1|BRS|0|0|0|100|DKK|68304|87604|lyfsjukr||||60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||68304||68304|87604| 015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|ţpakki||L04AA06|01.11.2004||R|||0|1|*|0|NOH|0|0|0|100|DKK|21902|30032|lyfalmen||||120|0|10,8000|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||21902||21902|30032| 015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|ţpakki||L04AA06|01.11.2004||R|||0|1|*|0|NOH|0|0|0|100|DKK|45622|59801|lyfalmen||||120|0|21,6000|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||45622||45622|59801| 015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|3089|5389|vetorma||||2|0||Icepharma hf|Bayer Animal Health GmbH|||3089||3089|5389| 015855|QP54AB5206|Advocate yfirstćrđar hundar|bl.lausn|125|mg|4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|4341|7573|vetorma||||12|0||Icepharma hf|Bayer Animal Health GmbH|||4341||4341|7573| 015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|2756|4808|vetorma||||1|0||Icepharma hf|Bayer Animal Health GmbH|||2756||2756|4808| 015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|3455|6027|vetorma||||3|0||Icepharma hf|Bayer Animal Health GmbH|||3455||3455|6027| 015883|M01CC0101|Atamir|hylki|250|mg|50|stk|1|ţpakki||M01CC01|01.05.1978||R|||0|0|B|0|SGM|0|0|0|100|DKK|4403|7002|lyfalmen|V0200|5341||50|0|25,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||4403||4403|7002| 015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|3871|6753|vetorma||||8|0||Icepharma hf|Bayer Animal Health GmbH|||3871||3871|6753| 015910|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|100|ml|1|fl||D01AC08|01.04.2012||L|||0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa||||100|0||LYFIS ehf|ratiopharm Oy|Ketókónazól|||||| 015912|D11AH0101|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AH01|01.03.2009||R|||0|0|E|0|ASP|0|0|1|100|XEU|1947|3642|lyfalmen||||10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||||1947|3642| 015923|D11AH0101|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AH01|01.10.2007||R|||0|0|E|0|ASP|0|0|1|100|XEU|2187|3971|lyfalmen||||10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||2187||2187|3971| 015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|||1|0|0|0|MAP|0|0|0|100|GBP|1589|3153|lyfalmen||||10|0|3,3300|Icepharma hf|Martindale Pharmaceuticals|Morfín||1589||1589|3153| 015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|3089|5389|vetorma||||1|0||Icepharma hf|Bayer Animal Health GmbH|||3089||3089|5389| 015956|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|60|ml|1|fl||D01AC08|01.04.2012||L|||0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa||||60|0||LYFIS ehf|ratiopharm Oy|Ketókónazól|||||| 015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|ţpakki||N06AB05|01.12.2006||R|||0|0|0|0|GSK|0|1|0|100|GBP|2028|3753|lyfalmen||||28|0|14,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||2028||2028|3753| 016017|C10AA0701|Crestor|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA07|01.03.2004||R|||0|0|0|0|AZD|0|0|0|100|SEK|15123|21525|lyfalmen|V0117|20454||100|0|100,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||15123||15123|21525| 016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|||1|0|0|0|MAP|0|0|0|100|GBP|1180|2593|lyfalmen||||10|0|1,2500|Icepharma hf|Martindale Pharmaceuticals|Petidín||1180||1180|2593| 016028|C10AA0701|Crestor|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA07|01.03.2004||R|||0|0|0|0|AZD|0|0|0|100|SEK|22645|30965|lyfalmen|V0118|29551||100|0|200,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||22645||22645|30965| 016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|||1|0|0|0|MAP|0|0|0|100|GBP|1251|2690|lyfalmen||||20|0|2,5000|Icepharma hf|Martindale Pharmaceuticals|Petidín||1251||1251|2690| 016038|N02CC0501|Almogran|töflur|12,5|mg|3|stk|1|ţpakki|filmuhúđađar töflur|N02CC05|01.05.2001||R|||0|0|E|0|ALM|0|0|0|100|SEK|2586|4516|lyfalmen|V0236|3884||3|0|3,0000|Vistor hf|Almirall S.A.|Almótriptan||2586||2586|4516| 016066|R02AA0303|Strepsils Sukkerfri med Citron og Örter|sogtfl|||24|stk|1|ţpakki||R02AA03|01.10.2005|31.07.2012|L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|ţpakki||N03AX16|01.12.2004||R|||0|0|0|0|PER|0|0|0|100|DKK|2577|4504|lyfalmen||||14|0|7,0000|Icepharma hf|Pfizer ApS|Pregabalín||2577||2577|4504| 016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|||0|0|0|0|PER|0|0|0|100|DKK|6488|9854|lyfalmen||||56|0|14,0000|Icepharma hf|Pfizer ApS|Pregabalín||6488||6488|9854| 016296|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|spr|lausn|G03GA08|01.03.2004||R|||0|1|E|0|MSE|0|0|0|100|SEK|5217|8115|lyfalmen||||0|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||5217||5217|8115| 016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|||0|0|0|0|PER|0|0|0|100|DKK|9839|14438|lyfalmen||||56|0|28,0000|Icepharma hf|Pfizer ApS|Pregabalín||9839||9839|14438| 016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|ţpakki||N03AX16|01.12.2004||R|||0|0|0|0|PER|0|0|0|100|DKK|1699|3303|lyfalmen||||14|0|3,5000|Icepharma hf|Pfizer ApS|Pregabalín||1699||1699|3303| 016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|||0|0|0|0|PER|0|0|0|100|DKK|14293|20483|lyfalmen||||56|0|56,0000|Icepharma hf|Pfizer ApS|Pregabalín||14293||14293|20483| 016337|C08CA0302|Lomir Retard|forđahlk|5|mg|100|stk|1|ţpakki||C08CA03|01.04.1992||R|||0|0|B|0|NOH|0|0|0|100|DKK|8579|12715|lyfalmen||||100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||8579||8579|12715| 016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|||0|0|0|1|PER|0|0|0|100|DKK|93356|119044|lyfsjukr||||70|0|7,0000|Icepharma hf|Pfizer ApS|Voricónazól||93356||93356|119044| 016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|||0|1|0|1|PER|0|0|0|100|DKK|4134|5966|lyfsjukr||||10|0||Icepharma hf|Pfizer ApS|Cýtarabín||4134||4134|5966| 016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|ţpakki||N03AX16|01.01.2007||R|||0|0|0|0|PER|0|0|0|100|DKK|2536|4448|lyfalmen||||56|0|4,6667|Icepharma hf|Pfizer ApS|Pregabalín||2536||2536|4448| 016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.03.2004||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.03.2004||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.03.2004||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.09.2005||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.01.2005||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.01.2005||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|ţpakki||N05AX12|01.02.2006||R|||0|0|0|0|OTS|0|1|0|100|DKK|17052|23945|lyfalmen||||28|0|9,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||17052||17052|23945| 016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.09.2005||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016622|A06AG1101|Microlax|innhl|||5|ml|50|túpa||A06AG11|01.09.2005||L|||0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen||||250|0|50,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||7590| 016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|ţpakki||N05AX12|01.02.2006||R|||0|0|0|0|OTS|0|1|0|100|DKK|33311|44350|lyfalmen||||56|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||33311||33311|44350| 016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|||0|0|0|0|LPM|0|0|1|100|IKR|1026|2367|lyfalmen|V0169|2367||12|0|10,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1015||1015|2367| 016640|B03XA0103|NeoRecormon|stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|||0|1|0|1|ROC|0|0|0|100|DKK|179587|227264|lyfsjukr||||2|0|120,0000|Icepharma hf|Roche|Epóetín||179587||179587|227264| 016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|||1|0|0|0|NOH|0|0|0|100|DKK|7602|11378|lyfalmen||||30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||7602||7602|11378| 016736|N03AF0107|Tegretol Retard (Lyfjaver)|forđatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|||0|0|E|0|LVR|0|0|0|100|DKK|2976|5050|lyfalmen|V0240|5050||200|0|40,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||2976||2976|5050| 016772|N03AF0107|Tegretol Retard (Lyfjaver)|forđatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|||0|0|E|0|LVR|0|0|0|100|DKK|5493|8493|lyfalmen|V0433|8493||200|0|80,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||5493||5493|8493| 016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|||0|0|0|0|AEU|0|0|0|100|DKK|59423|77121|lyfalmen||||28|0|28,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||59423||59423|77121| 016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|||0|0|0|0|AEU|0|0|0|100|DKK|87560|112433|lyfalmen||||28|0|42,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||87560||87560|112433| 016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|||0|0|0|0|AEU|0|0|0|100|DKK|28296|38057|lyfalmen||||28|0|14,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||28296||28296|38057| 016930|A16AB0401|Fabrazyme|irţ|5|mg/ml|5|mg|1|hgl|lausn|A16AB04|01.05.2012||R|||0|1|0|1|GZE|0|0|0|100|XEU|76504|97895|lyfsjukr||||5|0|5,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||76504||76504|97895| 016943|A02BC0301|Lanzo|munndr.t|30|mg|14|stk|1|ţpakki||A02BC03|01.02.2007||R|||0|0|0|0|PER|0|0|0|100|DKK|1953|3651|lyfalmen||||14|0|14,0000|Icepharma hf|Pfizer ApS|Lansóprazól||1953||1953|3651| 016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|ţpakki||A02BC03|01.11.2009||R|||0|0|0|0|PER|0|0|0|100|DKK|3454|5704|lyfalmen|V0007|5704||56|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||||3454|5704| 016957|A02BC0301|Lanzo|munndr.t|15|mg|98|stk|1|ţpakki||A02BC03|01.01.2004||R|||0|0|0|0|PER|0|0|0|100|DKK|7616|11397|lyfalmen|V0007|9982||98|0|49,0000|Icepharma hf|Pfizer ApS|Lansóprazól||7616||7616|11397| 016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|||0|1|0|1|GIS|0|0|0|100|XEU|38660|50401|lyfsjukr||||30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Emtrícítabín||38660||38660|50401| 016976|A02BC0301|Lanzo|munndr.t|30|mg|98|stk|1|ţpakki||A02BC03|01.02.2007||R|||0|0|0|0|PER|0|0|0|100|DKK|13550|19550|lyfalmen||||98|0|98,0000|Icepharma hf|Pfizer ApS|Lansóprazól||13550||13550|19550| 016979|N02AE0103|Norspan|forđapl|5|mg|4|stk|1|ţpakki||N02AE01|01.01.2006||R|||1|0|E|0|NOP|0|0|0|100|DKK|3059|5163|lyfalmen||||4|0|16,6700|Icepharma hf|Norpharma |Búprenorfín||3059||3059|5163| 016981|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dćlu|60|dćlur|1|pakki||QA02BX12|01.12.2006||R|||0|0|0|0|PAL|0|0|0|100|DKK|18275|35263|vetalmen||||60|0||Icepharma hf|Pfizer Oy Animal Health|||18275||18275|35263| 017006|B05BA1019|StructoKabiven Perifer|irl|830|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.06.2005||R|||0|0|0|1|FRP|0|0|0|100|DKK|24813|33023|lyfsjukr||||4824|0||Icepharma hf|Fresenius Kabi|Blöndur||24813||24813|33023| 017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|||0|0|E|0|PER|0|0|0|100|DKK|1488|3014|lyfalmen||||3|0|21,4286|Icepharma hf|Pfizer ApS|Medroxýprógesterón||1488||1488|3014| 017111|A09AA0201|Combizym|töflur|||100|stk|1|ţpakki||A09AA02|01.07.1988||R|||0|0|E|0|DSG|0|0|0|100|XEU|1396|2889|lyfalmen||||100|0|25,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||1396||1396|2889| 017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|||0|1|0|1|SKY|0|0|0|100|DKK|256922|324320|lyfsjukr||||5|0||Icepharma hf|SkyPharma PLC|Cýtarabín||256922||256922|324320| 017145|C08DB0102|Cardizem Retard|forđatfl|180|mg|60|stk|1|glas||C08DB01|01.04.1990||R|||0|0|B|0|FRO|0|0|0|100|DKK|7692|11501|lyfalmen||||60|0|45,0000|Vistor hf|Ferrosan A/S|Diltíazem||7692||7692|11501| 017182|N05CF0106|Zopiclone Actavis|filmhtfl|5|mg|500|stk|1|plglas||N05CF01|01.10.2012||R|||0|0|0|0|AGT|0|0|0|100|XEU|5877|9018|lyfalmen||||500|0|333,0000|Actavis Group hf|Actavis Group hf|Zópíklón||5877||5877|9018| 017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|||0|1|0|1|JCI|0|0|0|100|SEK|183052|231613|lyfsjukr||||1|0||Vistor hf|Janssen-Cilag International N.V.|Bortezomíb||183052||183052|231613| 017203|M05BA0601|Bondronat|irţ|1|mg/ml|6|ml|1|hgl||M05BA06|01.09.2004||R|||0|0|0|1|ROC|0|0|0|100|DKK|39213|51095|lyfsjukr||||6|0|1,0000|Icepharma hf|Roche|Íbandrónsýra||39213||39213|51095| 017210|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.02.2003||R|||0|0|E|0|NYC|0|0|0|100|DKK|1327|2794|lyfalmen|V0046|2211||100|0|33,3333|Vistor hf|Nycomed Danmark A/S|Spírónólaktón||1327||1327|2794| 017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|||0|1|0|1|BIB|0|0|0|100|XEU|124634|158298|lyfsjukr||||2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||124634||124634|158298| 017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|ţpakki||M05BA06|01.08.2004||R|||0|0|0|0|ROC|0|0|0|100|DKK|46604|61033|lyfalmen||||28|0|280,0000|Icepharma hf|Roche|Íbandrónsýra||46604||46604|61033| 017247|M05BA0601|Bondronat|filmhtfl|50|mg|84|stk|1|ţpakki||M05BA06|01.08.2004||R|||0|0|0|0|ROC|0|0|0|100|DKK|144723|184173|lyfalmen||||84|0|840,0000|Icepharma hf|Roche|Íbandrónsýra||144723||144723|184173| 017266|N02AE0103|Norspan|forđapl|10|mg|4|stk|1|ţpakki||N02AE01|01.01.2006||R|||1|0|E|0|NOP|0|0|0|100|DKK|5311|8244|lyfalmen||||4|0|33,3300|Icepharma hf|Norpharma |Búprenorfín||5311||5311|8244| 017326|N02AE0103|Norspan|forđapl|20|mg|4|stk|1|ţpakki||N02AE01|01.01.2006||R|||1|0|E|0|NOP|0|0|0|100|DKK|10113|14813|lyfalmen||||4|0|66,6600|Icepharma hf|Norpharma |Búprenorfín||10113||10113|14813| 017327|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.02.2003||R|||0|0|E|0|NYC|0|0|0|100|DKK|2625|4570|lyfalmen||||100|0|66,6667|Vistor hf|Nycomed Danmark A/S|Spírónólaktón||2625||2625|4570| 017331|A04AD1201|Emend|hylki|||3|stk|1|ţpakki|samsett pakkning|A04AD12|01.04.2004||R|||0|0|0|1|MSD|0|0|0|100|DKK|8787|12682|lyfsjukr||||3|0|3,0000|Vistor hf|M.S.D.|Aprepitant||8787||8787|12682| 017365|J01CR0201|Amoksiklav|töflur|375|mg|20|stk|1|glas|250+125 mg|J01CR02|01.12.2003||R|||0|0|0|0|LPM|0|0|1|100|XEU|864|2161|lyfalmen||||20|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||864||864|2161| 017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|||0|0|E|0|REP|0|0|1|100|SEK|3063|5169|lyfalmen||||30|0|150,0000|Vistor hf|Recip AB|Prednisón||3063||3063|5169| 017556|J01CR0201|Amoksiklav|töflur|625|mg|20|stk|1|glas|500+125 mg|J01CR02|01.12.2003||R|||0|0|0|0|LPM|0|0|1|100|IKR|1459|2641|lyfalmen|V0168|2641||20|0|10,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1215||1215|2641| 017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|||0|0|0|0|BOI|0|0|0|100|DKK|6522|12696|vetalmen||||100|0||Vistor hf|Boehringer Ingelheim|||6522||6522|12696| 017763|N06DA0401|Reminyl|forđahlk|16|mg|84|stk|1|ţpakki||N06DA04|01.08.2005||R|||0|0|E|0|JAS|0|0|0|100|SEK|41300|32512|lyfalmen|V0350|28117||84|0|84,0000|Vistor hf|Janssen-Cilag AB|Galantamín||23878||23878|32512| 017773|N06DA0401|Reminyl|forđahlk|8|mg|28|stk|1|ţpakki||N06DA04|01.08.2005||R|||0|0|E|0|JAS|0|0|0|100|SEK|13456|12047|lyfalmen|V0348|10933||28|0|14,0000|Vistor hf|Janssen-Cilag AB|Galantamín||8091||8091|12047| 017792|C03DA0401|Inspra|filmhtfl|50|mg|30|stk|1|ţpakki||C03DA04|01.08.2005||R|||0|0|0|0|PER|0|0|0|100|DKK|10152|14866|lyfalmen||||30|0|30,0000|Icepharma hf|Pfizer ApS|Eplerenón||10152||10152|14866| 017809|N06DA0401|Reminyl|forđahlk|24|mg|84|stk|1|ţpakki||N06DA04|01.08.2005||R|||0|0|E|0|JAS|0|0|0|100|SEK|44392|58257|lyfalmen||||84|0|126,0000|Vistor hf|Janssen-Cilag AB|Galantamín||44392||44392|58257| 017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|ţpakki||C03DA04|01.08.2005||R|||0|0|0|0|PER|0|0|0|100|DKK|9271|13661|lyfalmen||||30|0|15,0000|Icepharma hf|Pfizer ApS|Eplerenón||9271||9271|13661| 018268|G03FA1701|Angemin|töflur|||84|stk|1|ţpakki|2+1 mg|G03FA17|01.06.2005|30.09.2012|R|||0|0|0|0|BYP|0|0|0|100|SEK|7122|10721|lyfalmen||||84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrogen||7122||7122|10721| 018311|C09CA0801|Olmetec|filmhtfl|10|mg|28|stk|1|ţpakki||C09CA08|01.05.2005||R|||0|0|0|0|DSH|0|0|0|100|DKK|2209|4001|lyfalmen||||28|0|14,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||2209||2209|4001| 018446|C09CA0801|Olmetec|filmhtfl|40|mg|28|stk|1|ţpakki||C09CA08|01.05.2005||R|||0|0|0|0|DSH|0|0|0|100|DKK|3243|5415|lyfalmen||||28|0|56,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||3243||3243|5415| 018502|C09CA0801|Olmetec|filmhtfl|40|mg|98|stk|1|ţpakki||C09CA08|01.05.2005||R|||0|0|0|0|DSH|0|0|0|100|DKK|10468|15299|lyfalmen||||98|0|196,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||10468||10468|15299| 018512|C09CA0801|Olmetec|filmhtfl|10|mg|98|stk|1|ţpakki||C09CA08|01.05.2005||R|||0|0|0|0|DSH|0|0|0|100|DKK|7286|10946|lyfalmen||||98|0|49,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||7286||7286|10946| 018514|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|||0|0|0|0|BAA|0|0|0|100|SEK|3952|6385|lyfalmen||||0|0||Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin međ blóđmaur||3952||3952|6385| 018527|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|||0|0|0|0|BAA|0|0|0|100|SEK|4316|6883|lyfalmen||||0|0||Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin međ blóđmaur||4316||4316|6883| 018534|C09CA0801|Olmetec|filmhtfl|20|mg|98|stk|1|ţpakki||C09CA08|01.05.2005||R|||0|0|0|0|DSH|0|0|0|100|DKK|8658|12823|lyfalmen||||98|0|98,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||8658||8658|12823| 018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|ţpakki||N03AX09|01.11.2004||R|||0|0|E|0|GSK|0|0|0|100|IKR|1499|1878|lyfalmen|V0243|1662||42|0|3,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||657||657|1878| 018586|C09CA0801|Olmetec|filmhtfl|20|mg|28|stk|1|ţpakki||C09CA08|01.05.2005||R|||0|0|0|0|DSH|0|0|0|100|DKK|2713|4690|lyfalmen||||28|0|28,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||2713||2713|4690| 018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|ţpakki||G04BD08|01.11.2004||R|||0|0|E|0|ASP|0|0|0|100|XEU|8049|11990|lyfalmen||||30|0|60,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||8049||8049|11990| 018663|J01DD0401|Rocephalin|sts|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|||0|0|0|1|ROC|0|0|0|100|DKK|13320|18599|lyfsjukr||||5|0|2,5000|Icepharma hf|Roche|Ceftríaxón||13320||13320|18599| 018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|ţpakki||G04BD08|01.11.2004||R|||0|0|E|0|ASP|0|0|0|100|XEU|19736|27314|lyfalmen|V0441|27313||90|0|180,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||19736||19736|27314| 018681|C09CA0301|Diovan|filmhtfl|40|mg|28|stk|1|ţpakki||C09CA03|01.07.2005||R|||0|0|0|0|NOH|0|0|0|100|DKK|2844|4869|lyfalmen||||28|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||2844||2844|4869| 018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|ţpakki||H02AB06|11.06.2004||R|||0|0|B|0|MKA|0|0|1|100|SEK|989|2332|lyfalmen|V0414|2002||100|0|50,0000|Icepharma hf|Merck KgaA|Prednisólón||989||989|2332| 018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|ţpakki||G04BD08|01.11.2004||R|||0|0|E|0|ASP|0|0|0|100|XEU|5700|8776|lyfalmen||||30|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||5700||5700|8776| 018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|ţpakki||G04BD08|01.11.2004||R|||0|0|E|0|ASP|0|0|0|100|XEU|16069|22712|lyfalmen|V0440|22712||90|0|90,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||16069||16069|22712| 018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|ţpakki||C03DA04|01.08.2005||R|||0|0|0|0|PER|0|0|0|100|DKK|33511|44601|lyfalmen||||100|0|100,0000|Icepharma hf|Pfizer ApS|Eplerenón||33511||33511|44601| 018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|||0|1|0|1|TEP|0|0|0|100|NOK|123504|156880|lyfsjukr||||28|0|28,0000|Vistor hf|Teva Pharmaceuticals Limited UK|Glatíramer acetat||123504||123504|156880| 018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|||0|1|0|1|VII|0|0|0|100|GBP|60830|78224|lyfsjukr||||60|0|30,0000|GlaxoSmithKline ehf|Viiv Healthcare UK Ltd|Fosamprenavír||60830||60830|78224| 018978|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.03.2003||R|||0|0|E|0|NYC|0|0|0|100|DKK|580|1772|lyfalmen||||100|0|50,0000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||580||580|1772| 018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|||0|0|0|0|KEL|1|0|0|100|NOK|1320|2626|vetalmen||||100|0||Icepharma hf|Kela Laboratoria NV|||1320||1320|2626| 018995|N02AB0301|Durogesic|forđapl|75|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|||1|0|E|0|JAS|0|0|0|100|SEK|10446|15269|lyfalmen|V0221|11007||5|0|22,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||10446||10446|15269| 019066|V08AB0201|Omnipaque|stl|140|mg J/ml|50|ml|10|plastf||V08AB02|01.04.2011||R|||0|0|0|1|GEH|0|0|0|100|NOK|21494|28857|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Jóhexól||21494||21494|28857| 019094|N02AB0301|Durogesic|forđapl|50|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|||1|0|E|0|JAS|0|0|0|100|SEK|7467|11193|lyfalmen|V0220|8709||5|0|15,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||7467||7467|11193| 019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|24258|32326|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Jóhexól||24258||24258|32326| 019108|N02AB0301|Durogesic|forđapl|25|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|||1|0|E|0|JAS|0|0|0|100|SEK|4140|6642|lyfalmen|V0219|5470||5|0|7,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||4140||4140|6642| 019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|33677|44147|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Jóhexól||33677||33677|44147| 019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|34531|45219|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Jódixanól||34531||34531|45219| 019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|42193|54835|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Jódixanól||42193||42193|54835| 019167|N02AB0301|Durogesic|forđapl|100|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|||1|0|E|0|JAS|0|0|0|100|SEK|9718|14273|lyfalmen|V0223|12664||5|0|30,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||9718||9718|14273| 019175|C09CA0601|Atacand|töflur|32|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|14398|20615|lyfalmen||||98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||14398||14398|20615| 019194|C09CA0601|Atacand|töflur|32|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|4938|7734|lyfalmen||||28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||4938||4938|7734| 019293|B02BC3001|TachoSil|svampur|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.05.2005||R|||0|1|0|1|NYC|0|0|0|100|DKK|50524|65290|lyfsjukr||||1|0||Vistor hf|Nycomed Danmark A/S|Fíbrínógen og Mannatromnín manna||50524||50524|65290| 019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|ţykkni, lausn|B01AE06|01.05.2005||R|||0|1|0|1|THE|0|0|0|100|XEU|722851|909061|lyfsjukr||||10|0|10,0000|The Medicines Company UK Ltd.|The Medicines Company UK Ltd.|Bívalirúdín||722851||722851|909061| 019308|QG03X0001|Alizin, vet.|stl|30|mg/ml|10|ml|1|hgl|fyrir hunda (tíkur)|QG03X|01.05.2012||R|||0|0|0|0|VIR|1|0|0|100|IKR|4877|9537|vetalmen||||10|0||Vistor hf|Virbac S.A|Aglepristóne||4877||4877|9537| 019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019403|QJ51CE0901|Carepen vet.|spenalyf|600|mg|10|g|100|stk|10 áf.spr|QJ51CE09|01.04.2010||R|||0|0|0|0|VET|0|0|0|100|DKK|20570|39670|vetalmen||||1000|0||Dýraheilsa ehf|Vetcare Ltd.|Benzylpenicillínprokaín||||20570|39670| 019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|ţpakki|sýruţ.hylki, hörđ|N06AX21|01.10.2004||R|||0|0|0|0|ELD|0|0|0|100|XEU|6649|10074|lyfalmen||||56|0|18,6700|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6649||6649|10074| 019445|L01XC0701|Avastin|irţ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|||0|1|0|1|RRL|0|0|0|100|DKK|50923|65791|lyfsjukr||||4|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||50923||50923|65791| 019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|ţpakki|sýruţ.hylki, hörđ|N06AX21|01.10.2004||R|||0|0|0|0|ELD|0|0|0|100|XEU|6649|10074|lyfalmen||||56|0|37,3300|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6649||6649|10074| 019513|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.03.2003||R|||0|0|E|0|NYC|0|0|0|100|DKK|583|1776|lyfalmen||||100|0|100,0000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||583||583|1776| 019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019681|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.01.2005||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|||0|1|0|1|ELI|0|0|0|100|XEU|3640|5253|lyfsjukr||||1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||3640||3640|5253| 019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.01.2005||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019724|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.01.2005||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019745|C03CA0101|Furix|töflur|40|mg|250|stk|1|glas|til vélskömmtunar|C03CA01|01.04.2005||R|||0|0|E|0|NYC|0|0|0|100|DKK|609|1812|lyfalmen||||250|0|250,0000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||609||609|1812| 019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|||0|1|0|1|ELI|0|0|0|100|XEU|15992|21952|lyfsjukr||||1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||15992||15992|21952| 019781|L01XC0701|Avastin|irţ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|||0|1|0|1|RRL|0|0|0|100|DKK|189100|239203|lyfsjukr||||16|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||189100||189100|239203| 019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019786|J01CA0411|Amoxicillin Mylan|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|||0|0|0|0|MYL|0|0|1|100|SEK|1138|2536|lyfalmen|V0159|2534||20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1138||1138|2536| 019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019797|L01BA0401|Alimta|irţ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|||0|1|0|1|ELD|0|0|0|100|XEU|192779|243820|lyfsjukr||||1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||192779||192779|243820| 019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|||0|1|0|0|ELI|0|0|0|100|XEU|12536|18278|lyfalmen||||28|0|3,5000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12536||12536|18278| 019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|||0|1|0|0|ELI|0|0|0|100|XEU|12536|18278|lyfalmen||||28|0|6,3000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12536||12536|18278| 019837|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.10.2005||R|||0|1|E|0|ORG|0|0|0|100|DKK|54115|70459|lyfalmen||||1|0|12,0000|Vistor hf|N.V. Organon|Follitrópín beta||54115||54115|70459| 019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|||0|1|0|0|ELI|0|0|0|100|XEU|12536|18278|lyfalmen||||28|0|8,7500|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12536||12536|18278| 019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|||0|1|0|0|ELI|0|0|0|100|XEU|12536|18278|lyfalmen||||28|0|14,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12536||12536|18278| 019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|||0|1|0|0|ELI|0|0|0|100|XEU|12536|18278|lyfalmen||||28|0|21,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12536||12536|18278| 019916|V03AF0801|Kepivance|sts|6,25|mg/hgl|6|hgl|1|pakki|lausn|V03AF08|01.07.2006||R|||0|1|0|1|BIA|0|0|0|100|DKK|763907|960586|lyfsjukr||||6|0|8,9300|Vistor hf|Biovitrum AB (publ)|Palifermín||763907||763907|960586| 019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|ţpakki||N04BC04|01.12.2006||R|||0|0|E|0|GSK|0|0|0|100|GBP|402|1529|lyfalmen||||12|0|0,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||||402|1529| 019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|ţpakki|600+300 mg|J05AR02|01.05.2004||R|||0|1|0|1|GGL|0|0|0|100|GBP|68931|88391|lyfsjukr||||30|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín og abacavír||68931||68931|88391| 019968|J01CA0411|Amoxicillin Mylan|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|||0|0|0|0|MYL|0|0|1|100|SEK|1704|3255|lyfalmen|V0160|3254||30|0|15,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1664||1664|3255| 020016|B03AA0704|Duroferon|forđatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|||0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa||||100|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Ferrósúlfat|||||| 020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||100|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||| 020193|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.01.2005||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 020238|G04CA0203|Omnic Ocas|forđatfl|0,4|mg|30|stk|1|ţpakki||G04CA02|01.04.2006||R|||0|0|E|0|ASP|0|0|0|100|XEU|2835|4857|lyfalmen||||30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||2835||2835|4857| 020244|J07CA0204|Boostrix Polio|stl|||0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|||0|0|0|0|GSK|0|0|0|100|GBP|26876|36275|lyfalmen||||5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, kíghósti, mćnusótt, stífkrampi||26876||26876|36275| 020276|A06AB0203|Dulcolax (Lyfjaver)|eţ-stíll|10|mg|50|stk|1|ţpakki||A06AB02|01.07.2005||R|||0|0|0|0|LVR|0|0|0|100|NOK|2809|4821|lyfalmen||||50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||2809||2809|4821| 020277|N06AX1602|Efexor Depot|forđahlk|37,5|mg|7|stk|1|ţpakki||N06AX16|01.02.2007||R|||0|0|0|0|PER|0|1|0|100|DKK|561|1746|lyfalmen|V0333|1578||7|0|2,6300|Icepharma hf|Pfizer ApS|Venlafaxín||561||561|1746| 020292|M02AA1502|Voltaren|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.06.2010||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||50|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||| 020338|G04CA0203|Omnic Ocas|forđatfl|0,4|mg|90|stk|1|ţpakki||G04CA02|01.04.2006||R|||0|0|E|0|ASP|0|0|0|100|XEU|6619|10033|lyfalmen||||90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||6619||6619|10033| 020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|||0|1|*|0|ASP|0|0|0|100|XEU|51662|67381|lyfalmen||||2|0|155,7500|Vistor hf|Astellas Pharma A/S|Leuprórelín||51662||51662|67381| 020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|ţpakki||N04BC04|01.06.2006||R|||0|0|E|0|GSK|0|0|0|100|GBP|6382|5975|lyfalmen|V0530|5241||84|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||3652||3652|5975| 020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|ţpakki||N04BC04|01.12.2006||R|||0|0|E|0|GSK|0|0|0|100|GBP|14220|7085|lyfalmen|V0531|6150||84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||4464||4464|7085| 020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|||0|1|*|0|ASP|0|0|0|100|XEU|23314|31804|lyfalmen||||2|0|51,9400|Vistor hf|Astellas Pharma A/S|Leuprórelín||23314||23314|31804| 020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|||0|0|B|0|ASP|0|0|1|100|XEU|587|1782|lyfalmen||||30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||587||587|1782| 020456|M05BX0301|Protelos|mixt.kyr|2|g|28|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|||0|0|0|0|SEV|0|0|0|100|DKK|5533|8548|lyfalmen||||28|0|28,0000|Icepharma hf|Servier|Strontíum ranelat||5533||5533|8548| 020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|||0|0|B|0|ASP|0|0|1|100|XEU|1788|3425|lyfalmen||||100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1788||1788|3425| 020533|M05BX0301|Protelos|mixt.kyr|2|g|84|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|||0|0|0|0|SEV|0|0|0|100|DKK|16113|22767|lyfalmen||||84|0|84,0000|Icepharma hf|Servier|Strontíum ranelat||16113||16113|22767| 020648|R06AX2201|Kestine|töflur|20|mg|10|stk|1|ţpakki||R06AX22|01.10.2005||L|||0|0|0|0|APS|0|0|1|100|IKR|||lyflausa||||10|0|20,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||| 020711|G03AD0102|Postinor|töflur|1500|mcg|1|stk|1|ţpakki||G03AD01|01.01.2007||L|||0|0|0|0|MEI|0|0|0|100|IKR|||lyflausa||||1|0|1,0000|Icepharma hf|Medimpex UK Limited|Levonorgestrel|||||| 020770|QP54AA5101|Eqvalan Duo|pasta|||7,74|g|1|sk-dćl||QP54AA51|01.10.2006||R|||0|0|0|0|MES|0|0|0|100|XEU|2160|3768|vetorma||||8|0||Vistor hf|Merial SAS|Ivermectinum í blöndum||2160||2160|3768| 020774|L04AB0101|Enbrel|sts|50|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.10.2005||R|||0|1|0|1|WTE|0|0|0|100|DKK|151738|192314|lyfsjukr||||4|0|28,5700|Icepharma hf|Wyeth Europe|Etanercept||151738||151738|192314| 020861|QP52AF0202|Twinhip Vet.|pasta|439|mg/g|52|g|1|spr||QP52AF02|01.08.2011||R|||0|0|0|0|VEB|0|0|0|100|XEU|2527|4408|vetorma||||52|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||2527||2527|4408| 020924|J01FA1003|Zithromax (D.A.C.)|töflur|500|mg|3|stk|1|ţpakki||J01FA10|01.09.2007||R|||0|0|0|0|DAC|0|0|1|100|DKK|1962|3663|lyfalmen|V0174|3663||3|0|5,0000|D.A.C. ehf|D.A.C. ehf|Azitrómýcín||1962||1962|3663| 020992|C09AA0402|Coversyl Novum|filmhtfl|5|mg|30|stk|1|glas||C09AA04|01.08.2011||R|||0|0|0|0|LLS|0|0|0|100|DKK|2924|4979|lyfalmen||||30|0|37,5000|Icepharma hf|Les Laboratoires Servier|Perindópríl||2924||2924|4979| 021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|||0|0|0|0|GAN|0|0|0|100|SEK|2540|4453|lyfalmen||||60|0||Icepharma hf|Galderma Nordic AB|Adapalen||2540||2540|4453| 021057|J01CR0203|Augmentine (D.A.C.)|töflur|625|mg|12|stk|1|ţpakki|500+125 mg|J01CR02|01.05.2005||R|||0|0|0|0|DAC|0|0|1|100|IKR|827|1956|lyfalmen||||12|0|6,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||714||714|1956| 021149|J01CR0203|Augmentine (D.A.C.)|töflur|1000|mg|12|stk|1|ţpakki|875+125 mg|J01CR02|01.05.2005||R|||0|0|0|0|DAC|0|0|1|100|IKR|1025|2381|lyfalmen|V0169|2367||12|0|10,5000|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||1025||1025|2381| 021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|ţpakki||M01AB05|01.03.2005||R|||0|0|E|0|ACA|0|0|1|100|IKR|453|1389|lyfalmen|V0188|1389||30|0|15,0000|Actavis Group hf|Actavis hf|Díklófenak||300||300|1389| 021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|||0|0|E|0|GEM|0|0|0|100|XEU|988|2330|lyfalmen||||10|0||Actavis Group hf|Gerhard Mann|Dexpantenól||988||988|2330| 021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|ţpakki||M01AB05|01.03.2005||R|||0|0|E|0|ACA|0|0|1|100|IKR|1187|2116|lyfalmen|V0189|2116||100|0|50,0000|Actavis Group hf|Actavis hf|Díklófenak||831||831|2116| 021257|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2005|30.09.2012|R|||0|0|E|0|BAP|0|0|0|100|SEK|17496|24503|lyfalmen||||4|0|55,5600|Icepharma hf|Bayer Schering Pharma AG|Testósterón||17496||17496|24503| 021341|R03AK0603|Seretide Diskus (Lyfjaver)|innúđadu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg, discus|R03AK06|01.05.2012||R|||0|0|0|0|LVR|0|0|0|100|GBP|9722|14059|lyfalmen|V0437|14059||60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9562||9562|14059| 021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.09.1998||R|||0|0|B|0|MSD|0|0|0|100|DKK|16646|23436|lyfalmen|V0490|10117||98|0|98,0000|Vistor hf|M.S.D.|Montelúkast||16646||16646|23436| 021365|R03AK0603|Seretide Diskus (Lyfjaver)|innúđadu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg, discus|R03AK06|01.05.2012||R|||0|0|0|0|LVR|0|0|0|100|GBP|6927|10455|lyfalmen|V0436|10455||60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||6927||6927|10455| 021375|M01AB0512|Voltaren Dolo|töflur|12,5|mg|20|stk|1|ţpakki||M01AB05|01.10.2004||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||20|0|2,5000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||| 021417|R01AD0504|Rhinocort (D.A.C.)|nefúđi|64|mcg/sk|120|skammtar|1|fl||R01AD05|01.11.2004||R|||0|0|E|0|DAC|0|0|1|100|SEK|1709|3265|lyfalmen|V0443|3265||120|0|38,4000|D.A.C. ehf|D.A.C. ehf|Búdesóníđ||1671||1671|3265| 021428|A06AB0201|Dulcolax|eţ-stíll|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|||0|0|0|0|BOI|0|0|0|100|IKR|||lyflausa||||6|0|6,0000|Vistor hf|Boehringer Ingelheim|Bisakódýl|||||| 021469|R03DC0301|Singulair|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.09.1998||R|||0|0|B|0|MSD|0|0|0|100|DKK|16910|23767|lyfalmen|V0491|18943||98|0|49,0000|Vistor hf|M.S.D.|Montelúkast||16910||16910|23767| 021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|||0|0|0|1|FRP|0|0|0|100|DKK|1535|2215|lyfsjukr||||100|0||Icepharma hf|Fresenius Kabi|Própófól||1535||1535|2215| 021593|H01BA0201|Minirin|frţ.tfl|60|mcg|30|stk|1|ţpakki||H01BA02|01.10.2005||R|||0|0|E|0|FEL|0|0|0|100|DKK|4267|6816|lyfalmen||||30|0|4,5000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||4267||4267|6816| 021604|H01BA0201|Minirin|frţ.tfl|60|mcg|100|stk|1|ţpakki||H01BA02|01.10.2005||R|||0|0|E|0|FEL|0|0|0|100|DKK|13060|18935|lyfalmen||||100|0|15,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||13060||13060|18935| 021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|ţpakki||C10AA07|01.01.2006||R|||0|0|0|0|AZD|0|0|0|100|SEK|14785|21100|lyfalmen||||98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||14785||14785|21100| 021614|H01BA0201|Minirin|frţ.tfl|120|mcg|30|stk|1|ţpakki||H01BA02|01.10.2005||R|||0|0|E|0|FEL|0|0|0|100|DKK|6902|10420|lyfalmen||||30|0|9,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||6902||6902|10420| 021625|A07EC0203|Pentasa Sachets|forđakyr|2|g|60|pokar|1|pakki||A07EC02|01.05.2011||R|||0|0|B|0|FER|0|0|0|100|DKK|14666|20951|lyfalmen||||60|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||14666||14666|20951| 021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|||0|0|0|1|FRP|0|0|0|100|DKK|15353|21151|lyfsjukr||||1000|0||Icepharma hf|Fresenius Kabi|Própófól||15353||15353|21151| 021641|H01BA0201|Minirin|frţ.tfl|120|mcg|100|stk|1|ţpakki||H01BA02|01.10.2005||R|||0|0|E|0|FEL|0|0|0|100|DKK|21985|30136|lyfalmen||||100|0|30,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||21985||21985|30136| 021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|||0|0|0|1|FRP|0|0|0|100|DKK|15353|21151|lyfsjukr||||500|0||Icepharma hf|Fresenius Kabi|Própófól||15353||15353|21151| 021659|V01AA0304|Alutard SQ, derm. pter.|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|23632|32203|lyfalmen||||20|0||Vistor hf|ALK-Abello A/S|rykmaurar||23632||23632|32203| 021674|C10AA0701|Crestor|filmhtfl|5|mg|28|stk|1|ţpakki||C10AA07|01.01.2006||R|||0|0|0|0|AZD|0|0|0|100|SEK|4609|7284|lyfalmen||||28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||4609||4609|7284| 021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|||0|0|0|1|FRP|0|0|0|100|DKK|8828|12741|lyfsjukr||||500|0||Icepharma hf|Fresenius Kabi|Própófól||8828||8828|12741| 021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|||0|0|0|1|PER|0|0|0|100|DKK|4455|6430|lyfsjukr||||50|0|2,5000|Icepharma hf|Pfizer ApS|Tranexamsýra||4455||4455|6430| 021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|18920|26290|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|rykmaurar||18920||18920|26290| 021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|ţpakki||N06AX21|01.04.2005||R|||0|0|0|0|ELD|0|1|0|100|XEU|3723|6072|lyfalmen||||28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||3723||3723|6072| 021950|B05AA0705|HyperHAES|irl|||250|ml|10|pokar||B05AA07|01.07.2005||R|||0|0|0|1|FRP|0|0|0|100|DKK|20958|28185|lyfsjukr||||2500|0||Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||20958||20958|28185| 021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|ţpakki||N06AX21|01.04.2005||R|||0|0|0|0|ELD|0|1|0|100|XEU|5145|8017|lyfalmen||||28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||5145||5145|8017| 021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|ţpakki||N06AX21|01.04.2005||R|||0|0|0|0|ELD|0|1|0|100|XEU|17731|24798|lyfalmen||||98|0|98,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||17731||17731|24798| 021999|L01XX3501|Xagrid|hylki|0,5|mg|100|stk|1|glas|hart|L01XX35|01.10.2012||R|||0|1|0|1|SHI|0|0|0|100|DKK|79368|101489|lyfsjukr||||100|0||Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Anagrelidum||79368||79368|101489| 022020|V01AA0304|Alutard SQ, derm. pter.|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|18920|26290|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|rykmaurar||18920||18920|26290| 022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|||0|1|0|1|RRL|0|0|0|100|DKK|81470|104127|lyfsjukr||||30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||81470||81470|104127| 022112|B05AA0112|Flexbumin|irl|200|g/líter|100|ml|12|pokar|lausn|B05AA01|01.06.2010||R|||0|0|0|1|BAM|0|0|0|100|SEK|126422|160542|lyfsjukr||||1200|0||Icepharma hf|Baxter Medical AB|Albúmín||126422||126422|160542| 022128|A01AA0117|Fludent Banan|munnstfl|0,25|mg|200|stk|1|plglas||A01AA01|01.01.2008||L|||0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa||||200|0|45,4500|Actavis Group hf|Actavis Group hf|Natríumflúoríđ|||||| 022135|C10BA0201|Inegy|töflur|30|mg|28|stk|1|ţpakki|10 mg + 20 mg|C10BA02|01.01.2010||R|||0|0|0|0|MSD|0|0|0|100|DKK|6992|10544|lyfalmen||||28|0|28,0000|Vistor hf|M.S.D.|Ezetimíb og simvastatín||6992||6992|10544| 022157|C10BA0201|Inegy|töflur|50|mg|28|stk|1|ţpakki|10 mg + 40 mg|C10BA02|01.01.2010||R|||0|0|0|0|MSD|0|0|0|100|DKK|8194|12188|lyfalmen||||28|0|28,0000|Vistor hf|M.S.D.|Ezetimíb og simvastatín||8194||8194|12188| 022159|C10BA0201|Inegy|töflur|50|mg|98|stk|1|ţpakki|10 mg + 40 mg|C10BA02|01.09.2005||R|||0|0|0|0|MSD|0|0|0|100|DKK|25127|34080|lyfalmen||||98|0|98,0000|Vistor hf|M.S.D.|Ezetimíb og simvastatín||25127||25127|34080| 022165|A10AB0606|Apidra [Clikstar]|stl|100|ein/ml|3|ml|5|lykjur|rörlykjur fyrir Clikstar penna|A10AB06|01.07.2010||R|||0|0|*|0|SAA|0|0|0|100|NOK|5481|8477|lyfalmen||||15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||5481||5481|8477| 022174|C10BA0201|Inegy|töflur|90|mg|28|stk|1|ţpakki|10 mg + 80 mg|C10BA02|01.01.2010||R|||0|0|0|0|MSD|0|0|0|100|DKK|8738|12932|lyfalmen||||28|0|28,0000|Vistor hf|M.S.D.|Ezetimíb og simvastatín||8738||8738|12932| 022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|||0|1|0|1|RRL|0|0|0|100|DKK|285114|359701|lyfsjukr||||30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||285114||285114|359701| 022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|||0|1|0|1|RRL|0|0|0|100|DKK|314646|396763|lyfsjukr||||30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||314646||314646|396763| 022218|QP52AA5102|Drontal Comp.vet.|töflur|||24|stk|1|ţpakki||QP52AA51|01.01.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|10967|19131|vetorma||||24|0||Icepharma hf|Bayer Animal Health GmbH|||10967||10967|19131| 022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|||0|1|0|0|ALL|0|0|0|100|SEK|25192|34161|lyfalmen||||1|0||Vistor hf|Allergan|Clostridium botulinum toxín-A||25192||25192|34161| 022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|2205|3847|vetorma||||2|0||Icepharma hf|Bayer Animal Health GmbH|||2205||2205|3847| 022269|C08CA0101|Norvasc|töflur|5|mg|30|stk|1|ţpakki||C08CA01|01.01.1992||R|||0|0|B|0|PER|0|0|0|100|DKK|1260|2703|lyfalmen||||30|0|30,0000|Icepharma hf|Pfizer ApS|Amlódipín||1260||1260|2703| 022281|QP52AA5102|Drontal Comp.vet.|töflur|||2|stk|1|ţpakki||QP52AA51|01.10.1991||L|||0|0|0|0|BAN|0|0|0|100|DKK|1342|2341|vetorma||||2|0||Icepharma hf|Bayer Animal Health GmbH|||||1342|2341| 022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.01.1992||R|||0|0|B|0|PER|0|0|0|100|DKK|3724|2664|lyfalmen|V0056|1737||100|0|100,0000|Icepharma hf|Pfizer ApS|Amlódipín||1232||1232|2664| 022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.01.1992||R|||0|0|B|0|PER|0|0|0|100|DKK|6546|3653|lyfalmen|V0057|2133||100|0|200,0000|Icepharma hf|Pfizer ApS|Amlódipín||1955||1955|3653| 022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|2088|3642|vetorma||||1|0||Icepharma hf|Bayer Animal Health GmbH|||2088||2088|3642| 022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|||0|0|B|0|ASP|0|0|1|100|XEU|612|1816|lyfalmen||||30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||612||612|1816| 022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|||0|0|B|0|ASP|0|0|1|100|XEU|1834|3488|lyfalmen||||100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1834||1834|3488| 022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|1352|2358|vetorma||||1|0||Icepharma hf|Bayer Animal Health GmbH|||1352||1352|2358| 022532|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|28|stk|1|ţpakki||C09DA03|01.11.2003||R|||0|0|0|0|NOH|0|0|0|100|DKK|4549|7202|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||4549||4549|7202| 022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|||0|0|B|0|ACA|0|1|0|100|IKR|2129|2993|lyfalmen|V0321|2993||100|0|100,0000|Actavis Group hf|Actavis hf|Paroxetín||1472||1472|2993| 022577|N06AB0504|Paxetin|töflur|20|mg|60|stk|1|glas||N06AB05|01.01.2005||R|||0|0|B|0|ACA|0|1|0|100|IKR|1554|2046|lyfalmen|V0321|1796||60|0|60,0000|Actavis Group hf|Actavis hf|Paroxetín||780||780|2046| 022757|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|60|sk-hyl||S01XA20|01.07.2012||L|||0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen||||30|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||4668| 022783|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|10|spr|áfyllt sprauta|B01AX05|01.10.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|26443|35731|lyfalmen||||8|0|40,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||26443||26443|35731| 022802|L01XC0401|MabCampath|irţ|30|mg/ml|1|ml|3|hgl||L01XC04|01.07.2007|30.09.2012|R|||0|1|0|1|GEU|0|0|0|100|SEK|225694|285128|lyfsjukr||||3|0||Icepharma hf|Genzyme Europe B.V. (I)|Alemtuzumab||225694||225694|285128| 022815|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|10|spr|áfyllt sprauta|B01AX05|01.10.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|13221|19137|lyfalmen||||4|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||13221||13221|19137| 022831|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|10|spr|áfyllt sprauta|B01AX05|01.04.2012||R|||0|0|E|0|GGL|0|0|0|100|GBP|19853|27461|lyfalmen||||6|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||19853||19853|27461| 022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|||0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen||||15|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||2823| 022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|ţpakki||D10BA01|01.02.2006||R|||0|1|C|0|ACA|0|0|0|30|IKR|1407|2827|lyfalmen|V0124|2827||30|0|10,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1351||1351|2827| 022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|ţpakki||D10BA01|01.02.2006||R|||0|1|C|0|ACA|0|0|0|30|IKR|2450|4196|lyfalmen|V0125|4196||30|0|20,0000|Actavis Group hf|Actavis hf|Ísótretínóín||2352||2352|4196| 022962|V01AA1104|Alutard SQ, hrossavćrur|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|23632|32203|lyfalmen||||20|0||Vistor hf|ALK-Abello A/S|dýr||23632||23632|32203| 022970|V01AA1104|Alutard SQ, hrossavćrur|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|18920|26290|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|dýr||18920||18920|26290| 023047|G04BD1001|Emselex|forđatfl|7,5|mg|28|stk|1|ţpakki||G04BD10|01.07.2005||R|||0|0|E|0|NOE|0|0|0|100|DKK|5500|8503|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||5500||5500|8503| 023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|||0|1|0|1|GIS|0|0|0|100|DKK|81464|104120|lyfsjukr||||30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl og emtrícítabín||81464||81464|104120| 023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|||0|1|0|0|SHI|0|0|0|100|DKK|25011|33934|lyfalmen||||90|0|20,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||25011||25011|33934| 023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|||0|1|0|0|SHI|0|0|0|100|DKK|39048|51550|lyfalmen||||90|0|30,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||39048||39048|51550| 023124|G04BD1001|Emselex|forđatfl|7,5|mg|98|stk|1|ţpakki||G04BD10|01.07.2005||R|||0|0|E|0|NOE|0|0|0|100|DKK|19774|27362|lyfalmen||||98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||19774||19774|27362| 023146|G04BD1001|Emselex|forđatfl|15|mg|28|stk|1|ţpakki||G04BD10|01.07.2005||R|||0|0|E|0|NOE|0|0|0|100|DKK|5555|8578|lyfalmen||||28|0|56,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||5555||5555|8578| 023193|G04BD1001|Emselex|forđatfl|15|mg|98|stk|1|ţpakki||G04BD10|01.07.2005||R|||0|0|E|0|NOE|0|0|0|100|DKK|19975|27614|lyfalmen||||98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||19975||19975|27614| 023329|N03AX1206|Gabapentin Mylan|hylki|300|mg|100|stk|1|glas||N03AX12|01.01.2010||R|||0|0|E|0|MYL|0|0|0|100|SEK|4972|4493|lyfalmen|V0250|4493||100|0|16,6667|Actavis Group PTC ehf|Mylan AB|Gabapentín||2569||2569|4493| 023376|N03AX1206|Gabapentin Mylan|hylki|400|mg|100|stk|1|glas||N03AX12|01.01.2010||R|||0|0|E|0|MYL|0|0|0|100|SEK|3722|6070|lyfalmen|V0251|3868||100|0|22,2200|Actavis Group PTC ehf|Mylan AB|Gabapentín||3722||3722|6070| 023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|||0|0|0|0|DED|0|0|1|100|XEU|17952|25075|lyfalmen||||34|0||Vistor hf|Dentsply DeTrey GmbH|Blöndur||17952||17952|25075| 023414|B03XA0201|Aranesp|stl|20|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|||0|1|0|1|AMG|0|0|0|100|DKK|7196|10386|lyfsjukr||||0|0|4,4400|Vistor hf|Amgen|Darbepóetín alfa||7196||7196|10386| 023419|B03XA0201|Aranesp|stl|80|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|||0|1|0|1|AMG|0|0|0|100|DKK|27670|36608|lyfsjukr||||0|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||27670||27670|36608| 023425|B03XA0201|Aranesp|stl|60|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|||0|1|0|1|AMG|0|0|0|100|DKK|20953|28179|lyfsjukr||||0|0|13,3300|Vistor hf|Amgen|Darbepóetín alfa||20953||20953|28179| 023441|B03XA0201|Aranesp|stl|150|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|||0|1|0|1|AMG|0|0|0|100|DKK|49901|64508|lyfsjukr||||0|0|33,3300|Vistor hf|Amgen|Darbepóetín alfa||49901||49901|64508| 023447|B03XA0201|Aranesp|stl|100|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|||0|1|0|1|AMG|0|0|0|100|DKK|33719|44200|lyfsjukr||||0|0|22,2200|Vistor hf|Amgen|Darbepóetín alfa||33719||33719|44200| 023448|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|glerfl||J06BA02|01.09.2007||R|||0|0|0|1|BAA|0|0|0|100|SEK|8684|12533|lyfsjukr||||10|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||8684||8684|12533| 023452|B03XA0201|Aranesp|stl|300|mcg/pen|0,6|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|||0|1|0|1|AMG|0|0|0|100|DKK|100504|128015|lyfsjukr||||1|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||100504||100504|128015| 023459|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|glerfl||J06BA02|01.09.2007||R|||0|0|0|1|BAA|0|0|0|100|SEK|21712|29131|lyfsjukr||||25|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||21712||21712|29131| 023463|B03XA0201|Aranesp|stl|40|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|||0|1|0|1|AMG|0|0|0|100|DKK|14464|20035|lyfsjukr||||0|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||14464||14464|20035| 023470|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|glerfl||J06BA02|01.09.2007||R|||0|0|0|1|BAA|0|0|0|100|SEK|37758|49269|lyfsjukr||||50|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||37758||37758|49269| 023476|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|glerfl||J06BA02|01.09.2007||R|||0|0|0|1|BAA|0|0|0|100|SEK|75516|96655|lyfsjukr||||100|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||75516||75516|96655| 023480|B03XA0201|Aranesp|stl|500|mcg/pen|1|ml|1|penni|áfyllur penni|B03XA02|01.07.2007||R|||0|1|0|1|AMG|0|0|0|100|DKK|175149|221694|lyfsjukr||||1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||175149||175149|221694| 023487|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|glerfl||J06BA02|01.09.2007||R|||0|0|0|1|BAA|0|0|0|100|SEK|151034|191430|lyfsjukr||||200|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||151034||151034|191430| 023501|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006|31.07.2012|R|||0|0|E|0|GGL|0|0|0|100|GBP|14354|20559|lyfalmen||||4|0|21,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||14354||14354|20559| 023506|J05AE0901|Aptivus|hylki|250|mg|120|stk|1|glas||J05AE09|01.03.2007||R|||0|1|0|1|BII|0|0|0|100|DKK|131387|166773|lyfsjukr||||120|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tipranavír||131387||131387|166773| 023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2007||R|||0|0|E|0|SBM|0|0|0|100|NOK|26985|31391|lyfalmen|V0029|7965||100|0|100,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||22985||22985|31391| 023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|||0|0|*|0|SAO|0|0|0|100|XEU|3508|5778|lyfalmen||||12|0|30,0000|Icepharma hf|Santen Oy|Tímólól||3508||3508|5778| 023608|N01AB0802|Sevofluran Baxter|innönd.l|100|%|250|ml|6|fl||N01AB08|01.04.2012||R|||0|0|0|1|BAX|0|0|0|100|SEK|159202|201681|lyfsjukr||||1500|0||Icepharma hf|Baxter|Sevóflúran||159202||159202|201681| 023708|J05AE0101|Invirase|filmhtfl|500|mg|120|stk|1|glas||J05AE01|01.01.2006||R|||0|1|0|1|ROC|0|0|0|100|DKK|55093|71024|lyfsjukr||||120|0|33,3300|Icepharma hf|Roche|Saquínavír||55093||55093|71024| 023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|ţpakki||G04BE03|01.08.2006||R|||0|1|0|1|IPI|0|0|0|100|DKK|74589|95492|lyfsjukr||||90|0|36,0000|Icepharma hf|Pfizer Limited|Síldenafíl||74589||74589|95492| 024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|||0|0|E|0|MSD|0|0|0|100|DKK|2851|4879|lyfalmen||||100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2851||2851|4879| 024024|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.02.2007|31.07.2012|R|||0|0|0|1|WTE|0|0|0|100|DKK|79110|101166|lyfsjukr||||10|0|5,0000|Icepharma hf|Wyeth Europe|Tigecýklín||79110||79110|101166| 024056|N02AB0301|Durogesic|forđapl|12|mcg/klst|5|stk|1|ţpakki||N02AB03|01.02.2006||R|||1|0|E|0|JAS|0|0|0|100|SEK|2636|4585|lyfalmen||||5|0|3,6000|Vistor hf|Janssen-Cilag AB|Fentanýl||2636||2636|4585| 024090|N04BD0201|Azilect|töflur|1|mg|30|stk|1|glas||N04BD02|01.10.2005||R|||0|0|E|0|TPG|0|0|0|100|DKK|18845|26196|lyfalmen||||30|0|30,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||18845||18845|26196| 024135|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||1000|ml|10|pokar|lausn|B05BB01|01.10.2005||R|||0|0|0|1|BAM|0|0|0|100|SEK|1860|2684|lyfsjukr||||10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1860||1860|2684| 024151|B05BA1020|StructoKabiven elektrolyfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2010||R|||0|0|0|1|FRP|0|0|0|100|DKK|22046|29550|lyfsjukr||||3944|0||Icepharma hf|Fresenius Kabi|Blöndur||22046||22046|29550| 024185|N05AH0309|Kozylex|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|||0|0|*|0|POF|0|1|0|100|XEU|14059|9397|lyfalmen|V0456|9397||28|0|28,0000|Portfarma ehf|Portfarma|Olanzapín||6154||6154|9397| 024200|N04BD0201|Azilect|töflur|1|mg|100|stk|1|ţpakki||N04BD02|01.10.2005||R|||0|0|E|0|TPG|0|0|0|100|DKK|62156|80551|lyfalmen||||100|0|100,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||62156||62156|80551| 024307|V01AA1105|Alutard SQ, hundahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|23632|32203|lyfalmen||||20|0||Vistor hf|ALK-Abello A/S|dýr||23632||23632|32203| 024478|V04CL0016|Soluprick SQ ALK553 - hundahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|7440|11156|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7440||7440|11156| 024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006||R|||0|0|B|0|AZD|0|0|0|100|SEK|445|1588|lyfalmen||||100|0|2,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||445||445|1588| 024482|V04CL0017|Soluprick SQ ALK555 - kattahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|7440|11156|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7440||7440|11156| 024504|V04CL0003|Soluprick SQ ALK106 - Rauđölur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|12535|18277|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12535||12535|18277| 024526|V04CL0006|Soluprick SQ ALK113 - Hesliviđur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|12556|18303|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12556||12556|18303| 024565|V04CL0009|Soluprick SQ ALK218 - Hávingull|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|12685|18465|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12685||12685|18465| 024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|5364|8317|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||5364||5364|8317| 024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|||0|1|0|0|NOE|0|0|0|100|DKK|68153|88077|lyfalmen||||100|0|1,2500|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||68153||68153|88077| 024600|V04CL0013|Soluprick SQ ALK231 - Rúgur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|12685|18465|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12685||12685|18465| 024603|V04CL0001|Soluprick Negativ Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|1528|3069|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||1528||1528|3069| 024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|5364|8317|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||5364||5364|8317| 024644|V04CL0015|Soluprick SQ ALK552 - Hrossavćrur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|7440|11156|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7440||7440|11156| 024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|7440|11156|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7440||7440|11156| 024681|V04CL0002|Soluprick Positiv Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|1528|3069|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||1528||1528|3069| 024991|M01AE0111|Burana|filmhtfl|600|mg|30|stk|1|ţpakki||M01AE01|01.06.2012||R|||0|0|E|0|OPF|0|0|1|100|XEU|368|1482|lyfalmen|V0563|1482||30|0|15,0000|Portfarma ehf|Orion Corporation|Íbúprófen||368||368|1482| 025009|M01AE0111|Burana|filmhtfl|400|mg|30|stk|1|ţpakki||M01AE01|01.07.2012||L|||0|0|0|0|OPF|0|0|1|100|IKR|||lyflausa||||30|0|10,0000|Portfarma ehf|Orion Corporation|Íbúprófen|||||| 025020|M01AE0111|Burana|filmhtfl|400|mg|100|stk|1|glas||M01AE01|01.06.2012||R|||0|0|E|0|OPF|0|0|1|100|XEU|737|1987|lyfalmen|V0562|1987||100|0|33,3300|Portfarma ehf|Orion Corporation|Íbúprófen||737||737|1987| 025053|M01AE0111|Burana|filmhtfl|600|mg|100|stk|1|glas||M01AE01|01.06.2012||R|||0|0|E|0|OPF|0|0|1|100|XEU|895|2203|lyfalmen|V0564|2203||100|0|50,0000|Portfarma ehf|Orion Corporation|Íbúprófen||895||895|2203| 025142|D07AB0202|Locoid Crelo|lausn|1|mg/g|30|g|1|glas|á húđ|D07AB02|01.04.1994||R|||0|0|B|0|ASP|0|0|1|100|XEU|620|1827|lyfalmen||||30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||620||620|1827| 025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|18920|26290|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|dýr||18920||18920|26290| 025174|D07AB0202|Locoid Crelo|lausn|1|mg/g|100|g|1|glas|á húđ|D07AB02|01.04.1994||R|||0|0|B|0|ASP|0|0|1|100|XEU|1887|3560|lyfalmen||||100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1887||1887|3560| 025262|V01AA1105|Alutard SQ, hundahar|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|18920|26290|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|dýr||18920||18920|26290| 025306|M05BB0301|Fosavance|töflur|||12|stk|1|ţpakki|70mg+70mcg|M05BB03|01.10.2006||R|||0|0|0|0|MSD|0|0|0|100|DKK|13435|19406|lyfalmen||||12|0|84,0000|Vistor hf|M.S.D.|Alendrónsýra og kólekalsíferól||13435||13435|19406| 025317|J05AF1001|Baraclude|filmhtfl|1|mg|30|stk|1|ţpakki||J05AF10|01.09.2007||R|||0|1|0|1|BSP|0|0|0|100|DKK|81799|104540|lyfsjukr||||30|0|60,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||81799||81799|104540| 025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|ţpakki||J05AF10|01.09.2007||R|||0|1|0|1|BSP|0|0|0|100|DKK|76404|97770|lyfsjukr||||30|0|30,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||76404||76404|97770| 025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|||0|0|0|0|BOI|1|0|0|100|DKK|9375|18174|vetalmen||||20|0||Vistor hf|Boehringer Ingelheim|||9375||9375|18174| 025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|ţpakki|frostţurrkađar|V01AA02|01.02.2008||R|||0|1|0|0|ALK|0|0|0|100|DKK|16229|22913|lyfalmen||||30|0||Vistor hf|ALK-Abello A/S|grasfrjó||16229||16229|22913| 025444|C09CA0301|Diovan|filmhtfl|320|mg|98|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.04.2007||R|||0|0|0|0|NOH|0|0|0|100|DKK|19262|26719|lyfalmen||||98|0|392,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||19262||19262|26719| 025455|C09CA0301|Diovan|töflur|320|mg|28|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.04.2007||R|||0|0|0|0|NOH|0|0|0|100|DKK|6161|9407|lyfalmen||||28|0|112,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||6161||6161|9407| 025458|A10BX0203|Repaglinide Portfarma|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|||0|0|*|0|POF|0|0|0|100|DKK|2254|2882|lyfalmen|V0462|2871||90|0|11,2500|Portfarma ehf|Portfarma|Repaglíníđ||1391||1391|2882| 025469|A10BX0203|Repaglinide Portfarma|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|||0|0|*|0|POF|0|0|0|100|DKK|2454|3010|lyfalmen|V0471|2999||90|0|22,5000|Portfarma ehf|Portfarma|Repaglíníđ||1485||1485|3010| 025578|S01EC0302|Trusopt (D.A.C.)|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.2010||R|||0|0|*|0|DAC|0|0|0|100|DKK|1783|3418|lyfalmen||||5|0|16,6667|D.A.C. ehf|D.A.C. ehf|Dorzólamíđ||1783||1783|3418|30.09.2012 025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|ţpakki||M05BA06|01.01.2006||R|||0|0|0|0|RRL|0|0|0|100|DKK|5134|8002|lyfalmen|V0205|1219||1|0|30,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||5134||5134|8002| 025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|ţpakki||M05BA06|01.01.2006||R|||0|0|0|0|RRL|0|0|0|100|DKK|13758|19811|lyfalmen|V0205|3656||3|0|90,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||13758||13758|19811| 025632|A10BX0203|Repaglinide Portfarma|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|||0|0|*|0|POF|0|0|0|100|DKK|2638|3252|lyfalmen|V0472|3241||90|0|45,0000|Portfarma ehf|Portfarma|Repaglíníđ||1662||1662|3252| 025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|ţpakki|frostţurrkađar|V01AA02|01.02.2008||R|||0|1|0|0|ALK|0|0|0|100|DKK|52130|67968|lyfalmen||||100|0||Vistor hf|ALK-Abello A/S|grasfrjó||52130||52130|67968| 025747|C01BB0101|Xylocard 100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|||0|0|0|1|AZD|0|0|0|100|SEK|7582|10943|lyfsjukr||||25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Lídókaín||7582||7582|10943| 025841|V01AA1106|Alutard SQ, kattahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|23632|32203|lyfalmen||||20|0||Vistor hf|ALK-Abello A/S|dýr||23632||23632|32203| 025917|L04AX0201|Thalidomide Celgene|hylki|50|mg|28|stk|1|ţpakki|hart|L04AX02|01.09.2011||R|||0|1|0|1|CEE|0|0|0|100|XEU|56353|72606|lyfsjukr||||28|0|14,0000|Celgene Europe ltd|Celgene Europe ltd|Thalidómíde||||56353|72606| 025941|R03DC0302|Montelukast Portfarma|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.01.2012||R|||0|0|B|0|POF|0|0|0|100|XEU|13066|18943|lyfalmen|V0492|18943||98|0|39,2000|Portfarma ehf|Portfarma|Montelúkast||13066||13066|18943| 025958|M01AE0218|Naproxen Mylan|töflur|250|mg|100|stk|1|glas||M01AE02|01.01.1991|31.08.2012|R|||0|0|E|0|MYL|0|0|1|100|SEK|1022|2377|lyfalmen||||100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||1022||1022|2377| 025963|R03DC0302|Montelukast Portfarma|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.01.2012||R|||0|0|B|0|POF|0|0|0|100|XEU|15847|18943|lyfalmen|V0491|18943||98|0|49,0000|Portfarma ehf|Portfarma|Montelúkast||13066||13066|18943| 025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|||0|0|0|0|MEF|0|0|0|100|XEU|4606|8035|vetorma||||1|0||Vistor hf|Merial (MSD)|Ivermectinum||4606||4606|8035| 025976|M01AE0218|Naproxen Mylan|töflur|500|mg|25|stk|1|glas||M01AE02|01.12.2009|31.08.2012|R|||0|0|E|0|MYL|0|0|1|100|SEK|531|1705|lyfalmen||||25|0|25,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||531||531|1705| 025986|R03DC0302|Montelukast Portfarma|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.11.2011||R|||0|0|B|0|POF|0|0|0|100|XEU|13365|10323|lyfalmen|V0490|10117||98|0|98,0000|Portfarma ehf|Portfarma|Montelúkast||6831||6831|10323| 025994|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.01.1991|31.07.2012|R|||0|0|E|0|MYL|0|0|1|100|SEK|2698|3534|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||1868||1868|3534| 025997|A07DA0302|Loperamid Portfarma|töflur|2|mg|20|stk|1|ţpakki||A07DA03|01.05.2011||L|||0|0|0|0|POF|0|0|0|100|IKR|||lyflausa||||20|0|4,0000|Portfarma ehf|Portfarma|Lóperamíđ|||||| 026000|QS02CA0301|Easotic|eyrnadr|||10|ml|1|fl|dreifa|QS02CA03|01.04.2012||R|||0|0|0|0|VIR|0|0|0|100|SEK|2728|5411|vetalmen||||10|0||Vistor hf|Virbac S.A|Hýdrókortisón,miconazol,gentamicin||2728||2728|5411| 026019|A07DA0302|Loperamid Portfarma|töflur|2|mg|100|stk|1|ţpakki||A07DA03|01.07.2011||R|||0|0|E|0|POF|0|0|0|100|IKR|820|2101|lyfalmen|V0447|2101||100|0|20,0000|Portfarma ehf|Portfarma|Lóperamíđ||820||820|2101| 026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|||0|0|0|0|MEF|0|0|0|100|XEU|9073|15827|vetorma||||2|0||Vistor hf|Merial (MSD)|Ivermectinum||9073||9073|15827| 026086|N05AH0309|Kozylex|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.11.2011||R|||0|0|*|0|POF|0|1|0|100|XEU|22622|18913|lyfalmen|V0475|18913||28|0|42,0000|Portfarma ehf|Portfarma|Olanzapín||13042||13042|18913| 026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|18920|26290|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|dýr||18920||18920|26290| 026101|L01CA0501|Javlor|irţ|25|mg/ml|2|ml|1|hgl|lausn|L01CA05|01.12.2010||R|||0|1|0|1|PFM|0|0|0|100|DKK|41730|54254|lyfsjukr||||2|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||41730||41730|54254| 026114|L01CA0501|Javlor|irţ|25|mg/ml|10|ml|1|hgl|lausn|L01CA05|01.12.2010||R|||0|1|0|1|PFM|0|0|0|100|DKK|208676|263771|lyfsjukr||||10|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||208676||208676|263771| 026569|R02AA0305|Strepsils Cool|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.2010||L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 026571|N03AX1801|Vimpat|filmhtfl|50|mg|14|stk|1|ţpakki||N03AX18|01.12.2009||R|||0|0|E|0|UCB|0|0|0|100|DKK|1778|3411|lyfalmen||||14|0|2,3300|Vistor hf|U.C.B|Lacosamíđ||||1778|3411| 026582|N03AX1801|Vimpat|filmhtfl|50|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|||0|0|E|0|UCB|0|0|0|100|DKK|6737|10195|lyfalmen||||56|0|9,3300|Vistor hf|U.C.B|Lacosamíđ||||6737|10195| 026593|N03AX1801|Vimpat|filmhtfl|100|mg|14|stk|1|ţpakki||N03AX18|01.12.2009||R|||0|0|E|0|UCB|0|0|0|100|DKK|3512|5783|lyfalmen||||14|0|4,6700|Vistor hf|U.C.B|Lacosamíđ||||3512|5783| 026605|N03AX1801|Vimpat|filmhtfl|100|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|||0|0|E|0|UCB|0|0|0|100|DKK|13911|20003|lyfalmen||||56|0|18,6700|Vistor hf|U.C.B|Lacosamíđ||||13911|20003| 026627|N03AX1801|Vimpat|filmhtfl|150|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|||0|0|E|0|UCB|0|0|0|100|DKK|20846|28707|lyfalmen||||56|0|28,0000|Vistor hf|U.C.B|Lacosamíđ||||20846|28707| 026638|N03AX1801|Vimpat|filmhtfl|200|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|||0|0|E|0|UCB|0|0|0|100|DKK|27782|37412|lyfalmen||||56|0|37,3300|Vistor hf|U.C.B|Lacosamíđ||||27782|37412| 026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|||0|0|0|0|REP|0|0|1|100|SEK|1491|3019|lyfalmen||||100|0|25,0000|Vistor hf|Recip AB|Nítrófúrantóín||1491||1491|3019| 026698|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|14|stk|1|glas|hart|A02BC01|01.02.2012||L|||0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa||||14|0|14,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||| 026702|C10AA0505|Atorvastatin Bluefish|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA05|01.10.2012||R|||0|0|0|0|BLP|0|0|0|100|XEU|4403|4946|lyfalmen|V0114|4946||100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Atorvastatín||2900||2900|4946| 026946|J01CA0412|Amoxicillin Mylan (D.A.C.)|hylki|500|mg|30|stk|1|glas||J01CA04|01.07.2011||R|||0|0|0|0|DAC|0|0|1|100|SEK|1663|3254|lyfalmen|V0160|3254||30|0|15,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||1663||1663|3254| 026957|J01CA0412|Amoxicillin Mylan (D.A.C.)|hylki|500|mg|20|stk|1|glas||J01CA04|01.05.2011||R|||0|0|0|0|DAC|0|0|1|100|SEK|1182|2534|lyfalmen|V0159|2534||20|0|10,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||1137||1137|2534| 027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|||0|0|0|0|REP|0|0|1|100|SEK|443|1585|lyfalmen||||50|0|1,2500|Vistor hf|Recip AB|Nítrófúrantóín||443||443|1585| 027144|M01CC0101|Atamir|hylki|150|mg|50|stk|1|ţpakki||M01CC01|01.06.1982||R|||0|0|B|0|SGM|0|0|0|100|DKK|2642|4593|lyfalmen|V0199|3411||50|0|15,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||2642||2642|4593| 027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|||0|0|*|0|ALA|0|0|0|100|USD|2458|4341|lyfalmen||||5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||2458||2458|4341| 027235|G03HA0104|Cyproteron Mylan|töflur|50|mg|50|stk|1|glas||G03HA01|01.04.1997||R|||0|0|*|0|MYL|0|0|0|100|SEK|7287|10947|lyfalmen||||50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Cýpróterón||7287||7287|10947| 027281|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|100|stk|1|ţpakki||N06DA02|01.05.2009||R|||0|0|E|0|ACA|0|0|0|100|XEU|28924|13605|lyfalmen|V0341|13605||100|0|66,6600|Actavis Group hf|Actavis hf|Dónepezíl||9230||9230|13605| 027305|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|100|stk|1|ţpakki||N06DA02|01.05.2009||R|||0|0|E|0|ACA|0|0|0|100|XEU|32460|14939|lyfalmen|V0342|14934||100|0|133,3300|Actavis Group hf|Actavis hf|Dónepezíl||10205||10205|14939| 027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|ţpakki||N03AX15|01.03.2007||R|||0|0|E|0|EIS|0|0|0|100|SEK|7527|11275|lyfalmen||||56|0|7,0000|Vistor hf|Eisai Ltd|Zonisamíđ||7527||7527|11275| 027595|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|ţpakki||N03AX15|01.03.2007||R|||0|0|E|0|EIS|0|0|0|100|SEK|9919|14548|lyfalmen||||56|0|14,0000|Vistor hf|Eisai Ltd|Zonisamíđ||9919||9919|14548| 027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|||0|0|B|0|NYC|0|0|0|100|DKK|822|2103|lyfalmen|V0153|2103||100|0|33,3300|Vistor hf|Nycomed Danmark A/S|Levótýroxínnatríum||822||822|2103| 027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|||0|0|B|0|NYC|0|0|0|100|DKK|822|2103|lyfalmen|V0154|1973||100|0|66,6667|Vistor hf|Nycomed Danmark A/S|Levótýroxínnatríum||822||822|2103| 027733|N05AH0409|Quetiapin Orion|filmhtfl|25|mg|100|stk|1|ţpakki||N05AH04|01.10.2012||R|||0|0|*|0|OPF|0|1|0|100|SEK|2072|2853|lyfalmen|V0284|2853||100|0|6,2500|Portfarma ehf|Orion Corporation|Quetíapín||1370||1370|2853| 027795|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.08.2006||R|||0|1|0|1|SPE|0|0|0|100|DKK|98332|125289|lyfsjukr||||105|0|5,2500|Vistor hf|SP Europe|Posacónazól||98332||98332|125289| 027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|ţpakki||N05AX12|01.01.2007||R|||0|0|0|0|OTS|0|1|0|100|DKK|20064|27725|lyfalmen||||28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||20064||20064|27725| 027976|N05AH0307|Zypadhera|sts|210|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|||0|0|0|1|ELD|0|1|0|100|XEU|31261|41115|lyfsjukr||||1|0|21,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||31261|41115| 027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|ţpakki||N05AX12|01.01.2007||R|||0|0|0|0|OTS|0|1|0|100|DKK|23189|31647|lyfalmen||||28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||23189||23189|31647| 027988|N05AH0307|Zypadhera|sts|300|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|||0|0|0|1|ELD|0|1|0|100|XEU|46063|59692|lyfsjukr||||1|0|30,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||46063||46063|59692| 027999|N05AH0307|Zypadhera|sts|405|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|||0|0|0|1|ELD|0|1|0|100|XEU|58026|74705|lyfsjukr||||1|0|40,5000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||58026|74705| 028045|G03AB0001|Qlaira|töflur|||84|stk|1|ţpakki|3x28 stk|G03AB|01.11.2009||R|||0|0|0|0|BAP|0|0|0|100|SEK|5197|8088|lyfalmen||||84|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Kaflaskipt lyf, prógestógen og östrógen||5197||5197|8088| 028112|R06AX2602|Nefoxef|filmhtfl|120|mg|30|stk|1|ţpakki||R06AX26|01.07.2008||L|||0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa||||30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín|||||| 028121|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|ţpakki|50/1000mg|A10BD07|01.01.2010||R|||0|0|*|0|MSD|0|0|0|100|DKK|23748|32349|lyfalmen|V0386|32349||196|0|98,0000|Vistor hf|M.S.D.|Metforminum og sitagliptinum||23748||23748|32349| 028124|R06AX2602|Nefoxef|filmhtfl|120|mg|100|stk|1|ţpakki||R06AX26|01.07.2008||R|||0|0|E|0|MYL|0|0|1|100|SEK|3715|4839|lyfalmen|V0364|4839||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||2822||2822|4839| 028168|C09XA5201|Rasilez HCT|filmhtfl|162,5|mg|28|stk|1|ţpakki|150/12,5 mg|C09XA52|01.06.2009|31.07.2012|R|||0|0|0|0|NOE|0|0|0|100|DKK|4040|6505|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og ţvagrćsilyf||||4040|6505| 028177|C10AD5201|Tredaptive|töflur|1020|mg|98|stk|2|ţpakki|1000+20 mg|C10AD52|01.12.2009||R|||0|0|0|0|MSD|0|0|0|100|DKK|18375|25606|lyfalmen|V0120|25606||196|0||Vistor hf|M.S.D.|Nikótínsýra og afleiđur-Nikótínsýra í blöndum||||18375|25606| 028268|R03DX0501|Xolair|stl|150|mg|1|áf.spr|1|pakki||R03DX05|01.04.2011||R|||0|1|0|1|NOE|0|0|0|100|DKK|55468|71495|lyfsjukr||||1|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||55468||55468|71495| 028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ ađsk. nál|J07AP03|01.05.2008||R|||0|0|0|0|SPM|0|0|0|100|XEU|2475|4365|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsađir mótefnavakar||2475||2475|4365| 028351|J07BL0101|Stamaril|sts|||0,5|ml|10|hgl|+ 10 áf.spr. međ leysi|J07BL01|01.01.1996||R|||0|0|0|0|SPM|0|0|0|100|XEU|20777|28620|lyfalmen||||5|0||Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluđ veira||20777||20777|28620| 028360|J07BG0101|Rabies - Imovax|bóluefni|||1|ml|1|hgl||J07BG01|01.01.1996||R|||0|0|0|0|MEX|0|0|0|100|SEK|10667|15571|lyfalmen||||1|0||Icepharma hf|Aventis Pasteur MSD A/S|Hundaćđi, dauđ veira||10667||10667|15571| 028387|M03BX0105|Baklofen Mylan|töflur|25|mg|50|stk|1|glas||M03BX01|01.10.2008||R|||0|0|E|0|MYL|0|0|1|100|SEK|1944|3638|lyfalmen|V0202|3638||50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Baklófen||1944||1944|3638| 028405|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|||0|0|E|0|MYL|0|0|1|100|SEK|2179|3960|lyfalmen|V0428|3444||50|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||2179||2179|3960| 028498|C08DB0102|Cardizem Retard|forđatfl|120|mg|60|stk|1|glas||C08DB01|01.04.1987||R|||0|0|B|0|FRO|0|0|0|100|DKK|5145|8017|lyfalmen||||60|0|30,0000|Vistor hf|Ferrosan A/S|Diltíazem||5145||5145|8017| 028575|N03AX0901|Lamictal|dreifit.|5|mg|56|stk|1|ţpakki||N03AX09|01.05.2009||R|||0|0|E|0|GSK|0|0|0|100|IKR|1278|2727|lyfalmen||||56|0|0,9334|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||1278|2727| 028586|N03AX0901|Lamictal|dreifit.|100|mg|98|stk|1|ţpakki||N03AX09|01.05.2009||R|||0|0|E|0|GSK|0|0|0|100|IKR|5812|5233|lyfalmen|V0245|4615||98|0|32,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||3110||3110|5233| 028598|N03AX0901|Lamictal|dreifit.|200|mg|98|stk|1|ţpakki||N03AX09|01.05.2009||R|||0|0|E|0|GSK|0|0|0|100|IKR|10358|10172|lyfalmen|V0232|9533||98|0|65,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||6720||6720|10172| 028599|N04BC0503|Pramipexole Portfarma|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.02.2010||R|||0|0|E|0|POF|0|0|0|100|XEU|780|1389|lyfalmen|V0266|1099||30|0|1,0600|Portfarma ehf|Portfarma|Pramipexól||300||300|1389| 028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|||0|0|0|0|OCO|1|0|0|100|DKK|7781|15113|vetalmen||||10|0||Icepharma hf|Orion Corporation (I)|||7781||7781|15113| 028609|R03DC0302|Montelukast Portfarma|filmhtfl|10|mg|28|stk|1|ţpakki||R03DC03|01.10.2011||R|||0|0|B|0|POF|0|0|0|100|XEU|4491|7122|lyfalmen||||28|0|28,0000|Portfarma ehf|Portfarma|Montelúkast||4491||4491|7122| 028610|N04BC0503|Pramipexole Portfarma|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.02.2010||R|||0|0|E|0|POF|0|0|0|100|XEU|5075|2778|lyfalmen|V0267|2519||100|0|7,2000|Portfarma ehf|Portfarma|Pramipexól||1315||1315|2778| 028622|N04BC0503|Pramipexole Portfarma|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.02.2010||R|||0|0|E|0|POF|0|0|0|100|XEU|18298|9786|lyfalmen|V0269|9786||100|0|28,0000|Portfarma ehf|Portfarma|Pramipexól||6438||6438|9786| 028907|J02AC0103|Fluconazole Portfarma|hylki|50|mg|7|stk|1|ţpakki||J02AC01|01.05.2010||R|||0|0|0|0|POF|0|0|1|100|IKR|1362|2842|lyfalmen|V0551|2439||7|0|1,7500|Portfarma ehf|Portfarma|Flúkónazól||1362||1362|2842| 028918|J02AC0103|Fluconazole Portfarma|hylki|50|mg|30|stk|1|ţpakki||J02AC01|01.05.2010||R|||0|0|0|0|POF|0|0|1|100|IKR|4998|7816|lyfalmen|V0552|6426||30|0|7,5000|Portfarma ehf|Portfarma|Flúkónazól||4998||4998|7816| 028929|J02AC0103|Fluconazole Portfarma|hylki|150|mg|1|stk|1|ţpakki||J02AC01|01.05.2010||R|||0|0|0|0|POF|0|0|1|100|IKR|577|1768|lyfalmen|V0554|1768||1|0|0,7500|Portfarma ehf|Portfarma|Flúkónazól||577||577|1768| 028940|J02AC0103|Fluconazole Portfarma|hylki|150|mg|2|stk|1|ţpakki||J02AC01|01.05.2010||R|||0|0|0|0|POF|0|0|1|100|IKR|563|1749|lyfalmen|V0555|1749||2|0|1,5000|Portfarma ehf|Portfarma|Flúkónazól||563||563|1749| 028953|J02AC0103|Fluconazole Portfarma|hylki|150|mg|4|stk|1|ţpakki||J02AC01|01.05.2010||R|||0|0|0|0|POF|0|0|1|100|IKR|2031|3757|lyfalmen|V0556|3187||4|0|3,0000|Portfarma ehf|Portfarma|Flúkónazól||2031||2031|3757| 029066|R01AD0801|Flixonase|nefúđi|50|mcg/sk|16|ml|1|stauk|120 sk|R01AD08|01.04.1992||R|||0|0|E|0|GSK|0|0|1|100|GBP|1119|2510|lyfalmen||||16|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||||1119|2510| 029078|N06AX2201|Valdoxan|filmhtfl|25|mg|28|stk|1|ţpakki||N06AX22|01.01.2010||R|||0|0|0|0|SEV|0|1|0|100|DKK|7427|11139|lyfalmen||||28|0|28,0000|Icepharma hf|Servier|Agómelatín||7427||7427|11139| 029100|N06AX2201|Valdoxan|filmhtfl|25|mg|84|stk|1|ţpakki||N06AX22|01.01.2010||R|||0|0|0|0|SEV|0|1|0|100|DKK|21186|29134|lyfalmen||||84|0|84,0000|Icepharma hf|Servier|Agómelatín||21186||21186|29134| 029198|R06AX2201|Kestine|filmhtfl|20|mg|30|stk|1|ţpakki||R06AX22|01.06.2012||R|||0|0|E|0|APS|0|0|1|100|DKK|2834|4856|lyfalmen||||30|0|60,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||2834||2834|4856| 029287|C03DB0105|Amiloride|töflur|5|mg|28|stk|1|ţpakki||C03DB01|01.04.2009||R|||0|0|E|0|AUK|0|0|0|100|GBP|262|1337|lyfalmen||||28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Amiloridhýdróklóríđ||||262|1337| 029361|C10AA0103|Zocor (Lyfjaver)|töflur|20|mg|98|stk|1|ţpakki||C10AA01|01.09.2005||R|||0|0|0|0|LVR|0|0|0|100|XEU|7409|9077|lyfalmen|V0109|1817||98|0|65,3400|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||5920||5920|9077| 029429|L01XX4101|Halaven|stl|0,44|mg/ml|2|ml|1|hgl|lausn|L01XX41|01.11.2011||R|||0|1|0|1|EIS|0|0|0|100|SEK|66827|85750|lyfsjukr||||2|0||Vistor hf|Eisai Ltd|Eribulin||66827||66827|85750| 029517|L01BB0503|Fludarabin Actavis|sts/irs|25|mg/ml|50|mg|1|hgl||L01BB05|01.04.2009||R|||0|1|0|1|AGP|0|0|0|100|XEU|22077|29589|lyfsjukr||||50|0||Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||22077||22077|29589| 029528|L01CA0402 |Vinorelbin Actavis|irţ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|||0|1|0|1|AGP|0|0|0|100|XEU|5708|8238|lyfsjukr||||5|0||Actavis Group hf|Actavis Group PTC ehf|Vínorelbín||5708||5708|8238| 029574|L01XX1904|Irinotecan Actavis|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.04.2009||R|||0|1|0|1|AGT|0|0|0|100|XEU|4385|6329|lyfsjukr||||5|0||Actavis Group hf|Actavis Group hf|Írinótekan||4385||4385|6329| 029695|C09DA0601|Atacand Plus|töflur|44,5|mg|28|stk|1|ţpakki|32+12,5 mg|C09DA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|5280|8202|lyfalmen||||28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||5280|8202| 029706|C09DA0601|Atacand Plus|töflur|44,5|mg|98|stk|1|ţpakki|32+12,5 mg|C09DA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|16582|23356|lyfalmen||||98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||16582|23356| 029717|C09DA0601|Atacand Plus|töflur|57|mg|28|stk|1|ţpakki|32+25 mg|C09DA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|5280|8202|lyfalmen||||28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||5280|8202| 029729|C09DA0601|Atacand Plus|töflur|57|mg|98|stk|1|ţpakki|32+25 mg|C09DA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|16582|23356|lyfalmen||||98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||16582|23356| 029800|J01AA0208|Oracea|hylki|40|mg|56|stk|1|ţpakki|međ br.losunarhrađa|J01AA02|01.12.2011||R|||0|0|0|0|GAN|0|0|1|100|SEK|6717|10167|lyfalmen||||56|0|22,4000|Icepharma hf|Galderma Nordic AB|Doxýcýklín||6717||6717|10167| 029811|B02BX0401|Nplate|sts|250|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|||0|1|0|1|AEU|0|0|0|100|DKK|98245|125180|lyfsjukr||||1|0|8,3300|Vistor hf|Amgen Europe B.V.|Romiplóstím||98245||98245|125180| 029822|B02BX0401|Nplate|sts|500|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|||0|1|0|1|AEU|0|0|0|100|DKK|196489|248476|lyfsjukr||||1|0|16,6600|Vistor hf|Amgen Europe B.V.|Romiplóstím||196489||196489|248476| 029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.05.2006||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|ţpakki||N07BA01|01.05.2006||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.05.2006||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.05.2006||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|ţpakki||N07BA01|01.05.2006||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.05.2006||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 030313|G04CA0206|Tamsulosin Portfarma|forđahlk|0,4|mg|90|stk|1|ţpakki||G04CA02|01.05.2011||R|||0|0|E|0|POF|0|0|0|100|SEK|4997|4009|lyfalmen|V0148|3942||90|0|90,0000|Portfarma ehf|Portfarma|Tamsúlósín||2215||2215|4009| 030315|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|ţpakki||N03AX15|01.03.2007||R|||0|0|E|0|EIS|0|0|0|100|SEK|23574|32131|lyfalmen||||98|0|49,0000|Vistor hf|Eisai Ltd|Zonisamíđ||23574||23574|32131| 030588|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|ţpakki||M01AX05|01.07.2006||L|||0|0|0|0|LEX|0|0|1|100|IKR|||lyflausa||||60|0|52,8000|Icepharma hf|Laboratories Expansvience|Glúkósamín|||||| 030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|||0|0|*|0|NOH|0|1|0|100|DKK|9043|13349|lyfalmen|V0277|13348||100|0|33,3333|Vistor hf|Novartis Healthcare A/S-|Klózapín||9043||9043|13349| 030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|||0|0|*|0|NOH|0|1|0|100|DKK|2884|4924|lyfalmen||||100|0|8,3333|Vistor hf|Novartis Healthcare A/S-|Klózapín||2884||2884|4924| 030754|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|770|l|1|hylki|kćlt|V03AN01|01.03.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||770|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 030765|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|11000|l|1|hylki|kćlt|V03AN01|01.03.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||11000|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 030822|QI02AB0001|Startvac|stl|||2|ml|20|glös|fleyti|QI02AB|01.05.2010||R|||0|0|0|0|LHS|0|0|0|100|XEU|15802|27566|vetorma||||40|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||||15802|27566| 030940|C07AB0210|Metoprolol Mylan|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|||0|0|B|0|MYL|0|0|0|100|SEK|1440|2949|lyfalmen|V0051|2949||100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Metóprólól||1440||1440|2949| 031039|C07AB0210|Metoprolol Mylan|töflur|100|mg|100|stk|1|glas||C07AB02|01.10.1995||R|||0|0|B|0|MYL|0|0|0|100|SEK|2276|4092|lyfalmen||||100|0|66,6667|Actavis Group PTC ehf|Mylan AB|Metóprólól||2276||2276|4092| 031070|A04AD0101|Scopoderm|forđapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||L|||0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen||||2|0|2,0000|Artasan ehf|Novartis Healthcare A/S|Skópólamín|||||2630| 031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|||0|0|*|0|ELD|0|0|0|100|XEU|3090|5206|lyfalmen||||10|0|25,0000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||3090||3090|5206| 031314|L01AX0301|Temodal|hylki|20|mg|20|sk-pokar|1|pakki||L01AX03|01.01.2010||R|||0|1|0|1|SCP|0|0|0|100|DKK|64223|82482|lyfsjukr||||20|0||Vistor hf|Schering-Plough|Temozolomid||64223||64223|82482| 031325|L01AX0301|Temodal|hylki|100|mg|5|sk-pokar|1|pakki||L01AX03|01.01.2010||R|||0|1|0|1|SCP|0|0|0|100|DKK|78246|100081|lyfsjukr||||5|0||Vistor hf|Schering-Plough|Temozolomid||78246||78246|100081| 031394|L01AX0301|Temodal|hylki|250|mg|5|sk-pokar|1|pakki||L01AX03|01.01.2010||R|||0|1|0|1|SCP|0|0|0|100|DKK|172509|218381|lyfsjukr||||5|0||Vistor hf|Schering-Plough|Temozolomid||172509||172509|218381| 031773|C01DA0801|Sorbangil|töflur|20|mg|100|stk|1|glas||C01DA08|01.01.1985||R|||0|0|B|0|REP|0|0|0|100|SEK|2186|3969|lyfalmen||||100|0|33,3333|Vistor hf|Recip AB|Ísósorbíđ dínítrat||2186||2186|3969| 031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|||0|0|*|0|NAS|0|0|0|100|DKK|5819|8939|lyfalmen||||15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5819||5819|8939| 031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|||0|0|0|1|FEL|0|0|0|100|DKK|22791|30485|lyfsjukr||||5|0|0,4200|Vistor hf|Ferring Lćgemidler A/S|Terlípressín||22791||22791|30485| 031971|C07AA0705|Sotalol Mylan|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|||0|0|B|0|MYL|0|0|0|100|SEK|2086|3832|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||2086||2086|3832| 032122|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.02.2009||R|||0|0|0|1|STM|0|0|0|100|DKK|9440|13624|lyfsjukr||||4|0||Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíđ||||9440|13624| 032145|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.02.2009||R|||0|0|0|1|STM|0|0|0|100|DKK|13797|19198|lyfsjukr||||10|0||Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíđ||||13797|19198| 032179|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.02.2009||R|||0|0|0|1|STM|0|0|0|100|DKK|47740|61796|lyfsjukr||||50|0||Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíđ||||47740|61796| 032190|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|1|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||1|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032202|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|2|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||2|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032236|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|4|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||4|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032247|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|5|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||5|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032258|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|10|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||10|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032270|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|20|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||20|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032281|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|50|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||50|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032304|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|50|l|12|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||600|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|||0|0|*|0|OTS|0|1|0|100|DKK|20687|28507|lyfalmen||||150|0|10,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||20687||20687|28507| 032649|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|50|ml|1|hgl|plast|QP54AA01|01.01.1985||R|||0|0|0|0|MEF|1|0|0|100|XEU|3727|6502|vetorma||||50|0||Vistor hf|Merial (MSD)|Ivermectinum||3727||3727|6502| 032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|||0|0|0|0|MEF|1|0|0|100|XEU|14544|25371|vetorma||||200|0||Vistor hf|Merial (MSD)|Ivermectinum||14544||14544|25371| 033124|L02BX0201|Firmagon|sts|80|mg|1|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|||0|1|*|0|FER|0|0|0|100|DKK|20967|28859|lyfalmen||||1|0|29,6300|Vistor hf|Ferring|Degarelix||||20967|28859| 033135|L02BX0201|Firmagon|sts|120|mg|2|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|||0|1|*|0|FER|0|0|0|100|DKK|41818|55027|lyfalmen||||2|0|88,8900|Vistor hf|Ferring|Degarelix||||41818|55027| 033193|QP54AA0105|Noromectin|pasta|18,7|mg/g|7,49|g|1|áf.spr|Fyrir hesta|QP54AA01|01.11.2011||L|||0|0|0|0|NOB|1|0|0|100|XEU|1201|2095|vetorma||||7|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||||1201|2095| 033195|N02AA5501|Targin|forđatfl|15|mg|28|stk|1|ţpakki|10+5 mg|N02AA55|01.10.2012||R|||1|0|0|0|NOP|0|0|0|100|DKK|3022|5113|lyfalmen||||28|0|3,7400|Icepharma hf|Norpharma|Oxycodonum í blöndum||3022||3022|5113| 033201|QJ01DD9001|Eficur vet.|stl|50|mg/ml|100|ml|1|hgl||QJ01DD90|01.02.2010||R|||0|0|0|0|LHS|0|0|0|100|XEU|8993|17440|vetalmen||||100|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Ceftiofurhydróklóríđ||||8993|17440| 033206|N02AA5501|Targin|forđatfl|15|mg|98|stk|1|ţpakki|10+5 mg|N02AA55|01.10.2012||R|||1|0|0|0|NOP|0|0|0|100|DKK|10297|15065|lyfalmen||||98|0|13,0700|Icepharma hf|Norpharma|Oxycodonum í blöndum||10297||10297|15065| 033218|N02AA5501|Targin|forđatfl|30|mg|28|stk|1|ţpakki|20+10 mg|N02AA55|01.10.2012||R|||1|0|0|0|NOP|0|0|0|100|DKK|6047|9251|lyfalmen||||28|0|7,4700|Icepharma hf|Norpharma|Oxycodonum í blöndum||6047||6047|9251| 033229|N02AA5501|Targin|forđatfl|30|mg|98|stk|1|ţpakki|20+10 mg|N02AA55|01.10.2012||R|||1|0|0|0|NOP|0|0|0|100|DKK|17849|24946|lyfalmen||||98|0|26,1400|Icepharma hf|Norpharma|Oxycodonum í blöndum||17849||17849|24946| 033251|S01CA0102|Tobradex|augndr|||5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|||0|0|E|0|ALC|0|0|1|100|USD|1264|2708|lyfalmen||||5|0||K.Pétursson hf|Alcon|Dexametasón||1264||1264|2708| 033777|L02BG0404|Letromal|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.04.2011||R|||0|0|*|0|WIH|0|0|0|100|XEU|45753|21578|lyfalmen|V0185|21552||100|0|100,0000|Portfarma ehf|Williams & Halls|Letrózól||15166||15166|21578| 033884|J05AE1001|Prezista|filmhtfl|400|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|||0|1|0|1|JCI|0|0|0|100|SEK|83880|107152|lyfsjukr||||60|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||83880||83880|107152| 033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|||0|1|0|1|JCI|0|0|0|100|SEK|109408|139190|lyfsjukr||||60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||109408||109408|139190| 034033|QJ01MA9001|Baytril vet.|töflur|50|mg|10|stk|1|ţpakki||QJ01MA90|01.03.2009||R|||0|0|0|0|BAN|0|0|0|100|DKK|2433|4840|vetalmen||||10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||2433|4840| 034157|J07AM5104|Diftavax|bóluefni|||0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000||R|||0|0|0|0|SPM|0|0|1|100|XEU|733|1982|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Stífkrampatoxóíđ í blöndum međ barnaveikistoxóíđum||733||733|1982| 034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|||0|0|0|1|CSB|0|0|0|100|SEK|24134|32171|lyfsjukr||||25|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||24134||24134|32171| 034423|J07BA0201|Ixiaro|stl|6|mcg|0,5|ml|1|spr|dreifa|J07BA02|01.01.2012||R|||0|0|0|0|IAG|0|0|0|100|SEK|15619|22147|lyfalmen||||0|0||Intercell AG|Intercell AG|Japönsk heilabólguveira óvirk||15619||15619|22147| 034468|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|ţpakki||B01AC22|01.12.2009||R|||0|0|E|0|ELD|0|0|0|100|XEU|7982|11898|lyfalmen||||28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||7982|11898| 034479|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|ţpakki||B01AC22|01.12.2009||R|||0|0|E|0|ELD|0|0|0|100|XEU|7982|11898|lyfalmen||||28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||7982|11898| 034494|N05CM1801|Dexdor|irţ|100|mcg/ml|10|ml|4|hgl|lausn|N05CM18|01.03.2012||R|||0|1|0|1|ORC|0|0|0|100|DKK|75297|96380|lyfsjukr||||40|0||Vistor hf|Orion Corporation|Dexmedetómid||75297||75297|96380| 034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|||0|0|E|0|NOH|0|0|1|100|DKK|1798|3438|lyfalmen|V0367|2598||6|0||Vistor hf|Novartis Healthcare A/S-|Díklófenak||1798||1798|3438| 034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|||0|0|E|0|NOH|0|0|1|100|DKK|3083|5196|lyfalmen|V0367|5196||12|0||Vistor hf|Novartis Healthcare A/S-|Díklófenak||3083||3083|5196| 034988|L03AB0702|Rebif|stl|44|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|||0|1|0|1|MSE|0|0|0|100|SEK|180526|228443|lyfsjukr||||2|0|40,9300|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||180526||180526|228443| 035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|||0|0|0|1|LEP|0|0|0|100|DKK|7324|10570|lyfsjukr||||25|0||Vistor hf|LEO Pharma A/S|Prótamín||7324||7324|10570| 035113|B05XA0501|Addex-Magnesium|irţ|1|mmol/ml|10|ml|10|plhgl||B05XA05|01.03.2010||R|||0|0|0|1|FRP|0|0|0|100|DKK|2224|3210|lyfsjukr||||100|0||Icepharma hf|Fresenius Kabi|Magnesíum súlfat||2224||2224|3210| 035212|A07EC0202|Pentasa|forđatfl|500|mg|300|stk|1|ţpakki||A07EC02|01.04.1992||R|||0|0|B|0|FER|0|0|0|100|DKK|15698|22246|lyfalmen||||300|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||15698||15698|22246| 035444|C09CA0601|Atacand|töflur|16|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|3709|6053|lyfalmen|V0079|6053||28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||3709|6053| 035494|C07AB0211|Metoprolol ratiopharm|forđatfl|23,75|mg|100|stk|1|ţpakki||C07AB02|01.05.2012||R|||0|0|B|0|RGM|0|0|0|100|XEU|982|2322|lyfalmen|V0050|2322||100|0|15,8300|Medical ehf|ratiopharm GmbH|Metóprólól||982||982|2322| 035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|ţpakki||N03AX09|01.11.2005||R|||0|0|E|0|ACA|0|0|0|100|IKR|1844|2575|lyfalmen|V0244|2575||56|0|9,3300|Actavis Group hf|Actavis hf|Lamótrigín||1167||1167|2575| 035528|C07AB0211|Metoprolol ratiopharm|forđatfl|47,5|mg|100|stk|1|ţpakki||C07AB02|01.06.2012||R|||0|0|B|0|RGM|0|0|0|100|XEU|1310|2771|lyfalmen|V0048|2771||100|0|31,6600|Medical ehf|ratiopharm GmbH|Metóprólól||1310||1310|2771| 035542|S01LA0301|Macugen|stl|0,3|mg/spr|1|spr|1|pakki|lausn|S01LA03|01.06.2006|31.07.2012|R|||0|1|0|1|PER|0|0|0|100|DKK|124059|157577|lyfsjukr||||1|0||Icepharma hf|Pfizer ApS|Pegaptaníb||124059||124059|157577| 035563|C07AB0211|Metoprolol ratiopharm|forđatfl|95|mg|100|stk|1|ţpakki||C07AB02|01.05.2012||R|||0|0|B|0|RGM|0|0|0|100|XEU|2339|4179|lyfalmen|V0049|4179||100|0|63,3300|Medical ehf|ratiopharm GmbH|Metóprólól||2339||2339|4179| 035568|C09CA0601|Atacand|töflur|16|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|10637|15530|lyfalmen|V0080|12231||98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||10637||10637|15530| 035597|C07AB0211|Metoprolol ratiopharm|forđatfl|190|mg|100|stk|1|ţpakki||C07AB02|01.06.2012||R|||0|0|B|0|RGM|0|0|0|100|XEU|5110|7277|lyfalmen|V0054|7277||100|0|126,6600|Medical ehf|ratiopharm GmbH|Metóprólól||4604||4604|7277| 036062|V03AE0202|Renvela|filmhtfl|800|mg|180|stk|1|pakki||V03AE02|01.04.2010||R|||0|0|0|0|GZE|0|0|0|100|XEU|30020|36595|lyfalmen||||180|0|22,5000|Vistor hf|Genzyme Europe B.V.|Sevelamer||27131||27131|36595| 036108|L03AB0702|Rebif|stl|22|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|||0|1|0|1|MSE|0|0|0|100|SEK|148021|187649|lyfsjukr||||2|0|20,4700|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||148021||148021|187649| 036145|M01AC0202|Tilcotil|töflur|20|mg|60|stk|1|glas||M01AC02|01.04.1988||R|||0|0|E|0|MAS|0|0|1|100|SEK|6185|9440|lyfalmen||||60|0|60,0000|Vistor hf|Meda AS|Tenoxíkam||6185||6185|9440| 036152|C09CA0601|Atacand|töflur|8|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|3035|5131|lyfalmen||||28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||3035||3035|5131| 036228|C09CA0601|Atacand|töflur|8|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|8840|13072|lyfalmen|V0081|10326||98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||8840||8840|13072| 036290|J05AE0301|Norvir|filmhtfl|100|mg|30|stk|1|glas||J05AE03|01.10.2010||R|||0|1|0|1|ABL|0|0|0|100|DKK|5960|8602|lyfsjukr||||30|0|2,5000|Vistor hf|Abbott Laboratories A/S|Ritonavír||5960||5960|8602| 036332|L01XE0401|Sutent|hylki|12,5|mg|30|stk|1|glas||L01XE04|01.10.2006||R|||0|1|0|1|IPI|0|0|0|100|DKK|193310|244487|lyfsjukr||||30|0||Icepharma hf|Pfizer Limited|Sunitíníb||193310||193310|244487| 036341|L01XE0401|Sutent|hylki|25|mg|30|stk|1|glas||L01XE04|01.10.2006||R|||0|1|0|1|IPI|0|0|0|100|DKK|385573|485777|lyfsjukr||||30|0||Icepharma hf|Pfizer Limited|Sunitíníb||385573||385573|485777| 036351|L01XE0401|Sutent|hylki|50|mg|30|stk|1|glas||L01XE04|01.10.2006||R|||0|1|0|1|IPI|0|0|0|100|DKK|769525|967636|lyfsjukr||||30|0||Icepharma hf|Pfizer Limited|Sunitíníb||769525||769525|967636| 036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|ţpakki||J01CE02|01.01.1988||R|||0|0|0|0|REP|0|0|1|100|SEK|846|2136|lyfalmen||||20|0|8,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||846||846|2136| 036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|||0|0|0|0|REP|0|0|1|100|SEK|1488|3014|lyfalmen||||60|0|3,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1488||1488|3014| 036541|A03AX1301|Minifom|dropar|||30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|||0|0|0|0|GSC|0|0|0|100|IKR|||lyflausa||||30|0|6,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Silíkonsambönd|||||| 036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|||0|0|0|0|REP|0|0|1|100|SEK|2936|4995|lyfalmen||||125|0|6,2500|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||2936||2936|4995| 036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|ţpakki||J01CE02|01.01.1988||R|||0|0|0|0|REP|0|0|1|100|SEK|890|2196|lyfalmen||||30|0|12,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||890||890|2196| 037287|N04BC0404|Requip Depot|forđatfl|2|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|||0|0|E|0|GSK|0|0|0|100|GBP|12450|18170|lyfalmen||||84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||12450||12450|18170| 037305|N04BC0404|Requip Depot|forđatfl|4|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|||0|0|E|0|GSK|0|0|0|100|GBP|22855|31228|lyfalmen||||84|0|56,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||22855||22855|31228| 037323|N04BC0404|Requip Depot|forđatfl|8|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|||0|0|E|0|GSK|0|0|0|100|GBP|44696|58639|lyfalmen||||84|0|112,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||44696||44696|58639| 037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|||0|0|E|0|ROC|0|0|0|100|DKK|2469|4356|lyfalmen|V0434|4356||100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2469||2469|4356| 037531|D07AC1301|Elocon|húđlausn|0,1|%|30|ml|1|glas||D07AC13|01.01.2009||R|||0|0|B|0|SPL|0|0|1|100|DKK|1129|2523|lyfalmen||||30|0||Vistor hf|Schering-Plough Europe|Mómetasón||1129||1129|2523| 037846|A12BA0101|Kaleorid|forđatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|||0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen||||100|0|25,0000|Vistor hf|LEO Pharma A/S|Kalíumklóríđ|||||2229| 037853|A12BA0101|Kaleorid|forđatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|||0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen||||250|0|62,5000|Vistor hf|LEO Pharma A/S|Kalíumklóríđ|||||3601| 037895|C09CA0601|Atacand|töflur|4|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|8710|12894|lyfalmen||||98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||8710|12894| 038174|N06AB0501|Seroxat|töflur|20|mg|20|stk|1|ţpakki||N06AB05|01.04.1993||R|||0|0|0|0|GSK|0|1|0|100|IKR|664|1499|lyfalmen||||20|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||380||380|1499| 038257|N06AB0501|Seroxat|töflur|20|mg|60|stk|1|ţpakki||N06AB05|01.04.1993|31.07.2012|R|||0|0|B|0|GSK|0|1|0|100|IKR|1766|2374|lyfalmen||||60|0|60,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1020||1020|2374| 038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|ţpakki||N06AB05|01.04.1993||R|||0|0|B|0|GSK|0|1|0|100|IKR|2667|3155|lyfalmen|V0321|2993||100|0|100,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1591||1591|3155| 038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|||0|0|0|0|SON|0|0|1|100|DKK|1022|2377|lyfalmen||||50|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||1022||1022|2377| 038554|C09CA0601|Atacand|töflur|4|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|2675|4638|lyfalmen||||28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||2675||2675|4638| 038607|L03AA1301|Neulasta|stl|6|mg/penna|0,6|ml|1|penni|áfylltur penni, lausn|L03AA13|01.07.2006||R|||0|1|0|1|AEU|0|0|0|100|DKK|171492|217105|lyfsjukr||||1|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||171492||171492|217105| 038689|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.04.2010||R|||0|1|0|1|WTE|0|0|0|100|DKK|74122|94906|lyfsjukr||||4|0|14,2900|Icepharma hf|Wyeth Europe|Etanercept||74122||74122|94906| 039005|L01XA0301|Eloxatin|irţ|5|mg/ml|10|ml|1|hgl||L01XA03|01.03.2007||R|||0|1|0|1|SNO|0|0|0|100|NOK|41922|54495|lyfsjukr||||10|0||Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||41922||41922|54495| 039014|L01XA0301|Eloxatin|irţ|5|mg/ml|20|ml|1|hgl||L01XA03|01.03.2007||R|||0|1|0|1|SNO|0|0|0|100|NOK|70079|89832|lyfsjukr||||20|0||Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||70079||70079|89832| 039141|B01AX0601 |Xarelto|filmhtfl|15|mg|42|stk|1|ţpakki||B01AX06|01.05.2012||R|||0|0|E|0|BAP|0|0|0|100|SEK|16173|22842|lyfalmen|V0031|21289||42|0|63,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||16173|22842| 039430|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|m.nál, dreifa|J07AL52|01.04.2012||R|||0|0|0|0|GLB|0|0|0|100|GBP|7260|10804|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||7182||7182|10804| 039575|D01AE1503|Lamisil (D.A.C.)|krem|10|mg/g|15|g|1|túpa||D01AE15|01.05.2009||L|||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa||||15|0||D.A.C. ehf|D.A.C. ehf|Terbínafín|||||| 039631|C01BD0701|Multaq|filmhtfl|400|mg|20|stk|1|ţpakki||C01BD07|01.08.2010||R|||0|1|0|0|SAA|0|0|0|100|NOK|4663|7358|lyfalmen||||20|0|10,0000|Vistor hf|Sanofi - Aventis|Dronedarón||||4663|7358| 039643|C01BD0701|Multaq|filmhtfl|400|mg|100|stk|1|ţpakki||C01BD07|01.08.2010||R|||0|1|0|0|SAA|0|0|0|100|NOK|22849|31221|lyfalmen||||100|0|50,0000|Vistor hf|Sanofi - Aventis|Dronedarón||||22849|31221| 039676|N06AX0307|Mianserin Mylan|filmhtfl|30|mg|100|stk|1|glas||N06AX03|01.06.2010||R|||0|0|B|0|MYL|0|1|0|100|SEK|3435|5678|lyfalmen||||100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Míanserín||3435||3435|5678| 039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|ţpakki||C07AB03|01.04.1992||R|||0|0|B|0|MYL|0|0|0|100|SEK|594|1604|lyfalmen|V0541|1565||98|0|32,6667|Actavis Group PTC ehf|Mylan AB|Atenólól||457||457|1604| 039709|C07AB0311|Atenolol Mylan|töflur|50|mg|98|stk|1|ţpakki||C07AB03|01.01.1991||R|||0|0|B|0|MYL|0|0|0|100|SEK|668|1653|lyfalmen|V0542|1613||98|0|65,3333|Actavis Group PTC ehf|Mylan AB|Atenólól||493||493|1653| 039776|J01FA1001|Zitromax|mixtúrud|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|||0|0|0|0|PER|0|0|1|100|DKK|1267|2712|lyfalmen||||15|0|2,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1267||1267|2712| 039784|J01FA1001|Zitromax|mixtúrud|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|||0|0|0|0|PER|0|0|1|100|DKK|1826|3477|lyfalmen||||22|0|3,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1826||1826|3477| 039909|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.07.1992||R|||0|1|0|1|BAM|0|0|0|100|SEK|686|990|lyfsjukr||||1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||686||686|990| 039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|||0|0|E|0|AGP|0|0|0|100|IKR|1630|2333|lyfalmen|V0110|2333||98|0|130,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||990||990|2333| 039957|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|42|stk|1|ţpakki||J05AB11|01.01.2010||R|||0|0|E|0|AGP|0|0|1|100|GBP|8711|8934|lyfalmen|V0182|8934||42|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||5815||5815|8934| 039958|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.01.1988||R|||0|1|0|1|BAM|0|0|0|100|SEK|1110|1602|lyfsjukr||||1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||1110||1110|1602| 039968|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|ţpakki||J05AB11|01.01.2010||R|||0|0|E|0|AGP|0|0|1|100|GBP|1887|2088|lyfalmen|V0033|2088||10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||811||811|2088| 040089|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.07.1994||R|||0|1|0|1|BAM|0|0|0|100|SEK|2577|3719|lyfsjukr||||1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||2577||2577|3719| 040426|R06AX2703|Desloratadine Actavis|filmhtfl|5|mg|30|stk|1|ţpakki||R06AX27|01.05.2012||R|||0|0|E|0|APC|0|0|1|100|XEU|1280|2380|lyfalmen|V0366|2266||30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín||1024||1024|2380| 040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|||0|0|E|0|SAL|0|0|0|100|IKR|||lyfalmen||||15|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Gervitár og ađrar óvirkar samsetningar|||||1723| 040822|C10AA0504|Atorvastatin Portfarma|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|||0|0|E|0|POF|0|0|0|100|IKR|4539|2449|lyfalmen|V0112|2449||100|0|50,0000|Portfarma ehf|Portfarma|Atorvastatín||1075||1075|2449| 041423|G03AA1203|Yasminelle|töflur|||63|stk|1|ţpakki|3+0,02 mg|G03AA12|01.12.2006||R|||0|0|0|0|BYP|0|0|0|100|SEK|3434|5676|lyfalmen||||63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrógen||3434||3434|5676| 041490|N06AB0404|Citalopram Bluefish|filmhtfl|20|mg|100|stk|1|ţpakki||N06AB04|01.09.2012||R|||0|0|B|0|BLP|0|1|0|100|XEU|2434|3542|lyfalmen|V0318|3542||100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||1874||1874|3542| 041704|QI09AX0001|Improvac|stl|300|mcg|20|ml|12|fl||QI09AX00|01.08.2010||R|||0|0|0|0|IPF|1|0|0|100|DKK|27444|47875|vetorma||||240|0||Icepharma hf|Pfizer Limited|GnRF hliđstćđa samtengd próteini||||27444|47875| 041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|||0|0|0|0|IBV|0|0|0|100|DKK|4298|7498|vetorma||||100|0||Vistor hf|Intervet International BV|||4298||4298|7498| 041795|M02AA1503|Voltaren Emulgel (D.A.C.)|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.05.2009||L|||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa||||100|0||D.A.C. ehf|D.A.C. ehf|Díklófenak|||||| 041898|N06AX0307|Mianserin Mylan|filmhtfl|10|mg|90|stk|1|ţpakki||N06AX03|01.06.2008||R|||0|0|B|0|MYL|0|1|0|100|SEK|1229|2660|lyfalmen||||90|0|15,0000|Actavis Group PTC ehf|Mylan AB|Míanserín||||1229|2660| 041938|A02BC0508|Esomeprazol Actavis|sţ-hylki|40|mg|28|stk|1|ţpakki|hart|A02BC05|01.03.2012||R|||0|0|0|0|APC|0|0|0|100|XEU|3938|1797|lyfalmen|V0005|1797||28|0|37,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||598||598|1797| 041996|A06AG1101|Microlax|innhl|||5|ml|4|túpa||A06AG11|01.12.1972||L|||0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa||||20|0|4,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||| 042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|||0|0|B|0|AZD|0|0|0|100|SEK|1580|3140|lyfalmen||||25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Metóprólól||1580||1580|3140| 042101|N01BB0902|Naropin|irl|2|mg/ml|100|ml|5|plpok||N01BB09|01.05.1998||R|||0|0|0|1|AZD|0|0|0|100|SEK|13294|18566|lyfsjukr||||500|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||13294||13294|18566| 042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|2482|3582|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2482||2482|3582| 042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|3000|4330|lyfsjukr||||7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||3000||3000|4330| 042323|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|4247|6129|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||4247||4247|6129| 042332|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|4352|6281|lyfsjukr||||7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||4352||4352|6281| 042357|N07BA0141|Nicotinell Fruktsmak (D.A.C.)|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.05.2009|30.09.2012|L|||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa||||204|0|13,6000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 042360|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|5545|8003|lyfsjukr||||7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||5545||5545|8003| 042369|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|40|plpok|Excel umbúđir|B05BA03|01.03.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|6843|9876|lyfsjukr||||4000|0||Icepharma hf|Fresenius Kabi|Kolvetni||6843||6843|9876| 042378|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|20|plpok|Freeflex umbúđir|B05BA03|01.03.2010||R|||0|0|0|1|FRP|0|0|0|100|DKK|3708|5352|lyfsjukr||||5000|0||Icepharma hf|Fresenius Kabi|Kolvetni||3708||3708|5352| 042387|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|2838|4096|lyfsjukr||||7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||2838||2838|4096| 042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|2169|3130|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2169||2169|3130| 042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|||1000|ml|10|plpok|Freeflex umbúđir|B05BB02|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|2715|3918|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2715||2715|3918| 042451|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Freeflex umbúđir|B05BB01|01.03.2010||R|||0|0|0|1|FRP|0|0|0|100|DKK|3563|5142|lyfsjukr||||5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||3563||3563|5142| 042460|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|2434|3513|lyfsjukr||||7500|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||2434||2434|3513| 042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|1753|2530|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||1753||1753|2530| 042478|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|plpok|Excel umbúđir|B05BB01|01.03.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|5950|8587|lyfsjukr||||4000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||5950||5950|8587| 042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|1986|2866|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||1986||1986|2866| 042549|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|1|dćla|einnota|J07BF03|01.01.1996||R|||0|0|0|0|SPM|0|0|0|100|XEU|756|2013|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||756||756|2013| 042551|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|||1000|ml|10|plpok||B05BB02|01.04.2009||R|||0|0|0|1|FRP|0|0|0|100|DKK|2811|4057|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2811||2811|4057| 042556|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|20|dćlur|einnota|J07BF03|01.01.1996||R|||0|0|0|0|SPM|0|0|0|100|XEU|14454|20685|lyfalmen||||10|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||14454||14454|20685| 042561|QM01AH9201|Trocoxil|tuggutfl|6|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|||0|0|0|0|IPF|0|0|0|100|DKK|1312|2610|vetalmen||||2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||1312||1312|2610| 042573|QM01AH9201|Trocoxil|tuggutfl|20|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|||0|0|0|0|IPF|0|0|0|100|DKK|1955|3889|vetalmen||||2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||1955||1955|3889| 042584|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|||0|0|0|0|IPF|0|0|0|100|DKK|2621|5205|vetalmen||||2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||2621||2621|5205| 042595|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|||0|0|0|0|IPF|0|0|0|100|DKK|5243|10240|vetalmen||||2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||5243||5243|10240| 042607|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|||0|0|0|0|IPF|0|0|0|100|DKK|6029|11749|vetalmen||||2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||6029||6029|11749| 042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúđir|B05BB02|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|2367|3416|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2367||2367|3416| 042669|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||4000|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 042775|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|500|stk|1|ţpakki||A06AB06|01.10.2012||R|||0|0|0|0|ICE|0|0|0|100|GBP|2321|4154|lyfalmen||||500|0||Icepharma hf|Icepharma hf|Senna||2321||2321|4154| 043232|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|30|stk|1|ţpakki||N05CD03|01.10.1992||R|||1|0|0|0|MYL|0|0|0|100|SEK|593|1790|lyfalmen||||30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Flúnítrazepam||593||593|1790| 043257|N01BB0902|Naropin|stl/irl|2|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|||0|0|0|1|AZD|0|0|0|100|SEK|3293|4753|lyfsjukr||||100|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||3293||3293|4753| 043345|N03AX1405|Matever|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|||0|0|0|0|PSA|0|0|0|100|XEU|23365|14515|lyfalmen|V0516|14515||100|0|66,6700|Portfarma ehf|Pharmathen S.A.|Levetíracetam||9895||9895|14515| 043379|R03AC1201|Serevent|innúđal|25|mcg/sk|120|skammtar|1|stauk|HFA 134a|R03AC12|01.04.2007||R|||0|0|B|0|GSK|0|0|1|100|GBP|5023|6083|lyfalmen||||120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3731||3731|6083| 043547|N01BB0902|Naropin|stl|7,5|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|||0|0|0|1|AZD|0|0|0|100|SEK|6088|8787|lyfsjukr||||100|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||6088||6088|8787| 043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|ţpakki||N05CD05|01.12.1983||R|||0|0|0|0|PER|0|0|1|100|DKK|551|1733|lyfalmen||||30|0|15,0000|Icepharma hf|Pfizer ApS|Tríazólam||551||551|1733| 043745|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|ţpakki||G03CA04|01.07.1989||R|||0|0|E|0|ORG|0|0|0|100|DKK|1198|2618|lyfalmen||||30|0|30,0000|Vistor hf|N.V. Organon|Estríól||1198||1198|2618| 043919|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 043935|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||10|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 043988|B03AA0705|Ferrous Sulphate|töflur|200|mg|100|stk|1|glas|sykurhúđađar|B03AA07|01.09.2009||L|||0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa||||100|0|32,5000|Actavis Group hf|Actavis UK Ltd.|Ferrósúlfat|||||| 044360|B03AC0203|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.05.2006||R|||0|0|E|0|LVR|0|0|1|100|CHF|12771|18573|lyfalmen|V0034|18573||25|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Járnoxíđ (sykurflétta)||12771||12771|18573| 044580|L01XE1001|Afinitor|töflur|5|mg|30|stk|1|ţpakki||L01XE10|01.09.2011||R|||0|1|0|1|NOE|0|0|0|100|DKK|372496|469365|lyfsjukr||||30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||372496|469365| 044591|L01XE1001|Afinitor|töflur|10|mg|30|stk|1|ţpakki||L01XE10|01.09.2011||R|||0|1|0|1|NOE|0|0|0|100|DKK|525658|661583|lyfsjukr||||30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||525658|661583| 044739|N04BC0502|Sifrol|forđatfl|0,52|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|||0|0|E|0|BII|0|0|0|100|DKK|22621|30934|lyfalmen||||100|0|20,8000|Vistor hf|Boehringer Ingelheim International|Pramipexól||22621||22621|30934| 044752|N04BC0502|Sifrol|forđatfl|2,1|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|||0|0|E|0|BII|0|0|0|100|DKK|86405|110983|lyfalmen||||100|0|84,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||86405||86405|110983| 044763|N04BC0502|Sifrol|forđatfl|0,52|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|||0|0|E|0|BII|0|0|0|100|DKK|2618|4560|lyfalmen||||10|0|2,0800|Vistor hf|Boehringer Ingelheim International|Pramipexól||2618||2618|4560| 044888|QN05CM9001|Domosedan, vet.|munnh.hl|7,6|mg/ml|3|ml|1|áf.spr|munnsk.dćla|QN05CM90|01.01.2012||R|||0|0|0|0|OCO|0|0|0|100|DKK|2039|4056|vetalmen||||3|0||Icepharma hf|Orion Corporation (I)|||2039||2039|4056| 045385|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|10|dćlur|einnota|J07BF03|01.01.1996||R|||0|0|0|0|SPM|0|0|0|100|XEU|7226|10864|lyfalmen||||5|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||7226||7226|10864| 045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|||0|0|E|0|AGP|0|0|0|100|IKR|1050|1817|lyfalmen|V0109|1817||98|0|65,3400|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||613||613|1817| 045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|||0|0|E|0|AGP|0|0|0|100|IKR|868|1683|lyfalmen|V0108|1683||98|0|32,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||515||515|1683| 045588|J01DC0204 |Cefuroxim Villerton|sts|750|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|||0|0|0|1|VIL|0|0|0|100|NOK|2934|4234|lyfsjukr||||10|0|2,5000|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||2934||2934|4234| 045599|J01DC0204 |Cefuroxim Villerton|sts|1500|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|||0|0|0|1|VIL|0|0|0|100|NOK|5869|8470|lyfsjukr||||10|0|5,0000|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||5869||5869|8470| 045634|N02AA5907|Pinex Comp Forte|eţ-stíll|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.01.2011||R|||0|0|0|0|AGT|0|0|1|100|XEU|368|1482|lyfalmen||||10|0|3,3333|Actavis Group hf|Actavis Group hf|Kódein í blöndum nema međ geđlyfjum||368||368|1482| 046077|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.01.2008||R|||0|0|0|0|PFV|0|0|0|100|DKK|20673|39868|vetalmen||||10|0||Icepharma hf|Pfizer vet.|||20673||20673|39868| 046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|ţpakki||C09AA05|01.03.2006||R|||0|0|B|0|ACA|0|0|0|100|XEU|1005|2354|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis hf|Ramipríl||1005||1005|2354| 046396|A04AA0102|Ondansetron Vian|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.02.2008||R|||0|0|E|0|VIS|0|0|0|100|DKK|3844|6237|lyfalmen|V0382|6237||10|0|1,2500|Icepharma hf|Vian SA|Ondansetrón||3844||3844|6237| 046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|||0|0|*|0|ACA|0|0|0|100|XEU|662|1884|lyfalmen|V0021|1884||90|0|45,0000|Actavis Group hf|Actavis hf|Glímepíríđ||662||662|1884| 046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|||0|0|*|0|ACA|0|0|0|100|XEU|1088|2361|lyfalmen|V0022|2361||90|0|90,0000|Actavis Group hf|Actavis hf|Glímepíríđ||1010||1010|2361| 046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|||0|0|*|0|ACA|0|0|0|100|XEU|1368|2737|lyfalmen|V0023|2737||90|0|135,0000|Actavis Group hf|Actavis hf|Glímepíríđ||1285||1285|2737| 046687|A04AA0102|Ondansetron Vian|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.02.2008||R|||0|0|E|0|VIS|0|0|0|100|DKK|6401|9735|lyfalmen|V0383|9735||20|0|2,5000|Icepharma hf|Vian SA|Ondansetrón||6401||6401|9735| 046745|N04BC0405|Ropinirol Portfarma|filmhtfl|0,5|mg|84|stk|1|ţpakki||N04BC04|01.02.2012||R|||0|0|E|0|POF|0|0|0|100|GBP|5160|5241|lyfalmen|V0530|5241||84|0|7,0000|Portfarma ehf|Portfarma|Rópíníról||3116||3116|5241| 046767|N04BC0405|Ropinirol Portfarma|filmhtfl|2|mg|84|stk|1|ţpakki||N04BC04|01.02.2012||R|||0|0|E|0|POF|0|0|0|100|GBP|6473|6150|lyfalmen|V0531|6150||84|0|28,0000|Portfarma ehf|Portfarma|Rópíníról||3780||3780|6150| 046779|N05AH0308|Lazapix|filmhtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|||0|0|*|0|POF|0|1|0|100|XEU|10194|9323|lyfalmen|V0283|8176||28|0|42,0000|Portfarma ehf|Portfarma|Olanzapín||6100||6100|9323| 046812|M05BA0603|Ibandronic acid Portfarma|filmhtfl|150|mg|3|stk|1|ţpakki||M05BA06|01.02.2012||R|||0|0|E|0|POF|0|0|0|100|XEU|10591|3656|lyfalmen|V0205|3656||3|0|90,0000|Portfarma ehf|Portfarma|Íbandrónsýra||1957||1957|3656| 046823|N05AH0308|Lazapix|filmhtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|||0|0|*|0|POF|0|1|0|100|XEU|3289|2384|lyfalmen|V0279|2384||28|0|14,0000|Portfarma ehf|Portfarma|Olanzapín||1027||1027|2384| 047159|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|||0|0|B|0|MYL|0|0|0|100|SEK|1053|2419|lyfalmen||||100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||1053||1053|2419| 047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|||0|0|0|1|AGA|0|0|0|100|IKR|13388|18684|lyfsjukr||||10|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||13388||13388|18684| 047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|||0|0|0|1|AGA|0|0|0|100|IKR|47555|61564|lyfsjukr||||50|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||47555||47555|61564| 047560|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.05.2008||R|||0|1|0|1|WTE|0|0|0|100|DKK|143683|182205|lyfsjukr||||4|0|28,5800|Icepharma hf|Wyeth Europe|Etanercept||143683||143683|182205| 047941|N03AX2101|Trobalt|filmhtfl|300|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|26254|35494|lyfalmen||||84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||26254||26254|35494| 047986|L02BB0305|Bicalutamide Portfarma|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.02.2011||R|||0|0|*|0|POF|0|0|0|100|XEU|12333|7538|lyfalmen|V0420|7519||30|0|30,0000|Portfarma ehf|Portfarma|Bíkalútamíđ||4795||4795|7538| 047998|L02BB0305|Bicalutamide Portfarma|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.02.2011||R|||0|0|*|0|POF|0|0|0|100|XEU|23355|18386|lyfalmen|V0421|18362||30|0|90,0000|Portfarma ehf|Portfarma|Bíkalútamíđ||12622||12622|18386| 048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|||0|0|0|1|BAM|0|0|0|100|SEK|5472|7897|lyfsjukr||||250|0||Icepharma hf|Baxter Medical AB|Albúmín||5472||5472|7897| 048028|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|50|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|8553|12344|lyfsjukr||||5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||8553||8553|12344| 048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|||0|0|0|1|BAM|0|0|0|100|SEK|8637|12465|lyfsjukr||||100|0||Icepharma hf|Baxter Medical AB|Albúmín||8637||8637|12465| 048100|N06AB1004|Esopram|töflur|5|mg|100|stk|1|ţpakki||N06AB10|01.04.2010||R|||0|0|B|0|APC|0|1|0|100|XEU|2642|2519|lyfalmen|V0324|2519||100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1126||1126|2519| 048111|N06AB1004|Esopram|töflur|10|mg|28|stk|1|ţpakki||N06AB10|01.04.2010||R|||0|0|0|0|APC|0|1|0|100|XEU|2454|3551|lyfalmen|V0035|3551||28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1880||1880|3551| 048122|N06AB1004|Esopram|töflur|10|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|||0|0|B|0|APC|0|1|0|100|XEU|7616|4887|lyfalmen|V0325|4604||100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2857||2857|4887| 048144|N06AB1004|Esopram|töflur|15|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|||0|0|B|0|APC|0|1|0|100|XEU|7482|4753|lyfalmen|V0326|4470||100|0|150,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2759||2759|4753| 048155|N06AB1004|Esopram|töflur|20|mg|28|stk|1|ţpakki||N06AB10|01.04.2010||R|||0|0|0|0|APC|0|1|0|100|XEU|3838|4395|lyfalmen|V0246|4395||28|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2497||2497|4395| 048166|N06AB1004|Esopram|töflur|20|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|||0|0|B|0|APC|0|1|0|100|XEU|14962|4753|lyfalmen|V0327|4470||100|0|200,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2759||2759|4753| 048199|A03CA0201|Librax|töflur|||100|stk|1|glas||A03CA02|01.12.1972||R|||0|0|E|0|MAB|0|0|0|100|DKK|1145|2545|lyfalmen||||100|0||Vistor hf|Meda AB|Klídín og geđlyf||1145||1145|2545| 048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|ţpakki|100+12,5 mg|C09DA01|01.06.2007||R|||0|0|0|0|MSD|0|0|0|100|DKK|13599|19612|lyfalmen||||98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||13599||13599|19612| 048355|C01DA0801|Sorbangil|töflur|40|mg|100|stk|1|glas||C01DA08|01.10.1988||R|||0|0|B|0|REP|0|0|0|100|SEK|4268|6817|lyfalmen||||100|0|66,6667|Vistor hf|Recip AB|Ísósorbíđ dínítrat||4268||4268|6817| 048447|G03AA0901|Marvelon|töflur|||63|stk|1|ţpakki||G03AA09|01.07.1986||R|||0|0|0|0|ORG|0|0|0|100|DKK|1755|3380|lyfalmen||||63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||1755||1755|3380| 048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|ţpakki||L04AA06|01.03.1999||R|||0|1|*|0|ROC|0|0|0|100|DKK|60299|74905|lyfalmen|V0187|38746||150|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||57657||57657|74905| 048505|L03AX1601|Mozobil|stl|20|mg/ml|1,2|ml|1|hgl|lausn|L03AX16|01.07.2010||R|||0|1|0|1|GZE|0|0|0|100|XEU|965823|1213990|lyfsjukr||||1|0|1,4300|Vistor hf|Genzyme Europe B.V.|Plerixaforum||965823||965823|1213990| 048744|N02BE0101|Panodil|töflur|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|||0|0|0|0|GSH|0|0|1|100|DKK|471|1623|lyfalmen|V0230|1536||100|0|16,6667|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||471||471|1623| 049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|ţpakki||A02BA02|01.10.1987||R|||0|0|E|0|ACA|0|0|0|100|XEU|2393|4252|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis hf|Ranitidín||2393||2393|4252| 049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|||0|0|0|0|RRL|0|0|0|100|DKK|16961|23831|lyfalmen||||3|0|0,5000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||16961||16961|23831| 049395|B01AC0701|Persantin|töflur|100|mg|100|stk|1|glas||B01AC07|01.10.1985||R|||0|0|E|0|BOI|0|0|0|100|DKK|2344|4185|lyfalmen||||100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||2344||2344|4185| 049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|||0|0|0|0|GAN|0|0|1|100|CHF|6519|9897|lyfalmen||||5|0||Icepharma hf|Galderma Nordic AB|Amorolfín||6519||6519|9897| 049561|C10AA0104|Simvastatin (Portfarma)|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA01|01.07.2006||R|||0|0|E|0|POF|0|0|0|100|IKR|1059|1822|lyfalmen|V0108|1683||98|0|32,6667|Portfarma ehf|Portfarma|Simvastatín||616||616|1822| 049579|C10AA0104|Simvastatin (Portfarma)|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA01|01.07.2006||R|||0|0|E|0|POF|0|0|0|100|IKR|1154|1982|lyfalmen|V0109|1817||98|0|65,3400|Portfarma ehf|Portfarma|Simvastatín||733||733|1982| 049597|C10AA0104|Simvastatin (Portfarma)|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA01|01.07.2006||R|||0|0|E|0|POF|0|0|0|100|IKR|1827|2551|lyfalmen|V0110|2381||100|0|133,3333|Portfarma ehf|Portfarma|Simvastatín||1149||1149|2551| 049650|D01BA0201|Lamisil|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.04.1993||R|||0|0|0|0|NOH|0|0|0|100|IKR|8006|4999|lyfalmen|V0123|3314||28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Terbínafín||2939||2939|4999| 049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|ţpakki||C09AA05|01.04.2006||R|||0|0|B|0|ACA|0|0|0|100|XEU|1170|2566|lyfalmen|V0496|2564||100|0|200,0000|Actavis Group hf|Actavis hf|Ramipríl||1160||1160|2566| 049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||L|||0|0|0|0|NHE|0|0|1|100|DKK|||lyflausa||||30|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||| 049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|ţpakki||C09AA05|01.08.2005||R|||0|0|B|0|ACA|0|0|0|100|XEU|2410|3581|lyfalmen||||100|0|400,0000|Actavis Group hf|Actavis hf|Ramipríl||1902||1902|3581| 049834|N02BE0113|Pinex Junior|eţ-stíll|125|mg|10|stk|1|ţpakki||N02BE01|01.12.2011||L|||0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa||||10|0|0,4167|Actavis Group hf|Actavis Group hf|Paracetamól|||||| 049845|N02BE0113|Pinex Junior|eţ-stíll|250|mg|10|stk|1|ţpakki||N02BE01|01.12.2011||L|||0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa||||10|0|0,8333|Actavis Group hf|Actavis Group hf|Paracetamól|||||| 049856|N02BE0114|Pinex|eţ-stíll|500|mg|10|stk|1|pakki||N02BE01|01.01.2012||L|||0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen||||10|0|1,6667|Actavis Group hf|Actavis Group hf|Paracetamól|||||1417| 049908|L04AA0601|Cellcept|hylki|250|mg|300|stk|1|ţpakki||L04AA06|01.03.1999||R|||0|1|*|0|ROC|0|0|0|100|DKK|60299|78220|lyfalmen|V0470|74061||300|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||60299||60299|78220| 050342|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|ţpakki||L01XE05|01.12.2006||R|||0|1|0|1|BAP|0|0|0|100|SEK|585904|737192|lyfsjukr||||112|0||Icepharma hf|Bayer Schering Pharma AG|Sorafeníb||585904||585904|737192| 050438|L04AA2701|Gilenya|hylki|0,5|mg|7|stk|1|ţpakki||L04AA27|01.09.2011||R|||0|1|0|1|NOE|0|0|0|100|DKK|70210|89996|lyfsjukr||||7|0|7,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||70210|89996| 050483|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|56|stk|1|ţpakki||A02BC05|01.11.2011||R|||0|0|0|0|POF|0|0|0|100|XEU|7361|3671|lyfalmen|V0012|2864||56|0|74,6700|Portfarma ehf|Portfarma|Esómeprazól||1968||1968|3671| 050510|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|ţpakki||A02BC01|01.05.2010||L|||0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa||||28|0|28,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||| 050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|ţpakki||N03AX16|01.04.2007||R|||0|0|0|0|PER|0|0|0|100|DKK|3238|5408|lyfalmen||||14|0|10,5000|Icepharma hf|Pfizer ApS|Pregabalín||3238||3238|5408| 050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|ţpakki||N03AX16|01.04.2007||R|||0|0|0|0|PER|0|0|0|100|DKK|12686|18466|lyfalmen||||56|0|42,0000|Icepharma hf|Pfizer ApS|Pregabalín||12686||12686|18466| 050660|C02CA0402|Carduran Retard|forđatfl|4|mg|100|stk|1|ţpakki||C02CA04|01.01.2007||R|||0|0|E|0|PER|0|0|0|100|DKK|5384|5068|lyfalmen|V0042|4579||100|0|100,0000|Icepharma hf|Pfizer ApS|Doxazósín||2989||2989|5068| 050679|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|100|stk|1|glas||A02BC01|01.09.2010||R|||0|0|E|0|AGT|0|0|0|100|IKR|4615|5247|lyfalmen|V0002|5247||100|0|50,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||3120||3120|5247| 050691|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|100|stk|1|glas||A02BC01|01.09.2010||R|||0|0|E|0|AGT|0|0|0|100|IKR|4435|4217|lyfalmen|V0006|4217||100|0|100,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||2367||2367|4217| 050702|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|100|stk|1|plglas||A02BC01|01.08.2010||R|||0|0|E|0|AGT|0|0|0|100|IKR|10567|5077|lyfalmen||||100|0|200,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||2996||2996|5077| 051029|N03AG0102|Orfiril|sh-tfl|150|mg|100|stk|1|glas||N03AG01|01.10.1995||R|||0|0|E|0|DEA|0|0|0|100|XEU|1666|3258|lyfalmen||||100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1666||1666|3258| 051076|D05AX5202|Daivobet (D.A.C.)|smyrsli|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.01.2007||R|||0|0|B|0|DAC|0|0|0|100|DKK|6522|8129|lyfalmen||||60|0||D.A.C. ehf|D.A.C. ehf|Kalcípótríól í blöndum||5227||5227|8129|30.09.2012 051110|N03AG0102|Orfiril|sh-tfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|||0|0|E|0|DEA|0|0|0|100|XEU|1721|3333|lyfalmen||||100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1721||1721|3333| 051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|ţpakki||R06AX26|01.07.2008||R|||0|0|E|0|MYL|0|0|1|100|SEK|1474|2633|lyfalmen|V0363|2633||30|0|45,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||1209||1209|2633| 051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|ţpakki||R06AX26|01.07.2008||R|||0|0|E|0|MYL|0|0|1|100|SEK|4009|5603|lyfalmen|V0365|5603||100|0|150,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||3380||3380|5603| 051550|N03AX1401|Keppra|irţ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|||0|0|0|1|UCB|0|0|0|100|DKK|29678|39128|lyfsjukr||||50|0|3,3300|Vistor hf|U.C.B|Levetíracetam||29678||29678|39128| 051732|C08CA0104|Amlódipín Portfarma|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.12.2006||R|||0|0|B|0|POF|0|0|0|100|XEU|1541|1932|lyfalmen|V0056|1737||100|0|100,0000|Portfarma ehf|Portfarma|Amlódipín||697||697|1932| 051750|C08CA0104|Amlódipín Portfarma|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.12.2006||R|||0|0|B|0|POF|0|0|0|100|XEU|2608|2174|lyfalmen|V0057|2133||100|0|200,0000|Portfarma ehf|Portfarma|Amlódipín||874||874|2174| 051761|R03AC0302|Bricanyl Turbuhaler|innönddu|0,5|mg/sk|100|skammtar|1|stauk||R03AC03|01.07.2012||R|||0|0|B|0|AZD|0|0|1|100|SEK|1018|2371|lyfalmen||||100|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||1018||1018|2371| 052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|ţpakki||N05BA12|01.10.2009||R|||0|0|0|0|MYL|0|0|1|100|SEK|221|1281|lyfalmen|V0047|1281||20|0|5,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||221||221|1281| 052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|ţpakki||N05BA12|01.10.2009||R|||0|0|0|0|MYL|0|0|0|100|SEK|521|1692|lyfalmen|V0305|1009||50|0|12,5000|Actavis Group PTC ehf|Mylan AB|Alprazólam||521||521|1692| 052305|L01XE0601|Sprycel|filmhtfl|20|mg|60|stk|1|glas||L01XE06|01.09.2007||R|||0|1|0|1|BSP|0|0|0|100|DKK|335853|423378|lyfsjukr||||60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||335853||335853|423378| 052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|ţpakki||N05BA12|01.07.2009||R|||0|0|0|0|MYL|0|0|1|100|SEK|369|1484|lyfalmen|V0439|1484||20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||||369|1484| 052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|ţpakki||N05BA12|01.10.2009||R|||0|0|0|0|MYL|0|0|0|100|SEK|1184|2599|lyfalmen||||50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||1184||1184|2599| 052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|||0|0|0|0|MYL|0|0|0|100|SEK|759|2017|lyfalmen|V0305|2017||100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||759||759|2017| 052333|L01XE0601|Sprycel|filmhtfl|50|mg|60|stk|1|glas||L01XE06|01.09.2007||R|||0|1|0|1|BSP|0|0|0|100|DKK|701597|882387|lyfsjukr||||60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||701597||701597|882387| 052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|||0|1|0|1|BSP|0|0|0|100|DKK|621836|782287|lyfsjukr||||60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||621836||621836|782287| 052405|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|1|glas||S01ED51|01.01.2010||R|||0|0|*|0|ALL|0|0|0|100|SEK|3902|6317|lyfalmen||||3|0|30,0000|Vistor hf|Allergan|Tímólól í blöndum||3902||3902|6317| 052478|D06BB0305|Zovirax (D.A.C.)|krem|50|mg/g|2|g|1|túpa|+sk.dćla|D06BB03|01.03.2007||L|||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa||||2|0||D.A.C. ehf|D.A.C. ehf|Acíklóvír|||||| 052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|36323|47468|lyfsjukr||||8212|0||Icepharma hf|Fresenius Kabi|Blöndur||36323||36323|47468| 052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|29528|38940|lyfsjukr||||7698|0||Icepharma hf|Fresenius Kabi|Blöndur||29528||29528|38940| 052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|31172|41003|lyfsjukr||||7680|0||Icepharma hf|Fresenius Kabi|Blöndur||31172||31172|41003| 052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|26080|34613|lyfsjukr||||7200|0||Icepharma hf|Fresenius Kabi|Blöndur||26080||26080|34613| 052542|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|35074|45900|lyfsjukr||||7880|0||Icepharma hf|Fresenius Kabi|Blöndur||35074||35074|45900| 052560|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|32568|42755|lyfsjukr||||7616|0||Icepharma hf|Fresenius Kabi|Blöndur||32568||32568|42755| 052838|A10BX0701|Victoza|stl|6|mg/ml|3|ml|2|lyfjap|lausn,áfylltur lyfjapenni|A10BX07|01.01.2012||R|||0|0|*|0|NAS|0|0|0|100|DKK|15161|21572|lyfalmen||||6|0|30,0000|Vistor hf|Novo-Nordisk A/S|Liraglútíđ||15161||15161|21572| 052979|J01CF0103|Dicloxacillin Arrow|hylki|250|mg|30|stk|1|ţpakki||J01CF01|01.06.2012||R|||0|0|0|0|PCO|0|0|1|100|DKK|1882|3504|lyfalmen||||30|1|3,7500|Distica|Distica - óskráđ lyf|Díkloxacillín||1846||1846|3504| 053006|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|100|stk|1|ţpakki||N05CF02|01.11.2006||R|||0|0|0|0|MYL|0|0|0|100|SEK|2463|3958|lyfalmen|V0313|3958||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Zolpidem||2178||2178|3958| 053025|G03HB0102|Diane mite|töflur|||63|stk|1|ţpakki||G03HB01|01.07.1989||R|||0|0|0|0|BAP|0|0|0|100|SEK|2316|4147|lyfalmen|V0134|3455||63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Cýpróterón og östrógen||2316||2316|4147| 053043|J05AE0601|Kaletra|filmhtfl|250|mg|120|stk|1|glös|200+50 mg|J05AE06|01.11.2006||R|||0|1|0|1|ABT|0|0|0|100|DKK|61071|78527|lyfsjukr||||120|0|30,0000|Vistor hf|Abbott Laboratories Ltd|Lopinavír||61071||61071|78527| 053055|C01BA0302|Durbis Retard|forđatfl|250|mg|100|stk|1|ţpakki||C01BA03|01.05.1983||R|||0|0|B|0|SNO|0|0|0|100|NOK|5639|8693|lyfalmen||||100|0|62,5000|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíđ||5639||5639|8693| 053155|N02AA5501|Targin|forđatfl|60|mg|28|stk|1|ţpakki|40+20 mg|N02AA55|01.10.2012||R|||1|0|0|0|NOP|0|0|0|100|DKK|11879|17229|lyfalmen||||28|0|14,9400|Icepharma hf|Norpharma|Oxycodonum í blöndum||11879||11879|17229| 053166|N02AA5501|Targin|forđatfl|60|mg|98|stk|1|ţpakki|40+20 mg|N02AA55|01.10.2012||R|||1|0|0|0|NOP|0|0|0|100|DKK|35380|46947|lyfalmen||||98|0|52,2700|Icepharma hf|Norpharma|Oxycodonum í blöndum||35380||35380|46947| 053200|N02AA5501|Targin|forđatfl|7,5|mg|98|stk|1|ţpakki|5+2,5 mg|N02AA55|01.10.2012||R|||1|0|0|0|NOP|0|0|0|100|DKK|5923|9081|lyfalmen||||98|0|6,5400|Icepharma hf|Norpharma|Oxycodonum í blöndum||5923||5923|9081| 053211|N02AA5501|Targin|forđatfl|7,5|mg|28|stk|1|ţpakki|5+2,5 mg|N02AA55|01.10.2012||R|||1|0|0|0|NOP|0|0|0|100|DKK|1737|3350|lyfalmen||||28|0|1,8700|Icepharma hf|Norpharma|Oxycodonum í blöndum||1733||1733|3350| 053231|J07BB0201|Fluarix|bóluefni|||0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1994||R|||0|0|0|0|GSK|0|0|0|100|GBP|6289|9582|lyfalmen||||5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsađir mótefnavakar||6289||6289|9582| 053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|||0|1|*|0|SDE|0|0|0|100|NOK|39791|52483|lyfalmen|V0453|42645||100|0|50,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíđ||39791||39791|52483| 053413|L04AA1301|Arava|töflur|20|mg|100|stk|1|glas||L04AA13|01.11.2000||R|||0|1|*|0|SDE|0|0|0|100|NOK|33400|44462|lyfalmen|V0454|38451||100|0|100,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíđ||33400||33400|44462| 053689|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|20|stk|1|ţpakki||N05CF02|01.11.2006||R|||0|0|0|0|MYL|0|0|1|100|SEK|656|1718|lyfalmen|V0060|1053||20|0|20,0000|Actavis Group PTC ehf|Mylan AB|Zolpidem||540||540|1718| 053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|||1|0|0|0|MAP|0|0|0|100|GBP|16069|22712|lyfalmen||||10|0|50,0000|Icepharma hf|Martindale Pharmaceuticals|Hýdrómorphón||16069||16069|22712| 053932|N05AX1201|Abilify|stl|7,5|mg/ml|1,33|ml|1|hgl||N05AX12|01.01.2010||R|||0|0|0|0|OTS|0|1|0|100|DKK|1519|3057|lyfalmen||||1|0|0,6650|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||1519||1519|3057| 053991|D10AF0101|Dalacin|lausn|10|mg/ml|30|ml|1|glas|Áburđur, lausn|D10AF01|01.07.1985||R|||0|0|0|0|PER|0|0|0|100|DKK|1133|2529|lyfalmen||||30|0||Icepharma hf|Pfizer ApS|Klindamýcín||1133||1133|2529| 054054|R03DC0303|Montelukast Actavis|filmhtfl|10|mg|100|stk|1|ţpakki||R03DC03|01.11.2011||R|||0|0|B|0|AGP|0|0|0|100|XEU|7670|10323|lyfalmen|V0490|10323||100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Montelúkast||6831||6831|10323| 054213|J07AG0101|Act-Hib|bóluefni|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|||0|0|0|0|MEX|0|0|0|100|XEU|2562|4484|lyfalmen||||0|0||Icepharma hf|Aventis Pasteur MSD A/S|Haemophilus influenzae B||2562||2562|4484| 054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|||0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa||||2|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||| 054278|D01AE1502|Lamisil Once|húđlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||4|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||| 054321|J01CA0801|Selexid|filmhtfl|400|mg|15|stk|1|ţpakki||J01CA08|01.04.2012||R|||0|0|0|0|LEP|0|0|1|100|DKK|2677|4641|lyfalmen||||15|0|10,0000|Vistor hf|LEO Pharma A/S|Pívmecillínam||2677||2677|4641| 054332|J01CA0801|Selexid|filmhtfl|400|mg|20|stk|1|ţpakki||J01CA08|01.04.2012||R|||0|0|0|0|LEP|0|0|1|100|DKK|3692|6029|lyfalmen||||20|0|13,3300|Vistor hf|LEO Pharma A/S|Pívmecillínam||3692||3692|6029| 054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|||0|1|0|1|ROA|0|0|0|100|DKK|63401|81451|lyfsjukr||||56|0|22,4000|Icepharma hf|Roche A.S.|Ribavirin||63401||63401|81451| 054376|B05AA0113|Albunorm 20%|irl|200|g/líter|100|ml|1|fl|lausn|B05AA01|01.06.2012||R|||0|0|0|1|OCT|0|0|0|100|DKK|9665|13949|lyfsjukr||||100|0||Vistor hf|Octapharma AB|Albúmín||9665||9665|13949| 054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|||0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa||||2|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||| 054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|||0|0|0|0|UCN|0|0|1|100|SEK|1132|2527|lyfalmen||||200|0|5,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1132||1132|2527| 054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|ţpakki||N06AB03|01.10.2006||R|||0|0|0|0|ACA|0|1|0|100|XEU|1670|3263|lyfalmen|V0061|3263||30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||1670||1670|3263| 054594|QN02AE0101|Vetergesic vet.|stl|300|mcg/ml|10|ml|1|hgl|lausn|QN02AE01|01.10.2010||R|||1|0|0|0|REB|0|0|0|100|DKK|4711|9218|vetalmen||||10|0||Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Buprenorphinhýdróklóríđ||||4711|9218| 054650|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|20|stk||QG03DA02|01.12.1978||R|||0|0|0|0|PAL|1|0|0|100|DKK|7629|13308|vetorma||||20|0||Icepharma hf|Pfizer Oy Animal Health|||7629||7629|13308| 055164|S01AX2201|Vigamox|augndr|5|mg/ml|5|ml|1|glas|án rotvarnar|S01AX22|01.08.2010||R|||0|0|0|0|ALA|0|0|1|100|USD|1749|3371|lyfalmen||||5|0||Vistor hf|Alcon Laboratories Ltd.|Moxífloxasín hýdróklóríđ||||1749|3371| 055186|J01FA0103|Ery-Max|sh-hylki|250|mg|20|stk|1|glas||J01FA01|01.01.1986||R|||0|0|0|0|REP|0|0|1|100|SEK|808|2084|lyfalmen||||20|0|5,0000|Vistor hf|Recip AB|Erýtrómýcín||808||808|2084| 055277|N02AA0101|Contalgin|forđatfl|60|mg|100|stk|1|ţpakki||N02AA01|01.10.1995||R|||1|0|E|0|PER|0|0|0|100|DKK|9139|13481|lyfalmen||||100|0|60,0000|Icepharma hf|Pfizer ApS|Morfín||9139||9139|13481| 055481|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|56|stk|1|ţpakki||A02BC04|01.06.2011||R|||0|0|E|0|APC|0|0|0|100|IKR|2064|2939|lyfalmen|V0467|2843||56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1433||1433|2939| 055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||36|0|1,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|glas||C10AA05|01.06.2006||R|||0|0|E|0|ACA|0|0|0|100|IKR|4539|2527|lyfalmen|V0112|2449||100|0|50,0000|Actavis Group hf|Actavis hf|Atorvastatín||1132||1132|2527| 056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|glas||C10AA05|01.06.2006||R|||0|0|E|0|ACA|0|0|0|100|IKR|6185|2649|lyfalmen|V0113|2649||100|0|100,0000|Actavis Group hf|Actavis hf|Atorvastatín||1221||1221|2649| 056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|glas||C10AA05|01.06.2006||R|||0|0|0|0|ACA|0|0|0|100|IKR|7867|6047|lyfalmen|V0114|4946||100|0|200,0000|Actavis Group hf|Actavis hf|Atorvastatín||3705||3705|6047| 056183|B01AC2401|Brilique|filmhtfl|90|mg|100|stk|1|ţpakki||B01AC24|01.06.2011||R|||0|0|E|0|AZA|0|0|0|100|SEK|18955|26334|lyfalmen|V0459|25303||100|0|50,0000|Vistor hf|AstraZeneca AB|Ticagrelor||18955||18955|26334| 056442|QG03DA0401|Prid alpha|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.04.2011||R|||0|0|0|0|CES|1|0|0|100|XEU|26756|46675|vetorma||||10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||26756||26756|46675| 056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|glas||J01FA01|01.01.1986||R|||0|0|0|0|REP|0|0|1|100|SEK|1314|2776|lyfalmen||||40|0|10,0000|Vistor hf|Recip AB|Erýtrómýcín||1314||1314|2776| 056664|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|100|stk|1|glas|Til skömmtunar|N06AX16|01.10.2011||R|||0|0|B|0|AGP|0|0|0|100|XEU|3689|6025|lyfalmen||||100|0|75,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||3689|6025| 056675|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|100|stk|1|glas|til skömmtunar|N06AX16|01.10.2011||R|||0|0|B|0|AGP|0|0|0|100|XEU|3689|6025|lyfalmen||||100|0|150,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||3689|6025| 056763|D11AH0201|Elidel|krem|1|%|15|g|1|túpa||D11AH02|01.09.2012||R|||0|0|E|0|MAB|0|0|1|100|DKK|2972|5044|lyfalmen||||15|0||Vistor hf|Meda AB|Pímekrólímus||2972||2972|5044| 056915|L04AA2301|Tysabri|irţ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|||0|1|0|1|EPI|0|0|0|100|XEU|230775|291505|lyfsjukr||||15|0|30,0000|Icepharma hf|Elan Pharma International|Natalizumab||230775||230775|291505| 056961|J05AF0702|Viread (Paranova)|filmhtfl|245|mg|30|stk|1|plglas||J05AF07|01.05.2008||R|||0|1|0|1|POF|0|0|0|100|DKK|57544|74100|lyfsjukr||||30|0|30,0000|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl||57544||57544|74100| 057042|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|11801|17122|lyfalmen|V0095|13463||98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||11801||11801|17122| 057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|||0|1|0|1|NOH|0|0|0|100|DKK|11652|16506|lyfsjukr||||5|0|1,4300|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||11652||11652|16506| 057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|||0|1|0|1|NOH|0|0|0|100|DKK|6700|9670|lyfsjukr||||5|0|0,7100|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||6700||6700|9670| 057367|J06BA0207|Kiovig|irl|100|mg/ml|300|ml|1|hgl|lausn|J06BA02|01.10.2011||R|||0|0|0|1|BAA|0|0|0|100|SEK|251984|318122|lyfsjukr||||300|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||251984||251984|318122| 057401|N06DA0404|Galantamine Portfarma|forđahlk|16|mg|84|stk|1|ţpakki||N06DA04|01.12.2011||R|||0|0|E|0|POF|0|0|0|100|SEK|24119|28117|lyfalmen|V0350|28117||84|0|84,0000|Portfarma ehf|Portfarma|Galantamín||20376||20376|28117| 057422|B05XA3102|Tracel|irţ|||10|ml|20|plastl||B05XA31|01.01.1987||R|||0|0|0|1|FRP|0|0|0|100|DKK|4847|6995|lyfsjukr||||200|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ öđrum efnum||4847||4847|6995| 057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|||0|1|0|1|NOH|0|0|0|100|DKK|3694|5331|lyfsjukr||||5|0|0,3600|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||3694||3694|5331| 057492|L01XC1001|Arzerra|irţ|20|mg/ml|50|ml|1|hgl|1000 mg pr. hgl.|L01XC10|01.03.2012||R|||0|1|0|1|GGL|0|0|0|100|GBP|366484|461820|lyfsjukr||||50|0||GlaxoSmithKline ehf|Glaxo Group Limited|Ofatúmúmabi||366484||366484|461820| 057556|L02BX0301|Zytiga|töflur|250|mg|120|stk|1|glas||L02BX03|01.12.2011||R|||0|1|0|1|JAS|0|0|0|100|SEK|564963|710911|lyfsjukr||||120|0||Vistor hf|Janssen-Cilag AB|Abírateron||564963||564963|710911| 057703|J01DD0401|Rocephalin|irţ|2|g|5|hgl|1|pakki|lausn|J01DD04|01.10.1985||R|||0|0|0|1|ROC|0|0|0|100|DKK|24559|32704|lyfsjukr||||5|0|5,0000|Icepharma hf|Roche|Ceftríaxón||24559||24559|32704| 058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|ţpakki||N07BA03|01.03.2009||R|||0|0|0|0|IPI|0|0|1|100|DKK|19992|27635|lyfalmen||||112|0|56,0000|Icepharma hf|Pfizer Limited|Vareniclin||||19992|27635| 058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|||0|0|E|0|BOI|0|0|0|100|DKK|423|1558|lyfalmen||||5|0|1,6667|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||423||423|1558| 058272|L01XE1101|Votrient|filmhtfl|200|mg|30|stk|1|glas||L01XE11|01.02.2011||R|||0|1|0|1|GGL|0|0|0|100|GBP|132582|168273|lyfsjukr||||30|0||GlaxoSmithKline ehf|Glaxo Group Limited|Pazópaníb||132582||132582|168273| 058283|QI01AD040|Avipro Thymovac|frţlyf|||500|skammtar|10|pakkar||QI01AD04|01.07.2009||R|||0|0|0|0|LOH|0|0|0|100|XEU|160749|280419|vetorma||||5000|0||Icepharma hf|Lohmann Animal Health|||||160749|280419| 058294|QI01AD040|Avipro Thymovac|frţlyf|||1000|skammtar|10|pakkar||QI01AD04|01.07.2009||R|||0|0|0|0|LOH|0|0|0|100|XEU|244193|425982|vetorma||||10000|0||Icepharma hf|Lohmann Animal Health|||||244193|425982| 058397|J07BM0101|Gardasil|stl|||0,5|ml|1|áf.spr|dreifa|J07BM01|01.01.2007||R|||0|0|0|0|SPM|0|0|0|100|XEU|17261|24208|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerđ 6, 11, 16, 18)||17261||17261|24208| 058503|J01EA0107|Trimetoprim Meda|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|||0|0|0|0|REP|0|0|1|100|SEK|1063|2433|lyfalmen||||100|0|2,5000|Vistor hf|Recip AB|Trímetóprím||1063||1063|2433| 058506|J05AF1001|Baraclude|mixtúra|0,05|mg/ml|210|ml|1|fl||J05AF10|01.09.2007||R|||0|1|0|1|BSP|0|0|0|100|DKK|99417|126651|lyfsjukr||||210|0|21,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||99417||99417|126651| 058609|N05AX1302|Xeplion|stl|50|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|||0|0|0|0|JCI|0|1|0|100|SEK|43159|56710|lyfalmen||||1|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||43159||43159|56710| 058735|C03CA0105|Lasix Retard|forđahlk|30|mg|100|stk|1|ţpakki||C03CA01|01.10.1995||R|||0|0|E|0|SNO|0|0|0|100|NOK|1274|2722|lyfalmen||||100|0|75,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíđ||1274||1274|2722| 058768|C03CA0105|Lasix Retard|forđahlk|60|mg|100|stk|1|ţpakki||C03CA01|01.10.1995||R|||0|0|E|0|SNO|0|0|0|100|NOK|2375|4228|lyfalmen||||100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíđ||2375||2375|4228| 058958|J07CA0601|Infanrix-Polio + Hib|bóluefni|||0,5|ml|1|dćla|einnota dćla|J07CA06|01.03.1999|31.08.2012|R|||0|0|0|0|GSK|0|0|0|100|GBP|4540|7189|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||4540||4540|7189| 059070|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|ţpakki||A02BC01|01.05.2011||R|||0|0|E|0|AGT|0|0|0|100|IKR|2374|2842|lyfalmen|V0006|2362||56|0|56,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||1362||1362|2842| 059204|C01DA0801|Sorbangil|töflur|5|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|||0|0|B|0|REP|0|0|0|100|SEK|1566|3121|lyfalmen||||250|0|20,8300|Vistor hf|Recip AB|Ísósorbíđ dínítrat||1566||1566|3121| 059295|S01AA0104|Kloramfenikol - Lyfjaver|augnsm|1|%|5|g|1|túpa||S01AA01|01.06.2012||R|||0|0|E|0|LAL|0|0|1|100|IKR|2297|4121|lyfalmen||||5|1||Lyfjaver ehf|Lyfjaver ehf|Klóramfeníkól||2297||2297|4121| 059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|||0|1|*|0|ASP|0|0|0|100|XEU|98378|126010|lyfalmen||||2|0|311,1900|Vistor hf|Astellas Pharma A/S|Leuprórelín||98378||98378|126010| 059659|J07CA0601|Infanrix-Polio + Hib|bóluefni|||0,5|ml|10|spr||J07CA06|01.01.2007||R|||0|0|0|0|GSK|0|0|0|100|GBP|33968|45175|lyfalmen||||5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||33968||33968|45175| 059687|J05AR0302|Truvada (Paranova)|filmhtfl|445|mg|30|stk|1|plglas|200+245 mg|J05AR03|01.05.2008||R|||0|1|0|1|POF|0|0|0|100|DKK|89783|114560|lyfsjukr||||30|0|30,0000|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl og emtrícítabín||89783||89783|114560| 059767|N03AF0401|Zebinix|töflur|800|mg|30|stk|1|ţpakki||N03AF04|01.03.2010||R|||0|0|E|0|BPC|0|0|0|100|SEK|42150|48545|lyfalmen||||30|0|30,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||36653||36653|48545| 059870|L04AD0201|Advagraf|forđahlk|3|mg|50|stk|1|ţpakki||L04AD02|01.11.2010||R|||0|1|*|0|APE|0|0|0|100|XEU|54558|71015|lyfalmen||||50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||54558||54558|71015| 060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|ţpakki||V03AC03|01.03.2007||R|||0|1|0|0|NOE|0|0|0|100|DKK|373408|471172|lyfalmen||||84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||373408||373408|471172| 060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|ţpakki||V03AC03|01.03.2007||R|||0|1|0|0|NOE|0|0|0|100|DKK|186720|236879|lyfalmen||||84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||186720||186720|236879| 060848|N06AA0402|Anafranil Retard|forđatfl|75|mg|100|stk|1|ţpakki||N06AA04|01.10.1989||R|||0|0|B|0|NOH|0|1|0|100|DKK|5587|8622|lyfalmen||||100|0|75,0000|Vistor hf|Novartis Healthcare A/S-|Klómípramín||5587||5587|8622| 061414|QA04AD901|Cerenia|töflur|60|mg|4|stk|1|ţpakki||QA04AD90|01.02.2009||R|||0|0|0|0|PFA|0|0|0|100|DKK|2723|5401|vetalmen||||4|0||Icepharma hf|Pfizer Animal Health|||||2723|5401| 061442|QA04AD901|Cerenia|töflur|24|mg|4|stk|1|ţpakki||QA04AD90|01.02.2009||R|||0|0|0|0|PFA|0|0|0|100|DKK|1427|2839|vetalmen||||4|0||Icepharma hf|Pfizer Animal Health|||||1427|2839| 061451|QA04AD901|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.02.2009||R|||0|0|0|0|PFA|1|0|0|100|DKK|8427|16354|vetalmen||||20|0||Icepharma hf|Pfizer Animal Health|||||8427|16354| 061460|G03CX0102|Livial (D.A.C.)|töflur|2,5|mg|84|stk|1|ţpakki||G03CX01|01.04.2010||R|||0|0|E|0|DAC|0|0|0|100|DKK|6921|10446|lyfalmen|V0133|10446||84|0|84,0000|D.A.C. ehf|D.A.C. ehf|Tíbólón||6921||6921|10446| 061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|túpa||M02AA07|01.04.1996||L|||0|0|0|0|PER|0|0|1|100|IKR|||lyflausa||||50|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||| 061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|ţpakki||G03CX01|01.07.1998||R|||0|0|E|0|ORG|0|0|0|100|DKK|6922|10448|lyfalmen|V0133|10446||84|0|84,0000|Vistor hf|N.V. Organon|Tíbólón||6922||6922|10448| 061580|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdćla|26|g|1|spr||QP52AF02|01.04.1992||L|||0|0|0|0|PAL|0|0|0|100|DKK|1686|2941|vetorma||||26|0||Icepharma hf|Pfizer Oy Animal Health|||||1686|2941| 061715|L01XE0901|Torisel|irţ|30|mg|1|hgl|1|pakki||L01XE09|01.05.2008||R|||0|1|0|1|IPI|0|0|0|100|DKK|158440|200725|lyfsjukr||||1|0||Icepharma hf|Pfizer Limited|Temsirolímus||158440||158440|200725| 061937|L04AD0101|Sandimmun|irţ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|||0|0|0|1|NOH|0|0|0|100|DKK|4399|6349|lyfsjukr||||10|0|2,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||4399||4399|6349| 061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|||0|1|0|1|NOE|0|0|0|100|DKK|15707|21595|lyfsjukr||||1|0|1,2500|Vistor hf|Novartis Europharm Ltd|Daptomýcín||15707||15707|21595| 061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|||0|1|0|1|NOE|0|0|0|100|DKK|22113|29634|lyfsjukr||||1|0|1,7900|Vistor hf|Novartis Europharm Ltd|Daptomýcín||22113||22113|29634| 062117|N05BA1204|Tafil Retard|forđatfl|0,5|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|||0|0|0|0|PER|0|0|1|100|DKK|455|1601|lyfalmen|V0307|1462||30|0|15,0000|Icepharma hf|Pfizer ApS|Alprazólam||455||455|1601| 062341|L04AA0604|Mykofenolatmofetil Actavis|filmhtfl|500|mg|150|stk|1|ţpakki||L04AA06|01.08.2010||R|||0|1|*|0|AGP|0|0|0|100|XEU|59092|38746|lyfalmen|V0187|38746||150|0|37,5000|Actavis Group hf|Actavis Group PTC ehf|Mýcófenólsýra||28845||28845|38746| 062387|N04BC0502|Sifrol|forđatfl|0,26|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|||0|0|E|0|BII|0|0|0|100|DKK|1634|3214|lyfalmen||||10|0|1,0400|Vistor hf|Boehringer Ingelheim International|Pramipexól||1634||1634|3214| 062638|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1985||R|||0|1|0|1|PER|0|0|0|100|DKK|6592|9514|lyfsjukr||||20|0||Icepharma hf|Pfizer ApS|Metótrexat||6592||6592|9514| 062661|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.10.1985||R|||0|1|0|1|PER|0|0|0|100|DKK|450|649|lyfsjukr||||1|0||Icepharma hf|Pfizer ApS|Metótrexat||450||450|649| 062704|R02AA0305|Strepsils Cool|sogtfl|||36|stk|1|ţpakki||R02AA03|01.09.2010||L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 062729|N05BA1204|Tafil Retard|forđatfl|0,5|mg|60|stk|1|ţpakki||N05BA12|01.04.1996||R|||0|0|0|0|PER|0|0|0|100|DKK|917|2233|lyfalmen|V0308|1958||60|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||917||917|2233| 062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.03.2008||R|||0|0|E|0|AGT|0|0|1|100|XEU|1832|3485|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis Group hf|Cyanocobalamin||1832||1832|3485| 062745|QP53AF0102|Sebacil vet.|húđlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|||0|0|0|0|BAN|0|0|0|100|DKK|17836|31114|vetorma||||1000|0||Icepharma hf|Bayer Animal Health GmbH|||17836||17836|31114| 062761|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|||0|1|0|1|SAR|0|0|0|100|SEK|41630|54128|lyfsjukr||||2|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||41630||41630|54128| 062772|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|||0|1|0|1|SAR|0|0|0|100|SEK|50827|65670|lyfsjukr||||2|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||50827||50827|65670| 062987|J07BM0201|Cervarix|stl|||0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|||0|0|0|0|GLB|0|0|0|100|GBP|16839|16638|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerđ 16, 18)||11447||11447|16638| 063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|ţpakki||J05AB09|01.10.1995||R|||0|0|E|0|NOH|0|0|1|100|DKK|4170|6683|lyfalmen||||10|0|1,6667|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||4170||4170|6683| 063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|||0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen||||500|0|49,7761|Vistor hf|Medic Team|Laktúlósa|||||2928| 063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.11.2006||R|||0|0|0|0|ACA|0|0|0|100|XEU|2513|3455|lyfalmen|V0123|3314||28|0|28,0000|Actavis Group hf|Actavis hf|Terbínafín||1810||1810|3455| 063715|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|100|stk|1|ţpakki||R06AX27|01.07.2011||R|||0|0|E|0|DAC|0|0|1|100|XEU|4482|6189|lyfalmen|V0458|5423||100|0|100,0000|D.A.C. ehf|D.A.C. ehf|Deslóratadín||3809||3809|6189| 063818|J06BB0102|Rhesonativ|stl|625|ae/ml|2|ml|1|lykja||J06BB01|01.05.2008||R|||0|0|0|1|OCT|0|0|0|100|DKK|7707|11123|lyfsjukr||||2|0||Vistor hf|Octapharma AB|And-D(rh) immúnóglóbúlín||7707||7707|11123| 063923|QP54AB5207|Equest Pramox vet|hlaup|||11,8|g|1|sk-dćl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2006||R|||0|0|0|0|PAS|0|0|0|100|XEU|2512|4382|vetorma||||12|0||Vistor hf|Pfizer Oy Animal Health|||2512||2512|4382| 063941|N05BA1204|Tafil Retard|forđatfl|1|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|||0|0|0|0|PER|0|0|1|100|DKK|964|2298|lyfalmen|V0309|2021||30|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||964||964|2298| 063958|N05BA1204|Tafil Retard|forđatfl|1|mg|60|stk|1|ţpakki||N05BA12|01.04.1996||R|||0|0|0|0|PER|0|0|0|100|DKK|2019|3741|lyfalmen|V0310|3177||60|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||2019||2019|3741| 064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|||0|1|0|1|UTE|0|0|0|100|XEU|1074922|1350910|lyfsjukr||||20|0|11,6300|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||1074922|1350910| 064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|||0|1|0|1|UTE|0|0|0|100|XEU|429968|541492|lyfsjukr||||20|0|4,6500|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||429968|541492| 064170|N05BA1204|Tafil Retard|forđatfl|2|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|||0|0|0|0|PER|0|0|1|100|DKK|2120|3879|lyfalmen|V0311|3241||30|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||2120||2120|3879| 064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|||0|1|0|1|UTE|0|0|0|100|XEU|4299689|5397992|lyfsjukr||||20|0|46,5100|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||4299689|5397992| 064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|||0|1|0|1|UTE|0|0|0|100|XEU|2149845|2699938|lyfsjukr||||20|0|23,2600|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||2149845|2699938| 064732|A03BB0101|Buscopan|húđuđtfl|10|mg|100|stk|1|ţpakki||A03BB01|01.03.2012||R|||0|0|E|0|BOI|0|0|0|100|DKK|2081|3826|lyfalmen||||100|0|16,6700|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||2081||2081|3826| 064733|J07BB0203|Vaxigrip|bóluefni|||0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1985||R|||0|0|0|0|SPM|0|0|0|100|XEU|816|2095|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsađir mótefnavakar||816||816|2095| 064742|B02BD0101|Octaplex|irs|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.12.2011||R|||0|0|0|1|OCT|0|0|0|100|DKK|57979|74646|lyfsjukr||||1|0|1,4300|Vistor hf|Octapharma AB|Storkuţćttir lX,ll,Vll,X||57979||57979|74646| 065032|D10AF5101|Duac|hlaup|||25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|||0|0|0|0|SLL|0|0|0|100|DKK|1934|3625|lyfalmen||||25|0||Vistor hf|Stiefel Laboratories (Ireland) Ltd.|Klindamýcín í blöndum||1934||1934|3625| 065314|G01AF0201|Canesten|sk-tfl|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|||0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa||||6|0|6,0000|Icepharma hf|Bayer AB|Klótrímazól|||||| 065332|G01AF0201|Canesten|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|||0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa||||1|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||| 065441|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|||0|0|0|1|GEH|0|0|0|100|NOK|15642|21513|lyfsjukr||||200|0||Icepharma hf|GE Healthcare AS|Jódixanól||15642||15642|21513| 065706|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.10.1999||R|||0|0|*|0|PER|0|0|0|100|DKK|2479|3698|lyfalmen|V0376|2121||2|0|25,0000|Icepharma hf|Pfizer ApS|Latanóprost||1988||1988|3698| 065711|L02AE0306|Zoladex (Lyfjaver)|vefjalyf|10,8|mg|1|stk|1|áf.spr|+ dćla|L02AE03|01.06.2011||R|||0|1|*|0|LVR|0|0|0|100|SEK|62916|78401|lyfalmen|V0451|78401||1|0|83,7209|Lyfjaver ehf|Lyfjaver ehf|Góserelín||60443||60443|78401| 065722|S01EE0101|Xalatan|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.05.2009||R|||0|0|*|0|PER|0|0|0|100|DKK|7432|10700|lyfalmen|V0376|6363||8|0|75,0000|Icepharma hf|Pfizer ApS|Latanóprost||7106||7106|10700| 065729|N07BA0142|Nicorette Invisi|forđapl|15|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||14|0|15,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065740|N07BA0142|Nicorette Invisi|forđapl|15|mg/16kls|7|stk|1|ţpakki||N07BA01|01.03.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||7|0|7,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065752|N07BA0142|Nicorette Invisi|forđapl|10|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065775|N07BA0142|Nicorette Invisi|forđapl|25|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||14|0|25,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065786|N07BA0142|Nicorette Invisi|forđapl|25|mg/16kls|7|stk|1|ţpakki||N07BA01|01.03.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||7|0|12,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065870|V08AB0201|Omnipaque|stl|180|mg J/ml|10|ml|10|glhgl||V08AB02|01.12.2009||R|||0|0|0|1|GEH|0|0|0|100|NOK|4851|7001|lyfsjukr||||100|0||Icepharma hf|GE Healthcare AS|Jóhexól||4851||4851|7001| 066195|QM01AC0605|Melovem|stl|5|mg/ml|100|ml|1|hgl||QM01AC06|01.08.2011||R|||0|0|0|0|DOR|1|0|0|100|DKK|4045|7940|vetalmen||||100|0||Icepharma hf|Dopharma Reserch B.V|||4045||4045|7940| 066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|||0|0|0|0|BII|0|0|0|100|DKK|6618|10032|lyfalmen||||60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tíótrópíumbrómíđ||6618||6618|10032| 066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05AA07|01.05.2008||R|||0|0|0|1|FRP|0|0|0|100|DKK|32601|42797|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||32601||32601|42797| 066399|N07BA0106|Nicotinell|forđapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||21|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 066407|N07BA0106|Nicotinell|forđapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||21|0|21,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 066411|A01AA0101|Duraphat|tannpast|5|mg/ml|51|g|1|túpa||A01AA01|01.04.2011||R|||0|0|0|0|GOG|0|0|1|100|DKK|839|2127|lyfalmen||||51|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||839||839|2127| 066423|N07BA0106|Nicotinell|forđapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||21|0|31,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 066688|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|6|glerfl||V08AB02|01.12.1983||R|||0|0|0|1|GEH|0|0|0|100|IKR|4575|6603|lyfsjukr||||120|0||Icepharma hf|GE Healthcare AS|Jóhexól||4575||4575|6603| 066751|C01BD0103|Cordarone (D.A.C.)|töflur|100|mg|30|stk|1|ţpakki||C01BD01|01.11.2006||R|||0|0|B|0|DAC|0|0|0|100|NOK|1547|3095|lyfalmen|V0036|3095||30|0|15,0000|D.A.C. ehf|D.A.C. ehf|Amíódarón||1547||1547|3095| 066862|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|ţpakki||A02BC01|01.05.2010||L|||0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa||||14|0|14,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||| 066897|L01CD0104|Paclitaxel Actavis|irţ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.06.2010||R|||0|1|0|1|AGP|0|0|0|100|XEU|15150|20896|lyfsjukr||||50|0||Actavis Group hf|Actavis Group PTC ehf|Paklítaxel||15150||15150|20896| 067001|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|50|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|8554|12346|lyfsjukr||||5000|0||Icepharma hf|Fresenius Kabi|Kolvetni||8554||8554|12346| 067587|N05BB0101|Atarax|töflur|25|mg|100|stk|1|ţpakki||N05BB01|01.07.1994||R|||0|0|0|0|UCN|0|0|0|100|SEK|1509|3043|lyfalmen||||100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1509||1509|3043| 067748|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.09.2010||R|||0|0|*|0|APC|0|0|0|100|DKK|1837|2540|lyfalmen|V0376|2121||2|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||1141||1141|2540| 067751|J02AC0102|Candizol|hylki|50|mg|7|stk|1|glas||J02AC01|01.12.1998||R|||0|0|0|0|ACA|0|0|1|100|IKR|1567|2842|lyfalmen|V0551|2439||7|0|1,7500|Actavis Group hf|Actavis hf|Flúkónazól||1362||1362|2842| 067769|J02AC0102|Candizol|hylki|50|mg|30|stk|1|glas||J02AC01|01.12.1998||R|||0|0|0|0|ACA|0|0|1|100|IKR|5748|7816|lyfalmen|V0552|6426||30|0|7,5000|Actavis Group hf|Actavis hf|Flúkónazól||4998||4998|7816| 067785|J02AC0102|Candizol|hylki|150|mg|1|stk|1|glas||J02AC01|01.12.1998||R|||0|0|0|0|ACA|0|0|1|100|IKR|664|1768|lyfalmen|V0554|1768||1|0|0,7500|Actavis Group hf|Actavis hf|Flúkónazól||577||577|1768| 067793|J02AC0102|Candizol|hylki|150|mg|2|stk|1|glas||J02AC01|01.12.1998||R|||0|0|0|0|ACA|0|0|1|100|IKR|612|1749|lyfalmen|V0555|1749||2|0|1,5000|Actavis Group hf|Actavis hf|Flúkónazól||563||563|1749| 067801|J02AC0102|Candizol|hylki|150|mg|4|stk|1|glas||J02AC01|01.12.1998||R|||0|0|0|0|ACA|0|0|1|100|IKR|2031|3757|lyfalmen|V0556|3187||4|0|3,0000|Actavis Group hf|Actavis hf|Flúkónazól||2031||2031|3757| 067827|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.12.1998||R|||0|0|0|0|ACA|0|0|1|100|IKR|14199|13437|lyfalmen|V0419|13437||30|0|30,0000|Actavis Group hf|Actavis hf|Flúkónazól||9107||9107|13437| 068043|R01AA0704|Otrivin ukonserveret|nefúđi|1|mg/ml|10|ml|2|glas|sk-úđari|R01AA07|01.02.2010||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||20|0|25,0000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 068312|QN01AX0302|Narketan, vet.|stl|100|mg/ml|50|ml|1|hgl||QN01AX03|01.01.1991||R|||1|0|0|0|VEQ|1|0|0|100|XEU|6044|11778|vetalmen||||50|0||Icepharma hf|Vétoquinol AG|||6044||6044|11778| 068358|L01XC1001|Arzerra|irţ|20|mg/ml|5|ml|3|hgl|100 mg pr. hgl.|L01XC10|01.03.2012||R|||0|1|0|1|GGL|0|0|0|100|GBP|109945|139863|lyfsjukr||||15|0||GlaxoSmithKline ehf|Glaxo Group Limited|Ofatúmúmabi||109945||109945|139863| 068381|B02BX0501|Revolade|filmhtfl|25|mg|14|stk|1|ţpakki||B02BX05|01.04.2011||R|||0|1|0|1|GTS|0|0|0|100|GBP|80877|103383|lyfsjukr||||14|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline Trading Services Ltd.|Eltrombópag||80877||80877|103383| 068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|ţpakki||C01BC04|01.04.1987||R|||0|1|B|0|MEB|0|0|0|100|SEK|1847|3506|lyfalmen||||20|0|10,0000|Vistor hf|Meda AB (V)|Flekaíníđ||1847||1847|3506| 068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|ţpakki||C01BC04|01.04.1987||R|||0|1|B|0|MEB|0|0|0|100|SEK|6117|9347|lyfalmen||||100|0|50,0000|Vistor hf|Meda AB (V)|Flekaíníđ||6117||6117|9347| 068698|N06DA0206|Donepezil Medical|filmhtfl|10|mg|98|stk|1|ţpakki||N06DA02|01.04.2012||R|||0|0|E|0|MED|0|0|0|100|XEU|26231|14635|lyfalmen|V0342|14635||98|0|130,6600|Medical ehf|Medical ehf|Dónepezíl||9983||9983|14635| 068896|B05XA0303|Natriumklorid B.Braun|irţ|1|mmol/ml|20|ml|20|plastl||B05XA03|01.09.2010||R|||0|0|0|1|BRA|0|0|0|100|XEU|2490|3594|lyfsjukr||||400|0||Actavis Group hf|Braun|Natríumklóríđ||2490||2490|3594| 068905|B05XA0103|Kaliumklorid B.Braun|irţ|1|mmol/ml|20|ml|20|plastl||B05XA01|01.09.2010||R|||0|0|0|1|BRA|0|0|0|100|XEU|3099|4473|lyfsjukr||||400|0||Actavis Group hf|Braun|Kalíumklóríđ||3099||3099|4473| 068923|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|||0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa||||200|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 068933|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|||0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa||||400|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 068951|V07AB09|Sterilt Vann B. Braun|leysir|||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|||0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa||||200|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 068960|V07AB09|Sterilt Vann B. Braun|leysir|||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|||0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa||||400|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 069106|H01BA0201|Minirin|frţ.tfl|240|mcg|30|stk|1|ţpakki||H01BA02|01.08.2012||R|||0|0|E|0|FEL|0|0|0|100|DKK|14014|20133|lyfalmen||||30|0|18,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||14014||14014|20133| 069115|H01BA0201|Minirin|frţ.tfl|240|mcg|100|stk|1|ţpakki||H01BA02|01.08.2012||R|||0|0|E|0|FEL|0|0|0|100|DKK|44233|58058|lyfalmen||||100|0|60,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||44233||44233|58058| 069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||15|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||| 069850|C09AA0210|Enalapril LYFIS|töflur|5|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|||0|0|B|0|LYF|0|0|0|100|XEU|426|1392|lyfalmen|V0448|1378||100|0|50,0000|LYFIS ehf|LYFIS ehf|Enalapríl||302||302|1392| 070020|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|||0|0|*|0|JAS|0|1|0|100|SEK|19046|26448|lyfalmen||||1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||||19046|26448| 070031|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|||0|0|*|0|JAS|0|1|0|100|SEK|27547|37117|lyfalmen||||1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||||27547|37117| 070042|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|||0|0|*|0|JAS|0|1|0|100|SEK|35675|47317|lyfalmen||||1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||35675|47317| 070113|B01AC0601|Hjartamagnyl|sţ-tfl|75|mg|500|stk|1|glas||B01AC06|01.10.2012||L|||0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa||||500|0|500,0000|Actavis Group hf|Actavis Group hf|Asetýlsalicýlsýra|||||| 070342|V08AB0201|Omnipaque|stl|350|mg J/ml|100|ml|10|glerfl||V08AB02|01.12.1983||R|||0|0|0|1|GEH|0|0|0|100|NOK|47394|61362|lyfsjukr||||1000|0||Icepharma hf|GE Healthcare AS|Jóhexól||47394||47394|61362| 070557|QH01BB0203|Partoxin vet.|stl|17|mcg|10|ml|10|hgl||QH01BB02|01.12.2006||R|||0|0|0|0|PAB|1|0|0|100|IKR|10511|20355|vetalmen||||100|0||Vistor hf|Pharmaxim AB|||10511||10511|20355| 070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|međ skammtasprautu|N05AX08|01.01.1997||R|||0|0|*|0|JAS|0|1|0|100|SEK|12945|18791|lyfalmen||||100|0|20,0000|Vistor hf|Janssen-Cilag AB|Risperídón||12945||12945|18791| 071076|QA12CE9902|Selevitan, vet.|kyrni|||1250|g|1|plbrús||QA12CE99|01.12.2006||R|||0|0|0|0|PAB|0|0|0|100|SEK|6505|12663|vetalmen||||1250|0||Vistor hf|Pharmaxim AB|||6505||6505|12663| 071134|N05AN0104|Litiumsitrat Actavis|töflur|500|mg|100|stk|1|glas||N05AN01|01.10.1995||R|||0|0|*|0|ACA|0|1|0|100|XEU|691|1924|lyfalmen||||100|0|22,1631|Actavis Group hf|Actavis hf|Litíum||691||691|1924| 071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|||0|1|0|1|EIS|0|0|0|100|SEK|68684|88081|lyfsjukr||||1|0|8,3300|Vistor hf|Eisai Ltd|Ziconotíđ||68684||68684|88081| 071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|||0|1|0|1|EIS|0|0|0|100|SEK|343424|432880|lyfsjukr||||5|0|41,6500|Vistor hf|Eisai Ltd|Ziconotíđ||343424||343424|432880| 071591|N05AH0405|Seroquel Prolong|forđatfl|150|mg|30|stk|1|ţpakki||N05AH04|01.10.2011||R|||0|0|0|0|ASA|0|1|0|100|SEK|8928|13192|lyfalmen||||30|0|11,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||8928|13192| 071611|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|||0|0|0|0|LYF|0|0|0|100|XEU|10765|9312|lyfalmen|V0144|8837||12|0|24,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||6092||6092|9312| 071975|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|ţpakki||L01BB05|01.09.2011||R|||0|1|0|1|GZE|0|0|0|100|SEK|92528|118005|lyfsjukr||||20|0||Vistor hf|Genzyme Europe B.V.|Flúdarabín||||92528|118005| 072044|B01AC0402|Grepid|töflur|75|mg|30|stk|1|ţpakki||B01AC04|01.01.2010||R|||0|0|E|0|PSA|0|0|0|100|XEU|3122|2038|lyfalmen|V0009|2038||30|0|30,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||774||774|2038| 072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|||0|0|0|0|ORF|1|0|0|100|DKK|6952|13521|vetalmen||||5|0||Vistor hf|Orion-Farmos|||6952||6952|13521| 072233|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|300|stk|1|ţpakki||N07BA01|01.02.2010||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||300|0|20,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 072380|B01AC0402|Grepid|töflur|75|mg|100|stk|1|ţpakki||B01AC04|01.12.2009||R|||0|0|E|0|PSA|0|0|0|100|XEU|9815|8169|lyfalmen|V0029|7965||100|0|100,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||5256||5256|8169| 072520|V01AA1104|Alutard SQ, hrossavćrur|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|18920|26290|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|dýr||18920||18920|26290| 072641|V04CX0001|Lung test gas CO (HE) Aga|lyfjagas|0,28|%|20|l|1|hylki|undir ţrýstingi|V04CX|01.05.2012||R|||0|0|0|1|AGA|0|0|0|100|IKR|143477|181946|lyfsjukr||||20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|181946| 072654|V04CX0002|Lung test gas CO (C2H2/CH4) Aga|lyfjagas|0,3|%|20|l|1|hylki|undir ţrýstingi|V04CX|01.05.2012||R|||0|0|0|1|AGA|0|0|0|100|IKR|143477|181946|lyfsjukr||||20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|181946| 072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|||1|0|0|1|JAS|0|0|0|100|SEK|674|973|lyfsjukr||||10|0||Vistor hf|Janssen-Cilag AB|Súfentaníl||674||674|973| 072770|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar||L04AB04|01.06.2007||R|||0|1|0|1|ABB|0|0|0|100|DKK|146713|186007|lyfsjukr||||2|0|27,5900|Vistor hf|Abbott|Adalimumab||146713||146713|186007| 072978|A10BX0401|Byetta|stl|5|mcg/sk|1,2|ml|1|penni|lausn|A10BX04|01.05.2007||R|||0|0|*|0|ELD|0|0|0|100|XEU|16356|23072|lyfalmen||||1|0|20,0000|Icepharma hf|Eli Lilly Nederland B.V.|Exenatíđ||16356||16356|23072| 072996|A10BX0401|Byetta|stl|10|mcg/sk|2,4|ml|1|penni|lausn|A10BX04|01.05.2007||R|||0|0|*|0|ELD|0|0|0|100|XEU|16356|23072|lyfalmen||||2|0|40,0000|Icepharma hf|Eli Lilly Nederland B.V.|Exenatíđ||16356||16356|23072| 073027|J05AG0401|Intelence|töflur|200|mg|60|stk|1|glas||J05AG04|01.04.2012||R|||0|1|0|1|JCI|0|0|0|100|SEK|77179|98742|lyfsjukr||||60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||77179||77179|98742| 073205|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.12.1972||R|||0|0|*|0|LBK|0|1|0|100|DKK|1043|2406|lyfalmen||||100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1043||1043|2406| 073559|G04CA5201|Duodart|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.12.2010||R|||0|0|E|0|GSK|0|0|0|100|GBP|3884|6292|lyfalmen||||30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ og tamsúlósínhýdroklóríđ||3884||3884|6292| 073684|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.12.1972||R|||0|0|*|0|LBK|0|1|0|100|DKK|1625|3202|lyfalmen||||100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1625||1625|3202| 073708|L02BG0405|Letrozol Actavis|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.09.2011||R|||0|0|*|0|AGP|0|0|0|100|XEU|50658|21578|lyfalmen|V0185|21552||100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Letrózól||15166||15166|21578| 073776|C09AA0210|Enalapril LYFIS|töflur|10|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|||0|0|B|0|LYF|0|0|0|100|XEU|709|1585|lyfalmen|V0066|1571||100|0|100,0000|LYFIS ehf|LYFIS ehf|Enalapríl||443||443|1585| 073825|N05BA1203|Tafil|töflur|0,25|mg|20|stk|1|ţpakki||N05BA12|01.04.1987||R|||0|0|0|0|PER|0|0|1|100|DKK|302|1392|lyfalmen|V0047|1281||20|0|5,0000|Icepharma hf|Pfizer ApS|Alprazólam||302||302|1392| 073833|N05BA1203|Tafil|töflur|0,25|mg|50|stk|1|ţpakki||N05BA12|01.04.1987||R|||0|0|0|0|PER|0|0|0|100|DKK|743|1995|lyfalmen|V0305|1009||50|0|12,5000|Icepharma hf|Pfizer ApS|Alprazólam||743||743|1995| 073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|ţpakki||N05BA12|01.04.1987||R|||0|0|0|0|PER|0|0|0|100|DKK|948|2276|lyfalmen|V0305|2017||100|0|25,0000|Icepharma hf|Pfizer ApS|Alprazólam||948||948|2276| 073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|ţpakki||N05BA12|01.04.1987||R|||0|0|0|0|PER|0|0|1|100|DKK|510|1677|lyfalmen|V0439|1484||20|0|10,0000|Icepharma hf|Pfizer ApS|Alprazólam||510||510|1677| 073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|ţpakki||N05BA12|01.04.1987||R|||0|0|0|0|PER|0|0|0|100|DKK|1387|2876|lyfalmen||||100|0|50,0000|Icepharma hf|Pfizer ApS|Alprazólam||1387||1387|2876| 073935|QP54AA0302|Noromectin Drench|mixtúra|0,8|mg/ml|1|l|1|fl|lausn|QP54AA03|01.11.2011||R|||0|0|0|0|NOB|1|0|0|100|XEU|3684|6427|vetorma||||1|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Doramectinum||3684||3684|6427| 073947|L04AX0102|Imurel|töflur|25|mg|50|stk|1|ţpakki||L04AX01|01.12.2010||R|||0|0|*|0|APT|0|0|0|100|GBP|1381|2868|lyfalmen||||50|0|8,3333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Azatíóprín||1381||1381|2868| 074016|G04BE0303|Viagra (D.A.C.)|filmhtfl|25|mg|4|stk|1|ţpakki||G04BE03|01.12.2009||R|||0|0|0|0|DAC|0|0|0|100|DKK|4594|7263|lyfalmen|V0142|7263||4|0|2,0000|D.A.C. ehf|D.A.C. ehf|Síldenafíl||4594||4594|7263| 074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|||0|0|0|0|NOE|0|0|0|100|DKK|3552|5838|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||3552||3552|5838| 074083|B03BB0106|Folic Acid (D.A.C.)|töflur|5|mg|28|stk|1|ţpakki||B03BB01|01.03.2011||R|||0|0|E|0|DAC|0|0|1|100|GBP|416|1541|lyfalmen|V0391|1541||28|0|350,0000|D.A.C. ehf|D.A.C. ehf|Fólínsýra||411||411|1541| 074443|V08CA0301|Omniscan|stl|0,5|mmol/ml|5|ml|10|hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|||0|0|0|1|GEH|0|0|0|100|NOK|17908|24357|lyfsjukr||||50|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||17908||17908|24357| 074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|||0|0|0|0|AGT|0|0|1|100|DKK|474|1627|lyfalmen||||25|0|12,5000|Actavis Group hf|Actavis Group hf|Díazepam||474||474|1627| 074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|||0|0|0|0|AGT|0|0|1|100|DKK|787|2055|lyfalmen||||50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||787||787|2055| 074492|N05BA0105|Stesolid|töflur|5|mg|100|stk|1|glas||N05BA01|01.08.2011||R|||0|0|0|0|AGT|0|0|0|100|DKK|1066|2437|lyfalmen||||100|0|50,0000|Actavis Group hf|Actavis Group hf|Díazepam||1066||1066|2437| 074617|QI06AA0402|Fel-O-Vax PCT vet.|bóluefni|||1|ml|25|spr|áfyllt sprauta|QI06AA04|01.06.2000||R|||0|0|0|0|SCA|1|0|0|100|DKK|20485|35735|vetorma||||25|0||Vistor hf|Scan Vet Animal Health AS|||20485||20485|35735| 074667|N06AA0905|Amitriptyline|filmhtfl|10|mg|98|stk|1|ţpakki||N06AA09|01.03.2011||R|||0|0|B|0|AUK|0|1|0|100|GBP|425|1538|lyfalmen|V0510|1525||98|0|13,0700|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||409||409|1538| 074679|N06AA0905|Amitriptyline|filmhtfl|25|mg|98|stk|1|ţpakki||N06AA09|01.02.2011||R|||0|0|B|0|AUK|0|1|0|100|GBP|777|1984|lyfalmen|V0512|1977||98|0|32,6600|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||735||735|1984| 074758|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.12.2010||R|||0|0|B|0|AEG|0|0|0|100|GBP|984|2325|lyfalmen||||60|0|12,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||984||984|2325| 074782|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.09.2010||R|||0|0|B|0|APT|0|0|0|100|GBP|525|1697|lyfalmen||||100|0|100,0000|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Digoxín||525||525|1697| 075009|L04AX0102|Imurel|töflur|50|mg|100|stk|1|ţpakki||L04AX01|01.08.2011||R|||0|0|*|0|APT|0|0|0|100|GBP|2629|4530|lyfalmen||||100|0|33,3333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Azatíóprín||2596||2596|4530| 075031|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|||0|0|B|0|NOE|0|0|1|100|DKK|4837|7596|lyfalmen||||30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||4837||4837|7596| 075042|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|||0|0|B|0|NOE|0|0|1|100|DKK|14511|20756|lyfalmen||||90|0|90,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||14511||14511|20756| 075044|J02AB0201|Fungoral|töflur|200|mg|10|stk|1|ţpakki||J02AB02|01.01.1985||R|||0|0|0|0|JAS|0|0|1|100|SEK|1832|3485|lyfalmen||||10|0|10,0000|Vistor hf|Janssen-Cilag AB|Ketókónazól||1832||1832|3485| 075064|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|||0|0|B|0|NOE|0|0|1|100|DKK|4837|7596|lyfalmen||||30|0|60,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||4837||4837|7596| 075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|ţpakki||R06AX26|01.11.1999||R|||0|0|E|0|SNO|0|0|1|100|NOK|2000|2804|lyfalmen|V0363|2633||30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1334||1334|2804| 075075|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|||0|0|B|0|NOE|0|0|1|100|DKK|14511|20756|lyfalmen||||90|0|180,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||14511||14511|20756| 075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|ţpakki||N07BA01|01.10.2008||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|||1|0|0|0|ACA|0|0|1|100|XEU|1850|3510|lyfalmen||||300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||1850||1850|3510| 075096|N02AA5902|Parkodin forte|töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|||1|0|0|0|ACA|0|0|1|100|NOK|3139|5273|lyfalmen||||300|0|100,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||3139||3139|5273| 075187|A06AD0001|Moviprep|mixtduft|||4|pokar|1|pakki||A06AD|01.09.2011||R|||0|0|0|0|NBV|0|0|0|100|XEU|2578|4505|lyfalmen||||4|0||Norgine BV|Norgine BV|Hćgđalyf međ osmótíska verkun||||2578|4505| 075310|M01AH0103|Celebra (Lyfjaver)|hylki|200|mg|100|stk|1|ţpakki||M01AH01|01.12.2009||R|||0|0|E|0|LVR|0|0|1|100|DKK|13138|19033|lyfalmen|V0196|19033||100|0|100,0000|Lyfjaver ehf|Lyfjaver ehf|Celekoxíb||13138||13138|19033| 075356|G04BD0703|Detrusitol SR (Lyfjaver)|forđahlk|4|mg|84|stk|1|ţpakki||G04BD07|01.07.2011||R|||0|0|E|0|LVR|0|0|0|100|DKK|17663|24712|lyfalmen||||84|0|84,0000|Lyfjaver ehf|Lyfjaver ehf|Tólteródín||||17663|24712| 075382|V04CL0030|Soluprick SQ, rauđölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7345|11026|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7345||7345|11026| 075408|V04CL0022|Soluprick SQ, graölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7345|11026|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7345||7345|11026| 075413|G04BD0802|Vesicare (Lyfjaver)|filmhtfl|10|mg|90|stk|1|ţpakki||G04BD08|01.05.2012||R|||0|0|E|0|LVR|0|0|0|100|XEU|19735|27313|lyfalmen|V0441|27313||90|0|180,0000|Lyfjaver ehf|Lyfjaver ehf|Sólífenacín||19735||19735|27313| 075424|V04CL0019|Soluprick SQ, birkifrjo|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7345|11026|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7345||7345|11026| 075425|G04BD0802|Vesicare (Lyfjaver)|filmhtfl|5|mg|90|stk|1|ţpakki||G04BD08|01.05.2012||R|||0|0|E|0|LVR|0|0|0|100|XEU|16069|22712|lyfalmen|V0440|22712||90|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Sólífenacín||16069||16069|22712| 075440|V04CL0026|Soluprick SQ, hesliviđur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7345|11026|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7345||7345|11026| 075451|G04CB0103|Finasteride Portfarma|filmhtfl|5|mg|98|stk|1|ţpakki||G04CB01|01.05.2011||R|||0|0|E|0|POF|0|0|0|100|XEU|4061|5410|lyfalmen|V0445|5410||98|0|98,0000|Portfarma ehf|Portfarma|Fínasteríđ||3239||3239|5410| 075465|V04CL0024|Soluprick SQ, haliđagras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7345|11026|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7345||7345|11026| 075470|L01CD0201|Taxotere|irţ|20|mg|1|ml|1|hgl|lausn|L01CD02|01.06.2010||R|||0|1|0|1|AVS|0|0|0|100|NOK|31690|41653|lyfsjukr||||1|0||Vistor hf|Aventis Pharma SA|Docetaxel||31690||31690|41653| 075482|L01CD0201|Taxotere|irţ|80|mg|4|ml|1|hgl|lausn|L01CD02|01.06.2010||R|||0|1|0|1|AVS|0|0|0|100|NOK|118942|151155|lyfsjukr||||4|0||Vistor hf|Aventis Pharma SA|Docetaxel||118942||118942|151155| 075507|V04CL0018|Soluprick SQ, axhnođapunktur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7345|11026|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7345||7345|11026| 075523|V04CL0025|Soluprick SQ, havingull|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7345|11026|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7345||7345|11026| 075549|V04CL0033|Soluprick SQ, vallarrygresi|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7345|11026|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7345||7345|11026| 075564|V04CL0032|Soluprick SQ, vallarfoxgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7345|11026|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7345||7345|11026| 075580|V04CL0034|Soluprick SQ, vallarsveifgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7345|11026|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7345||7345|11026| 075606|V04CL0031|Soluprick SQ, rugur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7345|11026|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7345||7345|11026| 075663|V04CL0021|Soluprick SQ, derm.pter.|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7345|11026|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7345||7345|11026| 075689|V04CL0027|Soluprick SQ, hrossavćrur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7345|11026|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7345||7345|11026| 075705|V04CL0028|Soluprick SQ, hundahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7345|11026|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7345||7345|11026| 075721|V04CL0029|Soluprick SQ, kattahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7345|11026|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7345||7345|11026| 075724|B02BD0901|BeneFIX|sts|||1000|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|||0|1|0|1|WTE|0|0|0|100|DKK|96808|123377|lyfsjukr||||1000|0|2,2200|Icepharma hf|Wyeth Europe|Storkuţáttur IX||96808||96808|123377| 075777|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|ţpakki||QG03DA02|01.03.2011||R|||0|0|0|0|DEC|0|0|0|100|DKK|947|1884|vetalmen||||20|0||Vistor hf|Dechra Veterinary Products A/S|||947||947|1884| 075869|B05DB0005|Balance|kviđ.sk|1,5|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|||0|0|0|1|FMC|0|0|0|100|XEU|5997|8655|lyfsjukr||||10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5997||5997|8655| 075888|B05DB0005|Balance|kviđ.sk|2,3|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|||0|0|0|1|FMC|0|0|0|100|XEU|5997|8655|lyfsjukr||||10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5997||5997|8655| 075906|B05DB0005|Balance|kviđ.sk|4,25|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|||0|0|0|1|FMC|0|0|0|100|XEU|5997|8655|lyfsjukr||||10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5997||5997|8655| 075936|P01BC0104|Quinine Sulphate Actavis|filmhtfl|200|mg|28|stk|1|ţpakki||P01BC01|01.07.2010||R|||0|0|0|0|AUK|0|0|0|100|GBP|455|1601|lyfalmen||||28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Kínín||455||455|1601| 075947|J01EE0107|Trimezol|töflur|480|mg|20|stk|1|ţpakki|80+400 mg|J01EE01|01.12.2009||R|||0|0|0|0|AEA|0|0|1|100|XEU|445|1588|lyfalmen||||20|0|5,0000|Actavis hf|Actavis EAD|Súlfametoxazól og trímetóprím||445||445|1588| 075991|C09AA0210|Enalapril LYFIS|töflur|20|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|||0|0|B|0|LYF|0|0|0|100|XEU|883|1860|lyfalmen|V0449|1846||100|0|200,0000|LYFIS ehf|LYFIS ehf|Enalapríl||644||644|1860| 076024|A10BH0101|Januvia|filmhtfl|100|mg|28|stk|1|ţpakki||A10BH01|01.01.2010||R|||0|0|*|0|MSD|0|0|0|100|DKK|6483|9847|lyfalmen||||28|0|28,0000|Vistor hf|M.S.D.|Sítagliptín||6483||6483|9847| 076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|ţpakki||A10BH01|01.11.2007||R|||0|0|*|0|MSD|0|0|0|100|DKK|22078|30253|lyfalmen||||98|0|98,0000|Vistor hf|M.S.D.|Sítagliptín||22078||22078|30253| 076052|A10BH0101|Januvia|filmhtfl|50|mg|98|stk|1|ţpakki||A10BH01|01.10.2012||R|||0|0|*|0|MSD|0|0|0|100|DKK|22597|30904|lyfalmen||||98|0|49,0000|Vistor hf|M.S.D.|Sítagliptín||22597||22597|30904| 076361|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir ţrýstingi/LIV|V03AN01|01.12.2009||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||2|0||Ísaga ehf|AGA AB|Súrefni|||||| 076369|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|20|stk|1|ţpakki||N05AX08|01.07.2007||R|||0|0|0|0|POF|0|1|0|100|IKR|445|1588|lyfalmen|V0045|1588||20|0|2,0000|Portfarma ehf|Portfarma|Risperídón||445||445|1588| 076378|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|60|stk|1|ţpakki||N05AX08|01.07.2007||R|||0|0|*|0|POF|0|1|0|100|IKR|1986|3099|lyfalmen|V0290|3099||60|0|6,0000|Portfarma ehf|Portfarma|Risperídón||1550||1550|3099| 076387|N05AX0805|Risperidon Portfarma|filmhtfl|1|mg|60|stk|1|ţpakki||N05AX08|01.07.2007||R|||0|0|*|0|POF|0|1|0|100|IKR|1946|3373|lyfalmen|V0291|3373||60|0|12,0000|Portfarma ehf|Portfarma|Risperídón||1750||1750|3373| 076533|N05AB0301|Trilafon|filmhtfl|2|mg|100|stk|1|ţpakki||N05AB03|01.04.2009||R|||0|0|*|0|SPL|0|1|0|100|DKK|872|2172|lyfalmen||||100|0|6,6667|Vistor hf|Schering-Plough Europe|Perfenazín||872||872|2172| 076542|N05AB0301|Trilafon|filmhtfl|4|mg|100|stk|1|ţpakki||N05AB03|01.04.2009||R|||0|0|*|0|SPL|0|1|0|100|DKK|1220|2648|lyfalmen||||100|0|13,3333|Vistor hf|Schering-Plough Europe|Perfenazín||||1220|2648| 076551|N05AB0301|Trilafon|filmhtfl|8|mg|100|stk|1|ţpakki||N05AB03|01.04.2009||R|||0|0|*|0|SPL|0|1|0|100|DKK|1738|3356|lyfalmen||||100|0|26,6667|Vistor hf|Schering-Plough Europe|Perfenazín||||1738|3356| 076752|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|100|ml|1|hgl|plast|QP54AA01|01.01.1985||R|||0|0|0|0|MEF|1|0|0|100|XEU|7055|12307|vetorma||||100|0||Vistor hf|Merial (MSD)|Ivermectinum||7055||7055|12307| 076814|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|dreifa|J07AL52|01.12.2009|30.09.2012|R|||0|0|0|0|GLB|0|0|0|100|GBP|7107|10596|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||7030||7030|10596| 076871|G01AF0202|Canesten (D.A.C.)|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.12.2009||L|||0|0|0|0|DAC|0|0|0|100|IKR|||lyflausa||||1|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klótrímazól|||||| 077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1985||R|||0|0|0|0|ACA|0|0|1|100|XEU|228|1291|lyfalmen||||30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||228||228|1291| 077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1985||R|||0|0|0|0|ACA|0|0|1|100|XEU|671|1897|lyfalmen||||100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||671||671|1897| 077821|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2010||R|||0|0|E|0|APC|0|0|0|100|XEU|9815|7965|lyfalmen|V0029|7965||100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||5107||5107|7965| 077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|||0|0|E|0|GSK|0|0|0|100|GBP|814|2092|lyfalmen||||10|0|0,8333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||814||814|2092| 078182|D01AC0302|Pevaryl (D.A.C.)|krem|10|mg/g|30|g|1|túpa||D01AC03|01.12.2009||L|||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa||||30|0||D.A.C. ehf|D.A.C. ehf|Ekónazól|||||| 078193|D01AC0102|Canesten (D.A.C.)|krem|1|%|20|g|1|túpa||D01AC01|01.12.2009||L|||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa||||20|0||D.A.C. ehf|D.A.C. ehf|Klótrímazól|||||| 078239|S01GX0202|Livostin (D.A.C.)|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.12.2009||L|||0|0|0|0|DAC|0|0|0|100|IKR|||lyflausa||||4|0||D.A.C. ehf|D.A.C. ehf|Levókabastín|||||| 078250|D01AC0803|Fungoral (D.A.C.)|sápa|20|mg/ml|120|ml|1|plastf||D01AC08|01.12.2009||L|||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa||||120|0||D.A.C. ehf|D.A.C. ehf|Ketókónazól|||||| 078307|J02AC0103|Fluconazole Portfarma|hylki|200|mg|28|stk|1|ţpakki||J02AC01|01.12.2010||R|||0|0|0|0|POF|0|0|1|100|IKR|11524|12606|lyfalmen|V0419|12541||28|0|28,0000|Portfarma ehf|Portfarma|Flúkónazól||8500||8500|12606| 078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|ţpakki||J01CE02|01.10.1985||R|||0|0|0|0|REP|0|0|1|100|SEK|548|1729|lyfalmen||||20|0|2,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||548||548|1729| 078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|ţpakki||J01CE02|01.10.1985||R|||0|0|0|0|REP|0|0|1|100|SEK|835|2121|lyfalmen||||40|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||835||835|2121| 078688|N01BB0204|Lidokain FarmaPlus|stl|10|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.04.2012||R|||0|0|0|0|FPL|0|0|1|100|XEU|1379|2865|lyfalmen|V0560|2865||100|0||FarmaPlus AS|FarmaPlus AS|Lídókaín||1379||1379|2865| 078699|N01BB0204|Lidokain FarmaPlus|stl|20|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.04.2012||R|||0|0|0|0|FPL|0|0|1|100|XEU|1971|3675|lyfalmen|V0561|3675||100|0||FarmaPlus AS|FarmaPlus AS|Lídókaín||1971||1971|3675| 078933|L03AB0801|Betaferon|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.01.2002||R|||0|1|0|1|SAG|0|0|0|100|SEK|127494|161887|lyfsjukr||||15|0|30,0000|Icepharma hf|Schering AG|Interferón beta-1b||127494||127494|161887| 079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|ţpakki||C09CA01|01.01.1995||R|||0|0|0|0|MSD|0|0|0|100|DKK|8791|6023|lyfalmen|V0069|2381||98|0|98,0000|Vistor hf|M.S.D.|Lósartan||3687||3687|6023| 079103|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.1998||R|||0|1|0|1|BAM|0|0|0|100|SEK|2862|4131|lyfsjukr||||1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||2862||2862|4131| 079111|L01AA0601|Holoxan|sts/irs|1|g|1|stk|1|hgl||L01AA06|01.07.1998||R|||0|1|0|1|BAM|0|0|0|100|SEK|4850|7000|lyfsjukr||||1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||4850||4850|7000| 079129|L01AA0601|Holoxan|sts/irs|2|g|1|stk|1|hgl||L01AA06|01.07.1998||R|||0|1|0|1|BAM|0|0|0|100|SEK|9020|13018|lyfsjukr||||1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||9020||9020|13018| 079202|J05AH0201|Tamiflu|hylki|75|mg|10|stk|1|ţpakki||J05AH02|01.11.2002||R|||0|0|0|0|RRL|0|0|0|100|DKK|3602|5906|lyfalmen||||10|0|5,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3602||3602|5906| 079269|N05AB0302|Trilafon decanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.01.1988||R|||0|0|*|0|SPL|0|1|0|100|DKK|18198|25384|lyfalmen||||10|0|154,5714|Vistor hf|Schering-Plough Europe|Perfenazín||18198||18198|25384| 079358|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.05.2010||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 079370|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.05.2010|31.08.2012|L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 079381|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.05.2010||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 079495|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|100|stk|1|ţpakki||N06AB03|01.05.2010||R|||0|0|B|0|ACA|0|1|0|100|XEU|3448|5696|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||3448||3448|5696| 079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|||0|0|0|1|BRS|0|0|0|100|DKK|2043|2949|lyfsjukr||||5|0|2,5000|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||2043||2043|2949| 080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|ţpakki||J01MA02|01.10.1992||R|||0|0|0|0|ACA|0|0|1|100|IKR|393|1517|lyfalmen|V0176|1517||10|0|2,5000|Actavis Group hf|Actavis hf|Cíprófloxacín||393||393|1517| 080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|ţpakki||J01MA02|01.10.1992||R|||0|0|0|0|ACA|0|0|1|100|IKR|638|1852|lyfalmen|V0418|1852||20|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||638||638|1852| 080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|ţpakki||J01MA02|01.05.2008||R|||0|0|0|0|ACA|0|0|1|100|IKR|647|1864|lyfalmen|V0177|1864||10|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||647||647|1864| 080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|ţpakki||J01MA02|01.01.1994||R|||0|0|0|0|ACA|0|0|1|100|IKR|1168|2577|lyfalmen|V0411|2577||20|0|10,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||1168||1168|2577| 080145|QG02AD9002|Genestran|stl|75|mcg/ml|20|ml|1|hgl|lausn|QG02AD90|01.11.2011||R|||0|0|0|0|ANI|1|0|0|100|IKR|4985|9745|vetalmen||||20|0||Dýraheilsa ehf|aniMedica GmbH|||4985||4985|9745| 080156|QN02AF0101|Morphasol handa hundum og köttum|stl|4|mg/ml|10|ml|1|hgl||QN02AF01|01.06.2010||R|||0|0|0|0|ANI|1|0|0|100|XEU|3957|7771|vetalmen||||10|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||||3957|7771| 080331|L02BB0306|Bicalutamid LYFIS|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.06.2012||R|||0|0|*|0|LYF|0|0|0|100|XEU|17381|18362|lyfalmen|V0421|18362||30|0|90,0000|LYFIS ehf|LYFIS ehf|Bíkalútamíđ||12603||12603|18362| 080424|G01AF0502|Pevaryl Depot|sk-stíll|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|||0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa||||1|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||| 080447|QP52AA5103|Drontal Vet.|filmhtfl|250|mg|24|stk|1|ţpakki|230+20 mg|QP52AA51|01.11.2011||R|||0|0|0|0|BAN|1|0|0|100|DKK|10068|17563|vetorma||||24|0||Icepharma hf|Bayer Animal Health GmbH|||10068||10068|17563| 080470|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|30|stk|1|ţpakki||L02BG04|01.03.2012||R|||0|0|*|0|RAT|0|0|0|100|XEU|16355|9786|lyfalmen|V0170|9786||30|0|30,0000|LYFIS ehf|ratiopharm GmbH|Letrózól||6438||6438|9786| 080482|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.03.2012||R|||0|0|*|0|RAT|0|0|0|100|XEU|36139|21552|lyfalmen|V0185|21552||100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Letrózól||15145||15145|21552| 080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|||0|0|B|0|LBK|0|1|0|100|DKK|2217|4012|lyfalmen||||100|0|66,6667|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2217||2217|4012| 080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|ţpakki|m/br. losunarhrađa|N06AX12|01.07.2007||R|||0|0|0|0|GSK|0|1|0|100|GBP|6105|9330|lyfalmen||||30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||6105||6105|9330| 080538|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|||0|0|0|0|AGP|0|0|0|100|XEU|2617|3529|lyfalmen|V0143|2424||4|0|4,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||1864||1864|3529| 080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|ţpakki|m/br. losunarhrađa|N06AX12|01.07.2007||R|||0|0|0|0|GSK|0|1|0|100|GBP|3170|5315|lyfalmen||||30|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||3170||3170|5315| 080549|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|500|ml|1|fl||QP54AA01|01.01.1985||R|||0|0|0|0|MEF|1|0|0|100|XEU|33672|58739|vetorma||||500|0||Vistor hf|Merial (MSD)|Ivermectinum||33672||33672|58739| 080550|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|||0|0|0|0|AGP|0|0|0|100|XEU|7396|7271|lyfalmen|V0143|7271||12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||4600||4600|7271| 080561|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|||0|0|0|0|AGP|0|0|0|100|XEU|2889|3622|lyfalmen|V0144|2946||4|0|8,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||1932||1932|3622| 080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|||0|1|0|1|PER|0|0|0|100|DKK|14750|20394|lyfsjukr||||1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||14750||14750|20394| 080573|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|||0|0|0|0|AGP|0|0|0|100|XEU|10766|9312|lyfalmen|V0144|8837||12|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||6092||6092|9312| 080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|||0|1|0|1|PER|0|0|0|100|DKK|29079|38377|lyfsjukr||||1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||29079||29079|38377| 081315|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dćlur|einnota dćlur plast|M09AX01|01.07.2012|30.09.2012|R|||0|0|E|0|ASA|0|0|0|100|SEK|37659|49807|lyfalmen||||12|0|34,7222|Vistor hf|Astra Zeneca A/S|Natríumhýalúrónat||37659||37659|49807| 081525|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||10|0||Ísaga ehf|AGA AB|Súrefni|||||| 081534|V03AN0101|Conoxia|lyfjagas|100|%|20|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||20|0||Ísaga ehf|AGA AB|Súrefni|||||| 081543|V03AN0101|Conoxia|lyfjagas|100|%|50|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||50|0||Ísaga ehf|AGA AB|Súrefni|||||| 081552|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||5|0||Ísaga ehf|AGA AB|Súrefni|||||| 081561|V03AN0101|Conoxia|lyfjagas|100|%|50|l|12|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||600|0||Ísaga ehf|AGA AB|Súrefni|||||| 081589|V03AN0101|Conoxia|lyfjagas|100|%|1|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||1|0||Ísaga ehf|AGA AB|Súrefni|||||| 081613|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.05.2010||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 081624|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.05.2010|31.08.2012|L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 081625|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||2|0||Ísaga ehf|AGA AB|Súrefni|||||| 081634|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||4|0||Ísaga ehf|AGA AB|Súrefni|||||| 081635|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.05.2010||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 081645|N03AX1405|Matever|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|||0|0|0|0|PSA|0|0|0|100|XEU|7926|4973|lyfalmen|V0515|4973||100|0|16,6700|Portfarma ehf|Pharmathen S.A.|Levetíracetam||2920||2920|4973| 081669|G03DA0404|Lutinus|sk-tafla|100|mg|21|stk|1|ţpakki||G03DA04|01.04.2011||R|||0|1|E|0|FEL|0|0|0|100|DKK|4545|7196|lyfalmen||||21|0|23,3300|Vistor hf|Ferring Lćgemidler A/S|Prógesterón||4545||4545|7196| 081671|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||4|0||Ísaga ehf|AGA AB|Súrefni|||||| 081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|||0|0|0|1|ROC|0|0|0|100|DKK|1800|2598|lyfsjukr||||10|0|3,3333|Icepharma hf|Roche|Mídazólam||1800||1800|2598| 081897|N05AH0305|Zyprexa Velotab (D.A.C.)|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.04.2010||R|||0|0|*|0|DAC|0|1|0|100|XEU|19302|15307|lyfalmen|V0456|9397||28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Olanzapín||10474||10474|15307| 081987|A10AB0602|Apidra [Solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AB06|01.01.2008||R|||0|0|*|0|SAA|0|0|0|100|NOK|5959|9131|lyfalmen||||15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||5959||5959|9131| 081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AE04|01.01.2008||R|||0|0|*|0|SDE|0|0|0|100|NOK|8951|13223|lyfalmen||||15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||8951||8951|13223| 082021|L02BG0302|Anastrozol Actavis|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.2011||R|||0|0|*|0|AGP|0|0|0|100|XEU|37425|14498|lyfalmen|V0184|14475||98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Anastrózól||9883||9883|14498| 082040|D07XC0101|Diprosalic|áburđur|||100|ml|1|glas||D07XC01|01.01.1987||R|||0|0|B|0|SPL|0|0|1|100|DKK|2211|4003|lyfalmen||||100|0||Vistor hf|Schering-Plough Europe|Betametasón||2211||2211|4003| 082233|V03AN0101|Conoxia|lyfjagas|100|%|36|l|1|hylki|kćlt|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||36|0||Ísaga ehf|AGA AB|Súrefni|||||| 082685|R03BA0502|Flixotide Diskus|innúđadu|250|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|||0|0|B|0|GSK|0|0|0|100|GBP|3267|4960|lyfalmen||||60|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2910||2910|4960| 082719|R03BA0502|Flixotide Diskus|innúđadu|500|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|||0|0|B|0|GSK|0|0|0|100|GBP|5790|8899|lyfalmen||||60|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5790||5790|8899| 082792|J01CA0411|Amoxicillin Mylan|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CA04|01.07.1998||R|||0|0|0|0|MYL|0|0|1|100|SEK|958|2289|lyfalmen||||125|0|6,2500|Actavis Group PTC ehf|Mylan AB|Amoxicillín||958||958|2289| 082797|N02BE0117|Panodil Zapp|filmhtfl|500|mg|20|stk|1|ţpakki||N02BE01|01.02.2012||L|||0|0|0|0|GGK|0|0|1|100|IKR|||lyflausa||||20|0|3,3333|GlaxoSmithKline ehf|GlaxoSmithKline Consumer Healthcare A/S|Paracetamól|||||| 082883|R03BA0201|Pulmicort|innúđal|0,125|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|||0|0|0|0|AZD|0|0|0|100|SEK|4874|7646|lyfalmen||||20|0|1,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||4874||4874|7646| 082933|R03BA0201|Pulmicort|innúđal|0,25|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|||0|0|0|0|AZD|0|0|0|100|SEK|5762|8861|lyfalmen||||20|0|3,3300|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||5762||5762|8861| 082940|C09CA0602|Candpress|töflur|16|mg|100|stk|1|ţpakki||C09CA06|01.01.2012||R|||0|0|0|0|AGP|0|0|0|100|XEU|8853|12481|lyfalmen|V0080|12481||100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||8408||8408|12481| 082958|N06DA0301|Exelon|hylki|1,5|mg|56|stk|1|ţpakki||N06DA03|01.10.2008||R|||0|0|E|0|NOH|0|0|0|100|DKK|12919|18758|lyfalmen||||56|0|9,3350|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||12919||12919|18758| 083113|L02BG0301|Arimidex|filmhtfl|1|mg|28|stk|1|ţpakki||L02BG03|01.03.1998||R|||0|0|*|0|AZA|0|0|0|100|SEK|19509|27029|lyfalmen|V0186|7271||28|0|28,0000|Vistor hf|AstraZeneca AB|Anastrózól||19509||19509|27029| 083121|N06DA0301|Exelon|hylki|3|mg|56|stk|1|ţpakki||N06DA03|01.10.2008||R|||0|0|E|0|NOH|0|0|0|100|DKK|13493|19479|lyfalmen|V0344|13596||56|0|18,6700|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||13493||13493|19479| 083154|R03BA0201|Pulmicort|innúđal|0,5|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|||0|0|0|0|AZD|0|0|0|100|SEK|7614|11394|lyfalmen||||20|0|6,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||7614||7614|11394| 083592|J05AE0301|Norvir|mixtúra|80|mg/ml|90|ml|5|glös||J05AE03|01.08.2003||R|||0|1|0|1|ABL|0|0|0|100|DKK|75402|96512|lyfsjukr||||450|0|30,0000|Vistor hf|Abbott Laboratories A/S|Ritonavír||75402||75402|96512| 083634|N06DA0301|Exelon|hylki|6|mg|112|stk|1|ţpakki||N06DA03|01.01.1999||R|||0|0|E|0|NOH|0|0|0|100|DKK|29279|39290|lyfalmen|V0346|29194||112|0|74,6667|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||29279||29279|39290| 083980|L02AE0101|Suprefact|stl|1|mg/ml|5,5|ml|2|hgl||L02AE01|01.10.1987||R|||0|1|0|1|SNO|0|0|0|100|NOK|8528|12308|lyfsjukr||||11|0|7,3333|Vistor hf|Sanofi-aventis Norge AS|Búserelín||8528||8528|12308| 084097|C09CA0105|Losartan LYFIS|filmhtfl|50|mg|98|stk|1|ţpakki||C09CA01|01.05.2012||R|||0|0|B|0|LYF|0|0|0|100|XEU|2079|2381|lyfalmen|V0069|2381||98|0|98,0000|LYFIS ehf|LYFIS ehf|Lósartan||1025||1025|2381| 084160|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.03.2003||R|||0|0|E|0|NYC|0|0|0|100|DKK|264|1340|lyfalmen||||10|0|2,5000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||264||264|1340| 084192|N05BA1206|Alprazolam Krka|forđatfl|2|mg|30|stk|1|ţpakki||N05BA12|01.08.2012||R|||0|0|0|0|KRK|0|0|1|100|XEU|1998|3241|lyfalmen|V0311|3241||30|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1654||1654|3241| 084376|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.03.2003||R|||0|0|E|0|NYC|0|0|0|100|DKK|509|1675|lyfalmen||||20|0|5,0000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||509||509|1675| 084591|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.04.2012||R|||0|1|0|1|IPI|0|0|0|100|DKK|71851|92056|lyfsjukr||||4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||71851||71851|92056| 084669|B03XA0301|Mircera|stl|150|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|||0|1|0|1|RRL|0|0|0|100|DKK|60106|77316|lyfsjukr||||0|0|37,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||60106||60106|77316| 084678|B03XA0301|Mircera|stl|200|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|||0|1|0|1|RRL|0|0|0|100|DKK|78356|100219|lyfsjukr||||0|0|50,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||78356||78356|100219| 084687|B03XA0301|Mircera|stl|250|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|||0|1|0|1|RRL|0|0|0|100|DKK|96938|123540|lyfsjukr||||0|0|62,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||96938||96938|123540| 084696|B03XA0301|Mircera|stl|50|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|||0|1|0|1|RRL|0|0|0|100|DKK|20036|27028|lyfsjukr||||0|0|12,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||20036||20036|27028| 084705|B03XA0301|Mircera|stl|75|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|||0|1|0|1|RRL|0|0|0|100|DKK|31292|41154|lyfsjukr||||0|0|18,7500|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||31292||31292|41154| 084714|B03XA0301|Mircera|stl|100|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|||0|1|0|1|RRL|0|0|0|100|DKK|40070|52170|lyfsjukr||||0|0|25,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||40070||40070|52170| 084751|B03XA0301|Mircera|stl|30|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|||0|1|0|1|RRL|0|0|0|100|DKK|12409|17456|lyfsjukr||||0|0|7,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||12409|17456| 084778|B03XA0301|Mircera|stl|120|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|||0|1|0|1|RRL|0|0|0|100|DKK|47304|61249|lyfsjukr||||0|0|30,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||47304|61249| 084787|B03XA0301|Mircera|stl|360|mcg/spr|0,6|ml|1|áf.spr||B03XA03|01.05.2009||R|||0|1|0|1|RRL|0|0|0|100|DKK|145694|184728|lyfsjukr||||1|0|90,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||145694|184728| 084878|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|ţpakki||N03AF03|01.09.2007||R|||0|1|E|0|EIS|0|0|0|100|SEK|972|2309|lyfalmen||||10|0|0,7100|Vistor hf|Eisai Ltd|Rúfínamíđ||972||972|2309| 084887|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|ţpakki||N03AF03|01.09.2007||R|||0|1|E|0|EIS|0|0|0|100|SEK|11538|16762|lyfalmen||||60|0|8,5700|Vistor hf|Eisai Ltd|Rúfínamíđ||11538||11538|16762| 084896|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|ţpakki||N03AF03|01.09.2007||R|||0|1|E|0|EIS|0|0|0|100|SEK|37547|49667|lyfalmen||||100|0|28,5700|Vistor hf|Eisai Ltd|Rúfínamíđ||37547||37547|49667| 085068|N02AA0101|Contalgin|forđatfl|100|mg|100|stk|1|ţpakki||N02AA01|01.10.1985||R|||1|0|E|0|PER|0|0|0|100|DKK|15190|21609|lyfalmen||||100|0|100,0000|Icepharma hf|Pfizer ApS|Morfín||15190||15190|21609| 085184|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.09.2010||R|||0|1|*|0|GAN|0|0|0|100|NOK|44233|58058|lyfalmen||||2|0||Icepharma hf|Galderma Nordic AB|Metýlamínólevúlínat||44233||44233|58058| 085205|S01AX1901|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AX19|01.03.2008||R|||0|0|0|0|SAO|0|0|1|100|XEU|2575|4501|lyfalmen||||15|0||Icepharma hf|Santen Oy|Levófloxacín||2575||2575|4501| 085316|N06DA0301|Exelon|hylki|4,5|mg|112|stk|1|ţpakki||N06DA03|01.01.1999||R|||0|0|E|0|NOH|0|0|0|100|DKK|29279|39290|lyfalmen|V0345|29194||112|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||29279||29279|39290| 085407|R03AC0206|Ventoline|lausn|1|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|||0|0|0|0|GSK|0|0|1|100|IKR|821|2102|lyfalmen||||20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||821||821|2102| 085542|G03GA0202|Menopur|sts|||75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|||0|1|E|0|FEL|0|0|0|100|DKK|19925|27551|lyfalmen|V0412|22950||375|0|12,5000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||19925||19925|27551| 085551|G03GA0202|Menopur|sts|||75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|||0|1|E|0|FEL|0|0|0|100|DKK|34545|45899|lyfalmen|V0412|45899||750|0|25,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||34545||34545|45899| 085770|G04BE0804|Adcirca|filmhtfl|20|mg|56|stk|1|ţpakki||G04BE08|01.12.2010||R|||0|1|0|1|ELD|0|0|0|100|XEU|92385|117826|lyfsjukr||||56|0|112,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||92385||92385|117826| 085804|M05BX0401|Prolia|stl|60|mg/ml|1|ml|1|áf.spr|lausn|M05BX04|01.10.2010||R|||0|0|0|0|AEU|0|0|0|100|DKK|39116|51636|lyfalmen||||1|0|181,8100|Vistor hf|Amgen Europe B.V.|Denosúmab||39116||39116|51636| 085838|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|1|glös|lausn|S01EE03|01.10.2011||R|||0|0|*|0|API|0|0|0|100|SEK|3043|5142|lyfalmen|V0465|4427||3|0|30,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Bimatóprost||3043||3043|5142| 085849|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|3|glös|lausn|S01EE03|01.10.2011||R|||0|0|*|0|API|0|0|0|100|SEK|8993|13281|lyfalmen|V0465|13281||9|0|90,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Bimatóprost||8993||8993|13281| 085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|ţpakki||R06AX26|01.11.1999||R|||0|0|E|0|SNO|0|0|1|100|NOK|4155|5237|lyfalmen|V0364|4839||100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3113||3113|5237| 086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|ţpakki||R06AX26|01.11.1999||R|||0|0|E|0|SNO|0|0|1|100|NOK|5627|6077|lyfalmen|V0365|5603||100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3727||3727|6077| 086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|||0|0|0|1|GSK|0|0|0|100|GBP|8467|12220|lyfsjukr||||5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||8467||8467|12220| 086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|||0|0|0|1|GSK|0|0|0|100|GBP|14719|20355|lyfsjukr||||5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||14719||14719|20355| 086368|G03GA0202|Menopur|sts|||600|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|||0|1|E|0|FEL|0|0|0|100|DKK|29609|39704|lyfalmen||||600|0|20,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||29609||29609|39704| 086380|G03GA0202|Menopur|sts|||1200|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|||0|1|E|0|FEL|0|0|0|100|DKK|59218|76864|lyfalmen||||1200|0|40,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||59218||59218|76864| 086434|L04AA2401|Orencia|stl/irţ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|||0|1|0|1|BSP|0|0|0|100|DKK|52542|67823|lyfsjukr||||1|0|9,2600|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Abatacept||52542||52542|67823| 086530|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.08.2012||R|||0|0|0|0|BOY|0|0|0|100|SEK|18812|26154|lyfalmen||||1|0||Icepharma hf|Bayer OY|Plast lyfjalykkja (IUD) međ prógestógen||18812||18812|26154| 086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|||0|0|0|1|ROA|0|0|0|100|DKK|49277|63725|lyfsjukr||||100|0|5,5000|Icepharma hf|Roche A.S.|Valgancíklóvír||49277||49277|63725| 087114|G03CX0101|Livial|töflur|2,5|mg|28|stk|1|ţpakki||G03CX01|01.07.1998||R|||0|0|E|0|ORG|0|0|0|100|DKK|2923|4977|lyfalmen||||28|0|28,0000|Vistor hf|N.V. Organon|Tíbólón||2923||2923|4977| 087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|ţpakki|mjúk hylki|A03AX13|01.12.2008||L|||0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa||||30|0|14,4000|Vistor hf|McNeil Sweden AB|Silíkonsambönd|||||| 087233|N05CF0201|Stilnoct|töflur|10|mg|30|stk|1|ţpakki||N05CF02|01.08.2012||R|||0|0|0|0|SNO|0|0|0|100|NOK|439|1579|lyfalmen|V0060|1579||30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||439||439|1579| 087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|ţpakki||J05AX09|01.04.2008||R|||0|1|0|1|VII|0|0|0|100|DKK|157755|199865|lyfsjukr||||60|0|15,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||157755||157755|199865| 087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|ţpakki||N05CF01|01.10.1995||R|||0|0|0|0|SNO|0|0|1|100|NOK|297|1385|lyfalmen|V0312|445||10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||297||297|1385| 087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|ţpakki||N05CF01|01.10.1995||R|||0|0|0|0|SNO|0|0|0|100|NOK|261|1336|lyfalmen|V0312|1336||30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||261||261|1336| 087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|ţpakki||N05CF01|01.10.1995||R|||0|0|0|0|SNO|0|0|0|100|NOK|2202|3991|lyfalmen||||100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||2202||2202|3991| 087445|A02BX1301|Gaviscon|mixtúra|||500|ml|1|glas||A02BX13|01.08.1984||L|||0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen||||500|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||3586| 087759|G03GB0202|Pergotime|töflur|50|mg|5|stk|1|ţpakki||G03GB02|01.07.1986||R|||0|0|E|0|MEC|0|0|0|100|SEK|905|2217|lyfalmen||||5|0|27,7778|Icepharma hf|Merck AB|Klómífen||905||905|2217| 087788|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.11.2010||R|||0|0|E|0|APC|0|0|0|100|XEU|3432|1902|lyfalmen|V0009|1902||28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||675||675|1902| 087832|L02BB0304|Bicalutamid Actavis|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.09.2007||R|||0|0|*|0|AGP|0|0|0|100|XEU|10520|7538|lyfalmen|V0420|7519||30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíđ||4795||4795|7538| 087867|QP52AA5108|Prazitel Plus|töflur|||104|stk|1|ţpakki|50/144/150|QP52AA51|01.07.2010||R|||0|0|0|0|CHP|0|0|0|100|XEU|30844|53806|vetorma||||104|0||Icepharma hf|Chanelle Pharmaceuticals|||30844||30844|53806| 087932|A02BX1301|Gaviscon|tuggutfl|||20|stk|1|ţpakki||A02BX13|01.10.1993||L|||0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa||||20|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||| 087969|QD07AC0001|Cortavance|húđúđi|0,584|mg/ml|76|ml|1|fl|lausn|QD07AC|01.04.2012||R|||0|0|0|0|VIR|0|0|0|100|DKK|4357|8539|vetalmen||||76|0||Vistor hf|Virbac S.A|Hýdrókortisón aceponat||4357||4357|8539| 088026|QG03DA0402|Prid delta|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.02.2012||R|||0|0|0|0|CES|1|0|0|100|SEK|28933|50472|vetorma||||10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||28933||28933|50472| 088261|R01AD1201|Avamys|nefúđi|27,5|mcg/sk|120|skammtar|1|glas||R01AD12|01.04.2008||R|||0|0|E|0|GGL|0|0|1|100|GBP|1375|2860|lyfalmen||||120|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Flútíkasón fúróat||1375||1375|2860| 088310|M01AX0101|Relifex|lausnart|1|g|20|stk|1|ţpakki||M01AX01|01.04.1995||R|||0|0|E|0|MAB|0|0|1|100|SEK|1578|3138|lyfalmen||||20|0|20,0000|Vistor hf|Meda AB|Nabúmeton||1578||1578|3138| 088328|M01AX0101|Relifex|lausnart|1|g|100|stk|1|ţpakki||M01AX01|01.04.1995||R|||0|0|E|0|MAB|0|0|1|100|SEK|6088|9307|lyfalmen||||100|0|100,0000|Vistor hf|Meda AB|Nabúmeton||6088||6088|9307| 088393|A03FA0101|Primperan|eţ-stíll|20|mg|6|stk|1|pakki||A03FA01|01.10.1995||R|||0|0|E|0|SNO|0|0|1|100|NOK|403|1530|lyfalmen||||6|0|4,0000|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíđ||403||403|1530| 088696|D05AX5201|Daivobet|hlaup|||30|g|1|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|||0|0|B|0|LEP|0|0|0|100|DKK|4965|7771|lyfalmen||||30|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||4965||4965|7771| 088705|D05AX5201|Daivobet|hlaup|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.02.2011||R|||0|0|B|0|LEP|0|0|0|100|DKK|9592|14100|lyfalmen||||60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||9592||9592|14100| 088714|D05AX5201|Daivobet|hlaup|||60|g|2|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|||0|0|B|0|LEP|0|0|0|100|DKK|14716|21014|lyfalmen||||120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||14716||14716|21014| 088723|L01XE0701|Tyverb|filmhtfl|250|mg|70|stk|1|ţpakki||L01XE07|01.11.2008|31.07.2012|R|||0|1|0|1|GGL|0|0|0|100|GBP|178960|226477|lyfsjukr||||70|0||GlaxoSmithKline ehf|Glaxo Group Limited|Labatinibum||||178960|226477| 088814|L02BB0304|Bicalutamid Actavis|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.12.2008||R|||0|0|*|0|AGP|0|0|0|100|XEU|22320|18386|lyfalmen|V0421|18362||30|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíđ||12622||12622|18386| 088964|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.08.2010||R|||0|0|*|0|POF|0|0|0|100|DKK|6244|6363|lyfalmen|V0376|6363||8|0|75,0000|Portfarma ehf|Portfarma|Latanóprost||3936||3936|6363| 088975|G03AA1005|Harmonet|töflur|||63|stk|1|ţpakki|20+75 mcg|G03AA10|01.10.2011||R|||0|0|0|0|PER|0|0|0|100|DKK|1715|3325|lyfalmen||||63|0|84,0000|Icepharma hf|Pfizer ApS|Gestóden og östrógen||1715||1715|3325| 089094|A02BX1301|Gaviscon|tuggutfl|||120|stk|1|ţpakki||A02BX13|01.01.1989||L|||0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen||||120|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||5674| 089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|ţpakki||J05AX09|01.04.2008||R|||0|1|0|1|VII|0|0|0|100|DKK|157755|199865|lyfsjukr||||60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||157755||157755|199865| 089156|A03AA0406|Mebeverin Dura|filmhtfl|135|mg|100|stk|1|ţpakki||A03AA04|01.07.2010||R|||0|0|E|0|MYD|0|0|0|100|SEK|4137|6638|lyfalmen||||100|0|45,0000|Actavis Group PTC ehf|Mylan dura GmbH|Mebeverín||4137||4137|6638| 089281|R06AX1305|Loratadin LYFIS|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.05.2012||L|||0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa||||10|0|10,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||| 089293|R06AX1305|Loratadin LYFIS|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.05.2012||L|||0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa||||30|0|30,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||| 089304|R06AX1305|Loratadin LYFIS|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.05.2012||R|||0|0|E|0|LYF|0|0|1|100|XEU|1583|2205|lyfalmen|V0362|2202||100|0|100,0000|LYFIS ehf|LYFIS ehf|Lóratadín||896||896|2205| 089533|V03AE0001|OsvaRen|filmhtfl|||180|stk|1|glas|435 mg / 235 mg|V03AE00|01.10.2012||R|||0|0|0|0|FMC|0|0|0|100|XEU|6542|9928|lyfalmen||||180|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Kalsíum asetat og ţungt magnesíum karbón||6542||6542|9928| 089801|B03AC0601|Monofer|irl|100|mg/ml|1|ml|5|hgl||B03AC06|01.10.2012||R|||0|0|0|0|PAC|0|0|1|100|DKK|24261|32993|lyfalmen||||5|0|5,0000|Vistor hf|Pharmacosmos A/S|Ferrii oxidum- dextran komplex||24261||24261|32993| 089913|B03AC0601|Monofer|irl|100|mg/ml|5|ml|5|hgl||B03AC06|01.10.2012||R|||0|0|0|0|PAC|0|0|1|100|DKK|130949|166886|lyfalmen||||25|0|25,0000|Vistor hf|Pharmacosmos A/S|Ferrii oxidum- dextran komplex||130949||130949|166886| 089936|B03AC0601|Monofer|irl|100|mg/ml|10|ml|2|hgl||B03AC06|01.10.2012||R|||0|0|0|0|PAC|0|0|1|100|DKK|97044|124335|lyfalmen||||20|0|20,0000|Vistor hf|Pharmacosmos A/S|Ferrii oxidum- dextran komplex||97044||97044|124335| 090159|C08DB0101|Cardizem|töflur|60|mg|100|stk|1|glas||C08DB01|01.10.1995||R|||0|0|B|0|FRO|0|0|0|100|DKK|2276|4092|lyfalmen||||100|0|25,0000|Vistor hf|Ferrosan A/S|Diltíazem||2276||2276|4092| 090229|J01DB0101|Keflex|töflur|500|mg|20|stk|1|ţpakki||J01DB01|01.07.2011||R|||0|0|0|0|PAD|0|0|1|100|DKK|1557|3109|lyfalmen||||20|0|5,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||1557||1557|3109| 090240|J01DB0101|Keflex|töflur|500|mg|40|stk|1|ţpakki||J01DB01|01.05.2011||R|||0|0|0|0|PAD|0|0|1|100|DKK|3091|5207|lyfalmen||||40|0|10,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||3091||3091|5207| 090320|J01DB0101|Keflex|mixt.kyr|50|mg/ml|100|ml|1|fl|dreifa|J01DB01|01.03.2012||R|||0|0|0|0|PAD|0|0|1|100|DKK|929|2250|lyfalmen||||100|0|2,5000|Icepharma hf|PharmaCoDane ApS|Cefalexín||929||929|2250| 090354|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.06.2011||R|||0|0|0|1|NOM|0|0|0|100|DKK|5690|8212|lyfsjukr||||10|0|3,3333|Icepharma hf|NordMedica ApS|Cefazólín||5690||5690|8212| 090662|R01AD1101|Nasacort|nefúđi|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|||0|0|E|0|SNO|0|0|1|100|NOK|1813|3459|lyfalmen||||16|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1813||1813|3459| 090979|S01JA0101|Anatera|stl|100|mg/ml|5|ml|12|hgl|lausn|S01JA01|01.10.2011||R|||0|1|0|1|ACK|0|0|0|100|USD|16464|22545|lyfsjukr||||60|0||Vistor hf|Alcon Denmark A/S|Flúorescein||||16464|22545| 091266|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.04.2012||R|||0|0|0|1|PER|0|0|0|100|DKK|2792|4030|lyfsjukr||||2|0|0,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||2792||2792|4030| 091277|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.04.2012||R|||0|0|0|1|PER|0|0|0|100|DKK|4826|6965|lyfsjukr||||5|0|1,6667|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||4826||4826|6965| 091289|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.04.2012||R|||0|0|0|1|PER|0|0|0|100|DKK|14160|19653|lyfsjukr||||18|0|5,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||14160||14160|19653| 091345|N06BA0403|Ritalin Uno|hylki|10|mg|30|stk|1|glas||N06BA04|01.03.2011||R|||1|0|0|0|NOH|0|0|0|100|DKK|3287|5475|lyfalmen||||30|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||3287||3287|5475| 091649|L01DB0105|Doxorubicin Actavis|sts|10|mg|1|stk|1|hgl|lausn|L01DB01|01.12.2011||R|||0|1|0|1|APC|0|0|0|100|XEU|1757|2536|lyfsjukr||||1|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||||1757|2536| 091662|L01DB0105|Doxorubicin Actavis|sts|50|mg|1|stk|1|hgl|lausn|L01DB01|01.12.2011||R|||0|1|0|1|APC|0|0|0|100|XEU|7187|10373|lyfsjukr||||1|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||||7187|10373| 091736|S01BA0102|Opnol|augndr|1|mg/ml|30|sk-hyl|1|pakki|lausn|S01BA01|01.05.2011||R|||0|0|E|0|CHA|0|0|1|100|DKK|3879|6285|lyfalmen||||30|0||Vistor hf|CCS Healthcare AB|Dexametasón||3879||3879|6285| 091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|||0|0|*|0|AVP|0|0|0|100|NOK|1284|1891|lyfalmen|V0021|1884||90|0|45,0000|Vistor hf|Aventis Pharma |Glímepíríđ||667||667|1891| 091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|||0|0|*|0|AVP|0|0|0|100|NOK|2219|2433|lyfalmen|V0022|2361||90|0|90,0000|Vistor hf|Aventis Pharma |Glímepíríđ||1063||1063|2433| 091872|C07AA0512|Pranolol|töflur|80|mg|100|stk|1|glas||C07AA05|01.12.2011||R|||0|0|B|0|AGT|0|0|0|100|XEU|611|1815|lyfalmen||||100|0|50,0000|Actavis Group hf|Actavis Group hf|Própranólól||611||611|1815| 092005|N06AB1001|Cipralex|dropar|20|mg/ml|15|ml|1|glerfl||N06AB10|01.04.2009||R|||0|0|0|0|LBK|0|0|0|100|DKK|3779|6148|lyfalmen||||15|0|30,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||||3779|6148| 092130|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|ţpakki||QJ01CA04|01.10.1987||R|||0|0|0|0|PAL|1|0|0|100|DKK|8956|17369|vetalmen||||100|0||Icepharma hf|Pfizer Oy Animal Health|||8956||8956|17369| 092241|J01AA0209|Doxycyclin Actavis Disper|töflur|100|mg|8|stk|1|ţpakki|0|J01AA02|01.02.2012|31.08.2012|R|||0|0|0|0|AGT|0|0|1|100|XEU|446|1589|lyfalmen||||8|0|8,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||446||446|1589| 092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|ţpakki||B01AC04|01.12.1999||R|||0|0|E|0|SBM|0|0|0|100|NOK|8071|10962|lyfalmen|V0009|1902||28|0|28,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||7298||7298|10962| 092553|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.08.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 092575|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.08.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 092586|N07BA0144|Nicorette Whitemint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.08.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 092609|N07BA0144|Nicorette Whitemint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.08.2010|31.08.2012|L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 092655|G03CA0310|Vagifem|sk-tfl|10|mcg|18|stk|1|pakki||G03CA03|01.03.2011||R|||0|0|E|0|NAS|0|0|0|100|DKK|2219|4014|lyfalmen||||18|0|7,2000|Vistor hf|Novo-Nordisk A/S|Estradíól||2219||2219|4014| 092750|N05AH0203|Leponex (D.A.C.)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2007||R|||0|0|*|0|DAC|0|1|0|100|DKK|9042|13348|lyfalmen|V0277|13348||100|0|33,3333|D.A.C. ehf|D.A.C. ehf|Klózapín||9042||9042|13348| 092787|C09DA0306|Diovan Comp 320/25 mg|filmhtfl|345|mg|98|stk|1|ţpakki|320/25 mg|C09DA03|01.11.2008||R|||0|0|0|0|NOH|0|0|0|100|DKK|23409|31923|lyfalmen||||98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||23409||23409|31923| 092879|M01AB0103|Indometacin Actavis|hylki|25|mg|28|stk|1|ţpakki||M01AB01|01.03.2010||R|||0|0|E|0|AUK|0|0|1|100|GBP|443|1585|lyfalmen||||28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||443||443|1585| 092891|M01AB0103|Indometacin Actavis|hylki|50|mg|28|stk|1|ţpakki||M01AB01|01.03.2010||R|||0|0|E|0|AUK|0|0|1|100|GBP|576|1767|lyfalmen||||28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||576||576|1767| 092958|M05BA0408|Ostacid|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.05.2010||R|||0|0|E|0|POF|0|0|0|100|XEU|3275|3620|lyfalmen|V0203|3620||12|0|84,0000|Portfarma ehf|Portfarma|Alendrónsýra||1931||1931|3620| 093016|N02AA0504|OxyNorm Dispersa|munndr.t|5|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|||1|0|0|0|NOR|0|0|0|100|DKK|1120|2511|lyfalmen||||28|0|1,8700|Icepharma hf|Norpharma a/s|Oxýcódon||||1120|2511| 093027|N02AA0504|OxyNorm Dispersa|munndr.t|10|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|||1|0|0|0|NOR|0|0|0|100|DKK|2570|4495|lyfalmen||||28|0|3,7300|Icepharma hf|Norpharma a/s|Oxýcódon||||2570|4495| 093038|N02AA0504|OxyNorm Dispersa|munndr.t|20|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|||1|0|0|0|NOR|0|0|0|100|DKK|4995|7812|lyfalmen||||28|0|7,4700|Icepharma hf|Norpharma a/s|Oxýcódon||||4995|7812| 093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|||0|0|E|0|GSK|0|0|0|100|GBP|7012|10571|lyfalmen||||1|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||7012||7012|10571| 093343|C09CA0301|Diovan|mixtúra|3|mg/ml|160|ml|1|fl|lausn|C09CA03|01.03.2012||R|||0|0|B|0|NOH|0|0|0|100|DKK|1432|2938|lyfalmen||||160|0|6,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||1432||1432|2938| 093617|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|100|stk||QG03DA02|01.10.1991||R|||0|0|0|0|PAL|1|0|0|100|DKK|25811|45026|vetorma||||100|0||Icepharma hf|Pfizer Oy Animal Health|||25811||25811|45026| 093736|L02AE0305|Zoladex LA (D.A.C.)|vefjalyf|10,8|mg|1|stk|1|áf.spr||L02AE03|01.06.2010||R|||0|1|*|0|DAC|0|0|0|100|SEK|62916|80272|lyfalmen|V0451|78401||1|0|83,7209|D.A.C. ehf|D.A.C. ehf|Góserelín||61934||61934|80272| 093747|C09AA0503|Ramipril Actavis (DAC)|töflur|5|mg|100|stk|1|ţpakki||C09AA05|01.11.2011||R|||0|0|B|0|DAC|0|0|0|100|XEU|1159|2564|lyfalmen|V0496|2564||100|0|200,0000|D.A.C. ehf|D.A.C. ehf|Ramipríl||1159||1159|2564| 093757|N02AA0501|Oxycontin|forđatfl|80|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|||1|0|E|0|NOP|0|0|0|100|DKK|15741|22300|lyfalmen||||28|0|29,8700|Icepharma hf|Norpharma |Oxýcódon||15741||15741|22300| 093770|L02AE0304|Zoladex (D.A.C.)|vefjalyf|3,6|mg|1|stk|1|áf.spr||L02AE03|01.06.2010||R|||0|1|*|0|DAC|0|0|0|100|SEK|23321|31813|lyfalmen|V0183|31813||1|0|27,9070|D.A.C. ehf|D.A.C. ehf|Góserelín||23321||23321|31813| 093799|N02AA0501|Oxycontin|forđatfl|80|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|||1|0|E|0|NOP|0|0|0|100|DKK|44421|58293|lyfalmen||||98|0|104,5300|Icepharma hf|Norpharma |Oxýcódon||44421||44421|58293| 093827|L04AC0501|Stelara|stl|45|mg/spr|0,5|ml|1|áf.spr||L04AC05|01.04.2011||R|||0|1|0|1|JCI|0|0|0|100|SEK|566663|713045|lyfsjukr||||0|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||566663||566663|713045| 093838|L04AC0501|Stelara|stl|90|mg/spr|1|ml|1|áf.spr||L04AC05|01.05.2011||R|||0|1|0|1|JCI|0|0|0|100|SEK|610267|767768|lyfsjukr||||1|0|166,6700|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||610267||610267|767768| 094111|N02CC0501|Almogran|töflur|12,5|mg|6|stk|1|ţpakki|filmuhúđađar töflur|N02CC05|01.07.2010||R|||0|0|E|0|ALM|0|0|0|100|SEK|5265|8181|lyfalmen|V0236|7768||6|0|6,0000|Vistor hf|Almirall S.A.|Almótriptan||5265||5265|8181| 094122|N02CC0501|Almogran|töflur|12,5|mg|9|stk|1|ţpakki|filmuhúđađar töflur|N02CC05|01.07.2010||R|||0|0|E|0|ALM|0|0|0|100|SEK|7802|11652|lyfalmen|V0236|11652||9|0|9,0000|Vistor hf|Almirall S.A.|Almótriptan||7802||7802|11652| 094132|QM01AC0604|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|||0|0|0|0|BOI|0|0|0|100|DKK|1739|3459|vetalmen||||15|0||Vistor hf|Boehringer Ingelheim|||1739||1739|3459| 094287|L04AD0201|Advagraf|forđahlk|0,5|mg|50|stk|1|ţpakki||L04AD02|01.10.2007||R|||0|1|*|0|APE|0|0|0|100|XEU|12696|18479|lyfalmen||||50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||12696||12696|18479| 094296|L04AD0201|Advagraf|forđahlk|1|mg|50|stk|1|ţpakki||L04AD02|01.10.2007||R|||0|1|*|0|APE|0|0|0|100|XEU|18186|25369|lyfalmen||||50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||18186||18186|25369| 094305|L04AD0201|Advagraf|forđahlk|5|mg|50|stk|1|ţpakki||L04AD02|01.10.2007||R|||0|1|*|0|APE|0|0|0|100|XEU|81830|105242|lyfalmen||||50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||81830||81830|105242| 094801|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|ţpakki|300+150+300 mg|J05AR04|01.08.2003||R|||0|1|0|1|VII|0|0|0|100|GBP|82540|105470|lyfsjukr||||60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín, lamívúdín og abacavír||82540||82540|105470| 094812|N01BX0403|Qutenza|plástur|179|mg|1|plástur|1|pakki||N01BX04|01.01.2011||R|||0|0|0|0|APE|0|0|1|100|XEU|46241|60578|lyfalmen||||1|0||Vistor hf|Astellas Phama Europe B.V.|Capsaicin||||46241|60578| 094834|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.05.2010||R|||0|0|0|0|LHS|0|0|0|100|XEU|6309|11006|vetorma||||50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Bakteríubólefni gegn Escherichia coli + Clostridium||6309||6309|11006| 095208|G04BX0101|Emgesan|töflur|250|mg|100|stk|1|glas||G04BX01|01.03.2001||R|||0|0|0|0|PCO|0|0|0|100|IKR|1577|3136|lyfalmen||||100|1|50,0000|Distica|Distica - óskráđ lyf|Magnesíum hýdroxíđ||1577||1577|3136| 095418|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|||0|0|0|0|LYF|0|0|0|100|XEU|4929|5161|lyfalmen|V0143|4847||8|0|8,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||3057||3057|5161| 095588|N07BB0101|Antabus|freyđit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|||0|0|E|0|AGT|0|0|0|100|DKK|5947|9114|lyfalmen||||50|0|100,0000|Actavis Group hf|Actavis Group hf|Dísúlfíram||5947||5947|9114| 095652|N05AX1301|Invega|forđatfl|3|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|||0|0|0|0|JCI|0|1|0|100|SEK|18402|25640|lyfalmen||||28|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||18402||18402|25640| 095680|N05AX1301|Invega|forđatfl|6|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|||0|0|0|0|JCI|0|1|0|100|SEK|18402|25640|lyfalmen||||28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||18402||18402|25640| 095692|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|100|ml|1|hgl||J01MA02|01.12.2010||R|||0|0|0|1|POF|0|0|0|100|XEU|1872|2702|lyfsjukr||||100|0|0,4000|Portfarma ehf|Portfarma|Cíprófloxacín||1872||1872|2702| 095704|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|200|ml|1|hgl||J01MA02|01.12.2010||R|||0|0|0|1|POF|0|0|0|100|XEU|2932|4232|lyfsjukr||||200|0|0,8000|Portfarma ehf|Portfarma|Cíprófloxacín||2932||2932|4232| 095707|N05AX1301|Invega|forđatfl|9|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|||0|0|0|0|JCI|0|1|0|100|SEK|18402|25640|lyfalmen||||28|0|42,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||18402||18402|25640| 095715|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|50|ml|1|hgl|lausn|J02AC01|01.10.2011||R|||0|0|0|1|POF|0|0|0|100|XEU|2457|3546|lyfsjukr||||50|0|0,5000|Portfarma ehf|Portfarma|Flúkónazól||||2457|3546| 095726|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.09.2011||R|||0|0|0|1|POF|0|0|0|100|XEU|3400|4907|lyfsjukr||||100|0|1,0000|Portfarma ehf|Portfarma|Flúkónazól||||3400|4907| 095748|N02AX0212|Tramadol Actavis|hylki|50|mg|100|stk|1|glas||N02AX02|01.09.2011||R|||0|0|E|0|AGP|0|0|1|100|XEU|1039|1491|lyfalmen|V0225|1491||100|0|16,6700|Actavis Group hf|Actavis Group PTC ehf|Tramadól||374||374|1491| 095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|||0|0|0|0|CHD|0|0|0|100|XEU|3552|6993|vetalmen||||100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||3552||3552|6993| 095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|||0|0|0|0|CHD|0|0|0|100|XEU|4688|9174|vetalmen||||100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||4688||4688|9174| 095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|||0|0|0|0|CHD|0|0|0|100|XEU|8537|16565|vetalmen||||100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||8537||8537|16565| 096115|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.10.1990||R|||0|0|0|1|BAM|0|0|0|100|SEK|7698|11110|lyfsjukr||||60|0||Icepharma hf|Baxter Medical AB|Mesna||7698||7698|11110| 096169|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|1|hgl|0|J06BA01|01.10.2008||R|||0|0|0|1|OCT|0|0|0|100|DKK|12474|17537|lyfsjukr||||10|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í ćđ||12474||12474|17537| 096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl|0|J06BA01|01.10.2008||R|||0|0|0|1|OCT|0|0|0|100|DKK|97519|124269|lyfsjukr||||100|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í ćđ||97519||97519|124269| 096203|C09DA0107|Losartan HCT Bluefish|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.05.2012||R|||0|0|B|0|BLP|0|0|0|100|XEU|2337|2682|lyfalmen|V0088|2655||98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og ţvagrćsilyf||1245||1245|2682| 096227|C09DA0107|Losartan HCT Bluefish|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.05.2012||R|||0|0|B|0|BLP|0|0|0|100|XEU|2432|2713|lyfalmen|V0089|2686||98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og ţvagrćsilyf||1268||1268|2713| 096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|||0|0|0|0|GGL|0|0|1|100|GBP|2079|3823|lyfalmen||||5|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retapamúlín||2079||2079|3823| 096260|N06DA0301|Exelon|forđapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|||0|0|E|0|NOE|0|0|0|100|DKK|15685|22230|lyfalmen|V0347|21004||30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||15685||15685|22230| 096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|||0|1|0|1|CEE|0|0|0|100|XEU|669120|841628|lyfsjukr||||21|0|10,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||669120||669120|841628| 096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|||0|1|0|1|CEE|0|0|0|100|XEU|709302|892057|lyfsjukr||||21|0|21,0000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||709302||709302|892057| 096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|||0|1|0|1|CEE|0|0|0|100|XEU|746012|938128|lyfsjukr||||21|0|31,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||746012||746012|938128| 096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|||0|1|0|1|CEE|0|0|0|100|XEU|818722|1029379|lyfsjukr||||21|0|52,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||818722||818722|1029379| 096679|N06DA0301|Exelon|forđapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|||0|0|E|0|NOE|0|0|0|100|DKK|15685|22230|lyfalmen|V0349|21004||30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||15685||15685|22230| 096685|C03BA1102|Natrilix Retard|forđatfl|1,5|mg|30|stk|1|ţpakki||C03BA11|01.03.1999||R|||0|0|E|0|SEV|0|0|0|100|DKK|1446|2957|lyfalmen||||30|0|18,0000|Icepharma hf|Servier|Indapamíđ||1446||1446|2957| 096688|N06DA0301|Exelon|forđapl|9,5|mg/sólh|60|pokar|1|pakki||N06DA03|01.01.2008||R|||0|0|E|0|NOE|0|0|0|100|DKK|31371|41916|lyfalmen||||60|0|60,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||31371||31371|41916| 096768|L02AE0102|Suprecur|nefúđi|0,15|mg/sk|10|g|2|fl|lausn|L02AE01|01.01.2012||R|||0|1|E|0|SNO|0|0|0|100|NOK|18863|26218|lyfalmen||||20|0|16,6700|Vistor hf|Sanofi-aventis Norge AS|Búserelín||18863||18863|26218| 096896|J02AX0601|Ecalta|irs|100|mg/hgl|1|hgl|1|pakki|+ leysir, lausn|J02AX06|01.03.2008|31.07.2012|R|||0|1|0|1|IPI|0|0|0|100|DKK|90844|115892|lyfsjukr||||1|0|1,0000|Icepharma hf|Pfizer Limited|Anidulafungin||90844||90844|115892| 097033|B05AA0706|Tetraspan|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05AA07|01.04.2010||R|||0|0|0|1|BRA|0|0|0|100|XEU|26539|35189|lyfsjukr||||10000|0||Actavis Group hf|Braun|Hýdróxyetýl sterkja||26539||26539|35189| 097061|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.10.2012||R|||0|0|0|0|ELA|0|0|0|100|DKK|71522|124767|vetorma||||1000|0||Icepharma hf|Elanco Animal Health A/S|Óvirkar bakteríur í bóluefnum||71522||71522|124767| 097092|QN02AF0102|Alvegesic vet.|stl|10|mg/ml|10|ml|1|hgl||QN02AF01|01.08.2010||R|||0|0|0|0|AUW|1|0|0|100|XEU|7883|15309|vetalmen||||10|0||Icepharma hf|ALVETRA u. WERFFTt GmbH|Bútorfanóltartrat||||7883|15309| 097269|J01FF0103|Dalacin (D.A.C.)|hylki|300|mg|20|stk|1|ţpakki||J01FF01|01.06.2007||R|||0|0|0|0|DAC|0|0|1|100|DKK|2136|3883|lyfalmen|V0461|3883||20|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klindamýcín||2123||2123|3883| 097288|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|fl||R06AX27|01.10.2008||R|||0|0|E|0|SCP|0|0|1|100|DKK|1074|2448|lyfalmen||||120|0|12,0000|Vistor hf|Schering-Plough|Deslóratadín||1074||1074|2448| 097531|N06AX1602|Efexor Depot|forđahlk|75|mg|98|stk|1|ţpakki||N06AX16|01.07.2012||R|||0|0|0|0|PER|0|1|0|100|DKK|10816|15775|lyfalmen|V0334|5904||98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||10816||10816|15775| 097577|N06AX1602|Efexor Depot|forđahlk|150|mg|98|stk|1|ţpakki||N06AX16|01.09.2011||R|||0|0|0|0|PER|0|1|0|100|DKK|20536|28318|lyfalmen|V0335|5904||98|0|147,0000|Icepharma hf|Pfizer ApS|Venlafaxín||||20536|28318| 097599|N05BA0603|Temesta|töflur|1|mg|100|stk|1|ţpakki||N05BA06|01.02.2012||R|||0|0|0|0|PCO|0|0|1|100|DKK|2362|4210|lyfalmen||||100|1|40,0000|Distica|Distica - óskráđ lyf|Lórazepam||2362||2362|4210| 097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|||0|0|*|0|AVP|0|0|0|100|NOK|3186|2830|lyfalmen|V0023|2737||90|0|135,0000|Vistor hf|Aventis Pharma |Glímepíríđ||1353||1353|2830| 097887|N02CC0104|Sumacta|húđuđtfl|50|mg|12|stk|1|ţpakki||N02CC01|01.11.2007||R|||0|0|E|0|AGP|0|0|0|100|IKR|2738|2780|lyfalmen||||12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||1244||1317|2780|30.09.2012 097896|N02CC0104|Sumacta|húđuđtfl|100|mg|6|stk|1|ţpakki||N02CC01|01.11.2007||R|||0|0|E|0|AGP|0|0|0|100|IKR|1917|2246|lyfalmen|V0234|2246||6|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||926||926|2246| 097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|ţpakki||N06AX11|01.11.2007||R|||0|0|0|0|AGP|0|1|0|100|XEU|1070|2422|lyfalmen|V0329|2422||30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1055||1055|2422| 098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|ţpakki||C09CA03|01.12.2007||R|||0|0|B|0|ACA|0|0|0|100|XEU|6406|3076|lyfalmen|V0072|2651||98|0|98,0000|Actavis Group hf|Actavis hf|Valsartan||1533||1533|3076| 098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|ţpakki||C09CA03|01.12.2007||R|||0|0|B|0|ACA|0|0|0|100|XEU|8209|3147|lyfalmen|V0073|2723||98|0|196,0000|Actavis Group hf|Actavis hf|Valsartan||1585||1585|3147| 098233|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|||0|0|B|0|BIG|0|0|1|100|SEK|618|1824|lyfalmen||||30|0||Icepharma hf|Bioglan AB|Flúócínólón||618||618|1824| 098245|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.08.2011||R|||0|0|B|0|BIG|0|0|1|100|SEK|618|1824|lyfalmen||||30|0||Icepharma hf|Bioglan AB|Flúócínólón||618||618|1824| 098290|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.06.2011||L|||0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa||||250|0||Icepharma hf|Bioglan AB|Klórhexidín|||||| 098378|N03AX0904|Lamotrigin ratiopharm|dreifit.|25|mg|50|stk|1|ţpakki||N03AX09|01.05.2012||R|||0|0|E|0|RGM|0|0|0|100|XEU|966|1978|lyfalmen|V0243|1978||50|0|4,1600|Medical ehf|ratiopharm GmbH|Lamótrigín||730||730|1978| 098387|N03AX0904|Lamotrigin ratiopharm|dreifit.|50|mg|50|stk|1|ţpakki||N03AX09|01.05.2012||R|||0|0|E|0|RGM|0|0|0|100|XEU|1647|2417|lyfalmen|V0244|2299||50|0|8,3300|Medical ehf|ratiopharm GmbH|Lamótrigín||1051||1051|2417| 098405|N03AX0904|Lamotrigin ratiopharm|dreifit.|100|mg|100|stk|1|ţpakki||N03AX09|01.05.2012||R|||0|0|E|0|RGM|0|0|0|100|XEU|4649|4820|lyfalmen|V0245|4709||100|0|33,3300|Medical ehf|ratiopharm GmbH|Lamótrigín||2808||2808|4820| 098423|N03AX0904|Lamotrigin ratiopharm|dreifit.|200|mg|100|stk|1|ţpakki||N03AX09|01.05.2012||R|||0|0|E|0|RGM|0|0|0|100|XEU|8330|9728|lyfalmen|V0232|9728||100|0|66,6600|Medical ehf|ratiopharm GmbH|Lamótrigín||6396||6396|9728| 098713|V03AB2502|Flumazenil B. Braun|stl|0,1|mg/ml|5|ml|5|lykjur||V03AB25|01.04.2011||R|||0|0|0|1|BRA|0|0|0|100|XEU|18175|24692|lyfsjukr||||25|0||Actavis Group hf|Braun|Flúmazeníl||18175||18175|24692| 098722|J07BM0101|Gardasil|stl|||0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|||0|0|0|0|SPM|0|0|0|100|XEU|17085|23987|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerđ 6, 11, 16, 18)||17085||17085|23987| 099204|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|2|spr||L02BA03|01.12.2010||R|||0|1|0|1|ASZ|0|0|0|100|SEK|100641|128187|lyfsjukr||||10|0|60,2400|Vistor hf|AstraZeneca UK Ltd|Fulvestrant||100641||100641|128187| 099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|||0|0|*|0|MYL|0|1|0|100|IKR|6128|3469|lyfalmen|V0284|2853||100|0|6,2500|Actavis Group PTC ehf|Mylan AB|Quetíapín||1820||1820|3469| 099485|N05AH0406|Quetiapin Mylan|filmhtfl|100|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|||0|0|*|0|MYL|0|1|0|100|IKR|14070|12880|lyfalmen|V0285|12347||100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Quetíapín||8700||8700|12880| 099494|N05AH0406|Quetiapin Mylan|filmhtfl|200|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|||0|0|*|0|MYL|0|1|0|100|IKR|23001|27090|lyfalmen|V0286|24658||100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Quetíapín||19558||19558|27090| 099705|D08AG0201|Betadine|áburđur|100|mg/ml|500|ml|1|brusar|vatnsl|D08AG02|01.04.1985||L|||0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa||||500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||| 099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|||0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa||||500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||| 099835|N03AX1107|Topiramat Actavis|filmhtfl|25|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|||0|0|E|0|AGP|0|0|0|100|XEU|2859|3915|lyfalmen|V0247|3915||60|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||2146||2146|3915| 099847|N03AX1107|Topiramat Actavis|filmhtfl|50|mg|60|stk|1|plglas||N03AX11|01.09.2010||R|||0|0|E|0|AGP|0|0|0|100|XEU|3954|5939|lyfalmen|V0248|5939||60|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||3626||3626|5939| 099858|N03AX1107|Topiramat Actavis|filmhtfl|100|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|||0|0|E|0|AGP|0|0|0|100|XEU|8031|9903|lyfalmen|V0249|9903||60|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||6524||6524|9903| 099902|H02AB0605|Prednisolone Actavis|töflur|5|mg|98|stk|1|ţpakki||H02AB06|01.01.2011||R|||0|0|B|0|AUK|0|0|1|100|GBP|719|1962|lyfalmen|V0414|1962||98|0|49,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||719||719|1962| 100291|G04BE0801|Cialis|filmhtfl|2,5|mg|28|stk|1|ţpakki||G04BE08|01.11.2008||R|||0|0|0|0|LIL|0|0|0|100|XEU|12800|18609|lyfalmen||||28|0|7,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||12800|18609| 100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|ţpakki||G04BE08|01.11.2008||R|||0|0|0|0|LIL|0|0|0|100|XEU|12800|18609|lyfalmen||||28|0|14,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||12800|18609| 100428|N06AX1103|Miron|filmhtfl|15|mg|100|stk|1|plglas||N06AX11|01.01.2012||R|||0|0|B|0|ACA|0|1|0|100|XEU|1847|3506|lyfalmen||||100|0|50,0000|Actavis Group hf|Actavis hf|Mirtazapín||1847||1847|3506| 101034|R06AX2704|Desloratadine ratiopharm|filmhtfl|5|mg|100|stk|1|ţpakki||R06AX27|01.10.2012||R|||0|0|E|0|RGM|0|0|1|100|XEU|3425|5423|lyfalmen|V0458|5423||100|0|100,0000|Medical ehf|ratiopharm GmbH|Deslóratadín||3249||3249|5423| 101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|||0|0|E|0|PER|0|0|0|100|DKK|12208|12970|lyfalmen||||100|0|33,3300|Icepharma hf|Pfizer ApS|Gabapentín||8766||8766|12970| 101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|||0|0|E|0|PER|0|0|0|100|DKK|16886|23737|lyfalmen||||100|0|44,4400|Icepharma hf|Pfizer ApS|Gabapentín||16886||16886|23737| 101691|C08CA0502|Adalat Oros|forđatfl|20|mg|28|stk|1|ţpakki||C08CA05|01.10.1999||R|||0|0|B|0|BAP|0|0|0|100|SEK|2045|3776|lyfalmen||||28|0|18,6667|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||2045||2045|3776| 101709|C08CA0502|Adalat Oros|forđatfl|20|mg|98|stk|1|ţpakki||C08CA05|01.10.1999||R|||0|0|B|0|BAP|0|0|0|100|SEK|6599|10006|lyfalmen||||98|0|65,3333|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||6599||6599|10006| 101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|ţpakki||N06AX11|01.11.2007||R|||0|0|0|0|AGP|0|1|0|100|XEU|1319|2783|lyfalmen|V0330|2783||30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1319||1319|2783| 101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|ţpakki||N06AX11|01.11.2007||R|||0|0|B|0|AGP|0|1|0|100|XEU|3002|5085|lyfalmen|V0331|5085||96|0|96,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||3002||3002|5085| 101756|C09DA0106|Lopress Comp|filmhtfl|62,5|mg|100|stk|1|glas|50+12,5 mg|C09DA01|01.11.2010||R|||0|0|B|0|APC|0|0|0|100|XEU|3765|2709|lyfalmen|V0088|2709||100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og ţvagrćsilyf||1265||1265|2709| 101760|N06AX1104|Miron Smelt|munndr.t|45|mg|96|stk|1|ţpakki||N06AX11|01.12.2011||R|||0|0|0|0|AGP|0|1|0|100|XEU|5375|8332|lyfalmen|V0332|8332||96|0|144,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||5375||5375|8332| 101767|C09DA0106|Lopress Comp|filmhtfl|125|mg|100|stk|1|glas|100+25 mg|C09DA01|01.11.2010||R|||0|0|B|0|APC|0|0|0|100|XEU|4367|2741|lyfalmen|V0089|2741||100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og ţvagrćsilyf||1288||1288|2741| 101769|N02AX0211|Nobligan Retard (D.A.C.)|forđatfl|150|mg|100|stk|1|ţpakki||N02AX02|01.09.2007||R|||0|0|E|0|DAC|0|0|1|100|DKK|4999|7817|lyfalmen|V0227|7293||100|0|50,0000|D.A.C. ehf|D.A.C. ehf|Tramadól||4999||4999|7817| 101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|||0|0|0|0|BOI|0|0|0|100|SEK|17771|34296|vetalmen||||250|0||Vistor hf|Boehringer Ingelheim|||||17771|34296| 101825|A09AA0206|Creon 10.000|sh-hylki|150|mg|100|stk|1|plglas||A09AA02|01.09.2011||R|||0|0|E|0|APR|0|0|0|100|DKK|3115|5240|lyfalmen||||100|0|16,6700|Vistor hf|Abbott Products GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||||3115|5240| 101893|G03DB0801|Visanne|töflur|2|mg|28|stk|1|ţpakki||G03DB08|01.05.2012||R|||0|0|0|0|BAB|0|0|0|100|SEK|6912|10434|lyfalmen||||28|0|28,0000|Icepharma hf|Bayer AB|Díenógest||6912||6912|10434| 101904|G03DB0801|Visanne|töflur|2|mg|84|stk|1|ţpakki||G03DB08|01.05.2012||R|||0|0|0|0|BAB|0|0|0|100|SEK|20734|28566|lyfalmen||||84|0|84,0000|Icepharma hf|Bayer AB|Díenógest||20734||20734|28566| 102871|C01DA1401|Imdur|forđatfl|60|mg|98|stk|1|ţpakki||C01DA14|01.07.1989||R|||0|0|B|0|AZD|0|0|0|100|SEK|3834|6224|lyfalmen|V0041|3674||98|0|147,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||3834||3834|6224| 102905|N01AX1001|Diprivan|stl|10|mg/ml|50|ml|1|dćla|einnota dćla|N01AX10|01.01.1994||R|||0|0|0|1|AZA|0|0|0|100|SEK|1922|2774|lyfsjukr||||50|0||Vistor hf|AstraZeneca AB|Própófól||1922||1922|2774| 102939|N01AX1001|Diprivan|stl|20|mg/ml|50|ml|1|dćla|einnota dćla|N01AX10|01.01.1988||R|||0|0|0|1|AZA|0|0|0|100|SEK|3124|4509|lyfsjukr||||50|0||Vistor hf|AstraZeneca AB|Própófól||3124||3124|4509| 103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.02.2008||R|||0|0|B|0|POF|0|0|0|100|XEU|3382|2709|lyfalmen|V0088|2655||98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og ţvagrćsilyf||1265||1265|2709| 103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.02.2008||R|||0|0|B|0|POF|0|0|0|100|XEU|4280|2741|lyfalmen|V0089|2686||98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og ţvagrćsilyf||1288||1288|2741| 103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|ţpakki||C09CA01|01.02.2008||R|||0|0|B|0|POF|0|0|0|100|XEU|2889|2408|lyfalmen|V0069|2381||98|0|98,0000|Portfarma ehf|Portfarma|Lósartan||1045||1045|2408| 103660|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|10|stk|1|ţpakki||J05AB11|01.02.2008||R|||0|0|E|0|POF|0|0|1|100|GBP|2595|2088|lyfalmen|V0033|2088||10|0|1,6667|Portfarma ehf|Portfarma|Valacíklóvír||811||811|2088| 103669|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|40|stk|1|ţpakki||J05AB11|01.02.2008||R|||0|0|E|0|POF|0|0|1|100|GBP|10267|8555|lyfalmen|V0182|8509||40|0|6,6700|Portfarma ehf|Portfarma|Valacíklóvír||5538||5538|8555| 103678|N06AX1604|Venlafaxin (Portfarma)|forđahlk|75|mg|100|stk|1|ţpakki||N06AX16|01.12.2007||R|||0|0|B|0|POF|0|1|0|100|XEU|4300|6024|lyfalmen|V0334|6024||100|0|75,0000|Portfarma ehf|Portfarma|Venlafaxín||3688||3688|6024| 103687|N06AX1604|Venlafaxin (Portfarma)|forđahlk|150|mg|100|stk|1|ţpakki||N06AX16|01.12.2007||R|||0|0|B|0|POF|0|1|0|100|XEU|6902|6024|lyfalmen|V0335|6024||100|0|150,0000|Portfarma ehf|Portfarma|Venlafaxín||3688||3688|6024| 103906|QD08AC5201|Malaseb vet.|hársápa|2|%|250|ml|1|glas|w/v|QD08AC52|01.10.2012||R|||0|0|0|0|DEC|0|0|0|100|DKK|3873|7609|vetalmen||||250|0|-1,0000|Vistor hf|Dechra Veterinary Products A/S|Bígvaníđ og amídín-Klórhexidín í blöndum||3873||3873|7609| 103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|||0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen||||25|0|5,0000|Vistor hf|Orion Pharma|Bisakódýl|||||1884| 103952|A06AG0201|Toilax|innhl/tf|||1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|||0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa||||1|0|1,0000|Vistor hf|Orion Pharma|Bisakódýl|||||| 104026|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|||0|0|0|1|GEH|0|0|0|100|NOK|13812|19217|lyfsjukr||||200|0||Icepharma hf|GE Healthcare AS|Jódixanól||13812||13812|19217| 104047|C09CA0304|Valsartan LYFIS|filmhtfl|160|mg|98|stk|1|ţpakki||C09CA03|01.06.2012||R|||0|0|B|0|LYF|0|0|0|100|XEU|2973|2723|lyfalmen|V0073|2723||98|0|196,0000|LYFIS ehf|LYFIS ehf|Valsartan||1275||1275|2723| 104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|||0|0|E|0|FEL|0|0|0|100|DKK|3059|5163|lyfalmen||||2|0|10,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||3059||3059|5163| 104498|N05CH0101|Circadin|forđatfl|2|mg|21|stk|1|ţpakki||N05CH01|01.11.2007||R|||0|0|0|0|NER|0|0|1|100|DKK|2104|3857|lyfalmen|V0574|3262||21|0|21,0000|Vistor hf|Neurim Pharmaceuticals EEC Ltd|Melatonin||2104||2104|3857| 104760|A07EC0202|Pentasa|eţ-stíll|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|||0|0|B|0|FER|0|0|0|100|DKK|8066|12013|lyfalmen||||28|0|18,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||8066||8066|12013| 104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|||0|0|B|0|FER|0|0|0|100|DKK|4530|7176|lyfalmen|V0017|7176||700|0|4,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||4530||4530|7176| 104851|A07EC0202|Pentasa|forđatfl|500|mg|100|stk|1|ţpakki||A07EC02|01.04.1992||R|||0|0|B|0|FER|0|0|0|100|DKK|5126|7991|lyfalmen||||100|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||5126||5126|7991| 104959|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|125266|159091|lyfsjukr||||2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||||125266|159091| 105278|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.09.2007||R|||0|0|0|0|DAC|0|0|0|100|SEK|4308|5987|lyfalmen||||28|0|18,6700|D.A.C. ehf|D.A.C. ehf|Esómeprazól||3661||3661|5987|30.09.2012 105297|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.09.2007||R|||0|0|0|0|DAC|0|0|0|100|SEK|13108|16222|lyfalmen||||100|0|66,6700|D.A.C. ehf|D.A.C. ehf|Esómeprazól||11143||11143|16222|30.09.2012 105306|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2007||R|||0|0|0|0|DAC|0|0|0|100|SEK|17431|19282|lyfalmen||||100|0|133,3300|D.A.C. ehf|D.A.C. ehf|Esómeprazól||13336||13336|19282|30.09.2012 105315|G03AA0705|Microgynon (D.A.C.)|töflur|||63|stk|1|ţpakki||G03AA07|01.05.2009||R|||0|0|0|0|DAC|0|0|0|100|SEK|1258|2700|lyfalmen|V0545|2700||63|0|84,0000|D.A.C. ehf|D.A.C. ehf|Levónorgestrel og östrógen||1258||1258|2700| 105586|C09XA0201|Rasilez|filmhtfl|150|mg|28|stk|1|ţpakki||C09XA02|01.01.2008||R|||0|0|0|0|NOE|0|0|0|100|DKK|3847|6241|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||3847||3847|6241| 105597|C09XA0201|Rasilez|filmhtfl|150|mg|98|stk|1|ţpakki|2 x 49 töflur|C09XA02|01.01.2008||R|||0|0|0|0|NOE|0|0|0|100|DKK|13373|19328|lyfalmen||||98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||13373||13373|19328| 105608|C09XA0201|Rasilez|filmhtfl|300|mg|28|stk|1|ţpakki||C09XA02|01.01.2008||R|||0|0|0|0|NOE|0|0|0|100|DKK|4434|7044|lyfalmen||||28|0|56,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||4434||4434|7044| 105620|C09XA0201|Rasilez|filmhtfl|300|mg|98|stk|1|ţpakki|2 x 49 töflur|C09XA02|01.01.2008||R|||0|0|0|0|NOE|0|0|0|100|DKK|15424|21902|lyfalmen||||98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||15424||15424|21902| 105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|||0|0|0|0|AZD|0|0|1|100|SEK|2493|4389|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||2493||2493|4389| 105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|||0|0|0|0|AZD|0|0|1|100|SEK|2947|5010|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||2947||2947|5010| 106006|J05AH0201|Tamiflu|hylki|30|mg|10|stk|1|ţpakki||J05AH02|01.11.2011||R|||0|0|0|0|RRL|0|0|0|100|DKK|1795|3434|lyfalmen||||10|0|2,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||1795||1795|3434| 106017|J05AH0201|Tamiflu|hylki|45|mg|10|stk|1|ţpakki||J05AH02|01.11.2011||R|||0|0|0|0|RRL|0|0|0|100|DKK|3590|5890|lyfalmen||||10|0|3,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3590||3590|5890| 106021|J01FA0901|Klacid|töflur|250|mg|14|stk|1|ţpakki||J01FA09|01.04.1992||R|||0|0|0|0|ABS|0|0|1|100|DKK|2597|4531|lyfalmen||||14|0|7,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||2597||2597|4531| 106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|||0|0|0|1|GSK|0|0|0|100|GBP|19076|25823|lyfsjukr||||5|0|0,6250|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||19076||19076|25823| 106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|||0|0|0|1|GSK|0|0|0|100|GBP|10550|15123|lyfsjukr||||5|0|0,3125|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||10550||10550|15123| 107092|N05AH0311|Olanzapine Ranbaxy|töflur|2,5|mg|28|stk|1|ţpakki||N05AH03|01.12.2011||R|||0|0|*|0|RAN|0|1|0|100|XEU|1976|1816|lyfalmen|V0278|1816||28|0|7,0000|Artasan ehf|Ranbaxy (UK) Ltd|Olanzapín||612||612|1816| 107138|C07AG0203|Carvedilol Actavis|filmhtfl|6,25|mg|100|stk|1|ţpakki||C07AG02|01.05.2012||R|||0|0|B|0|ADG|0|0|0|100|XEU|1238|2672|lyfalmen||||100|0|16,6600|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||1238||1238|2672| 107203|R06AX2201|Kestine|filmhtfl|10|mg|30|stk|1|ţpakki||R06AX22|01.06.2012||L|||0|0|0|0|APS|0|0|1|100|IKR|||lyflausa||||30|0|30,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||| 107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|||0|0|B|0|PER|0|0|0|100|DKK|1531|3073|lyfalmen||||100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1531||1531|3073| 107594|QP54AA0104|Bimectin Horse Oral Paste|pasta|18,7|mg/g|6,42|g|1|áf.spr||QP54AA01|01.04.2008||L|||0|0|0|0|CRO|0|0|0|100|XEU|1502|2620|vetorma||||6|0||Portfarma ehf|Cross Vetpharm Group Ltd.|Ivermectinum||||1502|2620| 107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|ţpakki||A02BA02|01.07.1986||R|||0|0|E|0|ACA|0|0|0|100|XEU|901|2211|lyfalmen||||60|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||901||901|2211| 108308|C08CA0501|Adalat|töflur|10|mg|100|stk|1|ţpakki||C08CA05|01.01.1991||R|||0|0|B|0|BAP|0|0|0|100|SEK|2916|4968|lyfalmen||||100|0|33,3333|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||2916||2916|4968| 108540|A10BH0201|Galvus|töflur|50|mg|30|stk|1|ţpakki||A10BH02|01.09.2008||R|||0|0|*|0|NOE|0|0|0|100|DKK|3212|5373|lyfalmen||||30|0|15,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||3212||3212|5373| 108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|ţpakki||A10BH02|01.09.2008||R|||0|0|*|0|NOE|0|0|0|100|DKK|9533|14020|lyfalmen||||90|0|45,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||9533||9533|14020| 108802|N05AH0310|Zalasta (LYFIS)|töflur|10|mg|56|stk|1|ţpakki||N05AH03|01.10.2011||R|||0|0|*|0|LYF|0|1|0|100|XEU|13411|6691|lyfalmen|V0282|6691||56|0|56,0000|LYFIS ehf|LYFIS ehf|Olanzapín||4176||4176|6691| 108845|R01AD0501|Rhinocort Aqua|nefúđi|32|mcg/sk|120|skammtar|1|fl||R01AD05|01.10.1988||R|||0|0|E|0|AZD|0|0|1|100|SEK|1205|2627|lyfalmen||||120|0|19,2000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||1205||1205|2627| 108852|R01AD0501|Rhinocort Aqua|nefúđi|64|mcg/sk|120|skammtar|1|fl||R01AD05|01.10.1988||R|||0|0|E|0|AZD|0|0|1|100|SEK|1672|3266|lyfalmen|V0443|3265||120|0|38,4000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||1672||1672|3266| 109357|A02BC0508|Esomeprazol Actavis|sţ-hylki|20|mg|28|stk|1|ţpakki|hart|A02BC05|01.03.2012||R|||0|0|0|0|APC|0|0|0|100|XEU|2133|1696|lyfalmen|V0004|1696||28|0|18,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||524||524|1696| 109421|V01AA0303|Alutard SQ, derm.farinae|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|23632|32203|lyfalmen||||20|0||Vistor hf|ALK-Abello A/S|rykmaurar||23632||23632|32203| 109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|18920|26290|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|rykmaurar||18920||18920|26290| 109462|V04CL0020|Soluprick SQ, derm.farinae|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7345|11026|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7345||7345|11026| 109678|N02BE0107|Paratabs|töflur|500|mg|20|stk|1|ţpakki||N02BE01|01.12.1983||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||20|0|3,3333|Actavis Group hf|Actavis hf|Paracetamól|||||| 109728|N02BE0107|Paratabs|töflur|500|mg|30|stk|1|ţpakki||N02BE01|01.07.1992||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól|||||| 109751|N02BE0107|Paratabs|töflur|500|mg|100|stk|1|ţpakki||N02BE01|01.11.1981||R|||0|0|0|0|ACA|0|0|1|100|XEU|407|1536|lyfalmen|V0230|1536||100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||407||407|1536| 110033|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|30|stk|1|ţpakki||R06AE07|01.09.2012||L|||0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa||||30|0|30,0000|Medical ehf|ratiopharm GmbH|Cetirizín|||||| 110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|||0|0|*|0|SAO|0|0|0|100|XEU|505|1670|lyfalmen||||5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||505||505|1670| 110242|V03AN0101|Conoxia|lyfjagas|100|%|3|l|1|hylki|undir ţrýstingi/LIV|V03AN01|01.04.2008||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||3|0||Ísaga ehf|AGA AB|Súrefni|||||| 110395|G03AA0902|Mercilon|töflur|||63|stk|1|ţpakki||G03AA09|01.07.1990||R|||0|0|0|0|ORG|0|0|0|100|DKK|1499|3029|lyfalmen||||63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||1499||1499|3029| 110635|C08DA0104|Veraloc Retard|forđatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|||0|0|B|0|ORC|0|0|0|100|DKK|3832|6221|lyfalmen||||100|0|83,3333|Vistor hf|Orion Corporation|Verapamíl||3832||3832|6221| 110750|J05AX0801|Isentress|filmhtfl|400|mg|60|stk|1|glas||J05AX08|01.04.2012||R|||0|1|0|1|MLD|0|0|0|100|DKK|109833|139723|lyfsjukr||||60|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Raltegravír||109833||109833|139723| 111479|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|3|glas|+ dorzólamid 20 mg/ml|S01ED51|01.11.2011||R|||0|0|*|0|POF|0|0|0|100|XEU|5720|7158|lyfalmen|V0373|7158||15|0|75,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||4517||4517|7158| 111955|N02BE0101|Panodil|töflur|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|||0|0|0|0|GSH|0|0|1|100|DKK|730|1978|lyfalmen||||100|0|33,3300|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||730||730|1978| 112022|G03AC0802|Implanon NXT|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2011||R|||0|0|0|0|ORG|0|0|0|100|DKK|21174|29119|lyfalmen||||1|0|1000,0000|Vistor hf|N.V. Organon|Etónógestrel||21174||21174|29119| 112641|M05BA0407|Alendronat Ranbaxy|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.04.2009||R|||0|0|E|0|RAN|0|0|0|100|XEU|8003|3745|lyfalmen|V0203|3620||12|0|84,0000|Artasan ehf|Ranbaxy (UK) Ltd|Alendrónsýra||2022||2022|3745| 113394|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|ţpakki|50mg/850mg|A10BD08|01.11.2008||R|||0|0|*|0|NOE|0|0|0|100|DKK|8282|12308|lyfalmen|V0024|11147||60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||8282||8282|12308| 113403|A10BD0801|Eucreas|filmhtfl|900|mg|180|stk|1|ţpakki|50mg/850mg|A10BD08|01.11.2008||R|||0|0|*|0|NOE|0|0|0|100|DKK|24619|33442|lyfalmen|V0024|33442||180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||24619||24619|33442| 113412|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|ţpakki|50mg/1000mg|A10BD08|01.11.2008||R|||0|0|*|0|NOE|0|0|0|100|DKK|8390|12456|lyfalmen|V0025|11267||60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||8390||8390|12456| 113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|stk|einnota dćla|B01AB05|01.10.1995||R|||0|0|E|0|SNO|0|0|1|100|NOK|3814|6196|lyfalmen||||2|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3814||3814|6196| 113421|A10BD0801|Eucreas|filmhtfl|1050|mg|180|stk|1|ţpakki|50mg/1000mg|A10BD08|01.11.2008||R|||0|0|*|0|NOE|0|0|0|100|DKK|24906|33802|lyfalmen|V0025|33802||180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||24906||24906|33802| 113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|stk|einnota dćla|B01AB05|01.10.1995||R|||0|0|E|0|SNO|0|0|1|100|NOK|6535|9918|lyfalmen||||4|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||6535||6535|9918| 113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|ţpakki||L01XE08|01.06.2008||R|||0|1|0|1|NOE|0|0|0|100|DKK|648751|816065|lyfsjukr||||112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||648751||648751|816065| 113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|ţpakki||J01CE02|01.10.1985||R|||0|0|0|0|REP|0|0|1|100|SEK|737|1987|lyfalmen||||20|0|10,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||737||737|1987| 113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|ţpakki||J01CE02|01.10.1985||R|||0|0|0|0|REP|0|0|1|100|SEK|936|2259|lyfalmen||||30|0|15,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||936||936|2259| 113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|ţpakki||J01CE02|01.10.1985||R|||0|0|0|0|REP|0|0|1|100|SEK|1429|2934|lyfalmen||||40|0|20,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1429||1429|2934| 114033|R03AC0210|Ventolin Diskus|innúđadu|200|mcg/sk|60|skammtar|1|stk|Diskus tćki|R03AC02|01.03.1999||R|||0|0|B|0|GSK|0|0|1|100|IKR|999|2345|lyfalmen||||60|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||999||999|2345| 114328|L01AX0303|Temomedac|hylki|100|mg|5|stk|1|glas||L01AX03|01.04.2011||R|||0|1|0|1|WIL|0|0|0|100|XEU|51146|66071|lyfsjukr||||5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||51146||51146|66071| 114440|M01AH0501|Arcoxia|filmhtfl|30|mg|28|stk|1|ţpakki||M01AH05|01.01.2010||R|||0|0|E|0|MSD|0|0|1|100|DKK|4022|6481|lyfalmen||||28|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||4022||4022|6481| 114447|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíđ 20 mg|S01ED51|01.03.1999||R|||0|0|*|0|MSD|0|0|0|100|DKK|2295|4118|lyfalmen|V0373|2386||5|0|25,0000|Vistor hf|M.S.D.|Tímólól í blöndum||2295||2295|4118| 114512|D06BB0401|Condyline|áburđur|5|mg/ml|3,5|ml|1|glas|til penslu|D06BB04|01.11.2010||R|||0|0|0|0|GAN|0|0|1|100|XEU|2156|3928|lyfalmen||||4|0||Icepharma hf|Galderma Nordic AB|Pódófýllótoxín||2156||2156|3928| 114675|D10AD5301|Epiduo|hlaup|||60|g|1|túpa|0,1% / 2,5%|D10AD53|01.12.2011||R|||0|0|0|0|GAN|0|0|0|100|SEK|6389|9719|lyfalmen||||60|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíđ||6389||6389|9719| 115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|||0|0|E|0|BII|0|0|0|100|DKK|1854|3515|lyfalmen||||10|0|3,4100|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1854||1854|3515| 115241|V03AB1504|Naloxon B. Braun|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.09.2010||R|||0|0|0|1|BRA|0|0|0|100|IKR|9164|13226|lyfsjukr||||10|0||Actavis Group hf|Braun|Naloxón||9164||9164|13226| 115285|J01CA0411|Amoxicillin Mylan|töflur|750|mg|20|stk|1|ţpakki||J01CA04|01.10.1998||R|||0|0|0|0|MYL|0|0|1|100|SEK|1610|3181|lyfalmen||||20|0|15,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1610||1610|3181| 115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|||0|0|E|0|BII|0|0|0|100|DKK|11122|16193|lyfalmen||||60|0|20,4600|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||11122||11122|16193| 115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|||0|0|E|0|BII|0|0|0|100|DKK|1854|3515|lyfalmen||||10|0|5,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1854||1854|3515| 115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|||0|0|E|0|BII|0|0|0|100|DKK|11122|16193|lyfalmen||||60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||11122||11122|16193| 115642|S01EC0301|Trusopt|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.1996||R|||0|0|*|0|MSD|0|0|0|100|DKK|1847|3506|lyfalmen|V0369|2927||5|0|16,6667|Vistor hf|M.S.D.|Dorzólamíđ||1847||1847|3506| 115931|R03AC1202|Serevent Diskus|innúđadu|50|mcg/sk|60|skammtar|1|pakki||R03AC12|01.01.1995||R|||0|0|B|0|GSK|0|0|1|100|GBP|3789|6162|lyfalmen||||60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3789||3789|6162| 115980|P03AX0301|Prioderm|húđlausn|5|mg/ml|55|ml|1|glas||P03AX03|01.12.1983||L|||0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa||||55|0||Icepharma hf|Norpharma |Malatíón|||||| 116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|||0|0|0|1|GSK|0|0|0|100|GBP|3806|5493|lyfsjukr||||5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||3806||3806|5493| 116046|J01DC0202|Zinacef|sts|750|mg|1|stk|5|hgl||J01DC02|01.09.1983||R|||0|0|0|1|GSK|0|0|0|100|GBP|1989|2871|lyfsjukr||||5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||1989||1989|2871| 116198|C08CA0105|Amlodipin Bluefish|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.03.2012||R|||0|0|B|0|BLP|0|0|0|100|XEU|1153|1760|lyfalmen|V0056|1737||100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||571||571|1760| 116220|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.03.2012||R|||0|0|B|0|BLP|0|0|0|100|XEU|1826|2170|lyfalmen|V0057|2133||100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||871||871|2170| 116244|D11AF01|Verucid|áburđur|||10|ml|1|glas||D11AF|01.11.1981||L|||0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa||||10|0||Icepharma hf|Galderma Nordic AB|Lyf viđ vörtum og líkţornum|||||| 116327|D07AC1301|Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|||0|0|B|0|SPL|0|0|1|100|DKK|2529|4438|lyfalmen||||100|0||Vistor hf|Schering-Plough Europe|Mómetasón||2529||2529|4438| 116418|D07AC1301|Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|||0|0|B|0|SPL|0|0|1|100|DKK|2906|4954|lyfalmen||||100|0||Vistor hf|Schering-Plough Europe|Mómetasón||2906||2906|4954| 116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|ţpakki||M01AE01|01.12.2008||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||20|0|3,3333|Actavis Group hf|Actavis hf|Íbúprófen|||||| 116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|ţpakki||M01AE01|01.05.2008||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||30|0|10,0000|Actavis Group hf|Actavis hf|Íbúprófen|||||| 116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|ţpakki||M01AE01|01.08.2008||R|||0|0|E|0|ACA|0|0|1|100|XEU|739|1990|lyfalmen|V0562|1987||100|0|33,3333|Actavis Group hf|Actavis hf|Íbúprófen||739||739|1990| 116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|ţpakki||M01AE01|01.07.2008||R|||0|0|E|0|ACA|0|0|1|100|XEU|368|1482|lyfalmen|V0563|1482||30|0|15,0000|Actavis Group hf|Actavis hf|Íbúprófen||368||368|1482| 116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|ţpakki||M01AE01|01.05.2008||R|||0|0|E|0|ACA|0|0|1|100|XEU|896|2205|lyfalmen|V0564|2203||100|0|50,0000|Actavis Group hf|Actavis hf|Íbúprófen||896||896|2205| 116694|G04BD1101|Toviaz|forđatfl|4|mg|84|stk|1|ţpakki||G04BD11|01.11.2008||R|||0|0|E|0|IPI|0|0|0|100|DKK|17240|24181|lyfalmen||||84|0|84,0000|Icepharma hf|Pfizer Limited|Fesóteródín||17240||17240|24181| 116697|C09CA0602|Candpress|töflur|8|mg|100|stk|1|ţpakki||C09CA06|01.01.2012||R|||0|0|0|0|AGP|0|0|0|100|XEU|7357|10537|lyfalmen|V0081|10537||100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||6987||6987|10537| 116705|G04BD1101|Toviaz|forđatfl|4|mg|28|stk|1|ţpakki||G04BD11|01.11.2008||R|||0|0|E|0|IPI|0|0|0|100|DKK|5875|9016|lyfalmen||||28|0|28,0000|Icepharma hf|Pfizer Limited|Fesóteródín||5875||5875|9016| 116716|G04BD1101|Toviaz|forđatfl|8|mg|28|stk|1|ţpakki||G04BD11|01.11.2008||R|||0|0|E|0|IPI|0|0|0|100|DKK|6308|9608|lyfalmen||||28|0|56,0000|Icepharma hf|Pfizer Limited|Fesóteródín||6308||6308|9608| 116727|G04BD1101|Toviaz|forđatfl|8|mg|84|stk|1|ţpakki||G04BD11|01.11.2008||R|||0|0|E|0|IPI|0|0|0|100|DKK|18624|25918|lyfalmen||||84|0|168,0000|Icepharma hf|Pfizer Limited|Fesóteródín||18624||18624|25918| 116928|J07AL0202|Prevenar 13|stl|2,2|mcg|0,5|ml|1|áf.spr||J07AL02|01.04.2010||R|||0|0|0|0|IPI|0|0|0|100|DKK|8035|11970|lyfalmen||||0|0||Icepharma hf|Pfizer Limited|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar (cojugated)||8035||8035|11970| 117408|QA12AX0001|Calcimag vet. Kela|irl|||500|ml|12|plastf||QA12AX00|01.04.2004||R|||0|0|0|0|KEL|1|0|0|100|NOK|10694|20707|vetalmen||||6000|0||Icepharma hf|Kela Laboratoria NV|||10694||10694|20707| 117515|M01AE0303|Orudis|forđahlk|200|mg|100|stk|1|glas||M01AE03|01.10.1995||R|||0|0|E|0|SNO|0|0|1|100|NOK|3281|5467|lyfalmen||||100|0|133,3333|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||3281||3281|5467| 117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|||0|0|E|0|ROC|0|0|0|100|DKK|4414|7017|lyfalmen|V0435|6914||100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4414||4414|7017| 117550|N05AH0405|Seroquel Prolong|forđatfl|50|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|||0|0|0|0|ASZ|0|1|0|100|SEK|15191|21610|lyfalmen||||100|0|12,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||15191|21610| 117561|N05AH0405|Seroquel Prolong|forđatfl|200|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|||0|0|0|0|ASZ|0|1|0|100|SEK|26849|36241|lyfalmen||||100|0|50,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||26849|36241| 117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|||0|0|E|0|ROC|0|0|0|100|DKK|1564|3118|lyfalmen||||100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1564||1564|3118| 117573|N05AH0405|Seroquel Prolong|forđatfl|300|mg|10|stk|1|ţpakki||N05AH04|01.12.2008||R|||0|0|0|0|ASZ|0|1|0|100|SEK|4643|7330|lyfalmen||||10|0|7,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||4643|7330| 117584|N05AH0405|Seroquel Prolong|forđatfl|300|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|||0|0|0|0|ASZ|0|1|0|100|SEK|46425|60809|lyfalmen||||100|0|75,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||46425|60809| 117595|N05AH0405|Seroquel Prolong|forđatfl|400|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|||0|0|0|0|ASZ|0|1|0|100|SEK|53698|69936|lyfalmen||||100|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||53698|69936| 117676|L01DB0103|Caelyx|irţ|2|mg/ml|10|ml|1|hgl||L01DB01|01.01.2011||R|||0|1|0|1|JCI|0|0|0|100|SEK|68322|87627|lyfsjukr||||10|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||68322||68322|87627| 117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|||0|0|0|0|BAN|0|0|0|100|DKK|9463|16508|vetorma||||250|0||Icepharma hf|Bayer Animal Health GmbH|||9463||9463|16508| 117788|C08CA0502|Adalat Oros|forđatfl|30|mg|28|stk|1|ţpakki||C08CA05|01.07.1994||R|||0|0|B|0|BAP|0|0|0|100|SEK|2381|4236|lyfalmen||||28|0|28,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||2381||2381|4236| 117796|C08CA0502|Adalat Oros|forđatfl|30|mg|98|stk|1|ţpakki||C08CA05|01.07.1994||R|||0|0|B|0|BAP|0|0|0|100|SEK|5692|8765|lyfalmen||||98|0|98,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||5692||5692|8765| 117820|C08CA0502|Adalat Oros|forđatfl|60|mg|98|stk|1|ţpakki||C08CA05|01.07.1994||R|||0|0|B|0|BAP|0|0|0|100|SEK|8522|12637|lyfalmen||||98|0|196,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||8522||8522|12637| 117929|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA00|01.04.2004||R|||0|0|0|0|KEL|0|0|0|100|NOK|7470|14516|vetalmen||||1200|0||Icepharma hf|Kela Laboratoria NV|||7470||7470|14516| 117937|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA00|01.04.2004||R|||0|0|0|0|KEL|0|0|0|100|NOK|13101|25328|vetalmen||||6000|0||Icepharma hf|Kela Laboratoria NV|||13101||13101|25328| 118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.05.2008||R|||0|0|*|0|AGP|0|1|0|100|XEU|3892|1816|lyfalmen|V0278|1816||28|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||612||612|1816| 118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.04.2008||R|||0|0|*|0|AGP|0|1|0|100|XEU|5532|2384|lyfalmen|V0279|2384||28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1027||1027|2384| 118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.03.2008||R|||0|0|*|0|AGP|0|1|0|100|XEU|21452|6957|lyfalmen|V0282|6691||56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||4370||4370|6957| 118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.04.2008||R|||0|0|*|0|AGP|0|1|0|100|XEU|16388|8742|lyfalmen|V0283|8176||28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||5675||5675|8742| 118158|J01DC0203|Zinnat|mixt.kyr|25|mg/ml|100|ml|1|glas||J01DC02|01.10.1990||R|||0|0|0|0|GSK|0|0|1|100|GBP|2266|4079|lyfalmen||||100|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2266||2266|4079| 118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|||0|0|0|1|AGA|0|0|0|100|IKR|9512|13728|lyfsjukr||||4|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||9512||9512|13728| 118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|ţpakki||A02BA02|01.04.1994||L|||0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa||||30|0|15,0000|Actavis Group hf|Actavis hf|Ranitidín|||||| 118406|A02BA0201|Asyran|töflur|300|mg|30|stk|1|ţpakki||A02BA02|01.04.1994|31.08.2012|R|||0|0|E|0|ACA|0|0|0|100|XEU|932|2254|lyfalmen||||30|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||932||932|2254| 118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|ţpakki||N05AH03|01.04.2008||R|||0|0|*|0|AGP|0|1|0|100|XEU|16865|8816|lyfalmen|V0280|8107||56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||5729||5729|8816| 118570|A07EC0203|Pentasa Sachets|forđakyr|1|g|50|stk|1|pakki||A07EC02|01.04.1998||R|||0|0|B|0|FER|0|0|0|100|DKK|7333|11010|lyfalmen|V0015|10267||50|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||7333||7333|11010| 118612|A07EC0203|Pentasa Sachets|forđakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|||0|0|B|0|FER|0|0|0|100|DKK|22514|30800|lyfalmen|V0015|30800||150|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||22514||22514|30800| 118793|C01AA0504|Lanoxin mite|töflur|62,5|mcg|120|stk|1|ţpakki||C01AA05|01.12.2010||R|||0|0|B|0|AEG|0|0|0|100|XEU|476|1630|lyfalmen||||120|0|30,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||476||476|1630| 119031|L01XC0801|Vectibix|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.06.2008||R|||0|1|0|1|AEU|0|0|0|100|DKK|75321|96410|lyfsjukr||||5|0||Vistor hf|Amgen Europe B.V.|Panitúmúmab||75321||75321|96410| 119825|N05BA1206|Alprazolam Krka|forđatfl|1|mg|30|stk|1|ţpakki||N05BA12|01.08.2012||R|||0|0|0|0|KRK|0|0|1|100|XEU|938|2021|lyfalmen|V0309|2021||30|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||762||762|2021| 119962|M01AE0109|Ibuprofen Portfarma|filmhtfl|400|mg|30|stk|1|ţpakki||M01AE01|01.03.2008||L|||0|0|0|0|POF|0|0|1|100|IKR|||lyflausa||||30|0|10,0000|Portfarma ehf|Portfarma|Íbúprófen|||||| 119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|ţpakki||C02KX02|01.12.2008||R|||0|1|0|1|GGL|0|0|0|100|GBP|454486|572262|lyfsjukr||||30|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||454486||454486|572262| 120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|ţpakki||C02KX02|01.12.2008||R|||0|1|0|1|GGL|0|0|0|100|GBP|454486|572262|lyfsjukr||||30|0|40,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||454486||454486|572262| 120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|||0|0|E|0|SAL|0|0|0|100|USD|978|2317|lyfalmen||||10|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Cýklópentólat||978||978|2317| 120062|L01BA0401|Alimta|irţ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|||0|1|0|1|LIL|0|0|0|100|XEU|46898|60739|lyfsjukr||||1|0||Icepharma hf|Lilly ICOS Limited|Pemetrexed||46898||46898|60739| 120392|M01AE0110|Ibuprofen Actavis|filmhtfl|200|mg|24|stk|1|ţpakki||M01AE01|01.01.2012||L|||0|0|0|0|AHF|0|0|1|100|IKR|||lyflausa||||24|0|4,0000|Actavis Group PTC ehf|Actavis Group hf|Íbúprófen|||||| 120798|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|||0|1|0|1|SDG|0|0|0|100|DKK|30949|40723|lyfsjukr||||2|0|15,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||30949||30949|40723| 120973|N03AX1402|Keppra (Lyfjaver)|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.05.2008||R|||0|0|0|0|LVR|0|0|0|100|DKK|17353|24323|lyfalmen|V0253|7520||100|0|33,3300|Lyfjaver ehf|Lyfjaver ehf|Levetíracetam||17353||17353|24323| 121164|A02BC0501|Nexium|mixt.kyr|10|mg|28|sk-pokar|1|pakki|dreifa|A02BC05|01.04.2009||R|||0|0|0|0|AZD|0|0|0|100|SEK|5779|8884|lyfalmen||||28|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5779||5779|8884| 121286|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.04.2009||R|||0|0|0|1|ORG|0|0|0|100|DKK|9234|13327|lyfsjukr||||50|0||Vistor hf|N.V. Organon|Rókúrón, brómíđ||9234||9234|13327| 121327|R03AC0204|Ventolin|innúđal|0,1|mg/sk|200|skammtar|1|stauk||R03AC02|01.12.1972||R|||0|0|B|0|GSK|0|0|1|100|IKR|467|1618|lyfalmen||||200|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||467||467|1618| 121550|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|98|stk|1|ţpakki||A02BC05|01.11.2011||R|||0|0|E|0|POF|0|0|0|100|XEU|7847|5155|lyfalmen|V0011|5012||98|0|65,3300|Portfarma ehf|Portfarma|Esómeprazól||3053||3053|5155| 121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|ţpakki||B03BB01|01.01.2008||R|||0|0|E|0|AUK|0|0|1|100|GBP|416|1544|lyfalmen|V0391|1541||28|0|350,0000|Actavis Group hf|Actavis UK Ltd.|Fólínsýra||413||413|1544| 121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|ţpakki||N06AA04|01.03.1977||R|||0|0|B|0|NOH|0|1|0|100|DKK|1715|3325|lyfalmen|V0314|2319||100|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Klómípramín||1715||1715|3325| 121691|H02AB0605|Prednisolone Actavis|töflur|1|mg|28|stk|1|ţpakki||H02AB06|01.01.2011||R|||0|0|B|0|AUK|0|0|1|100|GBP|278|1359|lyfalmen||||28|0|2,8000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||278||278|1359| 122411|QI09AA0701|Ingelvac CircoFLEX|stl|||50|ml|1|hgl|dreifa|QI09AA07|01.12.2010||R|||0|0|0|0|BIV|0|0|0|100|IKR|9600|16747|vetorma||||50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Porcine circovirus Type ORF-2 protein||9600||9600|16747| 122577|A04AA0105|Ondansetron BMM Pharma|filmhtfl|4|mg|10|stk|1|ţpakki||A04AA01|01.09.2012||R|||0|0|E|0|BMM|0|0|0|100|XEU|3040|5087|lyfalmen|V0381|5032||10|0|2,5000|LYFIS ehf|BMM Pharma AB|Ondansetrón||3003||3003|5087| 122610|A04AA0105|Ondansetron BMM Pharma|filmhtfl|8|mg|10|stk|1|ţpakki||A04AA01|01.09.2012||R|||0|0|E|0|BMM|0|0|0|100|XEU|3472|4764|lyfalmen|V0384|4764||10|0|5,0000|LYFIS ehf|BMM Pharma AB|Ondansetrón||2767||2767|4764| 123216|N05BA0105|Stesolid|eţ-stíll|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|||0|0|0|0|AGT|0|0|1|100|DKK|816|2095|lyfalmen||||10|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||816||816|2095| 123224|N05BA0105|Stesolid|eţ-stíll|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|||0|0|0|0|AGT|0|0|1|100|DKK|1102|2486|lyfalmen||||10|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1102||1102|2486| 123256|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|ţpakki|50+500 mg|QP52AA51|01.07.2011||R|||0|0|0|0|ICE|0|0|0|100|USD|26819|46784|vetorma||||100|0||Icepharma hf|Icepharma hf|||26819||26819|46784| 123806|C07AA0512|Pranolol|töflur|20|mg|100|stk|1|glas||C07AA05|01.09.2011||R|||0|0|B|0|AGT|0|0|0|100|XEU|239|1306|lyfalmen||||100|0|12,5000|Actavis Group hf|Actavis Group hf|Própranólól||||239|1306| 123954|N06AB0404|Citalopram Bluefish|filmhtfl|10|mg|100|stk|1|ţpakki||N06AB04|01.09.2012||R|||0|0|B|0|BLP|0|1|0|100|XEU|2244|3542|lyfalmen|V0317|3542||100|0|50,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||1874||1874|3542| 123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|ţpakki||N07XX02|01.05.1998||R|||0|0|E|0|AVS|0|0|0|100|NOK|46369|60738|lyfalmen||||56|0|28,0000|Vistor hf|Aventis Pharma SA|Rílúzól||46369||46369|60738| 124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|||0|0|0|0|CHP|0|0|0|100|XEU|1774|3529|vetalmen||||42|0||Icepharma hf|Chanelle Pharmaceuticals|||||1774|3529| 124119|B01AC0401|Plavix|töflur|300|mg|30|stk|1|ţpakki||B01AC04|01.09.2009||R|||0|0|0|0|SBM|0|0|0|100|NOK|38702|51116|lyfalmen||||30|0|120,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||||38702|51116| 124207|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|ţpakki||N02CC01|01.04.2012||R|||0|0|E|0|BLP|0|0|0|100|XEU|1861|2291|lyfalmen|V0234|2246||6|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||959||959|2291| 124251|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|12|stk|1|ţpakki||N02CC01|01.04.2012||R|||0|0|E|0|BLP|0|0|0|100|XEU|2658|2741|lyfalmen|V0233|2741||12|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||1288||1288|2741| 124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|ţpakki||G02AB01|01.03.1980||R|||0|0|E|0|NOH|0|0|0|100|DKK|974|2311|lyfalmen||||30|0|18,7500|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||974||974|2311| 124727|C09AA0201|Daren|töflur|10|mg|30|stk|1|ţpakki||C09AA02|01.01.1994||R|||0|0|B|0|ACA|0|0|0|100|XEU|498|1660|lyfalmen||||30|0|30,0000|Actavis Group hf|Actavis hf|Enalapríl||498||498|1660| 124870|S01ED5110|Duotrav|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|||0|0|*|0|ALC|0|0|0|100|USD|10481|15316|lyfalmen|V0464|15316||8|0|75,0000|K.Pétursson hf|Alcon|Tímólól í blöndum||10481||10481|15316| 124936|N07BC0101|Subutex|tungur.t|2|mg|7|stk|1|ţpakki||N07BC01|01.11.1999||R|||1|0|0|1|RBP|0|0|0|100|DKK|1240|1790|lyfsjukr||||7|0|1,7500|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||1240||1240|1790| 125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|ţpakki||C09AA02|01.01.1994||R|||0|0|B|0|ACA|0|0|0|100|XEU|819|1571|lyfalmen|V0066|1571||100|0|100,0000|Actavis Group hf|Actavis hf|Enalapríl||433||433|1571| 125973|D01BA0205|Terbinafin BMM Pharma|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.08.2012||R|||0|0|0|0|BMM|0|0|0|100|XEU|2416|3314|lyfalmen|V0123|3314||28|0|28,0000|LYFIS ehf|BMM Pharma AB|Terbínafín||1707||1707|3314| 126326|A07DA0301|Imodium|töflur|2|mg|16|stk|1|ţpakki||A07DA03|01.10.1991||L|||0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa||||16|0|3,2000|Vistor hf|McNeil Sweden AB|Lóperamíđ|||||| 126374|L01XX1702|Hycamtin|hylki|1|mg|10|stk|1|ţpakki|hart|L01XX17|01.11.2008||R|||0|1|0|1|SKB|0|0|0|100|GBP|115712|147101|lyfsjukr||||10|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||115712|147101| 126385|L01XX1702|Hycamtin|hylki|0,25|mg|10|stk|1|ţpakki|hart|L01XX17|01.11.2008||R|||0|1|0|1|SKB|0|0|0|100|GBP|29696|39151|lyfsjukr||||10|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||29696|39151| 126540|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.10.1995||R|||0|0|0|1|INN|0|0|0|100|XEU|24698|32878|lyfsjukr||||1|0|0,5417|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||24698||24698|32878| 126649|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.10.1995||R|||0|0|0|1|INN|0|0|0|100|XEU|8232|11881|lyfsjukr||||1|0|0,1354|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||8232||8232|11881| 126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|||0|0|0|1|CSB|0|0|0|100|SEK|48247|62432|lyfsjukr||||50|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||48247||48247|62432| 126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|||0|0|0|1|CSB|0|0|0|100|SEK|96520|123015|lyfsjukr||||100|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||96520||96520|123015| 126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|||0|0|0|1|CSB|0|0|0|100|SEK|192972|244062|lyfsjukr||||200|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||192972||192972|244062| 126926|B01AX0601 |Xarelto|filmhtfl|15|mg|100|stk|1|ţpakki||B01AX06|01.05.2012||R|||0|0|E|0|BAP|0|0|0|100|SEK|38361|50688|lyfalmen|V0031|50688||100|0|150,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||38361|50688| 126953|A07DA0301|Imodium|töflur|2|mg|100|stk|1|ţpakki||A07DA03|01.10.1991||R|||0|0|E|0|MCS|0|0|0|100|SEK|1060|2429|lyfalmen|V0447|2101||100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíđ||1060||1060|2429| 127383|R02AA0302|Strepsils med honning og citron|sogtfl|||36|stk|1|ţpakki||R02AA03|01.01.2009||L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 128058|N05AH0301|Zyprexa|húđuđtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.03.1998||R|||0|0|*|0|ELD|0|1|0|100|XEU|8490|6066|lyfalmen|V0279|2384||28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||3719||3719|6066| 128131|QG51AG0101|Sulfa-Streptocillin vet.|legstíl|||30|stk|1|ţpakki||QG51AG01|01.03.2009||R|||0|0|0|0|BID|1|0|0|100|DKK|11967|23151|vetalmen||||30|0||Vistor hf|Boehringer Ingelheim Danmark|Súlfónamíđar í blöndu međ öđrum lyfjum||11967||11967|23151| 128348|C03AB0102|Centyl mite med kaliumklorid|töflur|||100|stk|1|glas||C03AB01|01.05.1999||R|||0|0|E|0|LEP|0|0|0|100|DKK|1199|2619|lyfalmen||||100|0|50,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||1199||1199|2619| 128777|N02BA5102|Treo|freyđit|||60|stk|1|glas||N02BA51|01.07.1988||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||60|0|10,0000|Vistor hf|McNeil Denmark ApS|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole|||||| 128934|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.10.1990||R|||0|0|0|1|BAM|0|0|0|100|SEK|4083|5893|lyfsjukr||||100|0||Icepharma hf|Baxter Medical AB|Mesna||4083||4083|5893| 129098|N05AH0301|Zyprexa|húđuđtfl|7,5|mg|56|stk|1|ţpakki||N05AH03|01.03.1998||R|||0|0|0|0|ELD|0|1|0|100|XEU|30607|29348|lyfalmen|V0280|8107||56|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||21357||21357|29348| 129106|N05AH0301|Zyprexa|húđuđtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.03.1998||R|||0|0|*|0|ELD|0|1|0|100|XEU|33266|22644|lyfalmen|V0282|6691||56|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||16015||16015|22644| 129158|H02AB0605|Prednisolone Actavis|töflur|5|mg|28|stk|1|ţpakki||H02AB06|01.02.2011||R|||0|0|B|0|AUK|0|0|1|100|GBP|233|1298|lyfalmen||||28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||233||233|1298| 129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH00|01.08.2005||L|||0|0|0|0|REP|0|0|0|100|SEK|||lyfalmen||||100|0||Vistor hf|Recip AB|Natríumhýdrógenkarbonat|||||3267| 129817|R03BB0101|Atrovent|innúđal|0,25|mg/ml|60|plastl|1|pakki|í vél|R03BB01|01.04.1989||R|||0|0|B|0|BOI|0|0|0|100|DKK|4264|6812|lyfalmen||||60|0|100,0000|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíđ||4264||4264|6812| 130013|N05AH0401|Seroquel|töflur|100|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|||0|0|0|0|AZA|0|1|0|100|SEK|19005|23357|lyfalmen|V0285|12347||100|0|25,0000|Vistor hf|AstraZeneca AB|Quetíapín||16583||16583|23357| 130021|N05AH0401|Seroquel|töflur|200|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|||0|0|0|0|AZA|0|1|0|100|SEK|30083|35490|lyfalmen|V0286|24658||100|0|50,0000|Vistor hf|AstraZeneca AB|Quetíapín||26251||26251|35490| 130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|||0|0|0|0|MYL|0|0|1|100|SEK|2389|4247|lyfalmen||||10|0|20,0000|Actavis Group PTC ehf|Mylan AB|Adrenalín tartrat||2389||2389|4247| 130397|QH01CA9301|Suprelorin|vefjalyf|4,7|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|||0|0|0|0|VIR|1|0|0|100|DKK|13609|26304|vetalmen||||2|0||Vistor hf|Virbac S.A|Deslorelín||13609||13609|26304| 130575|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.03.2003||R|||0|0|E|0|NYC|0|0|0|100|DKK|3891|6302|lyfalmen||||125|0|31,2500|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||3891||3891|6302| 130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|||0|0|0|0|MYL|0|0|1|100|SEK|1867|3533|lyfalmen||||10|0|3,3400|Actavis Group PTC ehf|Mylan AB|Atrópínsúlfat||1867||1867|3533| 130596|N07BA0301|Champix|filmhtfl|||53|stk|1|ţpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|||0|0|0|0|IPI|0|0|1|100|DKK|11072|16125|lyfalmen||||53|0|23,7500|Icepharma hf|Pfizer Limited|Vareniclin||||11072|16125| 130772|QI10AB0201|Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10AB02|01.05.2009||R|||0|0|0|0|PHA|0|0|0|100|NOK|65465|106806|veteldis||||500|0||Vistor hf|PHARMAQ AS|Aeromónas+Vibrio||||65465|106806| 131136|C01CA2601|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||C01CA26|01.06.2009||R|||0|0|0|0|MYL|0|0|0|100|SEK|3424|5663|lyfalmen||||10|0|10,0000|Actavis Group PTC ehf|Mylan AB|Efedrínhýdróklóríđ||||3424|5663| 131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|||0|0|E|0|REP|0|0|0|100|SEK|483|1640|lyfalmen||||100|0|33,3333|Vistor hf|Recip AB|Fenýtóín||483||483|1640| 131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|||0|0|E|0|REP|0|0|0|100|SEK|760|2019|lyfalmen||||100|0|15,0000|Vistor hf|Recip AB|Fenemal||760||760|2019| 131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|||0|0|E|0|REP|0|0|0|100|SEK|1014|2366|lyfalmen||||100|0|50,0000|Vistor hf|Recip AB|Fenemal||1014||1014|2366| 131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|||0|0|E|0|REP|0|0|0|100|SEK|1122|2514|lyfalmen||||100|0|100,0000|Vistor hf|Recip AB|Fenemal||1122||1122|2514| 131450|B01AC0405|Clopidogrel Qualigen (Lyfjaver)|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.07.2011||R|||0|0|E|0|LVR|0|0|0|100|XEU|2542|2872|lyfalmen|V0009|1902||28|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Klópídógrel||1384||1384|2872| 131565|G03CA0306|Evorel|forđapl|100|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|||0|0|E|0|JAS|0|0|0|100|SEK|5781|8887|lyfalmen|V0132|8887||26|0|182,0000|Vistor hf|Janssen-Cilag AB|Estradíól||5781||5781|8887| 131740|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|90|stk|1|ţpakki||N07BA01|01.10.2008||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 131817|B01AX0601 |Xarelto|filmhtfl|10|mg|10|stk|1|ţpakki||B01AX06|01.05.2009||R|||0|0|E|0|BAP|0|0|0|100|SEK|3826|6213|lyfalmen|V0032|5560||10|0|10,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||3826||3826|6213| 131828|B01AX0601 |Xarelto|filmhtfl|10|mg|30|stk|1|ţpakki||B01AX06|01.05.2009||R|||0|0|E|0|BAP|0|0|0|100|SEK|11477|16679|lyfalmen|V0032|16679||30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||11477||11477|16679| 131840|B01AX0601 |Xarelto|filmhtfl|10|mg|100|stk|1|ţpakki||B01AX06|01.05.2009||R|||0|0|E|0|BAP|0|0|0|100|SEK|38106|50368|lyfalmen||||100|0|100,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||38106||38106|50368| 132229|N06AA0905|Amitriptyline|töflur|10|mg|28|stk|1|ţpakki||N06AA09|01.04.2008|31.08.2012|R|||0|0|B|0|AUK|0|1|0|100|GBP|264|1258|lyfalmen||||28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||204||204|1258| 132260|N06DA0404|Galantamine Portfarma|forđahlk|8|mg|28|stk|1|ţpakki||N06DA04|01.12.2011||R|||0|0|E|0|POF|0|0|0|100|SEK|8173|10933|lyfalmen|V0348|10933||28|0|14,0000|Portfarma ehf|Portfarma|Galantamín||7277||7277|10933| 132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|ţpakki||C09DA03|01.10.2008||R|||0|0|0|0|AGP|0|0|0|100|XEU|9024|3951|lyfalmen||||98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og ţvagrćsilyf||2173||2173|3951| 132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|ţpakki||C09DA03|01.10.2008||R|||0|0|0|0|AGP|0|0|0|100|XEU|7232|3951|lyfalmen||||98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og ţvagrćsilyf||2173||2173|3951| 132662|R05DA0403|Kodein Recip|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|||1|0|E|0|REP|0|0|1|100|SEK|1517|3054|lyfalmen||||100|0|25,0000|Vistor hf|Recip AB|Kódein||1517||1517|3054| 132663|N06BA0402|Concerta|forđatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|||1|0|0|0|JAS|0|0|0|100|SEK|7941|11842|lyfalmen||||30|0|27,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||7941||7941|11842| 132761|D08AG0201|Betadine|áburđur|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|||0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa||||8|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||| 132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|||0|0|0|0|SAL|0|0|0|100|USD|1114|2503|lyfalmen||||15|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Proxýmetakaín||1114||1114|2503| 132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|||0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa||||100|0|3,0000|Vistor hf|Abigo Medical AB|Lyfjakol|||||| 132902|G03AB0402|Trinovum 28|töflur|||84|stk|1|ţpakki||G03AB04|01.01.1993||R|||0|0|0|0|JAS|0|0|0|100|SEK|1413|2912|lyfalmen||||84|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1413||1413|2912| 133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|||0|1|0|1|EIS|0|0|0|100|SEK|28886|38134|lyfsjukr||||0|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||28886||28886|38134| 133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|||0|1|0|1|EIS|0|0|0|100|SEK|38424|50105|lyfsjukr||||1|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||38424||38424|50105| 133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|||0|1|0|1|EIS|0|0|0|100|SEK|50206|64891|lyfsjukr||||2|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||50206|64891| 133508|A06AD6501|Moxalole|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.05.2011||L|||0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa||||8|0||Vistor hf|Meda AB (V)|Makrógól 3350|||||| 133530|A06AD6501|Moxalole|mixtduft|13,8|g|20|pokar|1|pakki||A06AD65|01.05.2011||L|||0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa||||20|0||Vistor hf|Meda AB (V)|Makrógól 3350|||||| 133552|A06AD6501|Moxalole|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.05.2011||L|||0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa||||50|0||Vistor hf|Meda AB (V)|Makrógól 3350|||||| 133736|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|glas||J04AB02|01.04.1993|30.09.2012|R|||0|0|E|0|SAD|0|0|0|100|DKK|8214|12215|lyfalmen||||100|0|25,0000|Icepharma hf|Sandoz GmbH|Rífampicín||8214||8214|12215| 134274|J02AC0302|Vfend (D.A.C.)|filmhtfl|200|mg|14|stk|1|ţpakki||J02AC03|01.05.2008||R|||0|0|0|1|DAC|0|0|0|100|DKK|89738|114504|lyfsjukr||||14|0|7,0000|D.A.C. ehf|D.A.C. ehf|Voricónazól||89738||89738|114504| 134338|J01FA0901|Klacid|mixt.kyr|50|mg/ml|50|ml|1|glas|pl.fl. m/sk.sprautu|J01FA09|01.07.1998||R|||0|0|0|0|ABS|0|0|1|100|DKK|1473|2994|lyfalmen||||50|0|5,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||1473||1473|2994| 134352|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|30|sk-hyl||S01EE05|01.03.2010||R|||0|0|*|0|SAO|0|0|0|100|XEU|3890|6300|lyfalmen|V0378|5644||9|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||3890||3890|6300| 134374|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|90|sk-hyl||S01EE05|01.06.2010||R|||0|0|*|0|SAO|0|0|0|100|XEU|11662|16932|lyfalmen|V0378|16932||27|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||11662||11662|16932| 134520|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.04.2009||R|||0|1|0|1|AGT|0|0|0|100|XEU|4595|6632|lyfsjukr||||25|0||Actavis Group hf|Actavis Group hf|Epírúbicín||4595||4595|6632| 134642|J05AE0801|Reyataz|hylki|300|mg|30|stk|1|plglas||J05AE08|01.01.2010||R|||0|1|0|1|BRS|0|0|0|100|DKK|68304|87604|lyfsjukr||||30|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||68304||68304|87604| 134862|J05AR0601|Atripla|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|||0|1|0|1|GSI|0|0|0|100|DKK|126558|160713|lyfsjukr||||30|0|30,0000|Lyfjaver ehf|Gilead Science International (L)|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||126558||126558|160713| 135111|H01AC0101|Genotropin|sts|12|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.04.1992||R|||0|1|0|1|PER|0|0|0|100|DKK|51446|66447|lyfsjukr||||1|0|18,0000|Icepharma hf|Pfizer ApS|Sómatrópín||51446||51446|66447| 135289|C07AG0203|Carvedilol Actavis|filmhtfl|12,5|mg|100|stk|1|ţpakki||C07AG02|01.07.2011||R|||0|0|B|0|ADG|0|0|0|100|XEU|2069|3809|lyfalmen||||100|0|33,3333|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||2069||2069|3809| 135319|C08DA0108|Verapamil Mylan|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990||R|||0|0|B|0|MYL|0|0|0|100|SEK|1033|2392|lyfalmen||||100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Verapamíl||1033||1033|2392| 135434|R03BA0502|Flixotide Diskus|innúđadu|100|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|||0|0|0|0|GSK|0|0|0|100|GBP|2290|4112|lyfalmen||||60|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2290||2290|4112| 136168|G03AB0401|Trinovum|töflur|||63|stk|1|ţpakki||G03AB04|01.10.1988||R|||0|0|0|0|JAS|0|0|0|100|SEK|1701|3306|lyfalmen||||63|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1701||1701|3306| 136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|||0|0|0|0|REP|0|0|0|100|SEK|7086|10672|lyfalmen||||100|0|100,0000|Vistor hf|Recip AB|Ísóníazíđ||7086||7086|10672| 136281|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.03.2012||R|||0|1|0|1|IPI|0|0|0|100|DKK|71851|92056|lyfsjukr||||4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||71851||71851|92056| 136658|N05BA1206|Alprazolam Krka|forđatfl|0,5|mg|30|stk|1|ţpakki||N05BA12|01.08.2012||R|||0|0|0|0|KRK|0|0|1|100|XEU|446|1462|lyfalmen|V0307|1462||30|0|15,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||353||353|1462| 136964|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|5|ml|1|hgl||L01CD01|01.10.2005||R|||0|1|0|1|HUK|0|0|0|100|SEK|2318|3345|lyfsjukr||||5|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||2318||2318|3345| 136975|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|||0|1|0|1|HUK|0|0|0|100|SEK|7261|10479|lyfsjukr||||17|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||7261||7261|10479| 136987|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|||0|1|0|1|HUK|0|0|0|100|SEK|5352|7724|lyfsjukr||||25|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||5352||5352|7724| 136998|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.10.2005||R|||0|1|0|1|HUK|0|0|0|100|SEK|8342|12040|lyfsjukr||||50|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||8342||8342|12040| 137110|L01XA0302|Oxaliplatin Hospira|irţ|5|mg/ml|20|ml|1|hgl||L01XA03|01.06.2011||R|||0|1|0|1|HUK|0|0|0|100|XEU|5764|8319|lyfsjukr||||20|0||Icepharma hf|Hospira UK Ltd|Oxalíplatín||5764||5764|8319| 137513|S01XA2011|Oculac|augndr|||10|ml|1|glas|međ rotvörn|S01XA20|01.10.1999||L|||0|0|E|0|ACK|0|0|0|100|DKK|||lyfalmen||||10|0||Vistor hf|Alcon Denmark A/S|Gervitár og ađrar óvirkar samsetningar|||||1656| 137521|S01XA2011|Oculac|augndr|||0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.10.1999||L|||0|0|E|0|ACK|0|0|0|100|DKK|||lyfalmen||||8|0||Vistor hf|Alcon Denmark A/S|Gervitár og ađrar óvirkar samsetningar|||||2024| 137809|M05BA0302|Pamidronatdinatrium Hospira|irţ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|||0|0|0|1|MAY|0|0|0|100|SEK|21342|28667|lyfsjukr||||25|0|1,2500|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||21342||21342|28667| 137820|M05BA0302|Pamidronatdinatrium Hospira|irţ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|||0|0|0|1|MAY|0|0|0|100|XEU|6097|8799|lyfsjukr||||10|0|0,5000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||6097||6097|8799| 137831|M05BA0302|Pamidronatdinatrium Hospira|irţ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|||0|0|0|1|MAY|0|0|0|100|XEU|10236|14729|lyfsjukr||||10|0|1,0000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||10236||10236|14729| 137842|M05BA0302|Pamidronatdinatrium Hospira|irţ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|||0|0|0|1|MAY|0|0|0|100|SEK|6125|8840|lyfsjukr||||10|0|1,5000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||6125||6125|8840| 137992|J01XA0106|Vancomycin Hospira|irs|500|mg/hgl|500|mg|1|hgl||J01XA01|01.04.1997||R|||0|0|0|1|HOS|0|0|0|100|XEU|722|1042|lyfsjukr||||500|0|0,2500|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||722||722|1042| 138073|J01XA0106|Vancomycin Hospira|irs|1|g/hgl|1|g|1|hgl||J01XA01|01.04.1997||R|||0|0|0|1|HOS|0|0|0|100|DKK|1467|2117|lyfsjukr||||1|0|0,5000|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||1467||1467|2117| 138594|S01ED0105|Optimol|augndr|5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|||0|0|*|0|SAO|0|0|0|100|XEU|1645|3229|lyfalmen||||15|0|60,0000|Icepharma hf|Santen Oy|Tímólól||1645||1645|3229| 139050|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíđ 20 mg|S01ED51|01.01.2012||R|||0|0|*|0|APC|0|0|0|100|XEU|4581|7158|lyfalmen|V0373|7158||15|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||4517||4517|7158| 139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|ţpakki||R06AA04|01.08.1981||L|||0|0|0|0|NEH|0|0|1|100|IKR|||lyflausa||||100|0|50,0000|Artasan ehf|Novartis Healthcare A/S|Klemastín|||||| 140130|V03AB3501|Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.04.2009||R|||0|1|0|1|ORG|0|0|0|100|DKK|132874|168639|lyfsjukr||||20|0||Vistor hf|N.V. Organon|Sugammadex||132874||132874|168639| 140141|V03AB3501|Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.04.2009||R|||0|1|0|1|ORG|0|0|0|100|DKK|332078|418640|lyfsjukr||||50|0||Vistor hf|N.V. Organon|Sugammadex||332078||332078|418640| 140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.05.2005||R|||0|0|E|0|BII|0|0|0|100|DKK|1407|2904|lyfalmen|V0266|1099||30|0|1,0600|Vistor hf|Boehringer Ingelheim International |Pramipexól||1407||1407|2904| 140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|||0|0|0|1|LBK|0|1|0|100|DKK|11384|16169|lyfsjukr||||10|0|16,6700|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||11384||11384|16169| 140566|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.12.1972||R|||0|0|0|1|DES|0|0|0|100|DKK|617|890|lyfsjukr||||5|0|3,3333|Swedish Orphan Biovitrum A/S|Defiante Farmaceutica S.A.|Oxýtócín||617||617|890| 140729|QN01AX0001|Finquel, vet|duft|100|%|1000|g|1|fl|bađlausn handa fiskum|QN01AX|01.01.2012||R|||0|0|0|0|SRR|1|0|0|100|NOK|94834|182268|vetalmen||||1000|0||Scan Aqua AS|Scan Aqua AS|Tricaine mesylate||94834||94834|182268| 140954|N07BA0103|Nicorette|nefúđi|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||10|0|3,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|spr|einnotaspr|H02AB04|01.04.1994||R|||0|0|B|0|PER|0|0|1|100|DKK|1202|2623|lyfalmen|V0413|2350||2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1202||1202|2623| 141197|N02BE0112|Perfalgan (D.A.C.)|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.05.2008||R|||0|0|0|1|DAC|0|0|0|100|DKK|4286|6018|lyfsjukr||||1200|0|4,0000|D.A.C. ehf|D.A.C. ehf|Paracetamól||4170||4170|6018| 141219|J02AC0302|Vfend (D.A.C.)|irs|200|mg|1|hgl|1|pakki||J02AC03|01.05.2008||R|||0|0|0|1|DAC|0|0|0|100|DKK|19681|26582|lyfsjukr||||1|0|0,5000|D.A.C. ehf|D.A.C. ehf|Voricónazól||19681||19681|26582|30.09.2012 141388|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|3732|5386|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||3732||3732|5386| 141432|N04BC0502|Sifrol|töflur|0,18|mg|30|stk|1|ţpakki||N04BC05|01.05.2005||R|||0|0|E|0|BII|0|0|0|100|DKK|2660|4618|lyfalmen||||30|0|2,1600|Vistor hf|Boehringer Ingelheim International |Pramipexól||2660||2660|4618| 141438|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.01.2012||R|||0|1|E|0|MSE|0|0|0|100|SEK|20734|28566|lyfalmen||||0|0|4,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||20734||20734|28566| 141684|G03AA1205|Yaz|filmhtfl|||84|stk|1|ţpakki|0,02mg/3mg|G03AA12|01.02.2009||R|||0|0|0|0|BAB|0|0|0|100|SEK|4835|7593|lyfalmen||||84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og östrógen||4835||4835|7593| 141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.05.2005||R|||0|0|E|0|BII|0|0|0|100|DKK|8337|12383|lyfalmen|V0267|2519||100|0|7,2000|Vistor hf|Boehringer Ingelheim International|Pramipexól||8337||8337|12383| 142034|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.07.2012||R|||0|0|E|0|MYL|0|0|1|100|SEK|2742|3629|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||1937||1937|3629| 142203|QP54AA0106|Otimectin vet.|eyrnahl|1|mg/g|10|g|1|túpa|Fyrir hesta|QP54AA01|01.10.2012||L|||0|0|0|0|LEV|1|0|0|100|XEU|1609|2807|vetorma||||10|0||Le Vet B.V.|Le Vet B.V.|Ivermectinum||||1609|2807| 142299|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|10|lykjur||C01BD01|01.04.1987||R|||0|0|0|1|SNO|0|0|0|100|NOK|3323|4796|lyfsjukr||||30|0|7,5000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||3323||3323|4796| 142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|ţpakki||C01BD01|01.04.1987||R|||0|0|B|0|SNO|0|0|0|100|NOK|1089|2469|lyfalmen||||30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1089||1089|2469| 142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|||0|0|0|0|MEB|0|0|1|100|SEK|2943|5005|lyfalmen||||100|0|50,0000|Vistor hf|Meda AB (V)|Metenamín||2943||2943|5005| 143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|||0|0|B|0|PER|0|0|1|100|DKK|1398|2891|lyfalmen||||1|0|6,2500|Icepharma hf|Pfizer ApS|Metýlprednisólón||1398||1398|2891| 143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|||0|0|0|1|PER|0|0|0|100|DKK|2197|3171|lyfsjukr||||1|0|25,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2197||2197|3171| 143511|J07BC2002|Twinrix Paediatric|bóluefni|||0,5|ml|1|dćla|einnota dćla|J07BC20|01.01.1999||R|||0|0|0|0|GLB|0|0|0|100|GBP|3888|6297|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||3888||3888|6297| 143526|C07AB0309|Atenolol Actavis|filmhtfl|50|mg|100|stk|1|glas||C07AB03|01.10.2012||R|||0|0|B|0|AGP|0|0|0|100|XEU|568|1646|lyfalmen|V0542|1646||100|0|66,6700|Actavis Group hf|Actavis Group PTC ehf|Atenólól||488||488|1646| 143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|||0|0|0|0|SAL|0|0|0|100|USD|920|2237|lyfalmen||||15|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Trópíkamíđ||920||920|2237| 143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|ţpakki||J01FA10|01.11.1998||R|||0|0|0|0|PER|0|0|1|100|DKK|1427|2931|lyfalmen||||2|0|3,3333|Icepharma hf|Pfizer ApS|Azitrómýcín||1427||1427|2931| 143610|N02CX0201|Catapresan|töflur|25|mcg|100|stk|1|ţpakki||N02CX02|01.04.1974||R|||0|0|E|0|BOI|0|0|0|100|DKK|1286|2738|lyfalmen||||100|0|25,0000|Vistor hf|Boehringer Ingelheim|Klónidín||1286||1286|2738| 143631|A10BD0701|Janumet|filmhtfl|1050|mg|56|stk|1|ţpakki|50/1000mg|A10BD07|01.03.2009||R|||0|0|*|0|MSD|0|0|0|100|DKK|8161|12143|lyfalmen|V0386|9243||56|0|28,0000|Vistor hf|M.S.D.|Metforminum og sitagliptinum||8161||8161|12143| 143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|||0|0|B|0|ASP|0|0|1|100|XEU|587|1782|lyfalmen||||30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||587||587|1782| 143800|N05AN0101|Litarex|forđatfl|564|mg|100|stk|1|glas||N05AN01|01.04.1974||R|||0|0|*|0|AGT|0|1|0|100|DKK|1165|2573|lyfalmen||||100|0|25,0000|Actavis Group hf|Actavis Group hf|Litíum||1165||1165|2573| 143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|ţpakki||J01FA10|01.11.1998||R|||0|0|0|0|PER|0|0|1|100|DKK|1962|3663|lyfalmen|V0174|3663||3|0|5,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1962||1962|3663| 144030|N04BA0207|Sinemet depot mite|forđatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|||0|0|E|0|MSD|0|0|0|100|DKK|2023|3746|lyfalmen||||100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2023||2023|3746| 144035|N05AH0501|Sycrest|tungur.t|10|mg|60|stk|1|ţpakki||N05AH05|01.10.2011||R|||0|0|0|0|ORR|0|1|0|100|DKK|22241|30458|lyfalmen||||60|0|30,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||22241||22241|30458| 144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|||0|1|0|1|NAS|0|0|0|100|DKK|78109|99909|lyfsjukr||||2|0|22,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||78109||78109|99909| 144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|||0|1|0|1|NAS|0|0|0|100|DKK|58379|75148|lyfsjukr||||2|0|15,0000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||58379||58379|75148| 144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|||0|1|0|1|NAS|0|0|0|100|DKK|36273|47405|lyfsjukr||||2|0|7,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||36273||36273|47405| 144808|D07AB0201|Locoid|lausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|||0|0|B|0|ASP|0|0|1|100|XEU|633|1845|lyfalmen||||30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||633||633|1845| 145077|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.06.2011||R|||0|1|0|1|CEO|0|0|0|100|DKK|82599|105544|lyfsjukr||||1|0|26,6700|Vistor hf|Centocor B.V.|Infliximab||82599||82599|105544| 145508|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|||0|0|B|0|SPL|0|0|1|100|DKK|2149|3919|lyfalmen||||100|0||Vistor hf|Schering-Plough Europe|Betametasón||2149||2149|3919| 145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|ţpakki||P02CX01|01.12.1972||L|||0|0|0|0|REP|0|0|0|100|IKR|||lyflausa||||8|0||Vistor hf|Recip AB|Pýrvín|||||| 145631|P02CX0101|Vanquin|töflur|50|mg|32|stk|1|ţpakki||P02CX01|01.01.1995|30.09.2012|L|||0|0|0|0|REP|0|0|0|100|IKR|||lyflausa||||32|0||Vistor hf|Recip AB|Pýrvín|||||| 145698|N05AH0301|Zyprexa|húđuđtfl|10|mg|28|stk|1|ţpakki||N05AH03|01.03.1998||R|||0|0|0|0|ELD|0|1|0|100|XEU|19913|19481|lyfalmen||||28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||13495||13495|19481| 146082|L04AA2601|Benlysta|irs|120|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|||0|1|0|1|GGL|0|0|0|100|GBP|31320|41189|lyfsjukr||||1|0||GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||31320||31320|41189| 146207|L01XX1903|Irinotecan Hospira|irţ|20|mg/ml|2|ml|1|hgl|lausn|L01XX19|01.03.2009||R|||0|1|0|1|HUK|0|0|0|100|XEU|2944|4249|lyfsjukr||||2|0||Icepharma hf|Hospira UK Ltd|Írinótekan||2944||2944|4249| 146218|L01XX1903|Irinotecan Hospira|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.03.2009||R|||0|1|0|1|HUK|0|0|0|100|XEU|5981|8632|lyfsjukr||||5|0||Icepharma hf|Hospira UK Ltd|Írinótekan||5981||5981|8632| 146473|N06BA0901|Strattera|hylki|80|mg|28|stk|1|glas|hart|N06BA09|01.01.2010||R|||0|1|0|0|ELI|0|0|0|100|XEU|17430|24420|lyfalmen||||28|0|28,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||17430||17430|24420| 146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|ţpakki||P01AB01|01.10.1995||R|||0|0|0|0|SNO|0|0|1|100|NOK|886|2191|lyfalmen||||10|0|2,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||886||886|2191| 147241|L01BC0102|Arabine|stl/irl|100|mg/ml|1|ml|5|hgl||L01BC01|01.03.2009||R|||0|1|0|1|HOP|0|0|0|100|XEU|2441|3523|lyfsjukr||||5|0||Icepharma hf|Hospira Nordic AB|Cýtarabín||2441||2441|3523| 147252|L01BC0102|Arabine|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.03.2009||R|||0|1|0|1|HOP|0|0|0|100|XEU|1513|2184|lyfsjukr||||10|0||Icepharma hf|Hospira Nordic AB|Cýtarabín||1513||1513|2184| 147343|A02BC0109|Omeprazol Pensa (Lyfjaver)|sţ-hylki|20|mg|28|stk|1|ţpakki||A02BC01|01.02.2012||L|||0|0|0|0|LVR|0|0|0|100|IKR|||lyflausa||||28|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Ómeprazól|||||| 148213|R05CB1301|Pulmozyme|innúđal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|||0|0|0|0|ROA|0|0|1|100|DKK|109493|139959|lyfalmen||||75|0|30,0000|Icepharma hf|Roche A.S.|Dornase alfa||109493||109493|139959| 148263|J01CA0802|Penomax|filmhtfl|200|mg|20|stk|1|ţpakki||J01CA08|01.09.2012||R|||0|0|0|0|OPF|0|0|1|100|DKK|1171|2581|lyfalmen|V0577|2581||20|0|6,6667|Portfarma ehf|Orion Corporation|Pívmecillínam||1171||1171|2581| 148274|J01CA0802|Penomax|filmhtfl|200|mg|30|stk|1|ţpakki||J01CA08|01.09.2012||R|||0|0|0|0|OPF|0|0|1|100|DKK|1742|3362|lyfalmen||||30|0|10,0000|Portfarma ehf|Orion Corporation|Pívmecillínam||1742||1742|3362| 148285|J01CA0802|Penomax|filmhtfl|200|mg|100|stk|1|glas||J01CA08|01.09.2012||R|||0|0|0|0|OPF|0|0|1|100|DKK|6244|9520|lyfalmen||||100|0|33,3300|Portfarma ehf|Orion Corporation|Pívmecillínam||6244||6244|9520| 148363|D11AH0401|Toctino|hylki|10|mg|30|stk|1|ţpakki|mjúk|D11AH04|01.03.2012||R|||0|1|0|0|BLT|0|0|0|100|DKK|80809|103960|lyfalmen||||30|0||Icepharma hf|Basilea Medical Ltd.|Alítretínóín||80809||80809|103960| 148374|D11AH0401|Toctino|hylki|30|mg|30|stk|1|ţpakki|mjúk|D11AH04|01.03.2012||R|||0|1|0|0|BLT|0|0|0|100|DKK|80809|103960|lyfalmen||||30|0||Icepharma hf|Basilea Medical Ltd.|Alítretínóín||80809||80809|103960| 148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|ţpakki||N04AA02|01.11.2005||R|||0|0|*|0|LFS|0|1|0|100|DKK|828|2112|lyfalmen||||100|0|20,0000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||828||828|2112| 148642|N01AX6301|Livopan|lyfjagas|||5|l|1|hylki|50% + 50%|N01AX63|01.05.2012||R|||0|0|0|1|AGA|0|0|0|100|IKR|62097|79814|lyfsjukr||||5|0||Ísaga ehf|AGA AB|Tvínituroxíđ og súrefni||62097||62097|79814| 148741|L01CA0207|Vincristine Hospira|stl|1|mg/ml|1|ml|5|hgl||L01CA02|01.01.1991||R|||0|1|0|1|HOP|0|0|0|100|SEK|6464|9329|lyfsjukr||||5|0||Icepharma hf|Hospira Nordic AB|Vínkristín||6464||6464|9329| 148752|L01CA0207|Vincristine Hospira|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|||0|1|0|1|HOP|0|0|0|100|SEK|13550|18888|lyfsjukr||||10|0||Icepharma hf|Hospira Nordic AB|Vínkristín||13550||13550|18888| 148917|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|||0|1|0|1|HOS|0|0|0|100|SEK|28987|38261|lyfsjukr||||1|0||Icepharma hf|Hospira Enterprises B.V. (I)|Raltítrexed||28987||28987|38261| 148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|||0|0|0|0|BAN|1|0|0|100|DKK|3526|6943|vetalmen||||25|0||Icepharma hf|Bayer Animal Health GmbH|||3526||3526|6943| 149146|N05AG0201|Orap|töflur|1|mg|75|stk|1|ţpakki||N05AG02|01.03.2004||R|||0|0|0|0|PCO|0|1|0|100|SEK|2157|3930|lyfalmen||||75|1|18,7500|Distica|Distica - óskráđ lyf|Pímózíđ||2157||2157|3930| 149375|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.03.2010||R|||0|0|*|0|POF|0|0|0|100|DKK|2111|2540|lyfalmen|V0376|2121||2|0|25,0000|Portfarma ehf|Portfarma|Latanóprost||1141||1141|2540| 150243|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|glas||J04AB02|01.04.1993|31.08.2012|R|||0|0|E|0|SAD|0|0|0|100|DKK|16026|22658|lyfalmen||||100|0|50,0000|Icepharma hf|Sandoz GmbH|Rífampicín||16026||16026|22658| 150521|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|50896|65757|lyfsjukr||||2|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||||50896|65757| 150539|C10AD5201|Tredaptive|töflur|1020|mg|28|stk|1|ţpakki|1000+20 mg|C10AD52|01.12.2009||R|||0|0|0|0|MSD|0|0|0|100|DKK|3677|6009|lyfalmen||||28|0||Vistor hf|M.S.D.|Nikótínsýra og afleiđur-Nikótínsýra í blöndum||||3677|6009| 150550|C10AD5201|Tredaptive|töflur|1020|mg|56|stk|1|ţpakki|1000+20 mg|C10AD52|01.12.2009||R|||0|0|0|0|MSD|0|0|0|100|DKK|6099|9322|lyfalmen|V0120|7316||56|0||Vistor hf|M.S.D.|Nikótínsýra og afleiđur-Nikótínsýra í blöndum||||6099|9322| 150996|J07AH0401|Mencevax ACWY|stl|50|mcg|0,5|ml|1|hgl||J07AH04|01.11.2008||R|||0|0|0|0|GSK|0|0|0|100|GBP|3714|6059|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hreinsađir fjórgildir meningókokka polysakkaríđ mótefnavakar||||3714|6059| 151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|||0|0|*|0|LBK|0|1|0|100|DKK|6374|9698|lyfalmen||||10|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||6374||6374|9698| 151217|G01AF0102|Flagyl|sk-stíll|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|||0|0|E|0|SNO|0|0|0|100|NOK|1195|2614|lyfalmen||||10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1195||1195|2614| 151518|N06DX0101|Ebixa|filmhtfl|20|mg|28|stk|1|ţpakki||N06DX01|01.11.2008||R|||0|0|E|0|LBK|0|0|0|100|DKK|15480|21973|lyfalmen||||28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||15480|21973| 151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|ţpakki||N06DX01|01.11.2008||R|||0|0|E|0|LBK|0|0|0|100|DKK|47797|59673|lyfalmen||||98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||45520||45520|59673| 151627|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|pakki|lausn,áf.lyfjap.+ spr.nál|G03GA08|01.04.2012||R|||0|1|E|0|MSE|0|0|0|100|SEK|5216|8114|lyfalmen||||0|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||5216||5216|8114| 151640|G04CA0204|Tamsulogen|hylki|0,4|mg|90|stk|1|ţpakki|međ br. losunarhrađa|G04CA02|01.05.2006||R|||0|0|E|0|MYL|0|0|0|100|SEK|5491|4047|lyfalmen|V0148|3942||90|0|90,0000|Actavis Group PTC ehf|Mylan AB|Tamsúlósín||2243||2243|4047| 151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|ţpakki||N06AA12|01.12.1972||R|||0|0|B|0|PER|0|1|0|100|DKK|1529|3070|lyfalmen||||100|0|25,0000|Icepharma hf|Pfizer ApS|Doxepín||1529||1529|3070| 151975|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.02.2012||R|||0|0|E|0|RAT|0|0|0|100|XEU|4359|4322|lyfalmen|V0006|4217||100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||2444||2444|4322| 152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|||0|0|0|1|NOH|0|0|0|100|DKK|1950|2814|lyfsjukr||||5|0|0,4500|Vistor hf|Novartis Healthcare A/S-|Baklófen||1950||1950|2814| 152318|D01BA0204|Terbinafine (D.A.C.)|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.12.2010||R|||0|0|0|0|DAC|0|0|0|100|XEU|2513|3774|lyfalmen|V0123|3314||28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Terbínafín||2043||2043|3774| 152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|túpa||M02AA07|01.04.1996||L|||0|0|0|0|PER|0|0|1|100|IKR|||lyflausa||||25|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||| 152397|R03BA0202|Pulmicort Turbuhaler|innúđadu|100|mcg/sk|200|skammtar|1|stauk||R03BA02|01.04.1991||R|||0|0|0|0|AZD|0|0|0|100|SEK|4005|6458|lyfalmen||||200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||4005||4005|6458| 152413|R03BA0202|Pulmicort Turbuhaler|innúđadu|200|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|||0|0|B|0|AZD|0|0|0|100|SEK|5853|8986|lyfalmen||||200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||5853||5853|8986| 152421|R03BA0202|Pulmicort Turbuhaler|innúđadu|400|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|||0|0|B|0|ASZ|0|0|0|100|SEK|10739|15669|lyfalmen||||200|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Búdesóníđ||10739||10739|15669| 152635|B01AC0601|Hjartamagnyl|sţ-tfl|75|mg|100|stk|1|glas||B01AC06|01.06.2012||L|||0|0|0|0|AGP|0|0|0|100|IKR|||lyflausa||||100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Asetýlsalicýlsýra|||||| 152663|N04BC0504|Oprymea (Lyfis)|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.07.2010||R|||0|0|E|0|LYF|0|0|0|100|XEU|18297|9786|lyfalmen|V0269|9786||100|0|28,0000|LYFIS ehf|LYFIS ehf|Pramipexól||6438||6438|9786| 152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|ţpakki|hart|J02AC02|01.01.1995||R|||0|0|0|0|JAS|0|0|1|100|SEK|1279|2729|lyfalmen||||4|0|2,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||1279||1279|2729| 153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|ţpakki||R06AE07|01.01.1998||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||10|0|10,0000|Actavis Group hf|Actavis hf|Cetirizín|||||| 153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|||0|0|0|0|AZD|0|0|1|100|SEK|1832|3485|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín í blöndum||1832||1832|3485| 153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|ţpakki||R06AE07|01.01.1998||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||30|0|30,0000|Actavis Group hf|Actavis hf|Cetirizín|||||| 153222|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|38654|50393|lyfsjukr||||1|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||||38654|50393| 153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.03.2003||R|||0|0|0|0|AZD|0|0|1|100|SEK|2314|4144|lyfalmen|V0561|3675||100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2314||2314|4144| 153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.03.2003||R|||0|0|0|0|AZD|0|0|1|100|SEK|1618|3192|lyfalmen|V0560|2865||100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||1618||1618|3192| 153288|R06AE0704|Histasin|töflur|10|mg|100|stk|1|ţpakki||R06AE07|01.01.1998||R|||0|0|E|0|ACA|0|0|1|100|XEU|2226|3415|lyfalmen|V0575|3274||100|0|100,0000|Actavis Group hf|Actavis hf|Cetirizín||1781||1781|3415| 153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|||0|0|0|1|GIS|0|0|0|100|DKK|222422|281022|lyfsjukr||||10|0|14,2857|Gilead Sience Sweden AB|Gilead Science International ltd.|Amfóterícín||222422||222422|281022| 153417|C07AA0512|Pranolol|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.2011||R|||0|0|B|0|AGT|0|0|0|100|XEU|530|1704|lyfalmen||||100|0|25,0000|Actavis Group hf|Actavis Group hf|Própranólól||||530|1704| 153507|L02BG0602|Exemestan Actavis|filmhtfl|25|mg|100|stk|1|ţpakki||L02BG06|01.08.2011||R|||0|0|*|0|APC|0|0|0|100|XEU|34155|45410|lyfalmen|V0452|45410||100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Exemestan||34155||34155|45410| 153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|ţpakki|hart|J02AC02|01.04.1995||R|||0|0|0|0|JAS|0|0|1|100|SEK|4417|7021|lyfalmen||||15|0|7,5000|Vistor hf|Janssen-Cilag AB|Ítracónazól||4417||4417|7021| 153553|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|glas||N05BA02|01.07.2012||R|||0|0|0|0|AGT|0|0|1|100|XEU|312|1406|lyfalmen||||24|0|8,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||312||312|1406| 153564|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|glas||N05BA02|01.07.2012||R|||0|0|0|0|AGT|0|0|1|100|XEU|517|1686|lyfalmen||||24|0|20,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||517||517|1686| 153601|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|1|lykja||B03BA03|01.06.2010||R|||0|0|E|0|SHS|0|0|1|100|DKK|1526|3066|lyfalmen||||1|0|50,0000|Artasan ehf|Sandoz A/S|Hýdroxókóbalamín||1526||1526|3066| 154475|D05AX5203|Xamiol|hlaup|||60|g|1|plastf|50 mcg/g+0,5 mg/g|D05AX52|01.05.2009|31.07.2012|R|||0|0|B|0|LEP|0|0|0|100|DKK|8265|12285|lyfalmen||||60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||8265||8265|12285| 154480|R06AX2201|Kestine|filmhtfl|20|mg|100|stk|1|ţpakki||R06AX22|01.06.2012||R|||0|0|E|0|APS|0|0|1|100|DKK|9158|13507|lyfalmen||||100|0|200,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||9158||9158|13507| 154591|M01AB5501|Arthrotec|töflur|50,2|mg|20|stk|1|pakki|ţp (0,2+50 mg)|M01AB55|01.04.1993||R|||0|0|E|0|PER|0|0|1|100|DKK|1027|2384|lyfalmen||||20|0|10,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||1027||1027|2384| 154618|B05BA1021|SmofKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|28346|37457|lyfsjukr||||3944|0||Icepharma hf|Fresenius Kabi|Blöndur||28346||28346|37457| 154629|B05BA1021|SmofKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|37137|48489|lyfsjukr||||5908|0||Icepharma hf|Fresenius Kabi|Blöndur||37137||37137|48489| 154640|B05BA1021|SmofKabiven|irl|2200|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|40803|53090|lyfsjukr||||7880|0||Icepharma hf|Fresenius Kabi|Blöndur||40803||40803|53090| 154662|B05BA1022|SmofKabiven Elektrolytfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|30200|39784|lyfsjukr||||3944|0||Icepharma hf|Fresenius Kabi|Blöndur||30200||30200|39784| 154673|B05BA1022|SmofKabiven Elektrolytfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|37149|48504|lyfsjukr||||5908|0||Icepharma hf|Fresenius Kabi|Blöndur||37149||37149|48504| 154706|B05BA1023|SmofKabiven Perifer|irl|800|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|26614|35283|lyfsjukr||||4824|0||Icepharma hf|Fresenius Kabi|Blöndur||26614||26614|35283| 154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|pakki|ţp (0,2+50 mg)|M01AB55|01.04.1993||R|||0|0|E|0|PER|0|0|1|100|DKK|3685|6020|lyfalmen||||100|0|50,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||3685||3685|6020| 154717|B05BA1023|SmofKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|34701|45432|lyfsjukr||||7616|0||Icepharma hf|Fresenius Kabi|Blöndur||34701||34701|45432| 154728|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|28|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|||0|0|0|0|AGP|0|0|0|100|XEU|1482|3006|lyfalmen|V0259|3006||28|0|21,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1482||1482|3006| 154732|G04CA0102|Xatral Uno|forđatfl|10|mg|90|stk|1|ţpakki||G04CA01|01.01.2003||R|||0|0|E|0|SNO|0|0|0|100|NOK|7479|11210|lyfalmen|V0550|7494||90|0|120,0000|Vistor hf|Sanofi-aventis Norge AS|Alfúzósín||7479||7479|11210| 154739|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|98|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|||0|0|B|0|AGP|0|0|0|100|XEU|4214|5923|lyfalmen|V0334|5904||98|0|73,5000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||3614||3614|5923| 154750|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|28|stk|1|ţpakki|hart|N06AX16|01.08.2009|31.08.2012|R|||0|0|0|0|AGP|0|0|0|100|XEU|2373|2452|lyfalmen||||28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1077||1077|2452| 154761|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|98|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|||0|0|B|0|AGP|0|0|0|100|XEU|6763|5923|lyfalmen|V0335|5904||98|0|147,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||3614||3614|5923| 154952|L04AX0501|Esbriet|hylki|267|mg|252|stk|1|ţpakki|hart|L04AX05|01.07.2012||R|||0|1|0|0|INT|0|0|0|100|DKK|437458|551555|lyfalmen||||252|0||Vistor hf|InterMune Europe Ltd.|Pírfenidon||437458||437458|551555| 155085|L01AA0201|Leukeran|töflur|2|mg|25|stk|1|glas||L01AA02|01.06.2001||R|||0|0|*|0|APT|0|0|0|100|XEU|1530|3072|lyfalmen||||25|0||GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Chlorambucíl||1530||1530|3072| 155219|N03AX1106|Topiramate Portfarma|filmhtfl|25|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|||0|0|E|0|POF|0|0|0|100|XEU|2154|3915|lyfalmen|V0247|3915||60|0|5,0000|Portfarma ehf|Portfarma|Tópíramat||2146||2146|3915| 155230|N03AX1106|Topiramate Portfarma|filmhtfl|50|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|||0|0|E|0|POF|0|0|0|100|XEU|3630|5939|lyfalmen|V0248|5939||60|0|10,0000|Portfarma ehf|Portfarma|Tópíramat||3626||3626|5939| 155241|N03AX1106|Topiramate Portfarma|filmhtfl|100|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|||0|0|E|0|POF|0|0|0|100|XEU|6527|9903|lyfalmen|V0249|9903||60|0|20,0000|Portfarma ehf|Portfarma|Tópíramat||6524||6524|9903| 155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|||0|0|*|0|LBK|0|1|0|100|DKK|1480|3003|lyfalmen||||100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1480||1480|3003| 155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|||0|0|*|0|LBK|0|1|0|100|DKK|634|1846|lyfalmen||||100|0|5,0000|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||634||634|1846| 155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|ţpakki|hart|J02AC02|01.04.1995||R|||0|0|0|0|JAS|0|0|1|100|SEK|6897|10414|lyfalmen||||28|0|14,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||6897||6897|10414| 156506|A10AB0405|Humalog KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AB04|01.05.2011||R|||0|0|*|0|ELD|0|0|0|100|XEU|5704|8782|lyfalmen||||15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||5704||5704|8782| 156517|A10AD0403|Humalog Mix25 KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AD04|01.05.2011||R|||0|0|*|0|ELD|0|0|0|100|XEU|5752|8847|lyfalmen||||15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||5752||5752|8847| 156528|J01XE0101|Furadantin|töflur|50|mg|15|stk|1|ţpakki||J01XE01|01.08.2010||R|||0|0|0|0|REP|0|0|1|100|SEK|444|1586|lyfalmen||||15|0|3,7500|Vistor hf|Recip AB|Nítrófúrantóín||444||444|1586| 156563|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|15|ml|1|hgl||L01XA02|01.04.1992||R|||0|1|0|1|HOP|0|0|0|100|XEU|2288|3302|lyfsjukr||||15|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||2288||2288|3302| 156574|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|5|ml|1|hgl||L01XA02|01.04.1992||R|||0|1|0|1|HOP|0|0|0|100|XEU|1341|1935|lyfsjukr||||5|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||1341||1341|1935| 156585|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|45|ml|1|hgl||L01XA02|01.04.1992||R|||0|1|0|1|HOP|0|0|0|100|XEU|6268|9046|lyfsjukr||||45|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||6268||6268|9046| 156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|ţpakki||A08AB01|01.07.1999||R|||0|0|0|0|ROC|0|0|0|100|DKK|9203|13568|lyfalmen||||84|0|28,0000|Icepharma hf|Roche|Orlístat||9203||9203|13568| 156597|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|60|ml|1|hgl||L01XA02|01.04.2007||R|||0|1|0|1|HOP|0|0|0|100|XEU|8395|12116|lyfsjukr||||60|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||8395||8395|12116| 156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|ţpakki||P02CA01|01.12.1982||R|||0|0|0|0|JAS|0|0|0|100|SEK|891|2198|lyfalmen||||6|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||891||891|2198| 156861|QJ01MA9002|Enrotron Flavour|töflur|50|mg|10|stk|1|ţpakki|handa hundum|QJ01MA90|01.09.2012||R|||0|0|0|0|ANI|0|0|0|100|IKR|1898|3775|vetalmen||||10|0||Dýraheilsa ehf|aniMedica GmbH|Enrofloxacinum||1898||1898|3775| 157047|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.11.2011||L|||0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa||||24|0|1,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||| 157206|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdćla|26|g|10|spr||QP52AF02|01.04.1992||R|||0|0|0|0|PAL|0|0|0|100|DKK|7090|12368|vetorma||||260|0||Icepharma hf|Pfizer Oy Animal Health|||7090||7090|12368| 157741|N05AH0311|Olanzapine Ranbaxy|töflur|5|mg|28|stk|1|ţpakki||N05AH03|01.12.2011||R|||0|0|*|0|RAN|0|1|0|100|XEU|2643|2384|lyfalmen|V0279|2384||28|0|14,0000|Artasan ehf|Ranbaxy (UK) Ltd|Olanzapín||1027||1027|2384| 157863|N03AF0104|Tegretol|töflur|200|mg|100|stk|1|ţpakki||N03AF01|01.01.2010||R|||0|0|E|0|NOH|0|0|0|100|DKK|1482|3006|lyfalmen|V0239|3006||100|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1482||1482|3006| 158163|N05AH0405|Seroquel Prolong|forđatfl|50|mg|10|stk|1|ţpakki||N05AH04|01.10.2011||R|||0|0|0|0|ASA|0|1|0|100|SEK|1615|3188|lyfalmen||||10|0|1,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||1615|3188| 158185|N05AH0405|Seroquel Prolong|forđatfl|150|mg|100|stk|1|ţpakki||N05AH04|01.10.2011||R|||0|0|0|0|ASA|0|1|0|100|SEK|29760|39894|lyfalmen||||100|0|37,5000|Vistor hf|Astra Zeneca A/S|Quetíapín||||29760|39894| 158287|N03AF0104|Tegretol|töflur|200|mg|50|stk|1|ţpakki||N03AF01|01.12.1972||R|||0|0|E|0|NOH|0|0|0|100|DKK|924|2243|lyfalmen|V0239|1503||50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||924||924|2243| 158431|B02BD0801|NovoSeven|sts|1|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|||0|1|0|1|NAS|0|0|0|100|DKK|100593|128127|lyfsjukr||||1|0|0,0200|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||100593|128127| 158442|B02BD0801|NovoSeven|sts|2|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|||0|1|0|1|NAS|0|0|0|100|DKK|201187|254372|lyfsjukr||||1|0|0,0400|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||201187|254372| 158453|B02BD0801|NovoSeven|sts|5|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|||0|1|0|1|NAS|0|0|0|100|DKK|570461|717811|lyfsjukr||||1|0|0,1000|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||570461|717811| 158608|J02AX0501|Mycamine|irs|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|||0|1|0|1|APG|0|0|0|100|XEU|51440|66440|lyfsjukr||||1|0|0,5000|Vistor hf|Astellas Pharma GmbH|Micafungin||||51440|66440| 158619|J02AX0501|Mycamine|irs|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|||0|1|0|1|APG|0|0|0|100|XEU|73381|93976|lyfsjukr||||1|0|1,0000|Vistor hf|Astellas Pharma GmbH|Micafungin||73381||73381|93976| 158683|H01BB0201|Syntocinon|nefúđi|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.07.1988||R|||0|0|E|0|DES|0|0|0|100|DKK|797|2069|lyfalmen||||5|0|13,3333|Swedish Orphan Biovitrum A/S|Defiante Farmaceutica S.A.|Oxýtócín||797||797|2069| 158725|M01AB0516|Diklofenak Mylan|sţ-tfl|50|mg|100|stk|1|ţpakki||M01AB05|01.12.2008||R|||0|0|E|0|MYL|0|0|1|100|SEK|1055|2422|lyfalmen|V0469|2422||100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Díklófenak||||1055|2422| 159107|N02AB0303|Fentanyl Actavis|forđapl|25|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|||1|0|E|0|AGP|0|0|0|100|XEU|3283|5470|lyfalmen|V0219|5470||5|0|7,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||3283||3283|5470| 159118|N02AB0303|Fentanyl Actavis|forđapl|50|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|||1|0|E|0|AGP|0|0|0|100|XEU|5651|8709|lyfalmen|V0220|8709||5|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||5651||5651|8709| 159130|N02AB0303|Fentanyl Actavis|forđapl|75|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|||1|0|E|0|AGP|0|0|0|100|XEU|7331|11007|lyfalmen|V0221|11007||5|0|22,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||7331||7331|11007| 159141|N02AB0303|Fentanyl Actavis|forđapl|100|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|||1|0|E|0|AGP|0|0|0|100|XEU|8542|12664|lyfalmen|V0223|12664||5|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||8542||8542|12664| 159517|N06AB0401|Cipramil|töflur|20|mg|56|stk|1|ţpakki||N06AB04|01.04.1993||R|||0|0|0|0|LBK|0|1|0|100|DKK|5044|4570|lyfalmen|V0318|1984||56|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2625||2625|4570| 159533|L02BG0601|Aromasin|töflur|25|mg|30|stk|1|ţpakki||L02BG06|01.06.2001||R|||0|0|*|0|PER|0|0|0|100|DKK|19745|27325|lyfalmen||||30|0|30,0000|Icepharma hf|Pfizer ApS|Exemestan||19745||19745|27325| 159541|N06AB0401|Cipramil|töflur|40|mg|56|stk|1|ţpakki||N06AB04|01.04.1993||R|||0|0|0|0|LBK|0|1|0|100|DKK|12934|12042|lyfalmen|V0320|3444||56|0|112,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||8087||8087|12042| 159558|N06AB0401|Cipramil|töflur|10|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|||0|0|0|0|LBK|0|1|0|100|DKK|1829|2600|lyfalmen|V0062|1746||28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||1185||1185|2600| 159632|N06AB0401|Cipramil|töflur|20|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|||0|0|0|0|LBK|0|1|0|100|DKK|3166|3627|lyfalmen|V0067|1654||28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||1936||1936|3627| 159640|N06AB0401|Cipramil|töflur|40|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|||0|0|0|0|LBK|0|1|0|100|DKK|6524|4806|lyfalmen|V0071|2164||28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2798||2798|4806| 159672|R05CB0105|Acetylcystein Mylan|freyđit|200|mg|25|stk|1|pakki||R05CB01|01.03.2010||R|||0|0|E|0|MYL|0|0|1|100|SEK|541|1719|lyfalmen||||25|0|10,0000|Actavis Group PTC ehf|Mylan AB|Acetýlcýstein||541||541|1719| 159683|R05CB0105|Acetylcystein Mylan|freyđit|200|mg|100|stk|1|pakki||R05CB01|01.03.2010||R|||0|0|E|0|MYL|0|0|1|100|SEK|1640|3222|lyfalmen||||100|0|40,0000|Actavis Group PTC ehf|Mylan AB|Acetýlcýstein||1640||1640|3222| 159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|||0|0|0|1|APC|0|0|0|100|DKK|98056|124943|lyfsjukr||||2|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||98056||98056|124943| 159973|QM01AG9002|Flunixin|stl|50|mg/ml|50|ml|1|hgl|nautg,hesta og svín|QM01AG90|01.11.2011||R|||0|0|0|0|NOB|1|0|0|100|XEU|4093|8032|vetalmen||||50|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||4093||4093|8032| 160279|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|56|stk|1|ţpakki||A02BC04|01.05.2011||R|||0|0|E|0|APC|0|0|0|100|IKR|2078|2939|lyfalmen|V0010|2937||56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1433||1433|2939| 160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|||0|0|0|1|AGT|0|0|0|100|DKK|2211|3191|lyfsjukr||||50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||2211||2211|3191| 160408|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|||0|0|0|1|GEH|0|0|0|100|NOK|36868|48152|lyfsjukr||||100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||36868||36868|48152| 160457|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|||0|0|0|1|GEH|0|0|0|100|NOK|53680|69251|lyfsjukr||||150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||53680||53680|69251| 160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|ţpakki||N05AB04|01.06.1981||R|||0|0|*|0|SNO|0|1|0|100|NOK|1012|2363|lyfalmen||||100|0|5,0000|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||1012||1012|2363| 160531|C10AC0101|Questran|skammtar|4|g|50|skammtar|1|pakki||C10AC01|01.04.1988||R|||0|0|0|0|BRS|0|0|0|100|DKK|2303|4129|lyfalmen||||50|0|14,2857|Vistor hf|Bristol-Myers Squibb|Kólestýramín||2303||2303|4129| 160622|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|||0|0|0|1|GEH|0|0|0|100|NOK|71613|91757|lyfsjukr||||200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||71613||71613|91757| 160852|R01AX0301|Atrovent|nefúđi|21|mcg/sk|15|ml|1|glas|180 sk, lausn|R01AX03|01.09.2009||R|||0|0|E|0|BOI|0|0|1|100|DKK|1170|2579|lyfalmen||||15|0|15,7500|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíđ||1170||1170|2579| 161065|J05AG0401|Intelence|töflur|100|mg|120|stk|1|glas||J05AG04|01.02.2009||R|||0|1|0|1|JCI|0|0|0|100|SEK|77179|98742|lyfsjukr||||120|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||77179||77179|98742| 161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|||0|0|B|0|PER|0|0|1|100|DKK|578|1770|lyfalmen||||1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||578||578|1770| 161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|||0|0|0|1|PER|0|0|0|100|DKK|897|1295|lyfsjukr||||1|0|8,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||897||897|1295| 161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|||0|0|0|1|PER|0|0|0|100|DKK|814|1175|lyfsjukr||||5|0|16,6667|Icepharma hf|Pfizer ApS|Hýdrókortisón||814||814|1175| 161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|||0|0|B|0|PER|0|0|1|100|DKK|591|1787|lyfalmen||||1|0|3,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||591||591|1787| 161133|G03CA0306|Evorel|forđapl|75|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|||0|0|E|0|JAS|0|0|0|100|SEK|5137|8006|lyfalmen|V0131|8006||26|0|136,5000|Vistor hf|Janssen-Cilag AB|Estradíól||5137||5137|8006| 161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|ţpakki||L02BG06|01.06.2001||R|||0|0|*|0|PER|0|0|0|100|DKK|58722|76241|lyfalmen|V0452|45410||100|0|100,0000|Icepharma hf|Pfizer ApS|Exemestan||58722||58722|76241| 161870|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|ţpakki|8+2 mg|N07BC51|01.08.2011||R|||1|1|0|1|RBP|0|0|0|100|DKK|13838|19141|lyfsjukr||||28|0|28,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||13752||13752|19141| 162080|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|||0|1|0|1|SDG|0|0|0|100|DKK|154748|196091|lyfsjukr||||8|0|75,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||154748||154748|196091| 162115|N06AA0906|Saroten|töflur|25|mg|100|stk|1|glas||N06AA09|01.12.2011||R|||0|0|B|0|LBK|0|1|0|100|DKK|759|2017|lyfalmen|V0512|2017||100|0|33,3300|Lundbeck Export A/S|H. Lundbeck A/S|Amitriptýlín||759||759|2017| 162149|N06AA0906|Saroten|töflur|10|mg|100|stk|1|glas||N06AA09|01.12.2011||R|||0|0|B|0|LBK|0|1|0|100|DKK|422|1556|lyfalmen|V0510|1556||100|0|13,3300|Lundbeck Export A/S|H. Lundbeck A/S|Amitriptýlín||422||422|1556| 162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|||0|0|B|0|PER|0|0|0|100|DKK|1869|3536|lyfalmen||||100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1869||1869|3536| 162778|QN05CM9002|Detonervin, vet.|stl|10|mg/ml|5|ml|1|hgl|f.hesta og nautgr.|QN05CM90|01.12.2011||R|||0|0|0|0|LEV|1|0|0|100|XEU|5300|10349|vetalmen||||5|0||Le Vet B.V.|Le Vet B.V.|||||5300|10349| 162808|C01DA1404|Fem-Mono Retard|forđatfl|60|mg|100|stk|1|ţpakki||C01DA14|01.03.2012||R|||0|0|B|0|GUK|0|0|0|100|SEK|2025|3749|lyfalmen|V0041|3749||100|0|150,0000|Actavis Group PTC ehf|Generics UK Ltd.|Ísósorbíđ mónónítrat||2025||2025|3749| 162841|A10BA0203|Metformin Bluefish|filmhtfl|500|mg|100|stk|1|ţpakki||A10BA02|01.09.2012||R|||0|0|*|0|BLP|0|0|0|100|XEU|430|1532|lyfalmen|V0500|1532||100|0|25,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||404||404|1532| 162852|A10BA0203|Metformin Bluefish|filmhtfl|850|mg|100|stk|1|ţpakki||A10BA02|01.09.2012||R|||0|0|*|0|BLP|0|0|0|100|XEU|697|1932|lyfalmen||||100|0|42,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||697||697|1932| 162863|A10BA0203|Metformin Bluefish|filmhtfl|1000|mg|60|stk|1|ţpakki||A10BA02|01.09.2012||R|||0|0|*|0|BLP|0|0|0|100|XEU|859|2154|lyfalmen||||60|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||859||859|2154| 162874|C10AA0106|Simvastatin Bluefish|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA01|01.08.2012||R|||0|0|E|0|BLP|0|0|0|100|XEU|743|1719|lyfalmen|V0108|1717||100|0|33,3400|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||541||541|1719| 162885|C10AA0106|Simvastatin Bluefish|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA01|01.08.2012||R|||0|0|E|0|BLP|0|0|0|100|XEU|836|1861|lyfalmen|V0109|1854||100|0|66,6700|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||645||645|1861| 162896|C10AA0106|Simvastatin Bluefish|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA01|01.08.2012||R|||0|0|E|0|BLP|0|0|0|100|XEU|1347|2406|lyfalmen|V0110|2381||100|0|133,3333|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||1043||1043|2406| 162903|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíđ 20 mg|S01ED51|01.01.2012||R|||0|0|*|0|APC|0|0|0|100|XEU|1598|3098|lyfalmen|V0373|2386||5|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||1549||1549|3098| 162929|G04CA0205|Ranomax|forđahlk|0,4|mg|100|stk|1|ţpakki||G04CA02|01.04.2009||R|||0|0|E|0|RAN|0|0|0|100|XEU|4631|4380|lyfalmen|V0148|4380||100|0|100,0000|Artasan ehf|Ranbaxy (UK) Ltd|Tamsúlósín||2486||2486|4380| 162933|R03BA0501|Flixotide|innúđal|50|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|||0|0|B|0|GSK|0|0|0|100|GBP|2290|4112|lyfalmen||||120|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2290||2290|4112| 163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|ţpakki||N06BA04|01.12.1972||R|||1|0|0|0|NOH|0|0|0|100|DKK|1116|2506|lyfalmen||||30|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||1116||1116|2506| 163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|ţpakki||P01AB01|01.10.1995||R|||0|0|0|0|SNO|0|0|1|100|NOK|1705|3311|lyfalmen||||30|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1705||1705|3311| 163274|C03AA0304|Dehydratin Neo|töflur|25|mg|20|stk|1|pakki||C03AA03|01.02.2009||R|||0|0|E|0|AEA|0|0|0|100|XEU|197|1248|lyfalmen||||20|0|20,0000|Actavis hf|Actavis EAD|hýdróklórtíazíđ||||197|1248| 163493|R03BA0501|Flixotide|innúđal|125|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|||0|0|B|0|GSK|0|0|0|100|GBP|3386|4960|lyfalmen||||120|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2910||2910|4960| 163709|V03AE0101|Resonium|duft|||454|g|1|stauk||V03AE01|01.01.2000||R|||0|0|0|0|PCO|0|0|0|100|IKR|8140|12114|lyfalmen||||454|1|10,0800|Distica|Distica - óskráđ lyf|Pólýstýren súlfónat||8140||8140|12114| 164119|J05AE1101|Incivo|filmhtfl|375|mg|42|stk|1|glas||J05AE11|01.02.2012||R|||0|1|0|1|JCI|0|0|0|100|SEK|356736|449586|lyfsjukr||||42|0||Vistor hf|Janssen-Cilag International N.V.|Telaprevír||356736||356736|449586| 164251|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.06.2001||R|||0|0|*|0|APT|0|0|0|100|XEU|3371|5590|lyfalmen||||25|0||GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Merkaptópúrín||3371||3371|5590| 164256|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|3784|5461|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||3784||3784|5461| 164807|N04BD0105|Selegilin Mylan|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995||R|||0|0|E|0|MYL|0|0|0|100|SEK|3079|5191|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Selegilín||||3079|5191| 164818|N04BD0105|Selegilin Mylan|töflur|10|mg|100|stk|1|glas||N04BD01|01.05.2010||R|||0|0|E|0|MYL|0|0|0|100|SEK|10151|14865|lyfalmen||||100|0|200,0000|Actavis Group PTC ehf|Mylan AB|Selegilín||10151||10151|14865| 164829|N06AA0406|Klomipramin Mylan|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.2010||R|||0|0|B|0|MYL|0|1|0|100|SEK|1062|2432|lyfalmen||||100|0|10,0000|Actavis Group PTC ehf|Mylan AB|Klómípramín||1062||1062|2432| 164840|N06AA0406|Klomipramin Mylan|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|||0|0|B|0|MYL|0|1|0|100|SEK|980|2319|lyfalmen|V0314|2319||100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Klómípramín||||980|2319| 164871|A07EC0204|Asacol|eţ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|||0|0|B|0|TIL|0|0|0|100|SEK|7521|11267|lyfalmen|V0014|11240||60|0|20,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||7521||7521|11267| 165001|C05AA0102|Proctosedyl|eţ-stíll|||12|stk|1|pakki||C05AA01|01.12.1972||L|||0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa||||12|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||| 165019|C05AA0102|Proctosedyl|eţ-smyr|||30|g|1|túpa||C05AA01|01.03.1981||L|||0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa||||30|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||| 165175|N05BA0205|Risolid|filmhtfl|10|mg|100|stk|1|glas||N05BA02|01.03.2012||R|||0|0|0|0|AGT|0|0|1|100|XEU|816|2095|lyfalmen||||100|0|33,3300|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||816||816|2095| 165306|QN05CM9501|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM95|01.05.2009||R|||0|0|0|0|LAS|1|0|0|100|XEU|6743|13120|vetalmen||||10|0||Dýraheilsa ehf|Laboratorios SYVA S.A.|||6743||6743|13120| 165431|C08CA0202|Plendil|forđatfl|2,5|mg|98|stk|1|ţpakki||C08CA02|01.01.1992|31.07.2012|R|||0|0|B|0|AZD|0|0|0|100|SEK|4538|7187|lyfalmen||||98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||4538||4538|7187| 165449|C08CA0202|Plendil|forđatfl|10|mg|98|stk|1|ţpakki||C08CA02|01.10.1995||R|||0|0|B|0|AZD|0|0|0|100|SEK|5210|8106|lyfalmen|V0059|3866||98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||5210||5210|8106| 165548|C08CA0202|Plendil|forđatfl|5|mg|98|stk|1|ţpakki||C08CA02|01.10.1995||R|||0|0|B|0|AZD|0|0|0|100|SEK|3363|5579|lyfalmen|V0058|2795||98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||3363||3363|5579| 165603|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|5|rörlyk||H01AC01|01.05.2011||R|||0|1|0|1|EMA|0|0|0|100|SEK|273800|345502|lyfsjukr||||8|0|90,0000|Icepharma hf|E. Merck AB|Sómatrópín||273800||273800|345502| 165662|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|||0|0|0|1|GEH|0|0|0|100|NOK|36868|48152|lyfsjukr||||100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||36868||36868|48152| 165670|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|||0|0|0|1|GEH|0|0|0|100|NOK|53680|69251|lyfsjukr||||150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||53680||53680|69251| 165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|ţpakki||R06AE05|01.12.1972||R|||0|0|E|0|UCN|0|0|1|100|SEK|721|1965|lyfalmen||||100|0|50,0000|Vistor hf|UCB Nordic A/S|Meklózín||721||721|1965| 165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|ţpakki||R06AE05|01.12.1972||R|||0|0|E|0|UCN|0|0|1|100|SEK|209|1265|lyfalmen||||25|0|12,5000|Vistor hf|UCB Nordic A/S|Meklózín||209||209|1265| 165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|ţpakki||R06AE05|01.12.1972||L|||0|0|0|0|UCN|0|0|1|100|IKR|||lyflausa||||10|0|5,0000|Vistor hf|UCB Nordic A/S|Meklózín|||||| 165791|N06DA0206|Donepezil Medical|filmhtfl|5|mg|98|stk|1|ţpakki||N06DA02|01.04.2012||R|||0|0|E|0|MED|0|0|0|100|XEU|23744|13334|lyfalmen|V0341|13333||98|0|65,3300|Medical ehf|Medical ehf|Dónepezíl||9032||9032|13334| 165859|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|3999|5772|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||3999||3999|5772| 165878|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|||0|0|0|1|GEH|0|0|0|100|NOK|71613|91757|lyfsjukr||||200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||71613||71613|91757| 165894|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|||0|0|0|1|GEH|0|0|0|100|NOK|242758|306544|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||242758||242758|306544| 166008|QJ51RC2202|Nafpenzal vet.|spenalyf|||3|g|20|spr||QJ51RC22|01.02.2010||R|||0|0|0|0|IBV|0|0|0|100|DKK|4564|8936|vetalmen||||60|0||Vistor hf|Intervet International BV|||||4564|8936| 166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|ţpakki||P01BA02|01.12.1972||R|||0|0|B|0|SNO|0|0|0|100|NOK|1924|3611|lyfalmen||||100|0|38,7597|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||1924||1924|3611| 166165|H01CA0201|Synarela|nefúđi|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|||0|1|E|0|PER|0|0|0|100|DKK|14819|21143|lyfalmen||||8|0|30,0000|Icepharma hf|Pfizer ApS|Nafarelín||14819||14819|21143| 166351|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|||0|0|E|0|MYL|0|0|1|100|SEK|2282|4101|lyfalmen||||100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||2282||2282|4101| 166362|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|||0|0|E|0|MYL|0|0|1|100|SEK|4319|6887|lyfalmen|V0428|6887||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||4319||4319|6887| 166709|G04CA0103|Alfuzosin Ranbaxy|forđatfl|10|mg|90|stk|1|ţpakki||G04CA01|01.07.2009||R|||0|0|E|0|RAN|0|0|0|100|XEU|4763|7494|lyfalmen|V0550|7494||90|0|120,0000|Artasan ehf|Ranbaxy (UK) Ltd|Alfúzósín||4763||4763|7494| 166858|M09AB0201|Xiapex|sts|0,9|mg/hgl|1|hgl|1|stk|+ leysir|M09AB02|01.09.2011||R|||0|1|E|0|IPI|0|0|0|100|DKK|127512|162573|lyfalmen||||1|0||Icepharma hf|Pfizer Limited|Clostridíum||127512||127512|162573| 166869|N02BA0110|Aspirin Actavis|töflur|300|mg|100|stk|1|glas||N02BA01|01.11.2010||L|||0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa||||100|0|10,0000|Actavis Group hf|Actavis UK Ltd.|Acetýlsalicýlsýra|||||| 167319|N06AX1608|Venlafaxin Actavis|forđahlk|37,5|mg|7|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|||0|0|0|0|AGP|0|0|0|100|XEU|438|1578|lyfalmen|V0333|1578||7|0|2,6300|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||438||438|1578| 168275|M04AA0104|Allopurinol|töflur|100|mg|100|stk|1|ţpakki||M04AA01|01.06.2009||R|||0|0|E|0|AUK|0|0|0|100|GBP|637|1850|lyfalmen||||100|0|25,0000|Actavis Group hf|Actavis UK Ltd.|Allópúrinol||||637|1850| 168309|A02BC0306|Lanser|sţ-hylki|30|mg|98|stk|1|ţpakki||A02BC03|01.08.2009||R|||0|0|E|0|AGP|0|0|0|100|IKR|4452|5144|lyfalmen||||98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lansóprazól||3045||3045|5144| 168740|N03AF0105|Tegretol Retard|forđatfl|200|mg|200|stk|1|ţpakki||N03AF01|01.07.1988||R|||0|0|E|0|NOH|0|0|0|100|DKK|2977|5051|lyfalmen|V0240|5050||200|0|40,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||2977||2977|5051| 168971|N03AF0105|Tegretol Retard|forđatfl|400|mg|200|stk|1|ţpakki||N03AF01|01.07.1988||R|||0|0|E|0|NOH|0|0|0|100|DKK|5494|8494|lyfalmen|V0433|8493||200|0|80,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||5494||5494|8494| 168997|L01CA0401|Navelbine|irţ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|||0|1|0|1|PFP|0|0|0|100|SEK|55470|71497|lyfsjukr||||10|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||55470||55470|71497| 169433|L01CA0401|Navelbine|irţ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|||0|1|0|1|PFP|0|0|0|100|SEK|241175|304557|lyfsjukr||||50|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||241175||241175|304557| 169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|||0|0|0|1|ROA|0|0|0|100|DKK|21163|28442|lyfsjukr||||5|0|5,0000|Icepharma hf|Roche A.S.|Gancíklóvír||21163||21163|28442| 169664|J07BK0101|Varilrix|bóluefni|||0,5|ml|1|hgl|ţurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|||0|0|0|0|GSK|0|0|0|100|GBP|5457|8444|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hlaupabóla, veikluđ veira||5457||5457|8444| 169729|D10BA0105|Isotretinoin Portfarma|hylki|10|mg|30|stk|1|ţpakki||D10BA01|01.10.2009||R|||0|1|C|0|POF|0|0|0|30|IKR|1407|2827|lyfalmen|V0124|2827||30|0|10,0000|Portfarma ehf|Portfarma|Ísótretínóín||1351||1351|2827| 169740|D10BA0105|Isotretinoin Portfarma|hylki|20|mg|30|stk|1|ţpakki||D10BA01|01.10.2009||R|||0|1|C|0|POF|0|0|0|30|IKR|2450|4196|lyfalmen|V0125|4196||30|0|20,0000|Portfarma ehf|Portfarma|Ísótretínóín||2352||2352|4196| 169751|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|20|stk|1|ţpakki||J01MA02|01.06.2009||R|||0|0|0|0|POF|0|0|1|100|IKR|1168|2577|lyfalmen|V0411|2577||20|0|10,0000|Portfarma ehf|Portfarma|Cíprófloxacín||1168||1168|2577| 169762|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|10|stk|1|ţpakki||J01MA02|01.06.2009||R|||0|0|0|0|POF|0|0|1|100|IKR|647|1864|lyfalmen|V0177|1864||10|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||647||647|1864| 169773|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|20|stk|1|ţpakki||J01MA02|01.06.2009||R|||0|0|0|0|POF|0|0|1|100|IKR|638|1852|lyfalmen|V0418|1852||20|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||638||638|1852| 169784|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|10|stk|1|ţpakki||J01MA02|01.06.2009||R|||0|0|0|0|POF|0|0|1|100|IKR|393|1517|lyfalmen|V0176|1517||10|0|2,5000|Portfarma ehf|Portfarma|Cíprófloxacín||393||393|1517| 169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|||0|0|0|0|AZD|0|0|1|100|SEK|3035|5131|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||3035||3035|5131| 169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|||0|0|0|0|AZD|0|0|1|100|SEK|3266|5447|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||3266||3266|5447| 170062|L04AC0701|RoActemra|irţ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|||0|1|0|1|RRL|0|0|0|100|DKK|23692|31616|lyfsjukr||||4|0|4,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||23692|31616| 170085|L04AC0701|RoActemra|irţ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|||0|1|0|1|RRL|0|0|0|100|DKK|58800|75677|lyfsjukr||||10|0|10,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||58800|75677| 170092|J07BC2001|Twinrix Adult|bóluefni|||1|ml|1|dćla|einnota dćla|J07BC20|01.01.1999||R|||0|0|0|0|GLB|0|0|0|100|GBP|5867|9005|lyfalmen||||1|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||5867||5867|9005| 170107|L04AC0701|RoActemra|irţ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|||0|1|0|1|RRL|0|0|0|100|DKK|111146|141371|lyfsjukr||||20|0|20,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||111146||111146|141371| 170505|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|glas||J04AB02|01.07.2012||R|||0|0|E|0|SAD|0|0|0|100|DKK|15649|22185|lyfalmen||||100|0|50,0000|Icepharma hf|Sandoz GmbH|Rífampicín||15649||15649|22185| 170514|C01BC0301|Rytmonorm|töflur|150|mg|100|stk|1|ţpakki||C01BC03|01.04.1996||R|||0|1|B|0|ABS|0|0|0|100|DKK|3804|6183|lyfalmen||||100|0|50,0000|Vistor hf|Abbott Scandinavia AB|Própafenón||3804||3804|6183| 170548|C01BC0301|Rytmonorm|töflur|300|mg|100|stk|1|ţpakki||C01BC03|01.04.1996||R|||0|1|B|0|ABS|0|0|0|100|DKK|6658|10087|lyfalmen||||100|0|100,0000|Vistor hf|Abbott Scandinavia AB|Própafenón||6658||6658|10087| 170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|||0|0|0|0|AZD|0|0|1|100|SEK|2483|4376|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín í blöndum||2483||2483|4376| 170628|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|20|fl|.|J01GB03|01.04.2011||R|||0|0|0|1|BRA|0|0|0|100|XEU|11151|15877|lyfsjukr||||1600|0|6,6700|Actavis Group hf|Braun|Gentamícín||11151||11151|15877| 170640|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|||0|0|0|1|BRA|0|0|0|100|XEU|26825|35548|lyfsjukr||||1600|0|20,0000|Actavis Group hf|Braun|Gentamícín||26825||26825|35548| 170651|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|20|fl||J01GB03|01.04.2011||R|||0|0|0|1|BRA|0|0|0|100|XEU|40238|52381|lyfsjukr||||2400|0|30,0000|Actavis Group hf|Braun|Gentamícín||40238||40238|52381| 170697|M05BA0406|Alendronat Actavis|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.06.2009||R|||0|0|E|0|AGP|0|0|0|100|XEU|3275|3620|lyfalmen|V0203|3620||12|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Alendrónsýra||1931||1931|3620| 170763|M05BA0706|Risedronate sodium Portfarma|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.03.2011||R|||0|0|0|0|POF|0|0|0|100|IKR|12363|4397|lyfalmen|V0207|3103||12|0|84,0000|Portfarma ehf|Portfarma|Rísedrónsýru||2499||2499|4397| 170997|L01BC0701|Vidaza|irţ|25|mg/ml|4|ml|1|hgl||L01BC07|01.09.2009||R|||0|1|0|1|CEE|0|0|0|100|XEU|56164|72368|lyfsjukr||||4|0||Celgene Europe ltd|Celgene Europe ltd|Azasitidín||56164||56164|72368| 171404|QS02CA0102|Canaural|eyrnadr|||25|ml|1|glas|handa hundum|QS02CA01|01.01.2012||R|||0|0|0|0|DEC|1|0|0|100|DKK|2671|5301|vetalmen||||25|0||Vistor hf|Dechra Veterinary Products A/S|||2671||2671|5301| 171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|||0|0|0|0|AZD|0|0|1|100|SEK|3762|6125|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín í blöndum||3762||3762|6125| 171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|||0|0|0|0|AZD|0|0|1|100|SEK|4053|6523|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín í blöndum||4053||4053|6523| 171777|H03BB0101|Neo-Mercazole|töflur|5|mg|100|stk|1|glas||H03BB01|01.08.2005||R|||0|0|0|0|LDR|0|0|0|100|NOK|1582|3143|lyfalmen||||100|1|33,3333|Parlogis hf|Parlogis - óskráđ lyf|Karbímazól||1582||1582|3143| 171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|||0|0|E|0|JAS|0|0|0|100|SEK|4592|7261|lyfalmen|V0247|3915||60|0|5,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||4592||4592|7261| 171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|||0|0|E|0|JAS|0|0|0|100|SEK|7560|11321|lyfalmen|V0248|5939||60|0|10,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||7560||7560|11321| 171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|||0|0|0|1|BAP|0|0|0|100|SEK|43688|56711|lyfsjukr||||75|0||Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||43688||43688|56711| 172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|||0|0|0|1|BAP|0|0|0|100|SEK|29126|38436|lyfsjukr||||50|0||Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||29126||29126|38436| 172249|QJ01MA9002|Enrotron Flavour|töflur|150|mg|10|stk|1|ţpakki|handa hundum|QJ01MA90|01.09.2012||R|||0|0|0|0|ANI|0|0|0|100|IKR|3289|6488|vetalmen||||10|0||Dýraheilsa ehf|aniMedica GmbH|Enrofloxacinum||3289||3289|6488| 172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|||0|0|E|0|JAS|0|0|0|100|SEK|13652|19678|lyfalmen|V0249|9903||60|0|20,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||13652||13652|19678| 172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|||0|0|E|0|JAS|0|0|0|100|SEK|25621|34699|lyfalmen||||60|0|40,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||25621||25621|34699| 172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|||0|0|0|1|BAP|0|0|0|100|SEK|66989|85954|lyfsjukr||||100|0||Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||66989||66989|85954| 172482|N06DA0303|Nimvastid (Lyfis)|hylki|6|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|||0|0|E|0|LYF|0|0|0|100|XEU|29275|29194|lyfalmen|V0346|29194||112|0|74,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||21234||21234|29194| 172619|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2001||R|||0|1|*|0|APT|0|0|0|100|XEU|3405|5637|lyfalmen||||100|0||GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Búsúlfan||3405||3405|5637| 172627|C07FB0202|Logimax forte|forđatfl|105|mg|98|stk|1|pakki|ţp 10 + 95 mg|C07FB02|01.07.1999||R|||0|0|B|0|AZD|0|0|0|100|SEK|11953|17330|lyfalmen||||98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóđţrýstingslćkkandi lyf||11953||11953|17330| 172684|N02AA0303|Palladon|forđahlk|4|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|||1|0|E|0|NOP|0|0|0|100|DKK|6206|9468|lyfalmen||||56|0|11,2000|Icepharma hf|Norpharma |Hýdrómorphón||6206||6206|9468| 172692|N02AA0303|Palladon|forđahlk|8|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|||1|0|E|0|NOP|0|0|0|100|DKK|11529|16750|lyfalmen||||56|0|22,4000|Icepharma hf|Norpharma |Hýdrómorphón||11529||11529|16750| 172759|N02AA0303|Palladon|forđahlk|16|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|||1|0|E|0|NOP|0|0|0|100|DKK|20001|27646|lyfalmen||||56|0|44,8000|Icepharma hf|Norpharma |Hýdrómorphón||20001||20001|27646| 172794|M05BA0707|Risedronato Semanal Qualigen (Lyfjaver)|filmhtfl|35|mg|4|stk|1|ţpakki||M05BA07|01.05.2011||R|||0|0|0|0|LVR|0|0|0|100|IKR|830|2114|lyfalmen|V0207|1034||4|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Rísedrónsýru||830||830|2114| 172916|N02AA0303|Palladon|forđahlk|24|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|||1|0|E|0|NOP|0|0|0|100|DKK|26083|35279|lyfalmen||||56|0|67,2000|Icepharma hf|Norpharma |Hýdrómorphón||26083||26083|35279| 173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|ţpakki||N05CD02|01.12.1972||R|||0|0|0|0|MAB|0|0|1|100|DKK|418|1551|lyfalmen||||50|0|50,0000|Vistor hf|Meda AB|Nítrazepam||418||418|1551| 173310|N05BE0108|Buspiron Mylan|töflur|5|mg|100|stk|1|ţpakki||N05BE01|01.04.1995||R|||0|0|E|0|MYL|0|0|1|100|SEK|3574|5868|lyfalmen||||100|0|16,6667|Actavis Group PTC ehf|Mylan AB|Búspírón hýdróklóríđ||3574||3574|5868| 173344|A06AG1101|Microlax|innhl|||5|ml|12|túpa||A06AG11|01.12.1972||L|||0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen||||60|0|12,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||3510| 173518|N05BE0108|Buspiron Mylan|töflur|10|mg|100|stk|1|ţpakki||N05BE01|01.04.1995||R|||0|0|E|0|MYL|0|0|1|100|SEK|6323|9628|lyfalmen||||100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Búspírón hýdróklóríđ||6323||6323|9628| 173750|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|spr|áfylltar spr.međ nálarvörn|B03XA02|01.08.2011||R|||0|1|0|1|AMG|0|0|0|100|DKK|16206|22097|lyfsjukr||||2|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||16107||16107|22097| 173856|N05CF0105|Zopiklon Mylan|töflur|5|mg|30|stk|1|ţpakki||N05CF01|01.10.2001||R|||0|0|0|0|MYL|0|0|1|100|SEK|363|1475|lyfalmen||||30|0|20,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||363||363|1475| 173942|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|||0|1|0|1|SDG|0|0|0|100|DKK|15476|21305|lyfsjukr||||2|0|7,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||15476||15476|21305| 173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|||0|0|0|1|AGT|0|0|0|100|DKK|1477|2132|lyfsjukr||||20|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1477||1477|2132| 174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|ţpakki||J01CE02|01.01.1989||R|||0|0|0|0|REP|0|0|1|100|SEK|693|1927|lyfalmen||||14|0|5,6000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||693||693|1927| 174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|ţpakki||J01CE02|01.01.1989||R|||0|0|0|0|REP|0|0|1|100|SEK|709|1949|lyfalmen||||14|0|7,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||709||709|1949| 174433|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|||0|0|*|0|ALL|0|0|0|100|SEK|1832|3485|lyfalmen|V0368|2776||5|0|25,0000|Vistor hf|Allergan|Brímónidín||1832||1832|3485| 174664|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|||0|0|*|0|ALL|0|0|0|100|SEK|5372|8328|lyfalmen|V0368|8328||15|0|75,0000|Vistor hf|Allergan|Brímónidín||5372||5372|8328| 175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|ţpakki||J05AB11|01.10.1996||R|||0|0|E|0|GSK|0|0|1|100|GBP|2595|2247|lyfalmen|V0033|2088||10|0|1,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||927||927|2247| 175868|V03AN0101|Conoxia|lyfjagas|100|%|37|l|1|gashyl|kćlt|V03AN01|01.10.2012||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||37|0||Ísaga ehf|AGA AB|Súrefni|||||| 176214|N05AH0301|Zyprexa|húđuđtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.01.1999||R|||0|0|0|0|ELD|0|1|0|100|XEU|6468|4864|lyfalmen|V0278|1816||28|0|7,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||2840||2840|4864| 176616|N05CH0101|Circadin|forđatfl|2|mg|30|stk|1|ţpakki||N05CH01|01.10.2012||R|||0|0|0|0|RAD|0|0|1|100|DKK|2691|4660|lyfalmen|V0574|4660||30|0|30,0000|Nycomed Danmark ApS|RAD Neurim Pharmaceuticals EEC Ltd.|Melatonin||2691||2691|4660| 177716|N05CH0101|Circadin|forđatfl|2|mg|30|stk|1|ţpakki||N05CH01|01.09.2012|30.09.2012|R|||0|0|0|0|RAD|0|0|1|100|DKK|2602|4538|lyfalmen||||30|0|30,0000|Nycomed Danmark ApS|RAD Neurim Pharmaceuticals EEC Ltd.|Melatonin||2602||2602|4538| 178004|H02AB0801|Kenalog|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2002||R|||0|0|0|0|PCO|0|0|1|100|IKR|723|1968|lyfalmen||||1|1|5,3330|Distica|Distica - óskráđ lyf|Tríamcínólón||723||723|1968| 178722|N06AB0404|Citalopram Bluefish|filmhtfl|40|mg|100|stk|1|ţpakki||N06AB04|01.09.2012||R|||0|0|B|0|BLP|0|1|0|100|XEU|5251|6150|lyfalmen|V0320|6150||100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||3780||3780|6150| 179157|L04AB0601|Simponi|stl|50|mg|1|spr|1|spr|áfyllt sprauta|L04AB06|01.06.2011||R|||0|1|0|1|CEO|0|0|0|100|DKK|162810|206209|lyfsjukr||||1|0|30,1200|Vistor hf|Centocor B.V.|Golimumab||162810||162810|206209| 179333|R02AA0304|Strepsils Menthol|sogtfl|||24|stk|1|ţpakki||R02AA03|01.12.2005|31.08.2012|L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 179364|N03AX1406|Zelta|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.04.2012||R|||0|0|0|0|LYF|0|0|0|100|XEU|12529|8671|lyfalmen|V0253|7520||100|0|33,3300|LYFIS ehf|LYFIS ehf|Levetíracetam||5623||5623|8671| 179552|B01AX0601 |Xarelto|filmhtfl|15|mg|28|stk|1|ţpakki||B01AX06|01.05.2012||R|||0|0|E|0|BAP|0|0|0|100|SEK|10782|15728|lyfalmen||||28|0|42,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||10782|15728| 180130|L01AX0303|Temomedac|hylki|250|mg|5|stk|1|glas||L01AX03|01.04.2011||R|||0|1|0|1|WIL|0|0|0|100|XEU|126963|161221|lyfsjukr||||5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||126963||126963|161221| 180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|||0|0|B|0|UCB|0|0|0|100|DKK|5466|8456|lyfalmen||||100|0|25,0000|Vistor hf|U.C.B|Olsalazín||5466||5466|8456| 180539|R01AA0705|Otrivin Menthol ukonserveret|nefúđi|1|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.05.2001||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|||5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|||0|0|E|0|PER|0|0|1|100|DKK|778|2043|lyfalmen||||5|0||Icepharma hf|Pfizer ApS|Hýdrókortisón og sýkingalyf||778||778|2043| 181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|||0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa||||50|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||| 181552|QJ51DA3201|Pathozone, vet.|spenalyf|250|mg/dćlu|10|ml|10|dćlur|dćla + rýja|QJ51DA32|01.10.1995||R|||0|0|0|0|PFV|0|0|0|100|DKK|7850|15246|vetalmen||||100|0||Icepharma hf|Pfizer vet.|||7850||7850|15246| 181750|L01BA0108|Methotrexate Pfizer|irţ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|||0|1|0|1|PER|0|0|0|100|DKK|9543|13773|lyfsjukr||||10|0||Icepharma hf|Pfizer ApS|Metótrexat||9543||9543|13773| 182170|QM01AG9001|Finadyne, vet.|kyrni|25|mg/g|10|g|10|skammt||QM01AG90|01.01.1991||R|||0|0|0|0|IBV|0|0|0|100|SEK|6036|11763|vetalmen||||100|0||Vistor hf|Intervet International BV|||6036||6036|11763| 183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|||0|0|0|0|IBV|1|0|0|100|DKK|5262|10276|vetalmen||||50|0||Vistor hf|Intervet International BV|||5262||5262|10276| 183660|C01CA2407|Jext|stl|300|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|||0|0|B|0|ALK|0|0|1|100|DKK|5650|8708|lyfalmen||||1|0|0,6000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5650|8708| 183735|J05AE1101|Incivo|filmhtfl|375|mg|168|stk|1|pakki||J05AE11|01.03.2012||R|||0|1|0|1|JCI|0|0|0|100|SEK|1426936|1792687|lyfsjukr||||168|0||Vistor hf|Janssen-Cilag International N.V.|Telaprevír||1426936||1426936|1792687| 183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|||0|0|B|0|BRS|0|0|0|100|DKK|1160|2566|lyfalmen||||100|0|100,0000|Vistor hf|Bristol-Myers Squibb|Flúdrókortisón||1160||1160|2566| 183947|P01AB0102|Flagyl|töflur|200|mg|21|stk|1|ţpakki||P01AB01|01.10.1995|31.08.2012|R|||0|0|0|0|SNO|0|0|1|100|NOK|848|2139|lyfalmen||||21|0|2,1000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||848||848|2139| 184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|||0|0|0|0|LPM|0|0|1|100|XEU|477|1631|lyfalmen||||100|0|2,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||477||477|1631| 184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|||0|0|0|0|LPM|0|0|1|100|IKR|1643|2121|lyfalmen||||100|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||835||835|2121| 184200|J01CR0201|Amoksiklav|töflur|375|mg|15|stk|1|glas|250+125 mg|J01CR02|01.01.1996||R|||0|0|0|0|LPM|0|0|1|100|XEU|605|1807|lyfalmen||||15|0|3,7500|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||605||605|1807| 184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|||0|0|B|0|TIL|0|0|0|100|SEK|5062|7903|lyfalmen|V0017|7176||700|0|4,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||5062||5062|7903| 184259|L02BG0401|Femar|töflur|2,5|mg|30|stk|1|ţpakki||L02BG04|01.03.1998||R|||0|0|*|0|NOH|0|0|0|100|DKK|21209|29162|lyfalmen|V0170|9786||30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Letrózól||21209||21209|29162| 184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|ţpakki||L02BG04|01.03.1998||R|||0|0|*|0|NOH|0|0|0|100|DKK|53901|70191|lyfalmen|V0185|21552||100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Letrózól||53901||53901|70191| 184341|J01CR0201|Amoksiklav|töflur|625|mg|16|stk|1|glas|500+125 mg|J01CR02|01.01.1996||R|||0|0|0|0|LPM|0|0|1|100|XEU|1152|2555|lyfalmen||||16|0|8,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1152||1152|2555| 184432|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|6|stk|1|ţpakki||N02CC03|01.05.2001||R|||0|0|E|0|AZA|0|0|0|100|SEK|5475|8468|lyfalmen|V0235|8011||6|0|6,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||5475||5475|8468| 187595|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.09.2012||R|||0|0|E|0|MAB|0|0|1|100|DKK|5015|7839|lyfalmen||||30|0||Vistor hf|Meda AB|Pímekrólímus||5015||5015|7839| 188364|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.08.2012||R|||0|0|0|1|WTE|0|0|0|100|DKK|75329|96420|lyfsjukr||||10|0|5,0000|Icepharma hf|Wyeth Europe|Tigecýklín||75329||75329|96420| 188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|||0|0|E|0|DEA|0|0|0|100|XEU|2860|4891|lyfalmen||||250|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||2860||2860|4891| 188987|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.12.1972||R|||0|0|*|0|GPL|0|0|0|100|USD|2002|3718|lyfalmen||||100|0|33,3333|Icepharma hf|Goldshield Pharmaceuticals Ltd|Acetazólamíđ||2002||2002|3718| 189052|M05BA0604|Iasibon|irţ|1|mg/ml|2|ml|1|lykja||M05BA06|01.10.2012||R|||0|0|0|1|PSA|0|0|0|100|DKK|9421|13597|lyfsjukr||||2|0|0,3400|Portfarma ehf|Pharmathen S.A.|Íbandrónsýra||9421||9421|13597| 189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|||0|0|0|1|NOH|0|0|0|100|DKK|6988|10085|lyfsjukr||||10|0||Vistor hf|Novartis Healthcare A/S-|Deferoxamín||6988||6988|10085| 189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|||0|0|B|0|PER|0|0|1|100|DKK|2434|4308|lyfalmen||||5|0|10,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2434||2434|4308| 189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|||0|0|B|0|PER|0|0|1|100|DKK|1002|2350|lyfalmen|V0413|2350||2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1002||1002|2350| 189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|||0|0|B|0|PER|0|0|1|100|DKK|485|1642|lyfalmen||||1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||485||485|1642| 189627|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.11.2011||R|||0|1|0|1|PER|0|0|0|100|DKK|450|649|lyfsjukr||||1|0||Icepharma hf|Pfizer ApS|Metótrexat||450||450|649| 190702|M01AB0101|Confortid|eţ-stíll|100|mg|10|stk|1|pakki||M01AB01|01.01.2012||R|||0|0|E|0|AGT|0|0|1|100|DKK|973|2310|lyfalmen||||10|0|10,0000|Actavis Group hf|Actavis Group hf|Indómetacín||973||973|2310| 190728|M01AB0101|Confortid|eţ-stíll|50|mg|10|stk|1|ţpakki||M01AB01|01.08.2012||R|||0|0|E|0|AGT|0|0|1|100|DKK|860|2155|lyfalmen||||10|0|5,0000|Actavis Group hf|Actavis Group hf|Indómetacín||860||860|2155| 191064|B05XC03|Vitalipid Infant|irţ|||10|ml|10|lykjur||B05XC|01.10.1985||R|||0|0|0|1|FRP|0|0|0|100|DKK|3770|5441|lyfsjukr||||100|0||Icepharma hf|Fresenius Kabi|Vítamín||3770||3770|5441| 191247|B05XC02|Vitalipid Adult|irţ|||10|ml|10|lykjur||B05XC|01.10.1985||R|||0|0|0|1|FRP|0|0|0|100|DKK|3591|5183|lyfsjukr||||100|0||Icepharma hf|Fresenius Kabi|Vítamín||3591||3591|5183| 191254|B05XC01|Soluvit|irs|||10|ml|10|hgl||B05XC|01.10.1985||R|||0|0|0|1|FRP|0|0|0|100|DKK|3705|5347|lyfsjukr||||100|0||Icepharma hf|Fresenius Kabi|Vítamín||3705||3705|5347| 191403|R01AA0503|Nezeril|nefúđi|0,25|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|||0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa||||8|0|4,6875|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||| 191742|C08CA0202|Plendil|forđatfl|2,5|mg|98|stk|1|ţpakki||C08CA02|01.08.2012||R|||0|0|B|0|AZD|0|0|0|100|SEK|4613|7289|lyfalmen||||98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||4613||4613|7289| 191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972||R|||0|0|E|0|PER|0|0|1|100|DKK|509|1675|lyfalmen||||4|0||Icepharma hf|Pfizer ApS|Klóramfeníkól||509||509|1675| 192456|N06AX1104|Miron Smelt|munndr.t|15|mg|96|stk|1|ţpakki||N06AX11|01.12.2011||R|||0|0|B|0|AGP|0|1|0|100|XEU|3739|6094|lyfalmen||||96|0|48,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||3739||3739|6094| 192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|||100|stk|1|glas||C03AB01|01.12.1972||R|||0|0|E|0|LEP|0|0|0|100|DKK|1568|3124|lyfalmen||||100|0|100,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||1568||1568|3124| 192625|C03AB0101|Centyl med kaliumklorid|sh-tfl|||25|stk|1|glas||C03AB01|01.12.1972|30.09.2012|R|||0|0|E|0|LEP|0|0|0|100|DKK|423|1558|lyfalmen||||25|0|25,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||423||423|1558| 192826|L01DB0103|Caelyx|irţ|2|mg/ml|25|ml|1|hgl||L01DB01|01.10.2012||R|||0|1|0|1|JCI|0|0|0|100|SEK|160981|203914|lyfsjukr||||25|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||160981||160981|203914| 192867|S01BA0103|Ozurdex|vefjalyf|700|mcg|1|stk|1|pakki|til ísetningar, vefjalyf|S01BA01|01.10.2012||R|||0|1|0|1|API|0|0|0|100|SEK|191829|243291|lyfalmen||||1|0||Vistor hf|Allergan Pharmaceuticals Ireland|Dexametasón||191829||191829|243291| 193821|A12AA0601|Calcium-Sandoz|freyđit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|||0|0|0|0|SAN|0|0|0|100|IKR|||lyfalmen||||20|0|7,5500|Vistor hf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2233| 194209|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|2|ml|1|hgl||L01BA01|01.10.1985||R|||0|1|0|1|PER|0|0|0|100|DKK|1039|1500|lyfsjukr||||2|0||Icepharma hf|Pfizer ApS|Metótrexat||1039||1039|1500| 195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|||0|0|B|0|MYL|0|0|0|100|SEK|1885|3557|lyfalmen||||250|0|83,3300|Actavis Group PTC ehf|Mylan AB|Atenólól||1885||1885|3557| 195149|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|5|lykjur||B03BA02|01.11.1981||R|||0|0|E|0|AGT|0|0|1|100|DKK|2411|4277|lyfalmen||||5|0|250,0000|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||2411||2411|4277| 195156|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|1|lykja||B03BA02|01.12.1972||R|||0|0|E|0|AGT|0|0|1|100|DKK|766|2027|lyfalmen||||1|0|50,0000|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||766||766|2027| 195472|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|98|stk|1|ţpakki||A02BC05|01.11.2011||R|||0|0|0|0|POF|0|0|0|100|XEU|13367|7920|lyfalmen|V0012|5012||98|0|130,6700|Portfarma ehf|Portfarma|Esómeprazól||5074||5074|7920| 195583|H01AC0104|Saizen|sts|8|mg/ml|2,5|ml|1|rörlyk||H01AC01|01.05.2011||R|||0|1|0|1|EMA|0|0|0|100|SEK|91267|116423|lyfsjukr||||2|0|30,0000|Icepharma hf|E. Merck AB|Sómatrópín||91267||91267|116423| 195587|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.06.2011||R|||0|1|0|1|CEO|0|0|0|100|DKK|162810|206209|lyfsjukr||||1|0|30,1200|Vistor hf|Centocor B.V.|Golimumab||162810||162810|206209| 195669|D01AC2002|Pevisone|krem|||15|g|1|túpa||D01AC20|01.10.1988||R|||0|0|0|0|JAS|0|0|1|100|SEK|776|2040|lyfalmen||||15|0||Vistor hf|Janssen-Cilag AB|Blöndur||776||776|2040| 195768|R01BA0101|Rinexin|forđatfl|50|mg|30|stk|1|ţpakki||R01BA01|01.03.1981||R|||0|0|E|0|REP|0|0|1|100|SEK|398|1523|lyfalmen||||30|0|15,0000|Vistor hf|Recip AB|Fenýlprópanólamín||398||398|1523| 195776|R01BA0101|Rinexin|forđatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|||0|0|E|0|REP|0|0|1|100|SEK|843|2132|lyfalmen||||100|0|50,0000|Vistor hf|Recip AB|Fenýlprópanólamín||843||843|2132| 196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|||0|0|B|0|MYL|0|0|0|100|SEK|2409|4274|lyfalmen||||250|0|166,6700|Actavis Group PTC ehf|Mylan AB|Atenólól||2409||2409|4274| 196121|G03AB0302|Triquilar|töflur|80|mcg|63|stk|1|pakki|ţp, 50+30 míkróg etc.|G03AB03|01.01.1985||R|||0|0|0|0|BAP|0|0|0|100|SEK|1501|3032|lyfalmen||||63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1501||1501|3032| 196327|N07BA0145|Nicorette Freshdrops|munnstfl|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||24|0|1,6000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 196551|N02BE0114|Pinex|mixtúra|24|mg/ml|100|ml|1|fl||N02BE01|01.07.2012||L|||0|0|0|0|APC|0|0|1|100|IKR|||lyflausa||||100|0|0,8000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||| 196851|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.05.2012||R|||0|0|B|0|APT|0|0|0|100|GBP|6014|9206|lyfalmen||||100|0|0,8333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Labetalól||6014||6014|9206| 196913|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|25933|34428|lyfsjukr||||2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||||25933|34428| 197103|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|1|hgl||QH01CA90|01.07.1998||R|||0|0|0|0|IBV|1|0|0|100|DKK|2495|4963|vetalmen||||10|0||Vistor hf|Intervet International BV|||2495||2495|4963| 197657|N05BA1203|Tafil|töflur|1|mg|20|stk|1|ţpakki||N05BA12|01.10.1990||R|||0|0|0|0|PER|0|0|1|100|DKK|831|2116|lyfalmen||||20|0|20,0000|Icepharma hf|Pfizer ApS|Alprazólam||831||831|2116| 197673|N05BA1203|Tafil|töflur|1|mg|100|stk|1|ţpakki||N05BA12|01.10.1990||R|||0|0|0|0|PER|0|0|0|100|DKK|2719|4698|lyfalmen||||100|0|100,0000|Icepharma hf|Pfizer ApS|Alprazólam||2719||2719|4698| 197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr||N01BB02|01.10.2003||R|||0|0|0|0|AZD|0|0|1|100|SEK|2229|4028|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2229||2229|4028| 198580|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2001||R|||0|1|*|0|APT|0|0|0|100|XEU|2057|3793|lyfalmen||||25|0||GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Melphalan||||2057|3793| 198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|||0|1|0|1|PER|0|0|0|100|DKK|6960|10045|lyfsjukr||||200|0||Icepharma hf|Pfizer ApS|Flúóróúracíl||6960||6960|10045| 198861|N04AA0201|Akineton|stl|5|mg/ml|1|ml|5|lykjur||N04AA02|01.12.1975||R|||0|0|0|1|LFS|0|1|0|100|DKK|395|570|lyfsjukr||||5|0|2,5000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||395||395|570| 199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|||0|0|*|0|PER|0|0|0|100|DKK|34976|46440|lyfalmen||||100|0||Icepharma hf|Pfizer ApS|Estramústín||34976||34976|46440| 199272|N03AX1404|Levetiracetam Actavis|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|||0|0|0|0|APC|0|0|0|100|XEU|8267|5676|lyfalmen|V0515|4973||100|0|16,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||3434||3434|5676| 199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|ţpakki||N05CD05|01.11.1981||R|||0|0|0|0|PER|0|0|1|100|DKK|614|1819|lyfalmen||||30|0|30,0000|Icepharma hf|Pfizer ApS|Tríazólam||614||614|1819| 199584|A02BC0508|Esomeprazol Actavis|sţ-hylki|20|mg|98|stk|1|glas|hart|A02BC05|01.03.2012||R|||0|0|E|0|APC|0|0|0|100|IKR|7641|5012|lyfalmen|V0011|5012||98|0|65,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||2948||2948|5012| 199692|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|91340|116514|lyfsjukr||||1|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||||91340|116514| 199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|||0|0|E|0|PER|0|0|0|100|DKK|4528|7173|lyfalmen|V0126|7173||8|0|8,0000|Icepharma hf|Pfizer ApS|Kabególín||4528||4528|7173| 199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997||R|||0|0|0|1|JAB|0|0|0|100|XEU|54606|70413|lyfsjukr||||5|0|0,4000|Janssen Biologics B.V.|Janssen Biologics B.V.|Abciximab||54606||54606|70413| 199940|L01XC1101|Yervoy|stţ|5|mg/ml|40|ml|1|hgl|lausn|L01XC11|01.05.2012||R|||0|1|0|1|BMS|0|0|0|100|DKK|2653485|3332006|lyfsjukr||||40|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||2653485||2653485|3332006| 300373|A05AA0201|Destolit|töflur|150|mg|60|stk|1|glas||A05AA02|01.01.1998||R|||0|0|0|0|PCO|0|0|0|100|GBP|5475|8293|lyfalmen||||60|1|12,0000|Distica|Distica - óskráđ lyf|Úrsódeoxýkól sýra||5347||5347|8293| 370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|||0|0|0|1|ROC|0|0|0|100|DKK|654|944|lyfsjukr||||1|0|0,5000|Icepharma hf|Roche|Fýtómenadíón||654||654|944| 370173|QH01CA9301|Suprelorin|vefjalyf|9,4|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|||0|0|0|0|VIR|1|0|0|100|DKK|30057|57887|vetalmen||||2|0||Vistor hf|Virbac S.A|Deslorelín||30057||30057|57887| 370434|A02BC0508|Esomeprazol Actavis|sţ-hylki|40|mg|98|stk|1|glas|hart|A02BC05|01.03.2012||R|||0|0|E|0|APC|0|0|0|100|IKR|11531|5012|lyfalmen|V0012|5012||98|0|130,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||2948||2948|5012| 370940|J01DB0401|Kefzol|sts|1|g|1|stk|1|hgl||J01DB04|01.07.1995||R|||0|0|0|1|NOM|0|0|0|100|DKK|569|821|lyfsjukr||||1|0|0,3333|Icepharma hf|NordMedica ApS|Cefazólín||569||569|821| 371284|D11AH0201|Elidel|krem|1|%|60|g|1|túpa||D11AH02|01.09.2012||R|||0|0|E|0|MAB|0|0|1|100|DKK|9978|14628|lyfalmen||||60|0||Vistor hf|Meda AB|Pímekrólímus||9978||9978|14628| 371583|A06AG1001|Klyx|innhl|||240|ml|1|fl||A06AG10|01.12.1978||L|||0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa||||240|0|1,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||| 371609|A06AG1001|Klyx|innhl|||120|ml|1|fl||A06AG10|01.12.1978||L|||0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa||||120|0|1,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||| 371617|A06AG1001|Klyx|innhl|||120|ml|10|fl||A06AG10|01.12.1978||L|||0|0|0|0|FEL|0|0|0|100|SEK|||lyfalmen||||1200|0|10,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||10184| 371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|ţpakki||A02BA02|01.10.1995||L|||0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa||||10|0|5,0000|Actavis Group hf|Actavis hf|Ranitidín|||||| 372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|ţpakki||N05AL05|01.01.2005||R|||0|0|0|0|SNO|0|1|0|100|NOK|6446|9797|lyfalmen||||90|0|11,2500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríđ||6446||6446|9797| 372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|||0|0|E|0|ROC|0|0|0|100|DKK|3548|5832|lyfalmen||||100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3548||3548|5832| 372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|ţp+munnstk|N07BA01|01.09.1977||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||42|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|ţp+munnstk|N07BA01|01.09.1977||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||18|0|3,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 373001|G03AB0501|Gracial|töflur|||66|stk|1|pakki|ţp 3 x (15+7 stk)|G03AB05|01.07.1998||R|||0|0|0|0|ORG|0|0|0|100|DKK|2433|4307|lyfalmen||||66|0|66,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||2433||2433|4307| 373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|ţpakki||N05AL05|01.01.2005||R|||0|0|*|0|SNO|0|1|0|100|NOK|19390|26880|lyfalmen||||90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríđ||19390||19390|26880| 373324|R03AK0602|Seretide Diskus|innúđadu|150|mcg/sk|60|skammtar|1|pakki|50+100 mcg, discus|R03AK06|01.05.2000||R|||0|0|B|0|GSK|0|0|0|100|GBP|4194|6716|lyfalmen||||60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4194||4194|6716| 373340|R03AK0602|Seretide Diskus|innúđadu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg, discus|R03AK06|01.05.2000||R|||0|0|0|0|GSK|0|0|0|100|GBP|6928|10456|lyfalmen|V0436|10455||60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||6928||6928|10456| 373365|R03AK0602|Seretide Diskus|innúđadu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg, discus|R03AK06|01.05.2000||R|||0|0|0|0|GSK|0|0|0|100|GBP|9563|14061|lyfalmen|V0437|14059||60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9563||9563|14061| 373853|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.06.2012||R|||0|0|*|0|MED|0|0|0|100|XEU|7220|7519|lyfalmen|V0420|7519||30|0|30,0000|Medical ehf|Medical ehf|Bíkalútamíđ||4781||4781|7519| 373857|C07AB0309|Atenolol Actavis|töflur|25|mg|100|stk|1|glas||C07AB03|01.10.2012||R|||0|0|B|0|APC|0|0|0|100|XEU|453|1599|lyfalmen|V0541|1597||100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Atenólól||453||453|1599| 373951|G02CB0301|Dostinex|töflur|0,5|mg|2|stk|1|glas||G02CB03|01.04.1998||R|||0|0|E|0|PER|0|0|0|100|DKK|1533|3076|lyfalmen|V0126|1793||2|0|2,0000|Icepharma hf|Pfizer ApS|Kabególín||1533||1533|3076| 374143|L01XE1201|Caprelsa|filmhtfl|100|mg|30|stk|1|ţpakki||L01XE12|01.07.2012||R|||0|1|0|1|AZA|0|0|0|100|SEK|399330|503042|lyfsjukr||||30|0||Vistor hf|AstraZeneca AB|Vandetaníb||399330||399330|503042| 374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|ţpakki||A10BA02|01.01.1987||R|||0|0|*|0|MCK|0|0|0|100|SEK|702|1939|lyfalmen|V0500|1532||100|0|25,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||702||702|1939| 374251|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|5561|8026|lyfsjukr||||7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||5561||5561|8026| 374348|G04CA0201|Omnic|forđahlk|0,4|mg|30|stk|1|ţpakki||G04CA02|01.08.1998||R|||0|0|E|0|ASP|0|0|0|100|XEU|4464|7085|lyfalmen||||30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4464||4464|7085| 374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|ţpakki||J05AB11|01.01.2003||R|||0|0|E|0|GSK|0|0|1|100|GBP|11699|16983|lyfalmen||||60|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||11699||11699|16983| 374504|G01AF0502|Pevaryl Depot|krem/sti|||15|g|1|sett|kr.+1sk-stíll m.forđaverkun|G01AF05|01.01.1997||L|||0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa||||15|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||| 374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|lykjur|einnota dćla|B01AB05|01.01.1993||R|||0|0|E|0|SNO|0|0|1|100|NOK|9144|13487|lyfalmen||||6|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||9144||9144|13487| 374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|lykjur|einnota dćla|B01AB05|01.01.1993||R|||0|0|E|0|SNO|0|0|1|100|NOK|10852|15824|lyfalmen||||8|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||10852||10852|15824| 374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dćla|B01AB05|01.01.1993||R|||0|0|E|0|SNO|0|0|1|100|NOK|12679|18457|lyfalmen||||10|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||12679||12679|18457| 376246|B01AC2401|Brilique|filmhtfl|90|mg|168|stk|1|ţpakki||B01AC24|01.06.2011||R|||0|0|E|0|AZA|0|0|0|100|SEK|31844|42509|lyfalmen|V0459|42509||168|0|84,0000|Vistor hf|AstraZeneca AB|Ticagrelor||31844||31844|42509| 376509|L04AD0202|Prograf|hylki|1|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|||0|1|*|0|ASP|0|0|0|100|XEU|19730|27306|lyfalmen||||50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||19730||19730|27306| 376533|L04AD0202|Prograf|hylki|5|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|||0|1|*|0|ASP|0|0|0|100|XEU|90406|116005|lyfalmen||||50|0|50,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||90406||90406|116005| 377242|J01FA0901|Klacid|töflur|500|mg|14|stk|1|ţpakki||J01FA09|01.04.1992||R|||0|0|0|0|ABS|0|0|1|100|DKK|4160|6670|lyfalmen||||14|0|14,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||4160||4160|6670| 377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|ţpakki||J05AB11|01.10.1996||R|||0|0|E|0|GSK|0|0|1|100|GBP|11330|9077|lyfalmen|V0182|8934||42|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||5920||5920|9077| 378686|D11AX1801|Solaraze|hlaup|3|%|100|g|1|túpa||D11AX18|01.08.2012||R|||0|0|0|0|ALM|0|0|0|100|XEU|15890|22487|lyfalmen||||100|0||Vistor hf|Almirall S.A.|Önnur húđlyf-Diclofenacum||15890||15890|22487| 379570|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.03.2012||R|||0|1|0|1|IPI|0|0|0|100|DKK|143683|182205|lyfsjukr||||4|0|28,5800|Icepharma hf|Pfizer Limited|Etanercept||143683||143683|182205| 379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|||0|1|0|1|NOH|0|0|0|100|DKK|111562|141893|lyfsjukr||||2|0|14,2900|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||111562||111562|141893| 379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|||0|1|0|1|NOH|0|0|0|100|DKK|157183|199147|lyfsjukr||||2|0|28,5700|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||157183||157183|199147| 379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|||0|1|0|1|NOH|0|0|0|100|DKK|199012|251643|lyfsjukr||||2|0|42,8600|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||199012||199012|251643| 379875|N05BA0105|Stesolid|innhl|5|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|||0|0|0|0|AGT|0|0|1|100|DKK|1465|2983|lyfalmen||||12|0|2,5000|Actavis Group hf|Actavis Group hf|Díazepam||1465||1465|2983| 379883|N05BA0105|Stesolid|innhl|10|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|||0|0|0|0|AGT|0|0|1|100|DKK|1810|3455|lyfalmen||||12|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||1810||1810|3455| 380276|N03AX1406|Zelta|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.04.2012||R|||0|0|0|0|LYF|0|0|0|100|XEU|8132|5672|lyfalmen|V0515|4973||100|0|16,6700|LYFIS ehf|LYFIS ehf|Levetíracetam||3431||3431|5672| 381005|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.11.2011||L|||0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa||||204|0|13,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||| 381194|A10AD0401|Humalog Mix25 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.09.1999||R|||0|0|*|0|ELD|0|0|0|100|XEU|5434|8412|lyfalmen||||15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||5434||5434|8412| 381505|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|||0|0|0|0|LYF|0|0|0|100|XEU|7395|7271|lyfalmen|V0143|7271||12|0|12,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||4600||4600|7271| 382383|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|kćlt|V03AN01|01.10.2012||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||10|0||Ísaga ehf|AGA AB|Súrefni|||||| 383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|||0|0|B|0|AZD|0|0|0|100|SEK|7169|10786|lyfalmen||||100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Bambúteról||7169||7169|10786| 383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|ţpakki|230+20 mg|QP52AA51|01.06.2000||L|||0|0|0|0|BAN|0|0|0|100|DKK|1248|2177|vetorma||||2|0||Icepharma hf|Bayer Animal Health GmbH|||||1248|2177| 383133|QP52AA5103|Drontal Vet.|töflur|250|mg|20|stk|1|ţpakki|230+20 mg|QP52AA51|01.06.2000||R|||0|0|0|0|BAN|0|0|0|100|DKK|7518|13115|vetorma||||20|0||Icepharma hf|Bayer Animal Health GmbH|||7518||7518|13115| 383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||60|0||Actavis Group hf|Actavis hf|Ketókónazól|||||| 383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||120|0||Actavis Group hf|Actavis hf|Ketókónazól|||||| 386278|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|||0|0|0|0|LYF|0|0|0|100|XEU|5980|5891|lyfalmen|V0144|5891||8|0|16,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||3591||3591|5891| 386953|L02BG0301|Arimidex|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.1998||R|||0|0|*|0|AZA|0|0|0|100|SEK|59199|76840|lyfalmen|V0184|14475||98|0|98,0000|Vistor hf|AstraZeneca AB|Anastrózól||59199||59199|76840| 387579|N05BA1206|Alprazolam Krka|forđatfl|0,5|mg|60|stk|1|ţpakki||N05BA12|01.08.2012||R|||0|0|0|0|KRK|0|0|0|100|XEU|901|1958|lyfalmen|V0308|1958||60|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||716||716|1958| 387662|QA12CC0202|Magnesiumsulfat Icepharma vet.|stl|200|mg/ml|100|ml|1|plhgl||QA12CC02|01.07.1996||R|||0|0|0|0|ICE|0|0|0|100|XEU|711|1414|vetalmen||||100|0||Icepharma hf|Icepharma hf|||711||711|1414| 387746|J02AA0101|Abelcet|irţ|5|mg/ml|20|ml|10|hgl|+ síunálar|J02AA01|01.04.1996||R|||0|0|0|1|CEP|0|0|0|100|DKK|195075|246702|lyfsjukr||||200|0|28,5714|Icepharma hf|Cephalon France (I)|Amfóterícín||195075||195075|246702| 388198|L01XE0901|Torisel|irţ|30|mg|1|hgl|1|pakki||L01XE09|01.09.2012||R|||0|1|0|1|IPI|0|0|0|100|DKK|158440|200725|lyfsjukr||||1|0||Icepharma hf|Pfizer Limited|Temsirolímus||158440||158440|200725| 388256|N01BB2001|Emla|krem|||5|g|5|túpa|+12 umbúđ.|N01BB20|01.01.1987||R|||0|0|0|0|AZD|0|0|1|100|SEK|3408|5641|lyfalmen||||25|0||Vistor hf|AstraZeneca A/S DK|Blöndur||3408||3408|5641| 388264|N01BB2001|Emla|krem|||30|g|1|túpa||N01BB20|01.01.1987||R|||0|0|0|0|AZD|0|0|1|100|SEK|4296|6856|lyfalmen||||30|0||Vistor hf|AstraZeneca A/S DK|Blöndur||4296||4296|6856| 388272|N01BB2001|Emla|plástur|||2|stk|1|pakki||N01BB20|01.04.1994||L|||0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa||||2|0||Vistor hf|AstraZeneca A/S DK|Blöndur|||||| 388280|N01BB2001|Emla|plástur|||20|stk|1|pakki||N01BB20|01.04.1994||R|||0|0|0|0|AZD|0|0|1|100|SEK|8336|12382|lyfalmen||||20|0||Vistor hf|AstraZeneca A/S DK|Blöndur||8336||8336|12382| 388482|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|28|stk|1|ţpakki||A02BC04|01.06.2011||R|||0|0|0|0|APC|0|0|0|100|XEU|779|1555|lyfalmen|V0466|1555||28|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||421||421|1555| 389106|G03FA0103|Femanor|töflur|||84|stk|1|pakki|ţp 2+1 mg |G03FA01|01.08.1998||R|||0|0|E|0|BIP|0|0|0|100|SEK|2888|4930|lyfalmen|V0410|4930||84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2888||2888|4930| 389122|G03FB0503|Femasekvens|töflur|||84|stk|1|pakki|ţp samsett pk. |G03FB05|01.08.1998||R|||0|0|E|0|BIP|0|0|0|100|DKK|2110|3865|lyfalmen||||84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2110||2110|3865| 389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|ţpakki||G03CA03|01.05.1997||R|||0|0|E|0|BIP|0|0|0|100|SEK|852|2144|lyfalmen|V0128|2144||84|0|84,0000|Vistor hf|BioPhausia AB|Estradíól||852||852|2144| 389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|ţpakki||G03CA03|01.05.1997||R|||0|0|E|0|BIP|0|0|0|100|DKK|619|1826|lyfalmen||||84|0|42,0000|Vistor hf|BioPhausia AB|Estradíól||619||619|1826| 389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|||0|0|E|0|NOH|0|0|1|100|DKK|944|2270|lyfalmen|V0367|1299||3|0||Vistor hf|Novartis Healthcare A/S-|Díklófenak||944||944|2270| 389414|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|||0|0|0|0|LYF|0|0|0|100|XEU|2616|3529|lyfalmen|V0143|2424||4|0|4,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||1864||1864|3529| 389443|N04BC0504|Oprymea (Lyfis)|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.07.2010||R|||0|0|E|0|LYF|0|0|0|100|XEU|5074|2519|lyfalmen|V0267|2519||100|0|7,2000|LYFIS ehf|LYFIS ehf|Pramipexól||1126||1126|2519| 389637|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg)|G03GA05|01.01.2012||R|||0|1|E|0|MSE|0|0|0|100|SEK|59752|77534|lyfalmen||||2|0|12,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||59752||59752|77534| 389944|L04AD0201|Advagraf|forđahlk|1|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|||0|1|*|0|APE|0|0|0|100|XEU|18186|25369|lyfalmen||||50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||18186||18186|25369| 390699|N05CM1801|Dexdor|irţ|100|mcg/ml|2|ml|25|lykjur|lausn|N05CM18|01.03.2012||R|||0|1|0|1|ORC|0|0|0|100|DKK|79905|102163|lyfsjukr||||50|0||Vistor hf|Orion Corporation|Dexmedetómid||79905||79905|102163| 390757|A07AA0201|Mycostatin|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.04.1974||R|||0|0|E|0|BRS|0|0|1|100|DKK|2845|4871|lyfalmen||||100|0|6,6667|Vistor hf|Bristol-Myers Squibb|Nýstatín||2845||2845|4871| 390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|ţpakki||M01AH01|01.07.2002||R|||0|0|E|0|PER|0|0|1|100|DKK|6818|10306|lyfalmen||||100|0|50,0000|Icepharma hf|Pfizer ApS|Celekoxíb||6818||6818|10306| 390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|ţpakki||M01AH01|01.07.2002||R|||0|0|E|0|PER|0|0|1|100|DKK|2693|4663|lyfalmen|V0037|4663||20|0|20,0000|Icepharma hf|Pfizer ApS|Celekoxíb||2693||2693|4663| 391010|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg)|G03GA05|01.01.2012||R|||0|1|E|0|MSE|0|0|0|100|SEK|31071|41539|lyfalmen||||1|0|6,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||31071||31071|41539| 391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|ţpakki||M01AH01|01.07.2002||R|||0|0|E|0|PER|0|0|1|100|DKK|13139|19035|lyfalmen|V0196|19033||100|0|100,0000|Icepharma hf|Pfizer ApS|Celekoxíb||13139||13139|19035| 391730|N01BB0203|Xylocain|úđalyf|100|mg/ml|50|ml|1|glas|+ sk-úđari|N01BB02|01.10.1990||R|||0|0|0|0|AZD|0|0|1|100|SEK|2745|4734|lyfalmen||||50|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2745||2745|4734| 392225|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plastf|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|||0|0|0|1|GEH|0|0|0|100|NOK|242758|306544|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||242758||242758|306544| 392563|A04AA0103|Zofran|mixtúra|0,8|mg/ml|50|ml|1|fl||A04AA01|01.08.2009||R|||0|0|0|0|PCO|0|0|0|100|IKR|12000|17605|lyfalmen||||50|1|2,5000|Distica|Distica - óskráđ lyf|Ondansetrón||||12000|17605| 393192|N05AH0409|Quetiapin Orion|filmhtfl|200|mg|100|stk|1|ţpakki||N05AH04|01.10.2012||R|||0|0|*|0|OPF|0|1|0|100|SEK|20927|25077|lyfalmen|V0286|24658||100|0|50,0000|Portfarma ehf|Orion Corporation|Quetíapín||17954||17954|25077| 393918|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dćlu|1|stk|24|spr||QJ51CF02|01.09.1983||R|||0|0|0|0|PAL|0|0|0|100|DKK|5476|10687|vetalmen||||24|0||Icepharma hf|Pfizer Oy Animal Health|||5476||5476|10687| 393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 394010|N06AB1005|Escitalopram LYFIS|filmhtfl|20|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|||0|0|B|0|LYF|0|1|0|100|XEU|4611|4470|lyfalmen|V0327|4470||100|0|200,0000|LYFIS ehf|LYFIS ehf|Escítalópram||2552||2552|4470| 394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 395522|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|spr|áfyllt spr.međ nálarvörn|B03XA02|01.08.2011||R|||0|1|0|1|AMG|0|0|0|100|DKK|144860|182549|lyfsjukr||||1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||143957||143957|182549| 395886|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innúđadu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|||0|0|0|0|LVR|0|0|0|100|SEK|28718|38077|lyfalmen|V0356|38077||360|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||28312||28312|38077| 395954|V08CA0101|Magnevist|stl|469|mg/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|||0|0|0|1|BAP|0|0|0|100|SEK|174754|221199|lyfsjukr||||300|0||Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||174754||174754|221199| 396318|R06AX2201|Kestine|filmhtfl|10|mg|100|stk|1|ţpakki||R06AX22|01.06.2012||R|||0|0|E|0|APS|0|0|1|100|DKK|3946|6377|lyfalmen||||100|0|100,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||3946||3946|6377| 397494|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.12.2011||R|||0|1|0|1|MKA|0|0|0|100|SEK|37281|48670|lyfsjukr||||20|0||Icepharma hf|Merck KgaA|Cetúxímab||37281||37281|48670| 397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|ţpakki||L01BC06|01.01.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|9645|13920|lyfsjukr||||60|0||Icepharma hf|Roche|Capecitabín||9645||9645|13920| 397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|ţpakki||L01BC06|01.01.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|55300|71284|lyfsjukr||||120|0||Icepharma hf|Roche|Capecitabín||55300||55300|71284| 397796|A06AB5801|Picoprep|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.10.2011||L|||0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa||||2|0||Vistor hf|Ferring Lćgemidler A/S|Natríumpicosúlfat|||||| 398821|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|56|stk|1|ţpakki||A02BC05|01.08.2011||R|||0|0|0|0|LYF|0|0|0|100|IKR|7175|3287|lyfalmen|V0012|2864||56|0|74,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||1687||1687|3287| 399241|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.07.2010||R|||0|0|E|0|LYF|0|0|0|100|XEU|3431|1902|lyfalmen|V0009|1902||28|0|28,0000|LYFIS ehf|LYFIS ehf|Klópídógrel||675||675|1902| 399510|N02AX0204|Tradolan|filmhtfl|50|mg|100|stk|1|ţpakki||N02AX02|01.05.2012||R|||0|0|E|0|GLP|0|0|1|100|SEK|405|1533|lyfalmen|V0225|1491||100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||405||405|1533| 399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|ţpakki||N03AX09|01.03.1999||R|||0|0|E|0|GSK|0|0|0|100|IKR|2049|2856|lyfalmen|V0244|2575||56|0|9,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||1372||1372|2856| 399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|áf.spr|7500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.1993||R|||0|0|E|0|PER|0|0|1|100|DKK|8791|13005|lyfalmen||||3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||8791||8791|13005| 399746|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|||0|1|0|1|SAR|0|0|0|100|SEK|41630|54128|lyfsjukr||||2|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||41630||41630|54128| 399782|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.04.1997||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||2|0||Artasan ehf|Novartis Healthcare A/S-A|Pencíklóvír|||||| 399856|L03AB1101|Pegasys|stl|180|mcg/pen|0,5|ml|4|lyfjap|áfylltur lyfjapenni|L03AB11|01.05.2012||R|||0|1|0|1|RRL|0|0|0|100|DKK|111124|141343|lyfsjukr||||2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||111124||111124|141343| 400044|S03CA0102|Sofradex|aug.eydr|||8|ml|1|glas||S03CA01|01.03.1980||R|||0|0|E|0|SNO|0|0|1|100|NOK|1518|3055|lyfalmen||||8|0||Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1518||1518|3055| 400101|R05DB2002|Pektolin|mixtúra|||150|ml|1|glas||R05DB20|01.06.1981||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||150|0||Actavis Group hf|Actavis hf|Blöndur|||||| 400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|ţpakki||C10AB04|01.04.1988||R|||0|0|0|0|PER|0|0|0|100|DKK|5020|7846|lyfalmen||||100|0|25,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||5020||5020|7846| 400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|||0|0|0|0|PER|0|0|1|100|DKK|218|1277|lyfalmen||||25|0|12,5000|Icepharma hf|Pfizer ApS|Oxazepam||218||218|1277| 400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|ţpakki||N05BA04|01.01.1985||R|||0|0|0|0|PER|0|0|0|100|DKK|395|1519|lyfalmen||||100|0|30,0000|Icepharma hf|Pfizer ApS|Oxazepam||395||395|1519| 400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|||0|0|0|0|PER|0|0|1|100|DKK|188|1236|lyfalmen||||25|0|7,5000|Icepharma hf|Pfizer ApS|Oxazepam||188||188|1236| 401801|B01AC2401|Brilique|filmhtfl|90|mg|56|stk|1|ţpakki||B01AC24|01.06.2011||R|||0|0|E|0|AZA|0|0|0|100|SEK|11002|16029|lyfalmen|V0459|14170||56|0|28,0000|Vistor hf|AstraZeneca AB|Ticagrelor||11002||11002|16029| 401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|||0|0|B|0|LBK|0|1|0|100|DKK|739|1990|lyfalmen||||100|0|13,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||739||739|1990| 401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|||0|0|B|0|LBK|0|1|0|100|DKK|1182|2596|lyfalmen||||100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1182||1182|2596| 401877|C09AA0103|Katopril|töflur|25|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|||0|0|B|0|ACA|0|0|0|100|XEU|1162|2568|lyfalmen||||100|0|50,0000|Actavis Group hf|Actavis hf|Kaptópríl||1162||1162|2568| 401901|C09AA0103|Katopril|töflur|50|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|||0|0|B|0|ACA|0|0|0|100|XEU|1865|3530|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis hf|Kaptópríl||1865||1865|3530| 402651|J07BB0205|Influvac|bóluefni|||0,5|ml|1|spr|einnotaspr|J07BB02|01.12.1998||R|||0|0|0|0|AHP|0|0|0|100|XEU|636|1849|lyfalmen||||0|0||Vistor hf|Abbott Healthcare Products B.V.|Inflúensa, hreinsađir mótefnavakar||636||636|1849| 402743|QJ01RA0102|Streptocillin, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.11.1979||R|||0|0|0|0|BID|0|0|0|100|DKK|1628|3238|vetalmen||||100|0||Vistor hf|Boehringer Ingelheim Danmark|||1628||1628|3238| 402873|N06DA0302|Exelon (Lyfjaver)|forđapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|||0|0|E|0|LVR|0|0|0|100|DKK|14708|21004|lyfalmen|V0349|21004||30|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||14708||14708|21004| 403226|L04AA0605|Myfenax (Lyfis)|hylki|250|mg|100|stk|1|ţpakki||L04AA06|01.03.2011||R|||0|1|*|0|LYF|0|0|0|100|XEU|20083|24687|lyfalmen|V0470|24687||100|0|12,5000|LYFIS ehf|LYFIS ehf|Mýcófenólsýra||17643||17643|24687| 403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|||0|0|0|0|IBV|1|0|0|100|DKK|5007|9787|vetalmen||||20|0||Vistor hf|Intervet International BV|||5007||5007|9787| 403550|C08CA0302|Lomir Retard|forđahlk|2,5|mg|100|stk|1|ţpakki||C08CA03|01.10.1992||R|||0|0|B|0|NOH|0|0|0|100|DKK|5718|8801|lyfalmen||||100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||5718||5718|8801| 403856|L01BA0108|Methotrexate Pfizer|irţ|100|mg/ml|50|ml|1|hgl||L01BA01|01.10.2011||R|||0|1|0|1|PER|0|0|0|100|DKK|36023|47091|lyfsjukr||||50|0||Icepharma hf|Pfizer ApS|Metótrexat||||36023|47091| 403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|||0|0|E|0|SNO|0|0|0|100|NOK|1448|2960|lyfalmen||||14|0||Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||1448||1448|2960| 404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|||0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen||||10|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||1834| 404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|||0|0|0|1|BOI|0|0|0|100|DKK|63448|81510|lyfsjukr||||1|0|0,5000|Vistor hf|Boehringer Ingelheim|Alteplasi||63448||63448|81510| 404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|||0|0|0|1|ROC|0|0|0|100|DKK|666|961|lyfsjukr||||5|0|2,5000|Icepharma hf|Roche|Fýtómenadíón||666||666|961| 405466|QM01AX9001|Cartrophen vet.|stl|100|mg/ml|10|ml|1|hgl|lausn f.hunda|QM01AX90|01.08.2011||R|||0|0|0|0|AEL|1|0|0|100|XEU|7919|15378|vetalmen||||10|0||Icepharma hf|Arthropharm Europe Limited|Pentosan Polysulfate Sodium||7919||7919|15378| 405589|J07BD5203|Priorix|bóluefni|||0,5|ml|1|hgl|+ einnota dćla|J07BD52|01.03.1999||R|||0|0|0|0|GSK|0|0|0|100|GBP|1821|3470|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||1821||1821|3470| 405597|J07BD5203|Priorix|bóluefni|||0,5|ml|10|hgl||J07BD52|01.11.2001||R|||0|0|0|0|GSK|0|0|0|100|GBP|19414|26910|lyfalmen||||5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||19414||19414|26910| 405985|N05AE0301|Serdolect|filmhtfl|12|mg|28|stk|1|ţpakki||N05AE03|01.01.2006||R|||0|0|0|0|LBK|0|1|0|100|DKK|17659|24707|lyfalmen||||28|0|21,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||17659||17659|24707| 406025|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|||0|0|0|1|GEH|0|0|0|100|IKR|20662|27813|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Jóhexól||20662||20662|27813| 406033|N05AE0301|Serdolect|filmhtfl|16|mg|28|stk|1|ţpakki||N05AE03|01.01.2006||R|||0|0|0|0|LBK|0|1|0|100|DKK|20146|27828|lyfalmen||||28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||20146||20146|27828| 406165|N05AE0301|Serdolect|filmhtfl|20|mg|28|stk|1|ţpakki||N05AE03|01.01.2006||R|||0|0|0|0|LBK|0|1|0|100|DKK|22081|30257|lyfalmen||||28|0|35,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||22081||22081|30257| 406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|||0|0|0|0|LBK|0|1|0|100|DKK|19919|27543|lyfalmen||||100|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||19919||19919|27543| 406355|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|||0|0|0|1|GEH|0|0|0|100|IKR|23122|30901|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Jóhexól||23122||23122|30901| 406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|||0|0|0|0|LBK|0|1|0|100|DKK|60056|77915|lyfalmen||||100|0|75,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||60056||60056|77915| 406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|||0|0|0|0|LBK|0|1|0|100|DKK|70500|91023|lyfalmen||||100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||70500||70500|91023| 406397|N05AE0301|Serdolect|filmhtfl|20|mg|100|stk|1|glas||N05AE03|01.10.2006||R|||0|0|0|0|LBK|0|1|0|100|DKK|79932|102860|lyfalmen||||100|0|125,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||79932||79932|102860| 406462|N05AE0301|Serdolect|filmhtfl|4|mg|30|stk|1|ţpakki||N05AE03|01.01.2006||R|||0|0|0|0|LBK|0|1|0|100|DKK|6095|9317|lyfalmen||||30|0|7,5000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||6095||6095|9317| 406894|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|||0|1|0|1|SDG|0|0|0|100|DKK|77376|98989|lyfsjukr||||8|0|37,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||77376||77376|98989| 407142|C09CA0304|Valsartan LYFIS|filmhtfl|80|mg|98|stk|1|ţpakki||C09CA03|01.06.2012||R|||0|0|B|0|LYF|0|0|0|100|XEU|3252|2651|lyfalmen|V0072|2651||98|0|98,0000|LYFIS ehf|LYFIS ehf|Valsartan||1222||1222|2651| 407395|N02CA7201|Anervan|töflur|160,5|mg|100|stk|1|pakki|ţp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|||0|0|E|0|REP|0|0|0|100|SEK|2246|4051|lyfalmen||||100|0|12,5000|Vistor hf|Recip AB|Ergotamínlyf í blöndum međ geđlyfjum (psycoleptica)||2246||2246|4051| 407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|||0|0|0|0|PER|0|0|1|100|DKK|163|1202|lyfalmen||||25|0|5,0000|Icepharma hf|Pfizer ApS|Oxazepam||163||163|1202| 407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|ţpakki||N05BA04|01.01.1985||R|||0|0|0|0|PER|0|0|0|100|DKK|355|1465|lyfalmen||||100|0|20,0000|Icepharma hf|Pfizer ApS|Oxazepam||355||355|1465| 408266|N05BA1206|Alprazolam Krka|forđatfl|1|mg|60|stk|1|ţpakki||N05BA12|01.08.2012||R|||0|0|0|0|KRK|0|0|0|100|XEU|1905|3177|lyfalmen|V0310|3177||60|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1607||1607|3177| 408740|D07AC0104|Diproderm|smyrsli|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|||0|0|B|0|SPL|0|0|1|100|DKK|2798|4806|lyfalmen||||100|0||Vistor hf|Schering-Plough Europe|Betametasón||2798||2798|4806| 408773|D07AC0104|Diproderm|áburđur|0,5|mg/ml|100|ml|1|glas||D07AC01|01.03.1977||R|||0|0|B|0|SPL|0|0|1|100|DKK|2193|3979|lyfalmen||||100|0||Vistor hf|Schering-Plough Europe|Betametasón||2193||2193|3979| 409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|||0|0|0|0|PER|0|0|1|100|DKK|4162|6672|lyfalmen||||35|0|1,7500|Icepharma hf|Pfizer ApS|Flúkónazól||4162||4162|6672| 409417|C09CA0701|Micardis|töflur|80|mg|28|stk|1|ţpakki||C09CA07|01.02.2008||R|||0|0|0|0|BII|0|0|0|100|DKK|3620|5931|lyfalmen||||28|0|56,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||3620||3620|5931| 409425|R01AD0502|Rhinocort Turbuhaler|nefúđad|100|mcg/sk|200|skammtar|1|stauk||R01AD05|01.01.1992||R|||0|0|E|0|AZD|0|0|1|100|SEK|4352|6932|lyfalmen||||200|0|100,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||4352||4352|6932| 409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|ţpakki||C09CA07|01.02.2008||R|||0|0|0|0|BII|0|0|0|100|DKK|12121|17757|lyfalmen||||98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||12121||12121|17757| 409516|C09CA0701|Micardis|töflur|40|mg|28|stk|1|ţpakki||C09CA07|01.02.2008||R|||0|0|0|0|BII|0|0|0|100|DKK|2891|4934|lyfalmen||||28|0|28,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||2891||2891|4934| 409532|QN05AA0402|Plegicil vet.|stl|10|mg/ml|20|ml|6|hgl||QN05AA04|01.11.2007||R|||0|0|0|0|PAB|1|0|0|100|DKK|10315|19979|vetalmen||||120|0||Vistor hf|Pharmaxim AB|||10315||10315|19979| 409745|N05AX1302|Xeplion|stl|100|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|||0|0|0|0|JCI|0|1|0|100|SEK|79957|102891|lyfalmen||||1|0|40,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||79957||79957|102891| 409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|ţpakki||C09CA07|01.02.2008||R|||0|0|0|0|BII|0|0|0|100|DKK|9821|14414|lyfalmen||||98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||9821||9821|14414| 410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|ţpakki||P01BA01|01.08.2005||R|||0|0|0|0|REP|0|0|0|100|SEK|1167|2575|lyfalmen||||20|0|6,2000|Vistor hf|Recip AB|Klórókín||1167||1167|2575| 410712|D10AD0102|Aberela|krem|0,05|%|30|g|1|túpa||D10AD01|01.10.2007||R|||0|0|0|0|JAS|0|0|0|100|SEK|797|2069|lyfalmen||||30|0||Vistor hf|Janssen-Cilag AB|Tretínóín||797||797|2069| 411033|M03BX0105|Baklofen Mylan|töflur|10|mg|50|stk|1|ţpakki||M03BX01|01.01.1990||R|||0|0|E|0|MYL|0|0|1|100|SEK|698|1934|lyfalmen||||50|0|10,0000|Actavis Group PTC ehf|Mylan AB|Baklófen||698||698|1934| 411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|||0|0|0|1|ROC|0|0|0|100|DKK|4748|6853|lyfsjukr||||50|0|16,6667|Icepharma hf|Roche|Mídazólam||4748||4748|6853| 411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|||0|1|0|1|VII|0|0|0|100|GBP|25805|34268|lyfsjukr||||60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Lamívúdín||25805||25805|34268| 411918|N02CC0101|Imigran|nefúđi|20|mg/sk|6|skammtar|1|pakki||N02CC01|01.07.2000||R|||0|0|E|0|GSK|0|0|0|100|GBP|7549|11306|lyfalmen||||6|0|6,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||7549||7549|11306| 412049|L02AE0301|Zoladex|vefjalyf|3,6|mg|1|stk|1|áf.spr|+ dćla|L02AE03|01.01.1990||R|||0|1|*|0|AZA|0|0|0|100|SEK|23322|31814|lyfalmen|V0183|31813||1|0|27,9070|Vistor hf|AstraZeneca AB|Góserelín||23322||23322|31814| 412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|međ rotv.|B01AB05|01.02.1999||R|||0|0|0|1|SNO|0|0|0|100|NOK|3807|5494|lyfsjukr||||3|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3807||3807|5494| 412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|||0|0|0|0|MER|1|0|0|100|DKK|8302|16114|vetalmen||||100|0||Vistor hf|Merial|||8302||8302|16114| 412547|L03AB0701|Avonex|stl|30|mcg/pen|0,5|ml|4|spr|lausn,áfylltur lyfjapenni|L03AB07|01.11.2011||R|||0|1|0|1|BIB|0|0|0|100|XEU|124634|158298|lyfsjukr||||2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||124634||124634|158298| 412581|N05AX1302|Xeplion|stl|75|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|||0|0|0|0|JCI|0|1|0|100|SEK|62186|80589|lyfalmen||||1|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||62186||62186|80589| 412825|L02BA0107|Tamoxifen Mylan|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|||0|0|*|0|MYL|0|0|0|100|SEK|3505|5774|lyfalmen||||100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Tamoxífen||3505||3505|5774| 412924|L02BA0107|Tamoxifen Mylan|töflur|20|mg|100|stk|1|glas||L02BA01|01.01.2010||R|||0|0|*|0|MYL|0|0|0|100|SEK|4305|6868|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Tamoxífen||4305||4305|6868| 414006|N06AB0404|Citalopram Bluefish|filmhtfl|10|mg|30|stk|1|ţpakki||N06AB04|01.09.2012||R|||0|0|B|0|BLP|0|1|0|100|XEU|859|1871|lyfalmen|V0062|1871||30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||652||652|1871| 414167|N06DA0205|Donesyn|filmhtfl|10|mg|98|stk|1|ţpakki||N06DA02|01.05.2011||R|||0|0|E|0|WIH|0|0|0|100|XEU|27723|14660|lyfalmen|V0342|14635||98|0|130,6700|Portfarma ehf|Williams & Halls|Dónepezíl||10001||10001|14660| 414680|C03BA1102|Natrilix Retard|forđatfl|1,5|mg|90|stk|1|ţpakki||C03BA11|01.03.1999||R|||0|0|E|0|SEV|0|0|0|100|DKK|4190|6711|lyfalmen||||90|0|54,0000|Icepharma hf|Servier|Indapamíđ||4190||4190|6711| 414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|||0|0|E|0|NOH|0|0|0|100|DKK|1287|2739|lyfalmen||||300|0|6,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1287||1287|2739| 415556|B03AC0204|Venofer (D.A.C.)|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.03.2011||R|||0|0|E|0|DAC|0|0|1|100|CHF|14645|18624|lyfalmen|V0034|18573||25|0|5,0000|D.A.C. ehf|D.A.C. ehf|Járnoxíđ (sykurflétta)||12812||12812|18624| 415679|G03CA0310|Vagifem|sk-tfl|25|mcg|15|stk|1|pakki||G03CA03|01.01.1995||R|||0|0|E|0|NAS|0|0|0|100|DKK|1849|3508|lyfalmen||||15|0|15,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||1849||1849|3508| 415946|N03AX1405|Matever|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|||0|0|0|0|PSA|0|0|0|100|XEU|12529|7520|lyfalmen|V0253|7520||100|0|33,3300|Portfarma ehf|Pharmathen S.A.|Levetíracetam||4782||4782|7520| 416446|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.09.1997||R|||0|0|0|0|MSD|0|0|0|100|DKK|9248|9321|lyfalmen|V0088|2655||98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||6098||6098|9321| 416494|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|28|stk|1|ţpakki||A02BC05|01.11.2011||R|||0|0|0|0|POF|0|0|0|100|XEU|4068|2466|lyfalmen|V0005|1797||28|0|37,3300|Portfarma ehf|Portfarma|Esómeprazól||1087||1087|2466| 416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.07.2000||R|||0|0|0|0|PCO|0|0|0|100|GBP|5170|8051|lyfalmen||||300|1|15,0000|Distica|Distica - óskráđ lyf|Ranitidín||5170||5170|8051| 416829|N07BC0101|Subutex|tungur.t|8|mg|7|stk|1|ţpakki||N07BC01|01.03.2011||R|||1|0|0|1|RBP|0|0|0|100|DKK|4775|6892|lyfsjukr||||7|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||4775||4775|6892| 416859|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|||0|0|E|0|GOG|0|0|1|100|XEU|2817|4832|lyfalmen||||10|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||2817||2817|4832| 416867|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|30|ml|5|túpa||A01AA01|01.10.1988||R|||0|0|E|0|GOG|0|0|1|100|DKK|25316|34317|lyfalmen||||150|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||25316||25316|34317| 416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|||0|0|0|0|IGB|0|0|0|100|SEK|1264|2708|lyfalmen||||30|0||Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1264||1264|2708| 417266|N05AH0409|Quetiapin Orion|filmhtfl|100|mg|100|stk|1|ţpakki||N05AH04|01.10.2012||R|||0|0|*|0|OPF|0|1|0|100|SEK|10510|12442|lyfalmen|V0285|12347||100|0|25,0000|Portfarma ehf|Orion Corporation|Quetíapín||8380||8380|12442| 417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|ţpakki||J05AF06|01.07.2005||R|||0|1|0|1|VII|0|0|0|100|GBP|42236|54889|lyfsjukr||||60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Abacavír||42236||42236|54889| 417880|B02BD0901|BeneFIX|sts|||1000|ae|1|hgl|+leysir|B02BD09|01.07.2012||R|||0|1|0|1|IPI|0|0|0|100|DKK|96808|123377|lyfsjukr||||1000|0|2,2200|Icepharma hf|Pfizer Limited|Storkuţáttur IX||96808||96808|123377| 418043|B01AE0701|Pradaxa|hylki|150|mg|180|stk|1|ţpakki|hart|B01AE07|01.10.2011||R|||0|0|E|0|BII|0|0|0|100|DKK|33365|44418|lyfalmen|V0460|44418||180|0|122,7200|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||33365|44418| 418483|A07EC0201|Mesasal|sh-tfl|250|mg|100|stk|1|ţpakki||A07EC02|01.10.1991||R|||0|0|B|0|SNO|0|0|0|100|NOK|4924|7715|lyfalmen||||100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||4924||4924|7715| 418592|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|áf.spr||L04AC03|01.06.2012||R|||0|1|0|1|BIO|0|0|0|100|DKK|131187|166522|lyfsjukr||||19|0|28,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||131187||131187|166522| 418665|D07XC0101|Diprosalic|smyrsli|||50|g|1|túpa||D07XC01|01.11.1979||R|||0|0|B|0|SPL|0|0|1|100|DKK|1559|3112|lyfalmen||||50|0||Vistor hf|Schering-Plough Europe|Betametasón||1559||1559|3112| 418731|A07EC0201|Mesasal|eţ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|||0|0|B|0|SNO|0|0|0|100|NOK|7501|11240|lyfalmen|V0014|11240||60|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||7501||7501|11240| 418950|N05AH0310|Zalasta (LYFIS)|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|||0|0|*|0|LYF|0|1|0|100|XEU|22993|18913|lyfalmen|V0475|18913||28|0|42,0000|LYFIS ehf|LYFIS ehf|Olanzapín||13042||13042|18913| 418981|R06AX2703|Desloratadine Actavis|filmhtfl|5|mg|100|stk|1|ţpakki||R06AX27|01.05.2012||R|||0|0|E|0|APC|0|0|1|100|XEU|3809|6189|lyfalmen|V0458|5423||100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín||3809||3809|6189| 418988|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|glas||QA07AA01|01.03.1981||R|||0|0|0|0|BID|0|0|0|100|DKK|1993|3964|vetalmen||||200|0||Vistor hf|Boehringer Ingelheim Danmark|||1993||1993|3964| 418996|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|sett|+ dćla|QA07AA01|01.03.1981||R|||0|0|0|0|BID|0|0|0|100|DKK|2586|5138|vetalmen||||200|0||Vistor hf|Boehringer Ingelheim Danmark|||2586||2586|5138| 419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|ţpakki||A11CC03|01.11.1979||R|||0|0|B|0|LEP|0|0|0|100|DKK|3241|5412|lyfalmen||||100|0|25,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||3241||3241|5412| 419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|ţpakki||A11CC03|01.11.1979||R|||0|0|B|0|LEP|0|0|0|100|DKK|6930|10459|lyfalmen||||100|0|100,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||6930||6930|10459| 419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|||0|1|0|1|MSD|0|0|0|100|DKK|50879|65736|lyfsjukr||||180|0|30,0000|Vistor hf|M.S.D.|Indínavír||50879||50879|65736| 419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|||0|1|0|1|ORP|0|0|0|100|DKK|38608|50336|lyfsjukr||||100|0|7,5000|Swedish Orphan International AB|Orphan Europe (S)|Mecaptamín||38608||38608|50336| 419945|D07AD0101|Dermovat|húđlausn|0,5|mg/ml|25|ml|1|glas|í hársvörđ|D07AD01|01.09.1982||R|||0|0|B|0|GSK|0|0|1|100|GBP|853|2146|lyfalmen||||25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||853||853|2146| 420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|||0|0|E|0|PER|0|0|1|100|DKK|11747|17048|lyfalmen||||10|0|40,0000|Icepharma hf|Pfizer ApS|Dalteparín||11747||11747|17048| 421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|ţpakki||C01BD01|01.07.1989||R|||0|0|B|0|SNO|0|0|0|100|NOK|1548|3096|lyfalmen|V0036|3095||30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1548||1548|3096| 422121|C07AB0205|Seloken|töflur|50|mg|100|stk|1|ţpakki||C07AB02|01.05.2009||R|||0|0|B|0|AZD|0|0|0|100|SEK|1555|3106|lyfalmen|V0051|2949||100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1555||1555|3106| 422246|C07AB0206|Seloken ZOC|forđatfl|95|mg|98|stk|1|ţpakki||C07AB02|01.07.1988||R|||0|0|B|0|AZD|0|0|0|100|SEK|3553|5839|lyfalmen|V0049|4095||98|0|62,0700|Vistor hf|AstraZeneca A/S DK|Metóprólól||3553||3553|5839| 422337|C07AB0206|Seloken ZOC|forđatfl|190|mg|98|stk|1|ţpakki||C07AB02|01.07.1988||R|||0|0|B|0|AZD|0|0|0|100|SEK|6122|9353|lyfalmen|V0054|7131||98|0|124,1300|Vistor hf|AstraZeneca A/S DK|Metóprólól||6122||6122|9353| 422474|B02BB0101|Riastap|sts/irs|1|g|1|hgl|1|pakki|lausn|B02BB01|01.12.2011||R|||0|1|0|1|CSB|0|0|0|100|SEK|75338|96432|lyfsjukr||||1|0|0,2000|Icepharma hf|CSL Behring GmbH|Manna Fíbrínógen||75338||75338|96432| 423527|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|56|stk|1|ţpakki||A02BC05|01.08.2011||R|||0|0|0|0|LYF|0|0|0|100|IKR|6383|3530|lyfalmen|V0011|2864||56|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||1865||1865|3530| 423737|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|10|fl||J01GB03|01.07.2012||R|||0|0|0|1|BRU|0|0|0|100|XEU|21315|28633|lyfsjukr||||1200|0|15,0000|Actavis Group hf|B.Braun Melsungen AG|Gentamícín||21315||21315|28633| 424960|QP52AC1302|Panacur, vet.|pasta|187,5|mg/g|24|g|1|sk-dćl||QP52AC13|01.05.1999||L|||0|0|0|0|IBV|0|0|0|100|DKK|1580|2756|vetorma||||24|0||Vistor hf|Intervet International BV|||||1580|2756| 425181|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|||1|0|0|0|MYL|0|0|0|100|SEK|1106|2492|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Flúnítrazepam||1106||1106|2492| 425608|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|ţpakki|2+0,5 mg|N07BC51|01.08.2011||R|||1|1|0|1|RBP|0|0|0|100|DKK|4650|6666|lyfsjukr||||28|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||4619||4619|6666| 425939|C09CA0102|Lopress|töflur|12,5|mg|100|stk|1|glas||C09CA01|01.06.2012||R|||0|0|B|0|ACA|0|0|0|100|SEK|2208|3834|lyfalmen||||100|0|25,0000|Actavis Group hf|Actavis hf|Lósartan||2087||2087|3834| 426122|R01AA0503|Nezeril|nefdr|0,1|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|||0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa||||2|0|0,5000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||| 426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|ţpakki||J01CE02|01.10.1985||R|||0|0|0|0|REP|0|0|1|100|SEK|693|1927|lyfalmen||||20|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||693||693|1927| 426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|ţpakki||J01CE02|01.10.1985||R|||0|0|0|0|REP|0|0|1|100|SEK|905|2217|lyfalmen||||30|0|7,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||905||905|2217| 427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|||0|0|0|0|BII|0|0|0|100|IKR|||lyfalmen||||30|0|45,0000|Vistor hf|Boehringer Ingelheim International |Natríum pícósúlfat|||||2738| 428018|R06AX2201|Kestine|filmhtfl|10|mg|10|stk|1|ţpakki||R06AX22|01.06.2012||L|||0|0|0|0|APS|0|0|1|100|IKR|||lyflausa||||10|0|10,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||| 428441|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|||0|0|B|0|SPL|0|0|1|100|DKK|838|2125|lyfalmen||||30|0||Vistor hf|Schering-Plough Europe|Mómetasón||838||838|2125| 428524|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|||0|0|B|0|SPL|0|0|1|100|DKK|983|2324|lyfalmen||||30|0||Vistor hf|Schering-Plough Europe|Mómetasón||983||983|2324| 428579|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|||0|1|0|1|SAR|0|0|0|100|SEK|50827|65670|lyfsjukr||||2|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||50827||50827|65670| 428822|C10AA0504|Atorvastatin Portfarma|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|||0|0|0|0|POF|0|0|0|100|IKR|6185|3019|lyfalmen|V0113|2649||100|0|100,0000|Portfarma ehf|Portfarma|Atorvastatín||1491||1491|3019| 428828|N06DA0303|Nimvastid (Lyfis)|hylki|3|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|||0|0|E|0|LYF|0|0|0|100|XEU|26923|27191|lyfalmen|V0344|27191||112|0|37,3300|LYFIS ehf|LYFIS ehf|Rívastigmín||19638||19638|27191| 429167|J07CA0602|Pentavac|bóluefni|||0,5|ml|1|hgl|+ dreifa í dćlu|J07CA06|01.10.1999||R|||0|0|0|0|SPM|0|0|0|100|XEU|4116|6609|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||4116||4116|6609| 429225|J07CA0602|Pentavac|bóluefni|||0,5|ml|10|hgl||J07CA06|01.12.1999||R|||0|0|0|0|SPM|0|0|0|100|XEU|40496|53368|lyfalmen||||5|0||Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||40496||40496|53368| 429503|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.07.2012||R|||0|1|0|1|MLD|0|0|0|100|DKK|98332|125289|lyfsjukr||||105|0|5,2500|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||98332||98332|125289| 429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|ţpakki||C03DA01|01.11.1981||R|||0|0|E|0|PER|0|0|0|100|DKK|3980|6423|lyfalmen||||100|0|133,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||3980||3980|6423| 430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|||1|0|0|1|JAS|0|0|0|100|SEK|1748|2523|lyfsjukr||||50|0||Vistor hf|Janssen-Cilag AB|Fentanýl||1748||1748|2523| 430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|||0|0|0|1|ROC|0|0|0|100|DKK|1405|2028|lyfsjukr||||50|0|3,3333|Icepharma hf|Roche|Mídazólam||1405||1405|2028| 430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|||0|0|0|0|IBV|0|0|0|100|DKK|4359|8542|vetalmen||||100|0||Vistor hf|Intervet International BV|||4359||4359|8542| 430281|L02BG0303|Astrozol|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.08.2011||R|||0|0|*|0|WIH|0|0|0|100|XEU|28538|14498|lyfalmen|V0184|14475||98|0|98,0000|Portfarma ehf|Williams & Halls|Anastrózól||9883||9883|14498| 430417|N03AX2101|Trobalt|filmhtfl|400|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|34303|45595|lyfalmen||||84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||34303||34303|45595| 430521|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|||0|0|0|0|LYF|0|0|0|100|XEU|2888|3622|lyfalmen|V0144|2946||4|0|8,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||1932||1932|3622| 430710|J07AP0301|Typhim Vi|bóluefni|||0,5|ml|1|spr|einnotaspr|J07AP03|01.07.1994||R|||0|0|0|0|SPM|0|0|0|100|XEU|2389|4247|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsađir mótefnavakar||2389||2389|4247| 431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|||0|0|0|0|LEP|0|0|1|100|DKK|741|1993|lyfalmen||||15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||741||741|1993| 431049|C01DA0801|Sorbangil|töflur|10|mg|100|stk|1|ţpakki||C01DA08|01.07.1989||R|||0|0|B|0|REP|0|0|0|100|SEK|1196|2615|lyfalmen||||100|0|16,6667|Vistor hf|Recip AB|Ísósorbíđ dínítrat||1196||1196|2615| 431495|L01CD0201|Taxotere|irţ|160|mg|8|ml|1|hgl|lausn|L01CD02|01.04.2011||R|||0|1|0|1|AVS|0|0|0|100|NOK|237886|300429|lyfsjukr||||8|0||Vistor hf|Aventis Pharma SA|Docetaxel||237886||237886|300429| 431759|M01AB5503|Arthrotec Forte|töflur|75,2|mg|20|stk|1|ţpakki|75+0,2 mg|M01AB55|01.09.2009||R|||0|0|E|0|PER|0|0|1|100|DKK|1377|2863|lyfalmen||||20|0|15,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||||1377|2863| 431783|M01AB5503|Arthrotec Forte|töflur|75,2|mg|100|stk|1|ţpakki|75+0,2 mg|M01AB55|01.09.2009||R|||0|0|E|0|PER|0|0|1|100|DKK|4669|7366|lyfalmen||||100|0|75,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||4669||4669|7366| 432665|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dćlur|einnota dćlur plast|M09AX01|01.10.2011||R|||0|0|E|0|NDR|0|0|0|100|SEK|38633|51030|lyfalmen||||12|0|34,7222|Vistor hf|Nordic Drugs AB|Natríumhýalúrónat||||38633|51030| 432880|N02BE0107|Paratabs|töflur|500|mg|300|stk|1|glas|öryggislok|N02BE01|01.11.1981||R|||0|0|0|0|ACA|0|0|1|100|XEU|1119|2510|lyfalmen||||300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól||1119||1119|2510| 432972|QJ01CR0201|Combisyn|töflur|50|mg|100|stk|1|töflur||QJ01CR02|01.02.2012||R|||0|0|0|0|NOB|1|0|0|100|XEU|3612|7108|vetalmen||||100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||3612||3612|7108| 433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|||0|0|E|0|ORC|0|0|0|100|DKK|10772|15714|lyfalmen||||100|0|20,0000|Vistor hf|Orion Corporation|Entakapón||10772||10772|15714| 433292|N02AA0106|Contalgin Uno|forđahlk|30|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|||1|0|E|0|PER|0|0|0|100|DKK|2519|4425|lyfalmen||||28|0|8,4000|Icepharma hf|Pfizer ApS|Morfín||2519||2519|4425| 433318|N02AA0106|Contalgin Uno|forđahlk|90|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|||1|0|E|0|PER|0|0|0|100|DKK|5515|8523|lyfalmen||||28|0|25,2000|Icepharma hf|Pfizer ApS|Morfín||5515||5515|8523| 433342|N02AA0106|Contalgin Uno|forđahlk|150|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|||1|0|E|0|PER|0|0|0|100|DKK|8418|12494|lyfalmen||||28|0|42,0000|Icepharma hf|Pfizer ApS|Morfín||8418||8418|12494| 433512|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|7|stk|1|ţpakki||A02BC05|01.11.2011||R|||0|0|0|0|POF|0|0|0|100|XEU|581|1774|lyfalmen|V0004|424||7|0|4,6700|Portfarma ehf|Portfarma|Esómeprazól||581||581|1774| 434639|QP52AC1302|Panacur, vet.|töflur|250|mg|10|stk|1|ţpakki||QP52AC13|01.04.1992||L|||0|0|0|0|IBV|0|0|0|100|DKK|1107|1931|vetorma||||10|0||Vistor hf|Intervet International BV|||||1107|1931| 434670|D01AC2001|Daktacort|krem|||50|g|1|túpa||D01AC20|01.10.1988||R|||0|0|0|0|MCS|0|0|1|100|SEK|921|2239|lyfalmen||||50|0||Vistor hf|McNeil Sweden AB|Blöndur||921||921|2239| 434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|||0|0|B|0|MEB|0|0|1|100|DKK|5650|8708|lyfalmen||||1|0|0,6000|Vistor hf|Meda AB (V)|Adrenalín tartrat||5650||5650|8708| 434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|||0|0|B|0|MEB|0|0|1|100|DKK|5650|8708|lyfalmen||||1|0|0,3000|Vistor hf|Meda AB (V)|Adrenalín tartrat||5650||5650|8708| 434852|N06AB0302|Fontex|dreifit.|20|mg|100|stk|1|pakki|ţp (10x10 stk)|N06AB03|01.06.1998||R|||0|0|0|0|ELI|0|1|0|100|XEU|10013|14676|lyfalmen||||100|0|100,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||10013||10013|14676| 435537|N02CC0301|Zomig|töflur|5|mg|6|stk|1|ţpakki||N02CC03|01.06.1999||R|||0|0|E|0|ASZ|0|0|0|100|SEK|6897|10414|lyfalmen||||6|0|12,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||6897||6897|10414| 435594|N02CC0301|Zomig|töflur|2,5|mg|6|stk|1|ţpakki||N02CC03|01.11.1998||R|||0|0|E|0|ASZ|0|0|0|100|SEK|4786|7526|lyfalmen||||6|0|6,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||4786||4786|7526| 435651|N05AH0401|Seroquel|töflur|25|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|||0|0|0|0|AZA|0|1|0|100|SEK|8511|11135|lyfalmen|V0284|2853||100|0|6,2500|Vistor hf|AstraZeneca AB|Quetíapín||7424||7424|11135| 435817|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|25|mg|60|stk|1|ţpakki||N05AH04|01.06.2011||R|||0|0|*|0|LVR|0|1|0|100|IKR|929|2073|lyfalmen|V0284|1712||60|0|3,7500|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||800||800|2073| 435974|C01DA0801|Sorbangil|töflur|10|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|||0|0|B|0|REP|0|0|0|100|SEK|2879|4917|lyfalmen||||250|0|41,6700|Vistor hf|Recip AB|Ísósorbíđ dínítrat||2879||2879|4917| 436010|L01AA0901|Levact|irţ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.11.2011||R|||0|1|0|1|AST|0|0|0|100|DKK|229997|290529|lyfsjukr||||500|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||229997||229997|290529| 436022|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999||R|||0|0|0|0|NOH|0|0|0|100|DKK|3445|5691|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||3445||3445|5691| 436147|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|20|stk|1|ţpakki||M01AE02|01.07.1993||L|||0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa||||20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Naproxen|||||| 436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|||0|0|0|0|LEP|0|0|1|100|DKK|722|1967|lyfalmen||||15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||722||722|1967| 436877|L01AA0901|Levact|irţ|2,5|mg/ml|25|mg|20|hgl|lausn|L01AA09|01.11.2011||R|||0|1|0|1|AST|0|0|0|100|DKK|235869|297898|lyfsjukr||||500|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||235869||235869|297898| 436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|ţpakki||N05AD01|01.12.1972||R|||0|0|*|0|JAS|0|1|0|100|SEK|983|2324|lyfalmen||||100|0|12,5000|Vistor hf|Janssen-Cilag AB|Halóperídól||983||983|2324| 436931|N05AD0101|Haldol|töflur|4|mg|100|stk|1|ţpakki||N05AD01|01.12.1972||R|||0|0|*|0|JAS|0|1|0|100|SEK|3597|5899|lyfalmen||||100|0|50,0000|Vistor hf|Janssen-Cilag AB|Halóperídól||3597||3597|5899| 437013|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2010||R|||0|0|E|0|LYF|0|0|0|100|XEU|9814|7965|lyfalmen|V0029|7965||100|0|100,0000|LYFIS ehf|LYFIS ehf|Klópídógrel||5107||5107|7965| 437935|L01AA0901|Levact|irţ|2,5|mg/ml|25|mg|5|hgl|lausn|L01AA09|01.11.2011||R|||0|1|0|1|AST|0|0|0|100|DKK|66111|84852|lyfsjukr||||125|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||66111||66111|84852| 438225|N07XX0701|Fampyra|forđatfl|10|mg|28|stk|1|glas||N07XX07|01.12.2011||R|||0|1|0|1|BIB|0|0|0|100|XEU|31805|41798|lyfsjukr||||28|0|14,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||31805||31805|41798| 438333|N06AX1602|Efexor Depot|forđahlk|150|mg|28|stk|1|ţpakki||N06AX16|01.10.1998||R|||0|0|0|0|PER|0|1|0|100|DKK|6005|9193|lyfalmen||||28|0|42,0000|Icepharma hf|Pfizer ApS|Venlafaxín||6005||6005|9193| 438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|||10|ml|1|túpa|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|||0|0|E|0|SAL|0|0|1|100|USD|1232|2664|lyfalmen||||10|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Hýdrókortisón og sýkingalyf||1232||1232|2664| 438424|N06AX1602|Efexor Depot|forđahlk|75|mg|28|stk|1|ţpakki||N06AX16|01.10.1998||R|||0|0|0|0|PER|0|1|0|100|DKK|3146|5282|lyfalmen|V0259|3006||28|0|21,0000|Icepharma hf|Pfizer ApS|Venlafaxín||3146||3146|5282| 438432|N06AX1602|Efexor Depot|forđahlk|75|mg|98|stk|1|ţpakki||N06AX16|01.10.1998||R|||0|0|0|0|PER|0|1|0|100|DKK|10816|15775|lyfalmen|V0334|5904||98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||10816||10816|15775| 438759|L01XE1501|Zelboraf|filmhtfl|240|mg|56|stk|1|ţpakki||L01XE15|01.08.2012||R|||0|1|0|1|RRL|0|0|0|100|DKK|337642|425623|lyfsjukr||||56|0|-1,0000|Icepharma hf|Roche Registration Limited|Vemurafeníb||337642||337642|425623| 438762|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.07.1989||L|||0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa||||10|0|10,0000|Vistor hf|Schering-Plough|Lóratadín|||||| 438770|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.07.1989||R|||0|0|0|0|SCP|0|0|1|100|DKK|1832|3485|lyfalmen||||30|0|30,0000|Vistor hf|Schering-Plough|Lóratadín||1832||1832|3485| 438788|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.07.1989||R|||0|0|E|0|SCP|0|0|1|100|DKK|5769|8871|lyfalmen|V0362|2202||100|0|100,0000|Vistor hf|Schering-Plough|Lóratadín||5769||5769|8871| 438806|B03XA0201|Aranesp|stl|130|mcg/spr|0,65|ml|4|áf.spr|nálavörn|B03XA02|01.12.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|160296|203054|lyfsjukr||||3|0|115,5600|Vistor hf|Amgen|Darbepóetín alfa||160296||160296|203054| 439208|J01DC0203|Zinnat|töflur|250|mg|14|stk|1|ţpakki||J01DC02|01.10.1990||R|||0|0|0|0|GSK|0|0|1|100|GBP|2801|4811|lyfalmen||||14|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2801||2801|4811| 439489|C07FB0201|Logimax|forđatfl|55|mg|98|stk|1|pakki|ţp 5+50 mg|C07FB02|01.04.1997||R|||0|0|B|0|AZD|0|0|0|100|SEK|8794|13009|lyfalmen||||98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóđţrýstingslćkkandi lyf||8794||8794|13009| 439794|R01AA0704|Otrivin ukonserveret|nefúđi|1|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.05.2001||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|||0|0|0|0|GSK|0|0|1|100|IKR|1066|2437|lyfalmen||||70|0|5,6000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1066||1066|2437| 440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|||0|0|0|1|AGT|0|0|0|100|DKK|1442|2081|lyfsjukr||||10|0|1,6700|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||1442||1442|2081| 440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|||0|0|0|1|AGT|0|0|0|100|DKK|2277|3286|lyfsjukr||||10|0|3,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||2277||2277|3286| 441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|ţpakki||C03DA01|01.12.1972||R|||0|0|E|0|PER|0|0|0|100|DKK|901|2211|lyfalmen|V0046|2211||100|0|33,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||901||901|2211| 441279|D01AC2002|Pevisone|krem|||30|g|1|túpa||D01AC20|01.10.1988||R|||0|0|0|0|JAS|0|0|1|100|SEK|1292|2746|lyfalmen||||30|0||Vistor hf|Janssen-Cilag AB|Blöndur||1292||1292|2746| 441619|J05AR0801|Eviplera|filmhtfl|470|mg|30|stk|1|glas|200+25+245 mg|J05AR08|01.05.2012||R|||0|1|0|1|GIL|0|0|0|100|DKK|122079|155092|lyfsjukr||||30|0||Gilead Sience Sweden AB|Gilead Science International Limited|Emtrícítabín, rilpívírin og tenófóvír||122079||122079|155092| 441634|P03AC0401|Nix|hársápa|10|mg/ml|59|ml|1|pakki||P03AC04|01.01.1996||L|||0|0|0|0|ACH|0|0|0|100|IKR|||lyflausa||||59|0||Aco Hud Nordic AB|ACO Hud AB|Permetrín|||||| 441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|glas||G03DC02|01.12.1972||R|||0|0|E|0|BAP|0|0|0|100|SEK|1025|2381|lyfalmen||||30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Noretísterón||1025||1025|2381| 442705|B01AE0701|Pradaxa|hylki|150|mg|60|stk|1|ţpakki|hart|B01AE07|01.10.2011||R|||0|0|E|0|BII|0|0|0|100|DKK|11122|16193|lyfalmen|V0460|14806||60|0|40,9000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||11122|16193| 443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|stk|1|hgl|dćla|H04AA01|01.01.1989||R|||0|0|*|0|NAS|0|0|1|100|DKK|3359|5574|lyfalmen||||1|0|1,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||3359||3359|5574| 443358|N02AA0101|Contalgin|forđatfl|200|mg|90|stk|1|ţpakki||N02AA01|01.04.1993||R|||1|0|E|0|PER|0|0|0|100|DKK|25605|34679|lyfalmen||||90|0|180,0000|Icepharma hf|Pfizer ApS|Morfín||25605||25605|34679| 444041|N05AH0501|Sycrest|tungur.t|10|mg|20|stk|1|ţpakki||N05AH05|01.10.2011||R|||0|0|0|0|ORR|0|1|0|100|DKK|7414|11121|lyfalmen||||20|0|10,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||7414||7414|11121| 444102|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|60|stk|1|ţpakki||A06AB06|01.10.2012||R|||0|0|0|0|ICE|0|0|0|100|GBP|890|2196|lyfalmen||||60|0||Icepharma hf|Icepharma hf|Senna||890||890|2196| 444315|N06AB0302|Fontex|dreifit.|20|mg|30|stk|1|pakki|ţp (2 x 15 stk)|N06AB03|01.06.1998||R|||0|0|0|0|ELI|0|1|0|100|DKK|3044|5143|lyfalmen|V0061|3263||30|0|30,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||3044||3044|5143| 444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|||0|0|E|0|ROC|0|0|0|100|DKK|2216|4010|lyfalmen||||100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2216||2216|4010| 445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|||0|0|B|0|LEO|0|0|1|100|DKK|1546|3094|lyfalmen||||30|0||Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1546||1546|3094| 446187|QA12CX9001|Tonophosphan, vet.|stl|200|mg/ml|50|ml|1|hgl||QA12CX90|01.12.1972||R|||0|0|0|0|IBV|0|0|0|100|DKK|1408|2801|vetalmen||||50|0||Vistor hf|Intervet International BV|||1408||1408|2801| 446618|N03AF0301|Inovelon|mixtúra|40|mg/ml|460|ml|1|fl||N03AF03|01.09.2012||R|||0|1|E|0|EIS|0|0|0|100|SEK|20014|27663|lyfalmen||||460|0|13,1400|Vistor hf|Eisai Ltd|Rúfínamíđ||20014||20014|27663| 447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|18000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|||0|0|E|0|PER|0|0|0|100|DKK|10311|15084|lyfalmen||||4|0|36,0000|Icepharma hf|Pfizer ApS|Dalteparín||10311||10311|15084| 447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|10000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|||0|0|E|0|PER|0|0|0|100|DKK|5876|9017|lyfalmen||||2|0|20,0000|Icepharma hf|Pfizer ApS|Dalteparín||5876||5876|9017| 447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|12500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|||0|0|E|0|PER|0|0|0|100|DKK|7273|10928|lyfalmen||||2|0|25,0000|Icepharma hf|Pfizer ApS|Dalteparín||7273||7273|10928| 447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|15000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|||0|0|E|0|PER|0|0|0|100|DKK|8656|12820|lyfalmen||||3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||8656||8656|12820| 448217|C05AA0801|Doloproct|eţ-stíll|||10|stk|1|pakki||C05AA08|01.01.1991||R|||0|0|0|0|IGB|0|0|0|100|SEK|649|1867|lyfalmen||||10|0||Icepharma hf|Intendis GmbH Berlin|Flúókortólón||649||649|1867| 448233|C05AA0801|Doloproct|eţ-krem|||30|g|1|túpa||C05AA08|01.01.1991||R|||0|0|0|0|IGB|0|0|0|100|SEK|1268|2713|lyfalmen||||30|0||Icepharma hf|Intendis GmbH Berlin|Flúókortólón||1268||1268|2713| 448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|ţpakki||M03BX01|01.12.1972||R|||0|0|E|0|NOH|0|0|1|100|DKK|2061|3798|lyfalmen|V0202|3638||50|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Baklófen||2061||2061|3798| 449470|B05BB0120|Natriumhydrogenkarbonat B.Braun|irl|500|mmól/l|0,25|l|1|fl|lausn|B05BB01|01.02.2012||R|||0|0|0|1|Bru|0|0|0|100|XEU|1117|1612|lyfsjukr||||0|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||1117||1117|1612| 449611|C07AB0311|Atenolol Mylan|töflur|100|mg|98|stk|1|ţpakki||C07AB03|01.01.1991||R|||0|0|B|0|MYL|0|0|0|100|SEK|1433|2939|lyfalmen||||98|0|130,6667|Actavis Group PTC ehf|Mylan AB|Atenólól||1433||1433|2939| 449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|||0|0|0|1|AGT|0|0|0|100|DKK|5400|7794|lyfsjukr||||10|0|8,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||5400||5400|7794| 449911|A10AC0110|Humulin NPH KwikPen|stl|100|ae/ml|3|ml|5|pennar|áfylltur penni|A10AC01|01.01.2012||R|||0|0|*|0|ELI|0|0|0|100|XEU|5245|8154|lyfalmen||||15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||5245||5245|8154| 450009|QN51AA0101|Euthasol vet.|stl|400|mg/ml|100|ml|1|fl||QN51AA01|01.07.2012||R|||1|0|0|0|LEV|1|0|0|100|XEU|4548|8905|vetalmen||||100|0||Le Vet B.V.|Le Vet B.V.|Pentobarbital||4548||4548|8905| 450155|J01CR0202|Augmentin|töflur|1|g|12|stk|1|pakki|ţp 875+125 mg|J01CR02|01.01.1997||R|||0|0|0|0|GSK|0|0|1|100|IKR|1115|2382|lyfalmen|V0169|2367||12|0|10,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1026||1026|2382| 450734|N05CF0201|Stilnoct|töflur|10|mg|20|stk|1|ţpakki||N05CF02|01.10.1992||R|||0|0|0|0|SNO|0|0|1|100|NOK|892|1764|lyfalmen|V0060|1053||20|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||574||574|1764| 450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|ţpakki||N05CF02|01.10.1992||R|||0|0|0|0|SNO|0|0|0|100|NOK|3098|4146|lyfalmen|V0313|3958||100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||2315||2315|4146| 450979|QP54AA0302|Noromectin Drench|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA03|01.11.2011||R|||0|0|0|0|NOB|1|0|0|100|XEU|7259|12663|vetorma||||2|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Doramectinum||7259||7259|12663| 451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|||0|0|0|1|GEH|0|0|0|100|NOK|55834|71954|lyfsjukr||||100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||55834||55834|71954| 451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|||0|0|0|1|GEH|0|0|0|100|NOK|83752|106991|lyfsjukr||||150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||83752||83752|106991| 451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|||0|0|0|1|GEH|0|0|0|100|NOK|111669|142027|lyfsjukr||||200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||111669||111669|142027| 451989|N06AB0401|Cipramil|töflur|30|mg|28|stk|1|ţpakki||N06AB04|01.11.1999||R|||0|0|0|0|LBK|0|1|0|100|DKK|5575|7842|lyfalmen||||28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||5017||5017|7842| 451997|N06AB0401|Cipramil|töflur|30|mg|100|stk|1|glas||N06AB04|01.11.1999||R|||0|0|0|0|LBK|0|1|0|100|DKK|14723|21023|lyfalmen||||100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||14723||14723|21023| 452022|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|fl||D01AC08|01.01.2012||L|||0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa||||120|0||Vistor hf|McNeil Sweden AB|Ketókónazól|||||| 452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|||0|0|E|0|ROA|0|0|1|100|DKK|1131|2526|lyfalmen||||5|0|5,0000|Icepharma hf|Roche A.S.|Ketórólak||1131||1131|2526| 452467|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.03.2011||R|||0|0|0|0|LHS|0|0|0|100|XEU|10875|18971|vetorma||||50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||10875||10875|18971| 452482|V07AB09|Sterilt Vann B. Braun|leysir|||100|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|||0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa||||2000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|||0|0|0|0|LAB|0|0|1|100|SEK|12232|17896|lyfalmen||||3000|0||Vistor hf|Laboratories 3M Santé|Imikvímóđ||12232||12232|17896| 452896|A06AD1701|Phosphoral|mixtúra|||45|ml|2|fl||A06AD17|01.03.1999||R|||0|0|0|0|LCC|0|0|0|100|DKK|2283|4102|lyfalmen||||90|0||Clean Chemical Sweden AB|Laboratorios Casen-Fleet S.L.U.|Natríumfosföt||2283||2283|4102| 452904|N02AA0501|Oxycontin|forđatfl|10|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|||1|0|E|0|NOP|0|0|0|100|DKK|2314|4144|lyfalmen||||28|0|3,7300|Icepharma hf|Norpharma |Oxýcódon||2314||2314|4144| 452920|N02AA0501|Oxycontin|forđatfl|10|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|||1|0|E|0|NOP|0|0|0|100|DKK|6803|10285|lyfalmen||||98|0|13,0700|Icepharma hf|Norpharma |Oxýcódon||6803||6803|10285| 452995|N02AA0501|Oxycontin|forđatfl|20|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|||1|0|E|0|NOP|0|0|0|100|DKK|4468|7091|lyfalmen||||28|0|7,4700|Icepharma hf|Norpharma |Oxýcódon||4468||4468|7091| 453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dćl||QP54AA01|01.01.1991||L|||0|0|0|0|MEF|0|0|0|100|XEU|1437|2507|vetorma||||6|0||Vistor hf|Merial (MSD)|Ivermectinum||||1437|2507| 453175|N02AA0501|Oxycontin|forđatfl|20|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|||1|0|E|0|NOP|0|0|0|100|DKK|13175|19080|lyfalmen||||98|0|26,1300|Icepharma hf|Norpharma |Oxýcódon||13175||13175|19080| 453498|N02AA0501|Oxycontin|forđatfl|40|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|||1|0|E|0|NOP|0|0|0|100|DKK|8551|12676|lyfalmen||||28|0|14,9300|Icepharma hf|Norpharma |Oxýcódon||8551||8551|12676| 453571|N02AA0501|Oxycontin|forđatfl|40|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|||1|0|E|0|NOP|0|0|0|100|DKK|24013|32681|lyfalmen||||98|0|52,2700|Icepharma hf|Norpharma|Oxýcódon||24013||24013|32681| 453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|||0|0|0|1|PER|0|1|0|100|DKK|2682|3871|lyfsjukr||||1|0|0,5000|Icepharma hf|Pfizer ApS|Ziprasidon||2682||2682|3871| 453795|J07AL0102|Pneumo 23|bóluefni|||0,5|ml|1|dćla||J07AL01|01.09.2003||R|||0|0|0|0|SPM|0|0|0|100|XEU|2240|4043|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar||2240||2240|4043| 454439|N06DA0201|Aricept|töflur|5|mg|28|stk|1|ţpakki||N06DA02|01.09.1998||R|||0|0|E|0|PER|0|0|0|100|DKK|14944|21300|lyfalmen||||28|0|18,6667|Icepharma hf|Pfizer ApS|Dónepezíl||14944||14944|21300| 454454|N06DA0201|Aricept|töflur|5|mg|98|stk|1|ţpakki||N06DA02|01.09.1998||R|||0|0|E|0|PER|0|0|0|100|DKK|42396|38038|lyfalmen|V0341|13333||98|0|65,3333|Icepharma hf|Pfizer ApS|Dónepezíl||28281||28281|38038| 454491|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|28|stk|1|ţpakki||A02BC05|01.11.2011||R|||0|0|0|0|POF|0|0|0|100|XEU|2065|2105|lyfalmen|V0004|1696||28|0|18,6700|Portfarma ehf|Portfarma|Esómeprazól||823||823|2105| 454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|ţpakki||N06DA02|01.09.1998||R|||0|0|E|0|PER|0|0|0|100|DKK|16775|23598|lyfalmen||||28|0|37,3333|Icepharma hf|Pfizer ApS|Dónepezíl||16775||16775|23598| 454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|ţpakki||N06DA02|01.09.1998||R|||0|0|E|0|PER|0|0|0|100|DKK|46710|42383|lyfalmen|V0342|14635||98|0|130,6667|Icepharma hf|Pfizer ApS|Dónepezíl||31743||31743|42383| 454819|N02BE0115|Paracet|eţ-stíll|60|mg|10|stk|1|pakki||N02BE01|01.07.2011||L|||0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa||||10|0|0,2000|Actavis Group hf|Actavis Group PTC ehf|Paracetamól|||||| 454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|||0|1|0|1|SKB|0|0|0|100|GBP|54422|70182|lyfsjukr||||1|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||54422||54422|70182| 454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|||0|0|0|0|BID|0|0|0|100|DKK|1119|2226|vetalmen||||100|0||Vistor hf|Boehringer Ingelheim Danmark|||1119||1119|2226| 455329|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|ţpakki||A10BF01|01.12.1997||R|||0|0|*|0|BAP|0|0|0|100|SEK|1046|2410|lyfalmen||||30|0|5,0000|Icepharma hf|Bayer Schering Pharma AG|Acarbósa||1046||1046|2410| 455337|A10BF0101|Glucobay|töflur|50|mg|120|stk|1|ţpakki||A10BF01|01.12.1997||R|||0|0|*|0|BAP|0|0|0|100|SEK|3758|6120|lyfalmen||||120|0|20,0000|Icepharma hf|Bayer Schering Pharma AG|Acarbósa||3758||3758|6120| 455584|J05AB0901|Famvir|töflur|500|mg|21|stk|1|ţpakki||J05AB09|01.10.1995||R|||0|0|E|0|NOH|0|0|1|100|DKK|21365|29358|lyfalmen||||21|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||21365||21365|29358| 455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|ţpakki|0|J01AA02|01.10.2008||R|||0|0|0|0|AGT|0|0|1|100|XEU|898|2207|lyfalmen||||10|0|10,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||898||898|2207| 455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|ţpakki||J01AA02|01.01.2009||R|||0|0|0|0|AGT|0|0|1|100|XEU|1016|2369|lyfalmen||||15|0|15,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||1016||1016|2369| 455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|ţpakki|0|J01AA02|01.10.2008||R|||0|0|0|0|AGT|0|0|1|100|XEU|2106|3860|lyfalmen||||30|0|30,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||2106||2106|3860| 457726|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|28|stk|1|ţpakki||A02BC04|01.05.2011||R|||0|0|0|0|APC|0|0|0|100|XEU|779|1555|lyfalmen|V0003|1555||28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||421||421|1555| 458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|||0|0|0|0|CHE|0|0|1|100|SEK|1207|2630|lyfalmen||||25|0|5,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Clómetíazól||1207||1207|2630| 458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|ţpakki||J01CA08|01.12.1980||R|||0|0|0|0|LEP|0|0|1|100|DKK|1405|2901|lyfalmen|V0577|2581||20|0|6,6667|Vistor hf|LEO Pharma A/S|Pívmecillínam||1405||1405|2901| 458865|A07AA0906|Vancomycin Xellia|hylki|250|mg|28|stk|1|ţpakki|hart hylki|A07AA09|01.01.2011||R|||0|0|E|0|XEL|0|0|1|100|DKK|23596|32158|lyfalmen||||28|0|3,5000|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||23596||23596|32158| 459104|N05AH0310|Zalasta (LYFIS)|töflur|2,5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|||0|0|*|0|LYF|0|1|0|100|XEU|2421|1816|lyfalmen|V0278|1816||28|0|7,0000|LYFIS ehf|LYFIS ehf|Olanzapín||612||612|1816| 459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|||0|0|0|1|PER|0|0|0|100|DKK|835|1205|lyfsjukr||||2|0|0,1667|Icepharma hf|Pfizer ApS|Klindamýcín||835||835|1205| 459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|||0|0|0|1|PER|0|0|0|100|DKK|1528|2205|lyfsjukr||||4|0|0,3333|Icepharma hf|Pfizer ApS|Klindamýcín||1528||1528|2205| 459766|N05AH0501|Sycrest|tungur.t|5|mg|20|stk|1|ţpakki||N05AH05|01.10.2011||R|||0|0|0|0|ORR|0|1|0|100|DKK|7414|11121|lyfalmen||||20|0|5,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||7414||7414|11121| 459828|N07BA0145|Nicorette Freshdrops|munnstfl|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||96|0|6,4000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|ţpakki||B02AA02|01.04.1989||R|||0|0|E|0|MAS|0|0|1|100|SEK|2253|4061|lyfalmen||||30|0|7,5000|Vistor hf|Meda AS|Tranexamsýra||2253||2253|4061| 459867|B02AA0201|Cyklokapron|töflur|500|mg|60|stk|1|ţpakki||B02AA02|01.04.1989||R|||0|0|E|0|MAS|0|0|1|100|SEK|4574|7236|lyfalmen||||60|0|15,0000|Vistor hf|Meda AS|Tranexamsýra||4574||4574|7236| 460170|J07BC0202|Avaxim|bóluefni|||0,5|ml|1|dćla|einnota dćla|J07BC02|01.04.1998||R|||0|0|0|0|MEX|0|0|0|100|XEU|3918|6339|lyfalmen||||0|0||Icepharma hf|Aventis Pasteur MSD A/S|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||3918||3918|6339| 460293|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|ţpakki||J04AB02|01.09.2012||R|||0|0|E|0|SAD|0|0|0|100|DKK|8021|11951|lyfalmen||||100|0|25,0000|Icepharma hf|Sandoz GmbH|Rífampicín||8021||8021|11951| 460303|J01CA0406|Flemoxin Solutab|lausnart|750|mg|20|stk|1|ţpakki||J01CA04|01.07.1989||R|||0|0|0|0|ASP|0|0|1|100|XEU|549|1730|lyfalmen||||20|0|15,0000|Vistor hf|Astellas Pharma A/S|Amoxicillín||549||549|1730| 460826|QJ01CR0201|Combisyn|töflur|250|mg|100|stk|1|töflur||QJ01CR02|01.11.2011||R|||0|0|0|0|NOB|1|0|0|100|XEU|6943|13504|vetalmen||||100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||6943||6943|13504| 460972|J07BB0205|Influvac|bóluefni|||0,5|ml|10|spr|einnotaspr|J07BB02|01.12.1998||R|||0|0|0|0|AHP|0|0|0|100|XEU|5457|8444|lyfalmen||||5|0||Vistor hf|Abbott Healthcare Products B.V.|Inflúensa, hreinsađir mótefnavakar||5457||5457|8444| 461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1989||R|||0|0|0|0|ACA|0|0|1|100|XEU|183|1229|lyfalmen||||10|0|1,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||183||183|1229| 462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|||0|0|B|0|GSK|0|0|1|100|GBP|682|1912|lyfalmen||||25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||682||682|1912| 462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|||0|0|B|0|GSK|0|0|1|100|GBP|682|1912|lyfalmen||||25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||682||682|1912| 462358|A07EA0601|Entocort|endaţ.dr|20|mcg/ml|7|stk|1|ţpakki|samsett pk|A07EA06|01.04.1993||R|||0|0|B|0|AZD|0|0|0|100|SEK|7826|11684|lyfalmen||||7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||7826||7826|11684| 462813|A07AA0906|Vancomycin Xellia|hylki|125|mg|28|stk|1|ţpakki|hart hylki|A07AA09|01.01.2011||R|||0|0|E|0|XEL|0|0|1|100|DKK|11782|17096|lyfalmen||||28|0|1,7500|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||11782||11782|17096| 462986|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2000||R|||0|0|0|0|PAL|1|0|0|100|DKK|6533|12717|vetalmen||||20|0||Icepharma hf|Pfizer Oy Animal Health|||||6533|12717| 463490|N03AX2101|Trobalt|filmhtfl|100|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|9164|13515|lyfalmen||||84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||9164||9164|13515| 463612|QM01AE9101|Rimadyl vet.|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.06.2000||R|||0|0|0|0|PAL|0|0|0|100|DKK|5211|10178|vetalmen||||100|0||Icepharma hf|Pfizer Oy Animal Health|||5211||5211|10178| 464164|N02BE0101|Panodil|töflur|500|mg|30|stk|1|ţpakki||N02BE01|01.04.1992||L|||0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa||||30|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||| 464370|N05AD0301|Buronil|töflur|25|mg|100|stk|1|glas||N05AD03|01.12.1972||R|||0|0|*|0|MEL|0|1|0|100|DKK|1724|3337|lyfalmen||||100|0|8,3333|Swedish Orphan Biovitrum A/S|MediLink A/S|Melperón||1724||1724|3337| 465065|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.10.2011||R|||0|0|*|0|APC|0|0|0|100|DKK|3974|6363|lyfalmen|V0376|6363||8|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||3936||3936|6363| 465203|QJ01RA0103|Depomycine, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.12.1982||R|||0|0|0|0|IBV|0|0|0|100|DKK|1157|2301|vetalmen||||100|0||Vistor hf|Intervet International BV|||1157||1157|2301| 465237|QJ01CR5001|Duplocillin L.A., vet.|stl|||100|ml|1|hgl||QJ01CR50|01.05.1983||R|||0|0|0|0|IBV|1|0|0|100|DKK|1093|2174|vetalmen||||100|0||Vistor hf|Intervet International BV|||1093||1093|2174| 465260|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.12.1982||R|||0|0|0|0|IBV|0|0|0|100|DKK|1172|2331|vetalmen||||100|0||Vistor hf|Intervet International BV|||1172||1172|2331| 465278|QJ51RC2301|Nafpenzal DC, vet.|spenalyf|||3|g|4|spr||QJ51RC23|01.04.1985||R|||0|0|0|0|IBV|0|0|0|100|XEU|618|1229|vetalmen||||12|0||Vistor hf|Intervet International BV|||618||618|1229| 466086|N02AA0101|Contalgin|forđatfl|10|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|||1|0|E|0|PER|0|0|0|100|DKK|650|1868|lyfalmen||||25|0|2,5000|Icepharma hf|Pfizer ApS|Morfín||650||650|1868| 466094|N02AA0101|Contalgin|forđatfl|10|mg|100|stk|1|ţpakki||N02AA01|01.08.1984||R|||1|0|E|0|PER|0|0|0|100|DKK|2012|3731|lyfalmen||||100|0|10,0000|Icepharma hf|Pfizer ApS|Morfín||2012||2012|3731| 466169|N02AA0101|Contalgin|forđatfl|30|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|||1|0|E|0|PER|0|0|0|100|DKK|1440|2949|lyfalmen||||25|0|7,5000|Icepharma hf|Pfizer ApS|Morfín||1440||1440|2949| 466219|N02AA0101|Contalgin|forđatfl|30|mg|100|stk|1|ţpakki||N02AA01|01.08.1984||R|||1|0|E|0|PER|0|0|0|100|DKK|5629|8679|lyfalmen||||100|0|30,0000|Icepharma hf|Pfizer ApS|Morfín||5629||5629|8679| 466466|N02AA0101|Contalgin|forđatfl|60|mg|25|stk|1|ţpakki||N02AA01|01.10.1995||R|||1|0|E|0|PER|0|0|0|100|DKK|2678|4642|lyfalmen||||25|0|15,0000|Icepharma hf|Pfizer ApS|Morfín||2678||2678|4642| 466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|||0|0|*|0|NOH|0|0|0|100|DKK|7714|11531|lyfalmen||||50|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||7714||7714|11531| 466680|N02AA0101|Contalgin|forđatfl|100|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|||1|0|E|0|PER|0|0|0|100|DKK|4406|7006|lyfalmen||||25|0|25,0000|Icepharma hf|Pfizer ApS|Morfín||4406||4406|7006| 466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|ţpakki||N06AG02|01.10.1990||R|||0|0|B|0|MAS|0|1|0|100|SEK|4670|7367|lyfalmen||||100|0|50,0000|Vistor hf|Meda AS|Móklóbemíđ||4670||4670|7367| 467191|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|||0|1|0|1|AEU|0|0|0|100|DKK|14880|20557|lyfsjukr||||0|0|0,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||14880||14880|20557| 467258|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|||0|1|0|1|AEU|0|0|0|100|DKK|22803|30500|lyfsjukr||||0|0|1,3700|Vistor hf|Amgen Europe B.V.|Fílgrastím||22803||22803|30500| 467480|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001|30.09.2012|R|||0|1|0|1|SCP|0|0|0|100|DKK|17414|23737|lyfsjukr||||1|0|9,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||17414||17414|23737| 467498|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001|30.09.2012|R|||0|1|0|1|SCP|0|0|0|100|DKK|28087|37132|lyfsjukr||||1|0|15,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||28087||28087|37132| 467514|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.04.2004||R|||0|1|*|0|WTE|0|0|0|100|DKK|33008|43970|lyfalmen||||60|0|20,0000|Icepharma hf|Wyeth Europe|Sirolimus||33008||33008|43970| 467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|||0|0|*|0|NOH|0|0|0|100|DKK|15048|21430|lyfalmen||||50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||15048||15048|21430| 467621|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001|30.09.2012|R|||0|1|0|1|SCP|0|0|0|100|DKK|52237|67440|lyfsjukr||||1|0|30,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||52237||52237|67440| 467699|G03FA1701|Angemin|töflur|||84|stk|1|ţpakki|2+1 mg|G03FA17|01.10.2012||R|||0|0|0|0|BYP|0|0|0|100|SEK|7306|10973|lyfalmen||||84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrogen||7306||7306|10973| 467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|||0|0|*|0|NOH|0|0|0|100|DKK|28653|38505|lyfalmen||||50|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||28653||28653|38505| 467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|||0|0|0|1|JAS|0|1|0|100|SEK|520|750|lyfsjukr||||5|0|3,1250|Vistor hf|Janssen-Cilag AB|Halóperídól||520||520|750| 468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|||0|0|B|0|LBK|0|1|0|100|DKK|6245|6514|lyfalmen|V0317|3542||100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4046||4046|6514| 468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|||1|0|0|1|JAS|0|0|0|100|SEK|395|570|lyfsjukr||||10|0||Vistor hf|Janssen-Cilag AB|Fentanýl||395||395|570| 468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|||0|0|B|0|LBK|0|1|0|100|DKK|9093|6207|lyfalmen|V0318|3542||100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3822||3822|6207| 468165|N06AB0401|Cipramil|töflur|40|mg|100|stk|1|glas||N06AB04|01.04.1993||R|||0|0|0|0|LBK|0|1|0|100|DKK|22974|12474|lyfalmen|V0320|6150||100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||8403||8403|12474| 468803|M05BA0705|Risedronat Actavis|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.03.2011||R|||0|0|E|0|APC|0|0|0|100|IKR|4530|3113|lyfalmen|V0207|3103||12|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rísedrónsýru||1560||1560|3113| 468996|A02BC0402|Rabeprazol Actavis|sţ-tfl|10|mg|100|stk|1|glas||A02BC04|01.01.2012||R|||0|0|E|0|APC|0|0|0|100|IKR|4172|5077|lyfalmen|V0467|5077||100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||2996||2996|5077| 469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|ţpakki||C10AB04|01.07.1991||R|||0|0|0|0|PER|0|0|0|100|DKK|5490|8489|lyfalmen||||98|0|49,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||5490||5490|8489| 469480|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|7393|10670|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||7393||7393|10670| 469817|N02AX0206|Nobligan Retard|forđatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|||0|0|E|0|GRU|0|0|1|100|DKK|6148|9389|lyfalmen|V0228|9385||100|0|66,6667|Icepharma hf|Grunenthal|Tramadól||6148||6148|9389| 469874|N02AX0206|Nobligan Retard|forđatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|||0|0|E|0|GRU|0|0|1|100|DKK|4999|7817|lyfalmen|V0227|7293||100|0|50,0000|Icepharma hf|Grunenthal|Tramadól||4999||4999|7817| 469932|N02AX0206|Nobligan Retard|forđatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|||0|0|E|0|GRU|0|0|1|100|DKK|3264|5444|lyfalmen|V0226|4789||100|0|33,3333|Icepharma hf|Grunenthal|Tramadól||3264||3264|5444| 470385|R03BA0501|Flixotide|innúđal|250|mcg/sk|120|skammtar|1|stauk||R03BA05|01.04.1995||R|||0|0|B|0|GSK|0|0|0|100|GBP|6002|9189|lyfalmen||||120|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||6002||6002|9189| 470397|N05CM1801|Dexdor|irţ|100|mcg/ml|4|ml|4|hgl|lausn|N05CM18|01.03.2012||R|||0|1|0|1|ORC|0|0|0|100|DKK|30119|39682|lyfsjukr||||16|0||Vistor hf|Orion Corporation|Dexmedetómid||30119||30119|39682| 470989|V08AB0201|Omnipaque|stl|180|mg J/ml|15|ml|10|plastf||V08AB02|01.01.2005||R|||0|0|0|1|GEH|0|0|0|100|NOK|7277|10503|lyfsjukr||||150|0||Icepharma hf|GE Healthcare AS|Jóhexól||7277||7277|10503| 471144|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|||0|0|0|1|GEH|0|0|0|100|NOK|9712|14017|lyfsjukr||||200|0||Icepharma hf|GE Healthcare AS|Jóhexól||9712||9712|14017| 471151|V08AB0201|Omnipaque|stl|300|mg J/ml|10|ml|10|plastf||V08AB02|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|IKR|4414|6371|lyfsjukr||||100|0||Icepharma hf|GE Healthcare AS|Jóhexól||4414||4414|6371| 471169|V08AB0201|Omnipaque|stl|300|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|||0|0|0|1|GEH|0|0|0|100|NOK|9703|14004|lyfsjukr||||200|0||Icepharma hf|GE Healthcare AS|Jóhexól||9703||9703|14004| 471177|V08AB0201|Omnipaque|stl|350|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|||0|0|0|1|GEH|0|0|0|100|NOK|13935|19371|lyfsjukr||||200|0||Icepharma hf|GE Healthcare AS|Jóhexól||13935||13935|19371| 471425|A10BB0701|Mindiab|töflur|5|mg|100|stk|1|ţpakki||A10BB07|01.07.1990||R|||0|0|*|0|PER|0|0|0|100|DKK|1187|2603|lyfalmen||||100|0|50,0000|Icepharma hf|Pfizer ApS|Glípízíđ||1187||1187|2603| 471821|QP52AC1302|Panacur, vet.|töflur|250|mg|20|stk|1|ţpakki||QP52AC13|01.04.1992||L|||0|0|0|0|IBV|0|0|0|100|DKK|2071|3613|vetorma||||20|0||Vistor hf|Intervet International BV|||||2071|3613| 471938|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|ţpakki||L01AA01|01.01.1988||R|||0|0|*|0|BAM|0|0|0|100|SEK|3423|5661|lyfalmen||||100|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||3423||3423|5661| 471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|||0|0|0|0|ORC|1|0|0|100|DKK|4639|9080|vetalmen||||10|0||Vistor hf|Orion Corporation|||4639||4639|9080| 472092|C07AB0206|Seloken ZOC|forđatfl|47,5|mg|98|stk|1|ţpakki||C07AB02|01.07.1989||R|||0|0|B|0|AZD|0|0|0|100|SEK|2183|3965|lyfalmen|V0048|2716||98|0|31,0300|Vistor hf|AstraZeneca A/S DK|Metóprólól||2183||2183|3965| 472099|R02AA0307|Strepsils Warm|sogtfl|||24|stk|1|ţpakki||R02AA03|01.08.2011||L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 472332|J07BC0201|Havrix|bóluefni|1440|ein/ml|0,5|ml|1|dćla|einnota dćla|J07BC02|01.10.1995||R|||0|0|0|0|GSK|0|0|0|100|GBP|3202|5359|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||3202||3202|5359| 472599|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|98|stk|1|glas||A02BC05|01.08.2011||R|||0|0|E|0|LYF|0|0|0|100|IKR|13009|5012|lyfalmen|V0012|5012||98|0|130,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||2948||2948|5012| 474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|||0|0|0|1|MAB|0|0|0|100|SEK|15929|21873|lyfsjukr||||400|0||Vistor hf|Meda AB|Dextran||15929||15929|21873| 474043|N01AH0601|Remifentanil Actavis|sts/irs|2|mg|5|hgl|1|pakki|ţykkni,lausn|N01AH06|01.06.2012||R|||1|0|0|1|AGP|0|0|0|100|XEU|5141|7420|lyfsjukr||||5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||5141||5141|7420| 474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|||0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa||||50|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||| 474114|N02CA7201|Anervan|töflur|160,5|mg|30|stk|1|pakki|ţp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|||0|0|E|0|REP|0|0|0|100|SEK|1050|2415|lyfalmen||||30|0|3,7500|Vistor hf|Recip AB|Ergotamínlyf í blöndum međ geđlyfjum (psycoleptica)||1050||1050|2415| 474197|M02AA1301|Deep Relief|hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|||0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa||||15|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||| 474395|J05AG0101|Viramune|töflur|200|mg|60|stk|1|ţpakki||J05AG01|01.03.2007||R|||0|1|0|1|BII|0|0|0|100|DKK|35597|46557|lyfsjukr||||60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Nevírapín||35597||35597|46557| 474431|N05AH0310|Zalasta (LYFIS)|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|||0|0|*|0|LYF|0|1|0|100|XEU|14058|9397|lyfalmen|V0456|9397||28|0|28,0000|LYFIS ehf|LYFIS ehf|Olanzapín||6154||6154|9397| 474551|R01AD0901|Nasonex|nefúđi|50|mcg/sk|140|skammtar|1|úđagl|18 g í pakkn.|R01AD09|01.05.1998||R|||0|0|E|0|SPL|0|0|1|100|DKK|1804|3447|lyfalmen||||140|0|35,0000|Vistor hf|Schering-Plough Europe|Mómetasón||1804||1804|3447| 474608|QB03AC9001|Uniferon|stl|200|mg/ml|100|ml|12|hgl|lausn|QB03AC90|01.08.2011||R|||0|0|0|0|PHM|0|0|0|100|DKK|26931|51884|vetalmen||||1200|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíđ||||26931|51884| 474657|N04BC0504|Oprymea (Lyfis)|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.07.2010||R|||0|0|E|0|LYF|0|0|0|100|XEU|779|1099|lyfalmen|V0266|1099||30|0|1,0600|LYFIS ehf|LYFIS ehf|Pramipexól||88||88|1099| 475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|||0|0|E|0|ACA|0|0|0|100|IKR|930|2251|lyfalmen||||100|0|26,6667|Actavis Group hf|Actavis hf|Warfarín||930||930|2251| 475467|G03CA0306|Evorel|forđapl|50|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|||0|0|E|0|JAS|0|0|0|100|SEK|3277|5462|lyfalmen|V0130|5462||26|0|91,0000|Vistor hf|Janssen-Cilag AB|Estradíól||3277||3277|5462| 475491|N02AA5902|Parkodin forte|töflur|530|mg|20|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|||0|0|0|0|ACA|0|0|1|100|NOK|291|1377|lyfalmen||||20|0|6,6667|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||291||291|1377| 475533|N02AA5902|Parkodin forte|töflur|530|mg|30|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|||0|0|0|0|ACA|0|0|1|100|NOK|355|1465|lyfalmen||||30|0|10,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||355||355|1465| 475715|N02AA5902|Parkodin forte|töflur|530|mg|100|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|||1|0|0|0|ACA|0|0|1|100|NOK|992|2336|lyfalmen||||100|0|33,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||992||992|2336| 475798|R03AC1302|Oxis Turbuhaler|innúđadu|4,5|mcg/sk|60|skammtar|1|stauk||R03AC13|01.10.1997||R|||0|0|0|0|AZD|0|0|1|100|SEK|3774|6142|lyfalmen||||60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||3774||3774|6142| 475822|R03AC1302|Oxis Turbuhaler|innúđadu|9|mcg/sk|60|skammtar|1|stauk||R03AC13|01.10.1997||R|||0|0|0|0|AZD|0|0|1|100|SEK|4972|7780|lyfalmen||||60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||4972||4972|7780| 475921|A10AB0404|Humalog Pen|stl|100|ae/ml|3|ml|5|pennar|einnota pennar|A10AB04|01.11.1999||R|||0|0|*|0|ELD|0|0|0|100|XEU|5436|8415|lyfalmen||||15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||5436||5436|8415| 476093|A10AC0106|Humulin NPH Pen|stl|100|ae/ml|3|ml|5|pennar|Einnota pennar|A10AC01|01.06.1999||R|||0|0|*|0|ELI|0|0|0|100|XEU|5874|9014|lyfalmen||||15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||5874||5874|9014| 476434|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|75488|96620|lyfsjukr||||1|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||||75488|96620| 476580|R03AC0206|Ventoline|lausn|2|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|||0|0|B|0|GSK|0|0|1|100|IKR|1200|2538|lyfalmen||||20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||1140||1140|2538| 476736|N05AH0311|Olanzapine Ranbaxy|töflur|10|mg|56|stk|1|ţpakki||N05AH03|01.12.2011||R|||0|0|*|0|RAN|0|1|0|100|XEU|11564|6957|lyfalmen|V0282|6691||56|0|56,0000|Artasan ehf|Ranbaxy (UK) Ltd|Olanzapín||4370||4370|6957| 477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|glas|250 + 100 mg|P01BB51|01.02.2006||R|||0|0|0|0|GSK|0|0|0|100|GBP|5273|8192|lyfalmen||||12|0|3,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Prógúaníl í blöndum||5273||5273|8192| 477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||20|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||50|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||500|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 477752|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 477760|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||500|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 477786|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|100|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||1000|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 478119|A10BA0202|Metformin Actavis|filmhtfl|500|mg|100|stk|1|glas||A10BA02|01.12.2011||R|||0|0|*|0|APC|0|0|0|100|XEU|483|1541|lyfalmen|V0500|1532||100|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||411||411|1541| 479407|L04AA1302|Leflunomide medac|filmhtfl|20|mg|100|stk|1|glas||L04AA13|01.07.2011||R|||0|1|*|0|WIL|0|0|0|100|XEU|28610|38451|lyfalmen|V0454|38451||100|0|100,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíđ||28610||28610|38451| 480867|N06DA0205|Donesyn|filmhtfl|5|mg|98|stk|1|ţpakki||N06DA02|01.05.2011||R|||0|0|E|0|WIH|0|0|0|100|XEU|25521|13353|lyfalmen|V0341|13333||98|0|65,3333|Portfarma ehf|Williams & Halls|Dónepezíl||9046||9046|13353| 480897|G03XC0101|Evista|töflur|60|mg|84|stk|1|ţpakki||G03XC01|01.02.1999||R|||0|0|E|0|DSG|0|0|0|100|SEK|13022|18888|lyfalmen||||84|0|84,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||13022||13022|18888| 481176|N06AX1201|Zyban|forđatfl|150|mg|100|stk|1|ţpakki||N06AX12|01.09.2000||R|||0|0|0|0|GSK|0|1|0|100|GBP|14216|20386|lyfalmen||||100|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||14216||14216|20386| 481534|N02AX0204|Tradolan|filmhtfl|50|mg|20|stk|1|ţpakki||N02AX02|01.05.2012||R|||0|0|E|0|GLP|0|0|1|100|SEK|342|1447|lyfalmen|V0055|1262||20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||342||342|1447| 483217|B01AX0601 |Xarelto|filmhtfl|20|mg|98|stk|1|ţpakki||B01AX06|01.05.2012||R|||0|0|E|0|BAP|0|0|0|100|SEK|37595|49727|lyfalmen|V0030|49674||98|0|196,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||37595|49727| 483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990||R|||0|0|0|1|PER|0|0|0|100|DKK|2701|3898|lyfsjukr||||50|0|0,5000|Icepharma hf|Pfizer ApS|Flúkónazól||2701||2701|3898| 483663|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|3|lykja||B03BA03|01.07.2012||R|||0|0|E|0|SHS|0|0|1|100|DKK|3443|5689|lyfalmen||||3|0|150,0000|Artasan ehf|Sandoz A/S|Hýdroxókóbalamín||3443||3443|5689| 483685|J02AC0101|Diflucan|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.03.2001||R|||0|0|0|1|PER|0|0|0|100|DKK|4662|6728|lyfsjukr||||100|0|1,0000|Icepharma hf|Pfizer ApS|Flúkónazól||4662||4662|6728| 483711|S01ED5114|Latanoprost/Timolol Portfarma|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml|S01ED51|01.01.2012||R|||0|0|*|0|POF|0|0|0|100|DKK|2362|4210|lyfalmen|V0374|4210||2|0|25,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||2362||2362|4210| 483996|N02AX0212|Tramadol Actavis|hylki|50|mg|20|stk|1|ţpakki||N02AX02|01.09.2011||R|||0|0|E|0|AGP|0|0|1|100|XEU|284|1262|lyfalmen|V0055|1262||20|0|3,3300|Actavis Group hf|Actavis Group PTC ehf|Tramadól||207||207|1262| 484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|||0|1|0|1|FER|0|0|0|100|DKK|55717|71807|lyfsjukr||||3|0|83,9552|Vistor hf|Ferring|Triptórelín||55717||55717|71807| 484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|ţpakki||D11AX10|01.08.1999||R|||0|0|0|0|MSD|0|0|0|100|DKK|5790|8899|lyfalmen||||28|0|28,0000|Vistor hf|M.S.D.|Fínasteríđ||5790||5790|8899| 484327|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|nálavörn|L03AA13|01.11.2010||R|||0|1|0|1|AEU|0|0|0|100|DKK|149124|189033|lyfsjukr||||1|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||149124||149124|189033| 484618|A01AD0201|Andolex|lausn|1,5|mg/ml|300|ml|1|glas|lausn til munnskolunar|A01AD02|01.01.1996||R|||0|0|E|0|MEB|0|0|1|100|SEK|1415|2915|lyfalmen||||300|0||Vistor hf|Meda AB (V)|Benzýdamín||1415||1415|2915| 484721|L04AD0201|Advagraf|forđahlk|3|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|||0|1|*|0|APE|0|0|0|100|XEU|54558|71015|lyfalmen||||50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||54558||54558|71015| 485006|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.01.2012||R|||0|0|E|0|ANS|0|0|1|100|XEU|1211|2635|lyfalmen||||5|0||Anstalt zur gewerblichen Produktion|Anstalt zur gewerblichen Produktion|Prednisólón||1211||1211|2635| 486779|M01AE0218|Naproxen Mylan|töflur|250|mg|20|stk|1|ţpakki||M01AE02|01.04.1995||L|||0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa||||20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Naproxen|||||| 486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|||0|0|E|0|SAL|0|0|1|100|USD|470|1622|lyfalmen||||5|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Dexametasón||470||470|1622| 486886|S01CA0101|Maxitrol|augndr|||5|ml|1|glas||S01CA01|01.07.1990||R|||0|0|E|0|SAL|0|0|1|100|USD|671|1897|lyfalmen||||5|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Dexametasón||671||671|1897| 487341|A10BG0302|Pioglitazone Actavis|töflur|30|mg|98|stk|1|ţpakki||A10BG03|01.09.2012||R|||0|0|*|0|APC|0|0|0|100|XEU|19168|26601|lyfalmen|V0573|26601||98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||19168||19168|26601| 487682|N06AB1005|Escitalopram LYFIS|filmhtfl|15|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|||0|0|B|0|LYF|0|1|0|100|XEU|4611|4470|lyfalmen|V0326|4470||100|0|150,0000|LYFIS ehf|LYFIS ehf|Escítalópram||2552||2552|4470| 487725|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|||0|1|0|1|SCP|0|0|0|100|DKK|54027|69686|lyfsjukr||||1|0|30,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||54027||54027|69686| 487796|L04AA1302|Leflunomide medac|töflur|10|mg|100|stk|1|glas||L04AA13|01.07.2011||R|||0|1|*|0|WIL|0|0|0|100|XEU|31952|42645|lyfalmen|V0453|42645||100|0|50,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíđ||31952||31952|42645| 488049|M01AX0101|Relifex|töflur|500|mg|20|stk|1|ţpakki||M01AX01|01.04.1995||R|||0|0|E|0|MAB|0|0|1|100|SEK|979|2318|lyfalmen||||20|0|10,0000|Vistor hf|Meda AB|Nabúmeton||979||979|2318| 488056|M01AX0101|Relifex|töflur|500|mg|60|stk|1|plglas||M01AX01|01.07.1998||R|||0|0|E|0|MAB|0|0|1|100|SEK|2720|4700|lyfalmen|V0198|3877||60|0|30,0000|Vistor hf|Meda AB|Nabúmeton||2720||2720|4700| 488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|ţpakki||D05BB02|01.04.1992||R|||0|1|B|0|APC|0|0|0|100|DKK|6121|9352|lyfalmen||||50|0|14,2857|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||6121||6121|9352| 488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|ţpakki||D05BB02|01.04.1992||R|||0|1|B|0|APC|0|0|0|100|DKK|11008|16037|lyfalmen||||50|0|35,7143|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||11008||11008|16037| 489259|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|100624|128166|lyfsjukr||||2|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||||100624|128166| 489591|M01AB0506|Voltaren Rapid|töflur|50|mg|10|stk|1|ţpakki||M01AB05|01.01.1996||R|||0|0|0|0|NOH|0|0|1|100|IKR|338|1242|lyfalmen|V0188|463||10|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||192||192|1242| 489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|ţpakki||M01AB05|01.01.1996||R|||0|0|E|0|NOH|0|0|1|100|IKR|882|1618|lyfalmen|V0188|1389||30|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||467||467|1618| 490417|G03FB0504|Evorel Sequi|forđapl|||8|stk|1|pakki||G03FB05|01.08.1999||R|||0|0|E|0|JAS|0|0|0|100|SEK|2448|4328|lyfalmen||||8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2448||2448|4328| 490425|G03FA0104|Evorel Conti|forđapl|||8|stk|1|pakki||G03FA01|01.08.1999||R|||0|0|E|0|JAS|0|0|0|100|SEK|2580|4508|lyfalmen||||8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2580||2580|4508| 490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|ţpakki||C10AA05|01.03.1998||R|||0|0|0|0|PER|0|0|0|100|DKK|3854|6251|lyfalmen||||30|0|15,0000|Icepharma hf|Pfizer ApS|Atorvastatín||3854||3854|6251| 490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|||0|0|0|0|PER|0|0|0|100|DKK|10548|10336|lyfalmen|V0112|2449||100|0|50,0000|Icepharma hf|Pfizer ApS|Atorvastatín||6840||6840|10336| 490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|ţpakki||C10AA05|01.03.1998||R|||0|0|0|0|PER|0|0|0|100|DKK|5124|7988|lyfalmen||||30|0|30,0000|Icepharma hf|Pfizer ApS|Atorvastatín||5124||5124|7988| 490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|||0|0|0|0|PER|0|0|0|100|DKK|14970|14000|lyfalmen|V0113|2649||100|0|100,0000|Icepharma hf|Pfizer ApS|Atorvastatín||9519||9519|14000| 490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|||0|0|0|0|PER|0|0|0|100|DKK|19039|17621|lyfalmen|V0114|4946||100|0|200,0000|Icepharma hf|Pfizer ApS|Atorvastatín||12013||12013|17621| 491860|L03AX0301|Oncotice|duft|500|millj ae|3|hgl|1|pakki|Fyrir ídreypivökva.|L03AX03|01.03.1999||R|||0|1|0|1|ORG|0|0|0|100|DKK|48102|62251|lyfsjukr||||3|0|20,8300|Vistor hf|N.V. Organon|BCG bóluefni||48102||48102|62251| 492405|N04BA0202|Madopar Depot|forđahlk|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.01.1991||R|||0|0|E|0|ROC|0|0|0|100|DKK|3198|5354|lyfalmen||||100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3198||3198|5354| 492512|A02BC0102|Losec|sh-tfl|10|mg|14|stk|1|ţpakki||A02BC01|01.09.2009||L|||0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa||||14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||| 492520|A02BC0102|Losec|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|||0|0|0|0|AZD|0|0|0|100|SEK|12936|18780|lyfalmen|V0002|5247||100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||12936||12936|18780| 492546|A02BC0102|Losec|sh-tfl|20|mg|14|stk|1|ţpakki||A02BC01|01.05.2009||L|||0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa||||14|0|14,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||| 493113|R02AA0306|Strepsils Jordbćr Sukkerfri|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.2011||L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 493689|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|||0|0|0|0|APC|0|0|0|100|XEU|23365|16906|lyfalmen|V0516|14515||100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||11643||11643|16906| 494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|||0|0|B|0|SNO|0|1|0|100|NOK|1429|2934|lyfalmen||||100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||1429||1429|2934| 494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|ţpakki||N02CX01|01.04.1974||R|||0|0|E|0|NOH|0|0|0|100|DKK|2404|4267|lyfalmen||||100|0|33,3333|Vistor hf|Novartis Healthcare A/S-|Pízótífen||2404||2404|4267| 494237|L01XC0201|MabThera|irţ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|||0|1|0|1|RRL|0|0|0|100|DKK|78747|100710|lyfsjukr||||20|0||Icepharma hf|Roche Registration Limited|Rítúxímab||78747||78747|100710| 494286|L01XC0201|MabThera|irţ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|||0|1|0|1|RRL|0|0|0|100|DKK|196869|248953|lyfsjukr||||50|0||Icepharma hf|Roche Registration Limited|Rítúxímab||196869||196869|248953| 494559|D10AF0101|Dalacin|fleyti|10|mg/ml|60|ml|1|glas|Áburđur, fleyti|D10AF01|01.10.1995||R|||0|0|0|0|PER|0|0|0|100|DKK|1962|3663|lyfalmen||||60|0||Icepharma hf|Pfizer ApS|Klindamýcín||1962||1962|3663| 494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|||0|0|E|0|NAS|0|0|0|100|DKK|2201|3990|lyfalmen|V0128|2144||84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||2201||2201|3990| 494724|G03FA0102|Kliogest|töflur|||84|stk|1|skífup||G03FA01|01.10.1986||R|||0|0|E|0|NAS|0|0|0|100|DKK|3198|5354|lyfalmen|V0410|4930||84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||3198||3198|5354| 494831|B01AC0702|Persantin retard|forđahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|||0|0|E|0|BII|0|0|0|100|DKK|1818|3466|lyfalmen||||60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||1818||1818|3466| 495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|ţpakki||A04AA01|01.01.1991||R|||0|0|E|0|GSK|0|0|0|100|GBP|18952|8445|lyfalmen|V0384|7146||15|0|7,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||5458||5458|8445| 495382|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.01.1991||R|||0|0|E|0|GSK|0|0|0|100|GBP|7371|6515|lyfalmen|V0382|6237||10|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||4047||4047|6515| 495390|A04AA0101|Zofran|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.01.1991||R|||0|0|E|0|GSK|0|0|0|100|GBP|10531|10135|lyfalmen|V0383|9735||20|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||6693||6693|10135| 495820|J05AH0101|Relenza|innúđadu|5|mg/úđask|20|skammtar|1|stauk|+diskhaler|J05AH01|01.02.2000||R|||0|0|0|0|GSK|0|0|0|100|GBP|2892|4935|lyfalmen||||20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Zanamivír||2892||2892|4935| 496040|N06DA0303|Nimvastid (Lyfis)|hylki|4,5|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|||0|0|E|0|LYF|0|0|0|100|XEU|29275|29194|lyfalmen|V0345|29194||112|0|56,0000|LYFIS ehf|LYFIS ehf|Rívastigmín||21234||21234|29194| 496174|QJ01MA9001|Baytril vet.|töflur|150|mg|10|stk|1|ţpakki||QJ01MA90|01.03.2009||R|||0|0|0|0|BAN|0|0|0|100|DKK|4117|8078|vetalmen||||10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||4117|8078| 496468|A10BG0302|Pioglitazone Actavis|töflur|15|mg|98|stk|1|ţpakki||A10BG03|01.09.2012||R|||0|0|*|0|APC|0|0|0|100|XEU|12393|18098|lyfalmen|V0572|18098||98|0|49,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||12393||12393|18098| 496547|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.01.1985||R|||0|0|B|0|APT|0|0|0|100|GBP|6014|9206|lyfalmen||||100|0|0,8333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Labetalól||6014||6014|9206| 496554|C07AG0101|Trandate|filmhtfl|100|mg|50|stk|1|glas||C07AG01|01.02.1982||R|||0|0|B|0|APT|0|0|0|100|GBP|1055|2422|lyfalmen||||50|0|8,3333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Labetalól||1055||1055|2422| 496644|L03AB0103|Multiferon|stl|3|millj ae|0,5|ml|6|áf.spr|lausn|L03AB01|01.12.2011||R|||0|1|0|1|SOI|0|0|0|100|DKK|83740|106976|lyfsjukr||||3|0|9,0000|Swedish Orphan International AB|Swedish Orphan International AB|Interferón-alfa natural||83740||83740|106976| 496752|C07AG0101|Trandate|filmhtfl|200|mg|100|stk|1|glas||C07AG01|01.01.1986||R|||0|0|B|0|APT|0|0|0|100|GBP|3309|5505|lyfalmen||||100|0|33,3333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Labetalól||3309||3309|5505| 496935|N02AG0201|Ketogan|eţ-stíll|||10|stk|1|pakki||N02AG02|01.07.1994||R|||1|0|E|0|PER|0|0|0|100|DKK|457|1604|lyfalmen||||10|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||457||457|1604| 496950|N02AG0201|Ketogan|töflur|||20|stk|1|ţpakki|5 + 25 mg|N02AG02|01.07.1994||R|||1|0|E|0|PER|0|0|0|100|DKK|824|2106|lyfalmen||||20|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||824||824|2106| 497012|A07AA1201|Dificlir|filmhtfl|200|mg|20|stk|1|ţpakki||A07AA12|01.08.2012||R|||0|0|0|1|APE|0|0|0|100|XEU|241282|304691|lyfsjukr||||20|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Fidaxomicin||241282||241282|304691| 497099|N02AG0201|Ketogan|töflur|||100|stk|1|ţpakki|5 + 25 mg|N02AG02|01.07.1994||R|||1|0|E|0|PER|0|0|0|100|DKK|3144|5280|lyfalmen||||100|0|20,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||3144||3144|5280| 497289|C09AA0201|Daren|töflur|5|mg|30|stk|1|ţpakki||C09AA02|01.07.1990||R|||0|0|B|0|ACA|0|0|0|100|XEU|331|1432|lyfalmen||||30|0|15,0000|Actavis Group hf|Actavis hf|Enalapríl||331||331|1432| 497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|ţpakki||C09AA02|01.07.1990||R|||0|0|B|0|ACA|0|0|0|100|XEU|491|1378|lyfalmen|V0448|1378||100|0|50,0000|Actavis Group hf|Actavis hf|Enalapríl||292||292|1378| 497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|ţpakki||C09AA02|01.07.1990||R|||0|0|B|0|ACA|0|0|0|100|XEU|1020|1846|lyfalmen|V0449|1846||100|0|200,0000|Actavis Group hf|Actavis hf|Enalapríl||634||634|1846| 497995|S01EC0303|Dorzolamide Portfarma|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.10.2011||R|||0|0|*|0|POF|0|0|0|100|XEU|1466|2927|lyfalmen|V0369|2927||5|0|16,6667|Portfarma ehf|Portfarma|Dorzólamíđ||1424||1424|2927| 498048|H02AB0103|Diprospan|stl|7|mg/ml|2|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|||0|0|B|0|SPL|0|0|1|100|DKK|1325|2791|lyfalmen||||2|0|9,3300|Vistor hf|Schering-Plough Europe|Betametasón||1325||1325|2791| 498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|||0|0|0|0|PER|0|1|0|100|DKK|16518|23275|lyfalmen||||56|0|14,0000|Icepharma hf|Pfizer ApS|Ziprasidon||16518||16518|23275| 498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|||0|0|0|0|PER|0|1|0|100|DKK|17620|24658|lyfalmen||||56|0|28,0000|Icepharma hf|Pfizer ApS|Ziprasidon||17620||17620|24658| 499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|||0|0|0|0|PER|0|1|0|100|DKK|21949|30091|lyfalmen||||56|0|42,0000|Icepharma hf|Pfizer ApS|Ziprasidon||21949||21949|30091| 499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|||0|0|0|0|PER|0|1|0|100|DKK|26516|35823|lyfalmen||||56|0|56,0000|Icepharma hf|Pfizer ApS|Ziprasidon||26516||26516|35823| 499273|B01AX0601 |Xarelto|filmhtfl|20|mg|28|stk|1|ţpakki||B01AX06|01.05.2012||R|||0|0|E|0|BAP|0|0|0|100|SEK|10782|15728|lyfalmen||||28|0|56,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||10782|15728| 501734|M01AB0508|Vostar-R|forđatfl|75|mg|100|stk|1|glas|0|M01AB05|01.03.2000||R|||0|0|E|0|ACA|0|0|1|100|XEU|2713|4690|lyfalmen||||100|0|75,0000|Actavis Group hf|Actavis hf|Díklófenak||2713||2713|4690| 502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|||0|0|E|0|ROC|0|0|0|100|DKK|2982|5058|lyfalmen|V0434|4356||100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2982||2982|5058| 502633|N06AA2101|Ludiomil|töflur|25|mg|100|stk|1|ţpakki||N06AA21|01.06.1977||R|||0|0|B|0|AML|0|1|0|100|DKK|2907|4956|lyfalmen||||100|0|25,0000|Vistor hf|Amdipharm Limited|Maprótilín||2907||2907|4956| 503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|||0|1|0|1|FER|0|0|0|100|DKK|29319|38678|lyfsjukr||||1|0|27,9851|Vistor hf|Ferring|Triptórelín||29319||29319|38678| 503491|N06DA0303|Nimvastid (Lyfis)|hylki|1,5|mg|28|stk|1|ţpakki||N06DA03|01.04.2011||R|||0|0|E|0|LYF|0|0|0|100|XEU|6455|6943|lyfalmen||||28|0|4,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||4360||4360|6943| 503795|M01AB0512|Voltaren Dolo|húđuđtfl|25|mg|20|stk|1|ţpakki||M01AB05|01.10.2011||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||20|0|5,0000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||| 504119|A10BB1202|Glimeryl|töflur|4|mg|90|stk|1|ţpakki||A10BB12|01.11.2011||R|||0|0|*|0|AGP|0|0|0|100|XEU|1612|3050|lyfalmen|V0494|3050||90|0|180,0000|Actavis Group hf|Actavis Group PTC ehf|Glímepíríđ||1514||1514|3050| 504191|N02BA5102|Treo|freyđit|||20|stk|1|glas||N02BA51|01.07.1988||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||20|0|3,3333|Vistor hf|McNeil Denmark ApS|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole|||||| 504266|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|ţpakki||G03CA04|01.01.1988||R|||0|0|E|0|ORG|0|0|0|100|DKK|1989|3700|lyfalmen||||90|0|45,0000|Vistor hf|N.V. Organon|Estríól||1989||1989|3700| 504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|glas||N05BA08|01.01.1987||R|||0|0|0|0|ROC|0|0|1|100|DKK|1131|2526|lyfalmen||||100|0|30,0000|Icepharma hf|Roche|Brómazepam||1131||1131|2526| 505743|N06AA2101|Ludiomil|töflur|75|mg|100|stk|1|ţpakki||N06AA21|01.05.1978||R|||0|0|B|0|AML|0|1|0|100|DKK|7997|11918|lyfalmen||||100|0|75,0000|Vistor hf|Amdipharm Limited|Maprótilín||7997||7997|11918| 505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|||0|1|0|1|PER|0|0|0|100|DKK|1758|2537|lyfsjukr||||5|0||Icepharma hf|Pfizer ApS|Doxórúbicín||1758||1758|2537| 505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|||0|1|0|1|PER|0|0|0|100|DKK|3511|5067|lyfsjukr||||10|0||Icepharma hf|Pfizer ApS|Doxórúbicín||3511||3511|5067| 505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|||0|1|0|1|PER|0|0|0|100|DKK|8011|11562|lyfsjukr||||25|0||Icepharma hf|Pfizer ApS|Doxórúbicín||8011||8011|11562| 506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|ţpakki||N06AA12|01.12.1972||R|||0|0|B|0|PER|0|1|0|100|DKK|2401|4263|lyfalmen||||100|0|50,0000|Icepharma hf|Pfizer ApS|Doxepín||2401||2401|4263| 506998|A06AB0202|Toilax|sh-tfl|5|mg|25|stk|1|ţpakki||A06AB02|01.12.1975||L|||0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa||||25|0|12,5000|Vistor hf|Orion Pharma|Bisakódýl|||||| 507004|A06AB0202|Toilax|sh-tfl|5|mg|100|stk|1|ţpakki||A06AB02|01.12.1975||R|||0|0|0|0|ERC|0|0|0|100|DKK|390|1512|lyfalmen||||100|0|50,0000|Vistor hf|Orion Pharma|Bisakódýl||390||390|1512| 507103|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|1|spr||QP52AF02|01.07.1995||L|||0|0|0|0|PAL|0|0|0|100|DKK|642|1120|vetorma||||24|0||Icepharma hf|Pfizer Oy Animal Health|||||642|1120| 507111|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|5|spr||QP52AF02|01.07.1995||L|||0|0|0|0|PAL|0|0|0|100|DKK|2728|4759|vetorma||||120|0||Icepharma hf|Pfizer Oy Animal Health|||||2728|4759| 507343|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|1000|ml|1|fl||QP52AC13|01.12.1978||R|||0|0|0|0|IBV|0|0|0|100|DKK|15663|27323|vetorma||||1000|0||Vistor hf|Intervet International BV|||15663||15663|27323| 508622|C08DA0103|Isoptin retard|forđatfl|240|mg|98|stk|1|ţpakki||C08DA01|01.10.1993||R|||0|0|B|0|ABS|0|0|0|100|DKK|2491|4386|lyfalmen||||98|0|98,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||2491||2491|4386| 508671|QJ01MA9001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|||0|0|0|0|BAN|0|0|0|100|DKK|4977|9729|vetalmen||||100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||4977|9729| 508689|QJ01MA9001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|||0|0|0|0|BAN|0|0|0|100|DKK|3992|7838|vetalmen||||50|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||3992||3992|7838| 508705|QJ01MA9001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|||0|0|0|0|BAN|0|0|0|100|DKK|12350|23886|vetalmen||||100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||12350||12350|23886| 508921|L01CD0401|Jevtana|irţ|60|mg|15|ml|1|hgl|+ leysir|L01CD04|01.08.2011||R|||0|1|0|1|SOF|0|0|0|100|NOK|731164|919493|lyfsjukr||||15|0||Vistor hf|SANOFI|Cabazitaxel||731164||731164|919493| 509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|||0|0|*|0|LBK|0|1|0|100|DKK|8858|13096|lyfalmen||||10|0|133,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||8858||8858|13096| 509273|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.01.1988||L|||0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen||||15|0|75,0000|Vistor hf|N.V. Organon|Estríól|||||2772| 509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|ţpakki|150+300 mg|J05AR01|01.05.2004||R|||0|1|0|1|VII|0|0|0|100|GBP|49017|63399|lyfsjukr||||60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín og lamívúdín||49017||49017|63399| 510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|16207|22222|lyfsjukr||||2|0|12,0000|Icepharma hf|Roche|Epóetín||16207||16207|22222| 510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|24261|32330|lyfsjukr||||2|0|18,0000|Icepharma hf|Roche|Epóetín||24261||24261|32330| 510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|39795|51825|lyfsjukr||||2|0|30,0000|Icepharma hf|Roche|Epóetín||39795||39795|51825| 510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|78698|100648|lyfsjukr||||4|0|60,0000|Icepharma hf|Roche|Epóetín||78698||78698|100648| 510810|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|182727|231205|lyfsjukr||||1|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||||182727|231205| 510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|||0|0|E|0|ACA|0|0|0|100|XEU|4060|5410|lyfalmen|V0445|5410||98|0|98,0000|Actavis Group hf|Actavis hf|Fínasteríđ||3239||3239|5410| 511071|C09CA0701|Micardis|töflur|20|mg|28|stk|1|ţpakki||C09CA07|01.03.2008||R|||0|0|0|0|BII|0|0|0|100|DKK|2639|4589|lyfalmen||||28|0|14,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||2639||2639|4589| 511245|N05AH0310|Zalasta (LYFIS)|munndr.t|20|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|||0|0|*|0|LYF|0|1|0|100|XEU|35448|30249|lyfalmen|V0540|30249||28|0|56,0000|LYFIS ehf|LYFIS ehf|Olanzapín||22075||22075|30249| 511303|G03FB0501|Trisekvens|töflur|||84|stk|1|skífup||G03FB05|01.12.1980||R|||0|0|E|0|NAS|0|0|0|100|DKK|2622|4566|lyfalmen||||84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2622||2622|4566| 511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|||0|0|0|1|MAB|0|0|0|100|SEK|23962|31955|lyfsjukr||||6000|0||Vistor hf|Meda AB|Dextran||23962||23962|31955| 511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|||500|ml|12|pokar||B05AA05|01.07.1991||R|||0|0|0|1|MAB|0|0|0|100|SEK|14990|20695|lyfsjukr||||6000|0||Vistor hf|Meda AB|Dextran||14990||14990|20695| 512192|N06AB1005|Escitalopram LYFIS|filmhtfl|10|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|||0|0|B|0|LYF|0|1|0|100|XEU|4611|4604|lyfalmen|V0325|4604||100|0|100,0000|LYFIS ehf|LYFIS ehf|Escítalópram||2650||2650|4604| 512608|B05XA3101|Peditrace|irţ|||10|ml|10|hgl||B05XA31|01.07.1993||R|||0|0|0|1|FRP|0|0|0|100|DKK|5118|7387|lyfsjukr||||100|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ öđrum efnum||5118||5118|7387| 513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|||0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa||||35|0||Vistor hf|AstraZeneca A/S DK|Lídókaín|||||| 513474|N05AH0501|Sycrest|tungur.t|5|mg|60|stk|1|ţpakki||N05AH05|01.10.2011||R|||0|0|0|0|ORR|0|1|0|100|DKK|22241|30458|lyfalmen||||60|0|15,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||22241||22241|30458| 513758|QJ01CR0201|Combisyn|stl|175|mg/ml|100|ml|1|hgl|140+35 mg/ml|QJ01CR02|01.11.2011||R|||0|0|0|0|NOB|1|0|0|100|XEU|2065|4108|vetalmen||||100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||2065||2065|4108| 514265|R03AC0302|Bricanyl Turbuhaler|innúđadu|0,25|mg/sk|200|skammtar|1|stauk||R03AC03|01.07.1993||R|||0|0|B|0|AZD|0|0|1|100|SEK|2100|3852|lyfalmen||||200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2100||2100|3852| 514427|C07AG0203|Carvedilol Actavis|filmhtfl|25|mg|100|stk|1|ţpakki||C07AG02|01.07.2011||R|||0|0|B|0|ADG|0|0|0|100|XEU|3045|5144|lyfalmen||||100|0|66,6667|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||3045||3045|5144| 515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|ţpakki||N06AX18|01.06.2000||R|||0|0|B|0|PER|0|1|0|100|DKK|4301|4222|lyfalmen||||60|0|30,0000|Icepharma hf|Pfizer ApS|Reboxetin||2371||2371|4222| 515239|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.05.2011||L|||0|0|B|0|NYC|0|0|0|100|DKK|||lyfalmen||||100|0|10,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||2527| 515247|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.05.2011||L|||0|0|B|0|NYC|0|0|0|100|DKK|||lyfalmen||||100|0|20,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||2540| 517073|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|120|stk|1|ţpakki||A02BC04|01.06.2011||R|||0|0|E|0|APC|0|0|0|100|IKR|5112|6293|lyfalmen|V0010|6293||120|0|120,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||3885||3885|6293| 517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|||0|0|*|0|NAS|0|0|0|100|DKK|2877|4914|lyfalmen|V0462|2871||90|0|11,2500|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||2877||2877|4914| 517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|||0|0|*|0|NAS|0|0|0|100|DKK|3133|5265|lyfalmen|V0471|2999||90|0|22,5000|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||3133||3133|5265| 517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|||0|0|*|0|NAS|0|0|0|100|DKK|3369|5588|lyfalmen|V0472|3241||90|0|45,0000|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||3369||3369|5588| 517990|R06AX2201|Kestine|filmhtfl|20|mg|10|stk|1|ţpakki||R06AX22|01.06.2012||L|||0|0|0|0|APS|0|0|1|100|IKR|||lyflausa||||10|0|20,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||| 518241|M01AB0509|Modifenac|forđahlk|75|mg|20|stk|1|ţpakki||M01AB05|01.11.2000||R|||0|0|E|0|AGT|0|0|1|100|DKK|894|2202|lyfalmen||||20|0|15,0000|Actavis Group hf|Actavis Group hf|Díklófenak||894||894|2202| 518258|M01AB0509|Modifenac|forđahlk|75|mg|100|stk|1|ţpakki|međ breyttan losunarhrađa|M01AB05|01.11.2000||R|||0|0|E|0|AGT|0|0|1|100|DKK|3293|5484|lyfalmen||||100|0|75,0000|Actavis Group hf|Actavis Group hf|Díklófenak||3293||3293|5484| 518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|ţpakki|3x28 stk|G03AC09|01.01.2001||R|||0|0|0|0|ORG|0|0|0|100|DKK|2030|3756|lyfalmen||||84|0|84,0000|Vistor hf|N.V. Organon|Desógestrel||2030||2030|3756| 518337|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|200|mg|60|stk|1|ţpakki||N05AH04|01.06.2011||R|||0|0|*|0|LVR|0|1|0|100|IKR|12890|15342|lyfalmen|V0286|14795||60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||10500||10500|15342| 518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|||0|0|0|0|REP|0|0|1|100|SEK|1135|2532|lyfalmen||||125|0|3,1250|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1135||1135|2532| 519463|J01EE0108|Eusaprim|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.07.2011||R|||0|0|0|0|AEG|0|0|1|100|SEK|1700|3304|lyfalmen||||100|0|2,5000|GlaxoSmithKline ehf|Aspen Europe GmbH|Súlfametoxazól og trímetóprím||1700||1700|3304| 519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|||0|0|E|0|NYC|0|0|0|100|DKK|7072|10653|lyfalmen|V0431|9232||2|0|5,7222|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||7072||7072|10653| 520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|||0|0|0|0|PER|0|0|0|100|DKK|4688|7392|lyfalmen|V0142|7263||4|0|2,0000|Icepharma hf|Pfizer ApS|Síldenafíl||4688||4688|7392| 520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|||0|0|0|0|PER|0|0|0|100|DKK|5294|8221|lyfalmen|V0143|2424||4|0|4,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5294||5294|8221| 520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|||0|0|0|0|PER|0|0|0|100|DKK|14917|21266|lyfalmen|V0143|7271||12|0|12,0000|Icepharma hf|Pfizer ApS|Síldenafíl||14917||14917|21266| 520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|||0|0|0|0|PER|0|0|0|100|DKK|5678|8746|lyfalmen|V0144|2946||4|0|8,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5678||5678|8746| 520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|||0|0|0|0|PER|0|0|0|100|DKK|15710|22261|lyfalmen|V0144|8837||12|0|24,0000|Icepharma hf|Pfizer ApS|Síldenafíl||15710||15710|22261| 520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|||0|0|B|0|ACA|0|0|0|100|IKR|1355|1737|lyfalmen|V0056|1737||100|0|100,0000|Actavis Group hf|Actavis hf|Amlódipín||554||554|1737| 520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|||0|0|B|0|ACA|0|0|0|100|IKR|2163|2133|lyfalmen|V0057|2133||100|0|200,0000|Actavis Group hf|Actavis hf|Amlódipín||844||844|2133| 520759|M03BC5101|Norgesic|töflur|||30|stk|1|ţpakki||M03BC51|01.03.1981||R|||0|0|E|0|MEB|0|0|1|100|SEK|366|1480|lyfalmen||||30|0|7,5000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||366||366|1480| 520874|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2011||L|||0|0|B|0|NYC|0|0|0|100|DKK|||lyfalmen||||25|0|2,5000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1694| 520882|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2011||L|||0|0|B|0|NYC|0|0|0|100|DKK|||lyfalmen||||25|0|5,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1705| 521203|N04BC0502|Sifrol|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.05.2005||R|||0|0|E|0|BII|0|0|0|100|DKK|31227|41735|lyfalmen|V0269|9786||100|0|28,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||31227||31227|41735| 521954|N03AX2101|Trobalt|filmhtfl|200|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|17897|25006|lyfalmen||||84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||17897||17897|25006| 521966|A10BX0202|Repaglinid Krka (LYFIS)|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|||0|0|*|0|LYF|0|0|0|100|XEU|2941|2999|lyfalmen|V0471|2999||90|0|22,5000|LYFIS ehf|LYFIS ehf|Repaglíníđ||1477||1477|2999| 522003|QJ01RA0102|Streptocillin, vet.|spenalyf|||8|g|40|spr||QJ01RA01|01.12.1982||R|||0|0|0|0|BID|0|0|0|100|DKK|8170|15860|vetalmen||||320|0||Vistor hf|Boehringer Ingelheim Danmark|||8170||8170|15860| 522599|J07CA0202|Tetravac|bóluefni|||0,5|ml|1|spr|einnota dćla|J07CA02|01.10.1999||R|||0|0|0|0|SPM|0|0|0|100|XEU|2226|4024|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|barnaveiki, kíghósti, mćnusótt, stífkrampi||2226||2226|4024| 522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|||0|1|0|1|NOE|0|0|0|100|DKK|181129|229199|lyfsjukr||||1|0|0,5000|Vistor hf|Novartis Europharm Ltd|Basiliximab||181129||181129|229199| 522730|N02AX0204|Tradolan|töflur|50|mg|20|stk|1|ţpakki||N02AX02|01.08.1998||R|||0|0|E|0|GLP|0|0|1|100|SEK|342|1447|lyfalmen|V0055|1262||20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||342||342|1447| 522771|N02AX0204|Tradolan|töflur|50|mg|100|stk|1|ţpakki||N02AX02|01.08.1998||R|||0|0|E|0|GLP|0|0|1|100|SEK|405|1533|lyfalmen|V0225|1491||100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||405||405|1533| 522797|N02AX0204|Tradolan|töflur|50|mg|250|stk|1|ţpakki||N02AX02|01.08.1998||R|||0|0|E|0|GLP|0|0|1|100|DKK|2696|4667|lyfalmen||||250|0|41,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||2696||2696|4667| 522813|N02AX0204|Tradolan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.08.1998||R|||0|0|E|0|GLP|0|0|1|100|DKK|384|1504|lyfalmen||||10|0|1,6667|Vistor hf|G.L.Pharma GmbH|Tramadól||384||384|1504| 523043|N02AA5902|Parkodin forte|töflur|530|mg|40|stk|1|pakki|ţp 30+500 mg|N02AA59|01.11.1998||R|||0|0|0|0|ACA|0|0|1|100|NOK|453|1599|lyfalmen||||40|0|13,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||453||453|1599| 523274|S01XA2008|Artelac|augndr|||10|ml|1|glas|plastglas|S01XA20|01.05.1998||L|||0|0|E|0|GEM|0|0|0|100|IKR|||lyfalmen||||10|0||Actavis Group hf|Gerhard Mann|Gervitár og ađrar óvirkar samsetningar|||||1395| 523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|ţpakki||R06AD02|01.10.1995||R|||0|0|E|0|SNO|0|0|1|100|NOK|1282|2733|lyfalmen||||100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1282||1282|2733| 524215|C01DA1401|Imdur|forđatfl|30|mg|28|stk|1|ţpakki||C01DA14|01.07.1993||R|||0|0|B|0|AZD|0|0|0|100|SEK|457|1604|lyfalmen||||28|0|21,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||457||457|1604| 524223|C01DA1401|Imdur|forđatfl|30|mg|98|stk|1|ţpakki||C01DA14|01.07.1993||R|||0|0|B|0|AZD|0|0|0|100|SEK|2881|4920|lyfalmen||||98|0|73,5000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||2881||2881|4920| 524276|A02BC0401|Pariet|sh-tfl|20|mg|98|stk|1|ţpakki||A02BC04|01.06.2011||R|||0|0|0|0|EIS|0|0|0|100|IKR|8619|5951|lyfalmen|V0010|5139||98|0|98,0000|Vistor hf|Eisai Ltd|Rabeprazól||3635||3635|5951| 524934|QM01AE9001|Quadrisol|hlaup|100|mg/ml|1|spr|1|pakki|f. hesta|QM01AE90|01.07.2010||R|||0|0|0|0|INI|0|0|0|100|DKK|1850|3680|vetalmen||||1|0||Icepharma hf|Intervet International B.V.|Vedaprófen||1850||1850|3680| 525014|M03BC5101|Norgesic|töflur|||100|stk|1|ţpakki||M03BC51|01.06.1981||R|||0|0|E|0|MEB|0|0|1|100|SEK|898|2207|lyfalmen||||100|0|25,0000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||898||898|2207| 525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007||R|||0|0|0|0|NOH|0|0|0|100|DKK|753|2009|lyfalmen||||15|0|3,7500|Vistor hf|Novartis Healthcare A/S-|Díklófenak||753||753|2009| 525076|A02BC0109|Omeprazol Pensa (Lyfjaver)|sţ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.02.2012||R|||0|0|E|0|LVR|0|0|0|100|IKR|4621|4282|lyfalmen|V0006|4217||100|0|100,0000|Lyfjaver ehf|Lyfjaver ehf|Ómeprazól||2415||2415|4282| 525147|M01AB0504|Klofen-L|forđahlk|100|mg|30|stk|1|glas||M01AB05|01.01.1993||R|||0|0|E|0|ACA|0|0|1|100|XEU|1453|2967|lyfalmen||||30|0|30,0000|Actavis Group hf|Actavis hf|Díklófenak||1453||1453|2967| 525170|M01AB0504|Klofen-L|forđahlk|100|mg|100|stk|1|glas||M01AB05|01.01.1993||R|||0|0|E|0|ACA|0|0|1|100|XEU|4843|7604|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis hf|Díklófenak||4843||4843|7604| 525188|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|ţpakki||N06BA07|01.03.2002||R|||0|0|0|0|CPA|0|0|0|100|DKK|10550|15411|lyfalmen||||30|0|10,0000|Vistor hf|Cephalon France (V)|Modafinil||10550||10550|15411| 525720|B01AX0601 |Xarelto|filmhtfl|20|mg|100|stk|1|ţpakki||B01AX06|01.05.2012||R|||0|0|E|0|BAP|0|0|0|100|SEK|38361|50688|lyfalmen|V0030|50688||100|0|200,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||38361|50688| 525857|B05XA0103|Kaliumklorid B.Braun|irţ|1|mmol/ml|50|ml|20|hgl||B05XA01|01.09.2010||R|||0|0|0|1|BRA|0|0|0|100|XEU|5282|7623|lyfsjukr||||1000|0||Actavis Group hf|Braun|Kalíumklóríđ||5282||5282|7623| 525865|B05XA0303|Natriumklorid B.Braun|irţ|1|mmol/ml|50|ml|20|hgl||B05XA03|01.09.2010||R|||0|0|0|1|BRA|0|0|0|100|XEU|4809|6941|lyfsjukr||||1000|0||Actavis Group hf|Braun|Natríumklóríđ||4809||4809|6941| 525998|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|||0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa||||1000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 526004|V07AB09|Sterilt Vann B. Braun|leysir|||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|||0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa||||1000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|||0|0|E|0|ROC|0|0|0|100|DKK|4339|6914|lyfalmen|V0435|6914||100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4339||4339|6914| 526376|N03AG0103|Orfiril Retard|forđatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|||0|0|E|0|DEA|0|0|0|100|XEU|4044|6511|lyfalmen||||100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||4044||4044|6511| 526384|QJ01EW1001|Tribrissen, vet.|pasta|400|mg/g|37,5|g|5|spr|til inntöku|QJ01EW10|01.03.2007|30.09.2012|R|||0|0|0|0|IBV|0|0|0|100|DKK|6274|12220|vetalmen||||188|0||Vistor hf|Intervet International BV|||6274||6274|12220| 526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|||0|0|E|0|DEA|0|0|0|100|XEU|3459|5711|lyfalmen||||100|0|40,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3459||3459|5711| 527112|N02BE0116|Pinex Smelt|munndr.t|250|mg|20|stk|1|ţpakki||N02BE01|01.09.2011||L|||0|0|0|0|APC|0|0|1|100|IKR|||lyflausa||||20|0|1,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||| 527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|||0|0|0|1|SNO|0|0|0|100|NOK|15499|21334|lyfsjukr||||2000|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||15499||15499|21334| 527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|||0|0|E|0|ALC|0|0|0|100|USD|1243|2679|lyfalmen||||5|0||K.Pétursson hf|Alcon|Emedastín||1243||1243|2679| 528374|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2012||R|||0|0|E|0|BGB|0|0|0|100|SEK|17680|24734|lyfalmen||||4|0|55,5600|Icepharma hf|Bayer Pharma AG|Testósterón||17680||17680|24734| 528472|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innúđadu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|||0|0|0|0|LVR|0|0|0|100|SEK|10079|13891|lyfalmen|V0356|12692||120|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9439||9439|13891| 528584|A07EC0202|Pentasa|forđatfl|1|g|60|stk|1|ţpakki|6 x 10 stk|A07EC02|01.06.2012||R|||0|0|B|0|FEL|0|0|0|100|DKK|6691|10132|lyfalmen||||60|0|40,0000|Vistor hf|Ferring Lćgemidler A/S|Mesalazín (5-amínósalicýlsýra)||6691||6691|10132| 529289|R02AA0301|Strepsils|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.1982||L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 529438|QJ51RC2002|Ampiclox vet.|spenalyf|||3|g|24|spr|spenadćlur|QJ51RC20|01.06.1998||R|||0|0|0|0|PAL|0|0|0|100|DKK|4372|8567|vetalmen||||72|0||Icepharma hf|Pfizer Oy Animal Health|||4372||4372|8567| 529446|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|ţpakki||QJ01CA04|01.10.1987||R|||0|0|0|0|PAL|0|0|0|100|DKK|4649|9099|vetalmen||||100|0||Icepharma hf|Pfizer Oy Animal Health|||4649||4649|9099| 529735|N03AB0501|Pro-Epanutin|irţ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|||0|0|0|1|PER|0|0|0|100|DKK|66744|85646|lyfsjukr||||100|0|11,1000|Icepharma hf|Pfizer ApS|Fosfenýtóín||66744||66744|85646| 529852|L02BG0304|Anastrozole Bluefish|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.2012||R|||0|0|*|0|BLP|0|0|0|100|XEU|27701|14475|lyfalmen|V0184|14475||98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Anastrózól||9866||9866|14475| 530188|A06AD6502|Movicol|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.09.2011||L|||0|0|0|0|NOI|0|0|0|100|XEU|||lyfalmen||||50|0|25,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||6693| 530379|L02BG0304|Anastrozole Bluefish|filmhtfl|1|mg|28|stk|1|ţpakki||L02BG03|01.03.2012||R|||0|0|*|0|BLP|0|0|0|100|XEU|11439|7271|lyfalmen|V0186|7271||28|0|28,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Anastrózól||4600||4600|7271| 530741|G03FA0105|Activelle|töflur|||84|stk|1|pakki|ţp 1+0,5 mg|G03FA01|01.03.2000||R|||0|0|E|0|NAS|0|0|0|100|DKK|3019|5109|lyfalmen||||84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||3019||3019|5109| 530828|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|5802|8374|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||5802||5802|8374| 531459|R03CC0303|Bricanyl Retard|forđatfl|7,5|mg|100|stk|1|glas||R03CC03|01.01.1985||R|||0|0|B|0|AZD|0|0|0|100|SEK|3051|5153|lyfalmen||||100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||3051||3051|5153| 531913|J05AG0101|Viramune|mixtúra|10|mg/ml|240|ml|1|fl||J05AG01|01.03.2007||R|||0|1|0|1|BII|0|0|0|100|DKK|7979|11516|lyfsjukr||||240|0|6,0000|Vistor hf|Boehringer Ingelheim International |Nevírapín||7979||7979|11516| 532048|L04AA0605|Myfenax (Lyfis)|hylki|500|mg|50|stk|1|ţpakki||L04AA06|01.03.2011||R|||0|1|*|0|LYF|0|0|0|100|XEU|19696|13416|lyfalmen|V0187|12915||50|0|12,5000|LYFIS ehf|LYFIS ehf|Mýcófenólsýra||9092||9092|13416| 532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|||0|0|0|0|JAS|0|0|0|100|SEK|675|1902|lyfalmen||||30|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||675||675|1902| 532504|R06AX2704|Desloratadine ratiopharm|filmhtfl|5|mg|30|stk|1|ţpakki||R06AX27|01.09.2012||R|||0|0|E|0|RGM|0|0|1|100|XEU|1184|2266|lyfalmen|V0366|2266||30|0|30,0000|Medical ehf|ratiopharm GmbH|Deslóratadín||941||941|2266| 532671|J01EA0107|Trimetoprim Meda|töflur|100|mg|30|stk|1|glas||J01EA01|01.03.2010||R|||0|0|0|0|MEB|0|0|1|100|SEK|356|1466|lyfalmen||||30|0|7,5000|Vistor hf|Meda AB (V)|Trímetóprím||356||356|1466| 532697|J01EA0107|Trimetoprim Meda|töflur|100|mg|100|stk|1|glas||J01EA01|01.03.2010||R|||0|0|0|0|MEB|0|0|1|100|SEK|1035|2395|lyfalmen||||100|0|25,0000|Vistor hf|Meda AB (V)|Trímetóprím||1035||1035|2395| 532705|J01EA0107|Trimetoprim Meda|töflur|160|mg|14|stk|1|glas||J01EA01|01.03.2010||R|||0|0|0|0|MEB|0|0|1|100|SEK|286|1370|lyfalmen||||14|0|5,6000|Vistor hf|Meda AB (V)|Trímetóprím||286||286|1370| 532721|J01EA0107|Trimetoprim Meda|töflur|160|mg|100|stk|1|glas||J01EA01|01.03.2010||R|||0|0|0|0|MEB|0|0|1|100|SEK|1824|3474|lyfalmen||||100|0|40,0000|Vistor hf|Meda AB (V)|Trímetóprím||1824||1824|3474| 533302|N05AH0310|Zalasta (LYFIS)|töflur|15|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|||0|0|*|0|LYF|0|1|0|100|XEU|14075|8176|lyfalmen|V0283|8176||28|0|42,0000|LYFIS ehf|LYFIS ehf|Olanzapín||5261||5261|8176| 533737|R03CC0303|Bricanyl Retard|forđatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|||0|0|B|0|AZD|0|0|0|100|SEK|2068|3808|lyfalmen||||100|0|33,3333|Vistor hf|AstraZeneca A/S DK|Terbútalín||2068||2068|3808| 534471|L04AA1001|Rapamune|filmhtfl|1|mg|100|stk|1|ţpakki||L04AA10|01.06.2012||R|||0|1|*|0|IPI|0|0|0|100|DKK|57129|74242|lyfalmen|V0567|74242||100|0|33,3300|Icepharma hf|Pfizer Limited|Sirolimus||57129||57129|74242| 535773|P03AA5401|Tenutex|áburđur|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|||0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa||||100|0||Icepharma hf|Bioglan AB|Dísúlfíram í blöndum|||||| 535844|N05AH0310|Zalasta (LYFIS)|töflur|5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|||0|0|*|0|LYF|0|1|0|100|XEU|3166|2384|lyfalmen|V0279|2384||28|0|14,0000|LYFIS ehf|LYFIS ehf|Olanzapín||1027||1027|2384| 535898|G04BD0401|Ditropan|töflur|5|mg|84|stk|1|ţpakki||G04BD04|01.06.1998||R|||0|0|E|0|SNO|0|0|0|100|NOK|6634|10054|lyfalmen||||84|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Oxýbútýnín||6634||6634|10054| 536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|||0|0|*|0|SAL|0|0|0|100|USD|438|1578|lyfalmen||||10|0|25,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Pílókarpín||438||438|1578| 536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|||0|0|*|0|SAL|0|0|0|100|USD|559|1744|lyfalmen||||10|0|25,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Pílókarpín||559||559|1744| 536115|C10AA0504|Atorvastatin Portfarma|filmhtfl|80|mg|100|stk|1|ţpakki||C10AA05|01.11.2011||R|||0|0|0|0|POF|0|0|0|100|IKR|12900|18735|lyfalmen|V0115|13292||100|0|400,0000|Portfarma ehf|Portfarma|Atorvastatín||12900||12900|18735| 536289|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|||0|1|0|1|SCP|0|0|0|100|DKK|29050|38340|lyfsjukr||||1|0|15,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||29050||29050|38340| 536460|N05AX1302|Xeplion|stl|150|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|||0|0|0|0|JCI|0|1|0|100|SEK|110879|141698|lyfalmen||||1|0|60,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||110879||110879|141698| 536840|N07XX0701|Fampyra|forđatfl|10|mg|56|stk|1|glas||N07XX07|01.12.2011||R|||0|1|0|1|BIB|0|0|0|100|XEU|63611|81714|lyfsjukr||||56|0|28,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||63611||63611|81714| 537373|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|2|g|1|spr||QP52AF02|01.07.1995||L|||0|0|0|0|PAL|0|0|0|100|DKK|573|1000|vetorma||||2|0||Icepharma hf|Pfizer Oy Animal Health|||||573|1000| 537465|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|6146|8870|lyfsjukr||||7500|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||6146||6146|8870| 537811|G03CA0401|Ovestin|sk-stíll|0,5|mg|15|stk|1|pakki||G03CA04|01.01.1988||L|||0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen||||15|0|37,5000|Vistor hf|N.V. Organon|Estríól|||||2371| 538181|A02AD0106|Rennie|sog/tugg|||24|stk|1|ţpakki||A02AD01|01.10.1995||L|||0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa||||24|0|2,4000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||| 538199|A02AD0106|Rennie|sog/tugg|||48|stk|1|ţpakki||A02AD01|01.10.1995||L|||0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa||||48|0|4,8000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||| 538207|A02AD0106|Rennie|sog/tugg|||96|stk|1|ţpakki||A02AD01|01.10.1995||L|||0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa||||96|0|9,6000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||| 538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|||0|1|0|1|MSE|0|0|0|100|SEK|138531|175739|lyfsjukr||||6|0|61,3953|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||138531||138531|175739| 539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|ţpakki||N03AG04|01.10.1992||R|||0|1|E|0|SNO|0|0|0|100|NOK|10635|15527|lyfalmen||||100|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||10635||10635|15527| 539152|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|100|mg|60|stk|1|ţpakki||N05AH04|01.06.2011||R|||0|0|*|0|LVR|0|1|0|100|IKR|5863|7682|lyfalmen|V0285|7408||60|0|15,0000|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||4900||4900|7682| 539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|||0|0|0|0|AGT|0|0|1|100|DKK|215|1273|lyfalmen||||25|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||215||215|1273| 539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|||0|0|0|0|AGT|0|0|0|100|DKK|624|1833|lyfalmen||||100|0|20,0000|Actavis Group hf|Actavis Group hf|Díazepam||624||624|1833| 539783|D01AC2001|Daktacort|krem|||15|g|1|túpa||D01AC20|01.04.1986||L|||0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa||||15|0||Vistor hf|McNeil Sweden AB|Blöndur|||||| 539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|||0|0|E|0|PER|0|0|0|100|DKK|1748|3370|lyfalmen||||40|0|8,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1748||1748|3370| 540070|D06BA0101|Flamazine|krem|10|mg/g|250|g|1|dos||D06BA01|01.10.1988||R|||0|0|0|0|SON|0|0|1|100|DKK|2714|4692|lyfalmen||||250|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||2714||2714|4692| 540989|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíđ 20 mg|S01ED51|01.07.2000||R|||0|0|*|0|MSD|0|0|0|100|DKK|5725|8810|lyfalmen|V0373|7158||15|0|75,0000|Vistor hf|M.S.D.|Tímólól í blöndum||5725||5725|8810| 541128|M01CC0101|Atamir|hylki|150|mg|200|stk|1|glas||M01CC01|01.09.1983||R|||0|0|B|0|SGM|0|0|0|100|DKK|9257|13642|lyfalmen|V0199|13642||200|0|60,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||9257||9257|13642| 541136|M01CC0101|Atamir|hylki|250|mg|200|stk|1|plglas||M01CC01|12.10.2004||R|||0|0|B|0|SGM|0|0|0|100|DKK|14995|21364|lyfalmen|V0200|21364||200|0|100,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||14995||14995|21364| 541169|R02AA0302|Strepsils med honning og citron|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.1982||L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 542216|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|10|fl|.|J01GB03|01.08.2011||R|||0|0|0|1|BRA|0|0|0|100|XEU|5720|8255|lyfsjukr||||800|0|3,3300|Actavis Group hf|Braun|Gentamícín||5720||5720|8255| 542977|J04BA0201|Dapson|töflur|50|mg|100|stk|1|glas||J04BA02|01.05.1998||R|||0|1|0|0|LDR|0|0|0|100|IKR|4756|7485|lyfalmen||||100|1|100,0000|Parlogis hf|Parlogis - óskráđ lyf|Dapsón||4756||4756|7485| 543236|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|ţpakki||N05AA02|01.10.2012||R|||0|0|0|0|SNO|0|1|0|100|NOK|714|1956|lyfalmen||||100|0|1,6667|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||714||714|1956| 543330|C07AA0302|Visken|töflur|10|mg|98|stk|1|ţpakki||C07AA03|01.12.1983||R|||0|0|B|0|NOH|0|0|0|100|DKK|2830|4850|lyfalmen||||98|0|65,3333|Vistor hf|Novartis Healthcare A/S-|Pindólól||2830||2830|4850| 543374|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamid 20mg/ml|S01ED51|01.11.2011||R|||0|0|*|0|POF|0|0|0|100|XEU|2156|3098|lyfalmen|V0373|2386||5|0|25,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||1549||1549|3098| 543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|||0|0|0|0|REP|0|0|0|100|IKR|||lyflausa||||250|0|21,7857|Vistor hf|Recip AB|Semen psyllii (ispaghula)|||||| 543743|N05AH0310|Zalasta (LYFIS)|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|||0|0|*|0|LYF|0|1|0|100|XEU|7179|4820|lyfalmen|V0457|4820||28|0|14,0000|LYFIS ehf|LYFIS ehf|Olanzapín||2808||2808|4820| 543744|R01AA0503|Nezeril|nefúđi|0,5|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|||0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa||||8|0|9,3750|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||| 543972|J05AE1201|Victrelis|hylki|200|mg|336|stk|1|ţpakki|hörđ|J05AE12|01.01.2012||R|||0|1|0|1|MLD|0|0|0|100|DKK|500021|629409|lyfsjukr||||336|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Boceprevír||500021||500021|629409| 544429|L04AD0202|Prograf|hylki|0,5|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|||0|1|*|0|ASP|0|0|0|100|XEU|12661|18435|lyfalmen||||50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||12661||12661|18435| 544919|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|7|stk|1|ţpakki||A02BC05|01.11.2011||R|||0|0|0|0|POF|0|0|0|100|XEU|951|2280|lyfalmen|V0005|449||7|0|9,3300|Portfarma ehf|Portfarma|Esómeprazól||951||951|2280| 545176|G03HB0103|Cypretyl|töflur|||63|stk|1|ţpakki||G03HB01|01.10.2012||R|||0|0|0|0|RGM|0|0|0|100|XEU|1880|3455|lyfalmen|V0134|3455||63|0|84,0000|Medical ehf|ratiopharm GmbH|Cýpróterón og östrógen||1810||1810|3455| 545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|||0|0|0|0|GSK|0|0|1|100|GBP|998|2344|lyfalmen||||15|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Múpírócín||998||998|2344| 545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|||0|0|*|0|LBK|0|1|0|100|DKK|881|2184|lyfalmen||||100|0|6,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||881||881|2184| 545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|||0|0|*|0|LBK|0|1|0|100|DKK|2174|3953|lyfalmen||||100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||2174||2174|3953| 545996|V01AA0507|Alutard SQ, birkifrjo|stl|||5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|29424|39472|lyfalmen||||20|0||Vistor hf|ALK-Abello A/S|trjáfrjó||29424||29424|39472| 546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|23723|32318|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|trjáfrjó||23723||23723|32318| 546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|||5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|29597|39689|lyfalmen||||20|0||Vistor hf|ALK-Abello A/S|grasfrjó||29597||29597|39689| 546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|25144|34101|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|grasfrjó||25144||25144|34101| 546143|N02BE0108|Paratabs Retard|forđatfl|500|mg|30|stk|1|ţpakki||N02BE01|01.10.1993||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól|||||| 546168|N02BE0108|Paratabs Retard|forđatfl|500|mg|100|stk|1|glas||N02BE01|01.10.1993||R|||0|0|0|0|ACA|0|0|1|100|XEU|1110|2497|lyfalmen||||100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||1110||1110|2497| 546844|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|100|stk|1|glas||A02BC04|01.10.2012||R|||0|0|E|0|APC|0|0|0|100|IKR|3141|5247|lyfalmen|V0010|5244||100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||3120||3120|5247| 547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|ţpakki||A02BX02|01.01.1986||L|||0|0|0|0|ORC|0|0|0|100|IKR|||lyfalmen||||60|0|15,0000|Vistor hf|Orion Corporation|Súkralfat|||||4791| 547659|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|28|stk|1|ţpakki||A02BC05|01.08.2011||R|||0|0|0|0|LYF|0|0|0|100|IKR|3215|2066|lyfalmen|V0004|1696||28|0|18,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||795||795|2066| 547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|||0|1|0|1|GGL|0|0|0|100|GBP|10467|15019|lyfsjukr||||100|0|0,3800|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíđ||10467||10467|15019| 547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|||0|1|0|1|GGL|0|0|0|100|GBP|3449|4978|lyfsjukr||||10|0|0,1000|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíđ||3449||3449|4978| 547729|G03GA0601|Puregon|stl|100|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|||0|1|E|0|ORG|0|0|0|100|DKK|7592|11364|lyfalmen||||0|0|1,3333|Vistor hf|N.V. Organon|Follitrópín beta||7592||7592|11364| 548120|C07AB0312|Atenolol LYFIS|filmhtfl|50|mg|100|stk|1|ţpakki||C07AB03|01.05.2012||R|||0|0|B|0|LYF|0|0|0|100|XEU|557|1646|lyfalmen|V0542|1646||100|0|66,6600|LYFIS ehf|LYFIS ehf|Atenólól||488||488|1646| 548326|M01AE0112|ibuxin rapid|filmhtfl|400|mg|10|stk|1|ţpakki||M01AE01|01.09.2012||L|||0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa||||10|0|3,3300|LYFIS ehf|ratiopharm GmbH|Íbúprófen|||||| 548784|M05BA0701|Optinate|filmhtfl|5|mg|84|stk|1|ţpakki||M05BA07|01.03.2001|31.08.2012|R|||0|0|0|0|SNO|0|0|0|100|NOK|15650|22186|lyfalmen||||84|0|84,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||15650||15650|22186| 549113|J06BB1601|Synagis|sts|50|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|||0|0|0|1|ABT|0|0|0|100|DKK|92041|117394|lyfsjukr||||1|0||Vistor hf|Abbott Laboratories Ltd|Palivisumab||92041||92041|117394| 549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|||0|0|*|0|JAS|0|1|0|100|SEK|9746|14311|lyfalmen||||5|0|151,5152|Vistor hf|Janssen-Cilag AB|Halóperídól||9746||9746|14311| 549170|J06BB1601|Synagis|sts|100|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|||0|0|0|1|ABT|0|0|0|100|DKK|136294|172931|lyfsjukr||||1|0||Vistor hf|Abbott Laboratories Ltd|Palivisumab||136294||136294|172931| 549674|B01AX0601 |Xarelto|filmhtfl|15|mg|98|stk|1|ţpakki||B01AX06|01.05.2012||R|||0|0|E|0|BAP|0|0|0|100|SEK|37595|49727|lyfalmen|V0031|49674||98|0|147,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||37595|49727| 550020|J07AP0302|Typherix|bóluefni|50|mcg/ml|0,5|ml|1|spr|einnota sprauta|J07AP03|01.10.2001|31.08.2012|R|||0|0|0|0|GSK|0|0|0|100|GBP|2230|4029|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Taugaveiki, hreinsađir mótefnavakar||2230||2230|4029| 550061|N02BE0102|Panodil Brus|freyđit|500|mg|24|stk|1|ţpakki||N02BE01|01.04.1992||L|||0|0|0|0|GSH|0|0|1|100|IKR|||lyfalmen||||24|0|4,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||1592| 550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|||0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa||||60|0|0,4800|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||| 550731|N02BE0103|Panodil Junior|eţ-stíll|125|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|||0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa||||10|0|0,4167|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||| 551183|N05AH0310|Zalasta (LYFIS)|töflur|7,5|mg|56|stk|1|ţpakki||N05AH03|01.10.2011||R|||0|0|*|0|LYF|0|1|0|100|XEU|10989|8107|lyfalmen|V0280|8107||56|0|42,0000|LYFIS ehf|LYFIS ehf|Olanzapín||5211||5211|8107| 551388|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.08.2012||R|||0|0|0|1|BAM|0|0|0|100|SEK|9302|13425|lyfsjukr||||10000|0||Icepharma hf|Baxter Medical AB|Mannitól||9302||9302|13425| 551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|ţpakki||N02CC03|01.05.2001||R|||0|0|E|0|AZA|0|0|0|100|SEK|10997|16022|lyfalmen|V0235|16022||12|0|12,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||10997||10997|16022| 551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|||0|0|B|0|MAB|0|0|1|100|SEK|1878|3548|lyfalmen||||1|0|2,6667|Vistor hf|Meda AB|Tríamcínólón||1878||1878|3548| 551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|ţpakki||M01AX01|01.04.1995||R|||0|0|E|0|MAB|0|0|1|100|SEK|4008|6462|lyfalmen|V0198|6462||100|0|50,0000|Vistor hf|Meda AB|Nabúmeton||4008||4008|6462| 551739|N02AA0102|Morfin|töflur|10|mg|20|stk|1|pakki||N02AA01|01.04.1999||R|||1|0|0|0|LDR|0|0|0|100|IKR|738|1988|lyfalmen||||20|1|2,0000|Parlogis hf|Parlogis - óskráđ lyf|Morfín||738||738|1988| 551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|ţpakki||A02BC04|01.05.2001||R|||0|0|0|0|EIS|0|0|0|100|IKR|2157|1752|lyfalmen|V0466|1555||28|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1752| 551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|ţpakki||A02BC04|01.05.2001||R|||0|0|0|0|EIS|0|0|0|100|IKR|3931|3432|lyfalmen|V0467|2843||56|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3432| 551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|ţpakki||A02BC04|01.11.2001||R|||0|0|0|0|EIS|0|0|0|100|SEK|1483|3008|lyfalmen|V0003|777||14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||1483||1483|3008| 551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|ţpakki||A02BC04|01.05.2001||R|||0|0|0|0|EIS|0|0|0|100|IKR|3631|1752|lyfalmen|V0003|1555||28|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1752| 551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|ţpakki||A02BC04|01.05.2001||R|||0|0|0|0|EIS|0|0|0|100|IKR|7648|3432|lyfalmen|V0010|2937||56|0|56,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3432| 551989|N03AX1406|Zelta|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.04.2012||R|||0|0|0|0|LYF|0|0|0|100|XEU|23365|16902|lyfalmen|V0516|14515||100|0|66,6700|LYFIS ehf|LYFIS ehf|Levetíracetam||11640||11640|16902| 552224|C08CA0501|Adalat|töflur|20|mg|100|stk|1|ţpakki||C08CA05|01.04.1985||R|||0|0|B|0|BAP|0|0|0|100|SEK|3663|5990|lyfalmen||||100|0|66,6667|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||3663||3663|5990| 552877|N05CF0105|Zopiklon Mylan|filmhtfl|7,5|mg|500|stk|1|plglas||N05CF01|01.07.2007||R|||0|0|0|0|MYL|0|0|0|100|SEK|5169|8050|lyfalmen||||500|0|500,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||5169||5169|8050| 552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|ţpakki||N03AF02|01.10.2000||R|||0|0|E|0|NOH|0|0|0|100|DKK|3203|5360|lyfalmen||||100|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||3203||3203|5360| 553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|ţpakki||N02CC06|01.08.2009||R|||0|0|E|0|PER|0|0|0|100|DKK|11684|16962|lyfalmen|V0237|16962||18|0|18,0000|Icepharma hf|Pfizer ApS|Eletriptan||||11684|16962| 553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|ţpakki||N02CC06|01.10.2001||R|||0|0|E|0|PER|0|0|0|100|DKK|3996|6445|lyfalmen|V0237|5654||6|0|6,0000|Icepharma hf|Pfizer ApS|Eletriptan||3996||3996|6445| 554154|QA12CE9902|Selevitan, vet.|stl|||100|ml|5|hgl||QA12CE99|01.05.1983||R|||0|0|0|0|BID|0|0|0|100|DKK|7406|14393|vetalmen||||500|0||Vistor hf|Boehringer Ingelheim Danmark|||7406||7406|14393| 556921|H01AC0104|Saizen|sts|5,83|mg/ml|1,03|ml|1|rörlyk||H01AC01|01.05.2011||R|||0|1|0|1|EMA|0|0|0|100|SEK|27402|36272|lyfsjukr||||1|0|9,0000|Icepharma hf|E. Merck AB|Sómatrópín||27402||27402|36272| 556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|ţpakki||N03AF02|01.02.2000||R|||0|0|E|0|NOH|0|0|0|100|DKK|4746|7471|lyfalmen||||100|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||4746||4746|7471| 556944|N03AF0201|Trileptal|filmhtfl|600|mg|50|stk|1|glas||N03AF02|01.02.2000||R|||0|0|E|0|NOH|0|0|0|100|DKK|6455|9809|lyfalmen|V0242|6819||50|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||6455||6455|9809| 556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|ţpakki||N03AF02|01.02.2000||R|||0|0|E|0|NOH|0|0|0|100|DKK|9253|13637|lyfalmen|V0242|13637||100|0|60,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||9253||9253|13637| 557546|D10AF0202|Zineryt|áburđur|||30|ml|1|glas|+ leysir|D10AF02|01.07.1985||R|||0|0|0|0|ASP|0|0|0|100|XEU|1555|3106|lyfalmen||||30|0||Vistor hf|Astellas Pharma A/S|Erýtrómýcín||1555||1555|3106| 558770|L04AA2701|Gilenya|hylki|0,5|mg|28|stk|1|ţpakki||L04AA27|01.09.2011||R|||0|1|0|1|NOE|0|0|0|100|DKK|273203|344752|lyfsjukr||||28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||273203|344752| 559013|C08DA0103|Isoptin retard|forđatfl|120|mg|28|stk|1|ţpakki||C08DA01|01.01.1995||R|||0|0|B|0|ABS|0|0|0|100|DKK|824|2106|lyfalmen||||28|0|14,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||824||824|2106| 559021|C08DA0103|Isoptin retard|forđatfl|120|mg|98|stk|1|ţpakki||C08DA01|01.01.1995||R|||0|0|B|0|ABS|0|0|0|100|DKK|1892|3567|lyfalmen||||98|0|49,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||1892||1892|3567| 559104|N02AX0201|Nobligan|eţ-stíll|100|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|||0|0|E|0|GRU|0|0|1|100|DKK|642|1857|lyfalmen||||20|0|6,6667|Icepharma hf|Grunenthal|Tramadól||642||642|1857| 559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|||0|0|0|0|STD|0|0|0|100|IKR|||lyflausa||||100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíđ|||||| 559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|||0|0|*|0|SAO|0|0|0|100|XEU|1521|3060|lyfalmen||||5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1521||1521|3060| 559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|||0|0|0|0|STD|0|0|0|100|IKR|||lyflausa||||100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíđ|||||| 559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|||0|0|E|0|PER|0|0|0|100|DKK|5573|8602|lyfalmen||||1|0|90,0000|Icepharma hf|Pfizer ApS|Estradíól||5573||5573|8602| 559971|C01DA0201|Discotrine|forđapl|10|mg/sólh|30|stk|1|ţpakki||C01DA02|01.01.1994||R|||0|0|B|0|MEB|0|0|0|100|SEK|3588|5887|lyfalmen||||30|0|60,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||3588||3588|5887| 559989|N01AB0701|Suprane|innönd.l|||240|ml|1|fl||N01AB07|01.01.1995||R|||0|0|0|1|BAX|0|0|0|100|SEK|14027|19486|lyfsjukr||||240|0||Icepharma hf|Baxter|Desflúran||14027||14027|19486| 560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|||0|0|E|0|GEM|0|0|0|100|XEU|||lyfalmen||||10|0||Actavis Group hf|Gerhard Mann|Gervitár og ađrar óvirkar samsetningar|||||1410| 560244|N06AB0404|Citalopram Bluefish|filmhtfl|20|mg|30|stk|1|ţpakki||N06AB04|01.09.2012||R|||0|0|B|0|BLP|0|1|0|100|XEU|764|1772|lyfalmen|V0067|1772||30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||580||580|1772| 560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|ţpakki||J05AB01|01.07.1989||R|||0|0|E|0|GSK|0|0|1|100|GBP|3118|5244|lyfalmen||||25|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||3118||3118|5244| 560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|||0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa||||2|0||GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Acíklóvír|||||| 560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|||0|0|E|0|GSK|0|0|1|100|GBP|1552|3102|lyfalmen||||4|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||1552||1552|3102| 560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|||0|0|E|0|GSK|0|0|1|100|GBP|5943|9109|lyfalmen||||125|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||5943||5943|9109| 560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|||0|0|E|0|GSK|0|0|1|100|GBP|6445|9795|lyfalmen||||100|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6445||6445|9795| 560490|C01CX0801|Simdax|irţ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|||0|1|0|1|ORC|0|0|0|100|DKK|97568|124330|lyfsjukr||||5|0|1,1400|Vistor hf|Orion Corporation|Levosimendan||97568||97568|124330| 560557|C01CX0801|Simdax|irţ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|||0|1|0|1|ORC|0|0|0|100|DKK|451220|568164|lyfsjukr||||20|0|4,5500|Vistor hf|Orion Corporation|Levosimendan||451220||451220|568164| 560761|C10AA0505|Atorvastatin Bluefish|filmhtfl|80|mg|100|stk|1|ţpakki||C10AA05|01.10.2012||R|||0|0|0|0|BLP|0|0|0|100|XEU|9001|13292|lyfalmen|V0115|13292||100|0|400,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Atorvastatín||9001||9001|13292| 561145|N03AX2101|Trobalt|filmhtfl|150|mg|63|stk|1|ţpakki|21x50mg+42x100mg|N03AX21|01.12.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|5759|8857|lyfalmen||||63|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||5759||5759|8857| 561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|||0|0|*|0|SAO|0|0|0|100|XEU|1671|3265|lyfalmen||||5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1671||1671|3265| 562014|C09BA0201|Daraziđ|töflur|32,5|mg|100|stk|1|glas|20+12,5 mg|C09BA02|01.06.2011||R|||0|0|B|0|APC|0|0|0|100|XEU|2431|4304|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Enalapríl og ţvagrćsilyf||2431||2431|4304| 562668|L04AA2601|Benlysta|irs|400|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|||0|1|0|1|GGL|0|0|0|100|GBP|104401|132906|lyfsjukr||||1|0||GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||104401||104401|132906| 563111|L04AX0501|Esbriet|hylki|267|mg|63|stk|1|ţpakki|hart|L04AX05|01.07.2012||R|||0|1|0|0|INT|0|0|0|100|DKK|111725|142760|lyfalmen||||63|0||Vistor hf|InterMune Europe Ltd.|Pírfenidon||111725||111725|142760| 563346|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|3|spr|einnota sprauta|M09AX01|01.01.2001||R|||0|0|E|0|NYC|0|0|0|100|DKK|20599|28397|lyfalmen|V0431|27696||6|0|17,1667|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||20599||20599|28397| 563361|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|5|spr|einnota sprauta|M09AX01|01.01.2001||R|||0|0|E|0|NYC|0|0|0|100|DKK|34753|46160|lyfalmen|V0431|46160||10|0|28,6111|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||34753||34753|46160| 563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|||0|0|B|0|GSK|0|0|1|100|GBP|768|2029|lyfalmen||||30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||768||768|2029| 563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995||R|||0|0|B|0|GSK|0|0|1|100|GBP|694|1928|lyfalmen||||30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||694||694|1928| 563502|N02AA0101|Contalgin|forđatfl|5|mg|100|stk|1|ţpakki||N02AA01|01.10.1993||R|||1|0|E|0|PER|0|0|0|100|DKK|1345|2819|lyfalmen||||100|0|5,0000|Icepharma hf|Pfizer ApS|Morfín||1345||1345|2819| 563528|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|30|spr|einnota sprauta|M09AX01|01.01.2001||R|||0|0|E|0|NYC|0|0|0|100|DKK|200370|254009|lyfalmen||||60|0|171,6667|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||200370||200370|254009| 563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|||0|0|*|0|SAO|0|0|0|100|XEU|3486|5748|lyfalmen||||15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3486||3486|5748| 563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|||0|0|*|0|SAO|0|0|0|100|XEU|3614|5923|lyfalmen||||15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3614||3614|5923| 563779|M05BA0708|Risedronate Bluefish|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.07.2012||R|||0|0|E|0|BLP|0|0|0|100|XEU|2184|3103|lyfalmen|V0207|3103||12|0|84,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Rísedrónsýru||1553||1553|3103| 563899|QP54AA0105|Noromectin|áhella|0,5|w/v|1000|ml|1|fl|lausn|QP54AA01|01.11.2011||R|||0|0|0|0|NOB|1|0|0|100|XEU|11066|19304|vetorma||||1000|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||11066||11066|19304| 564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|ţpakki|hart|J05AB04|01.02.2002||R|||0|1|0|1|SCP|0|0|0|100|DKK|79699|101905|lyfsjukr||||168|0|33,6000|Vistor hf|Schering-Plough|Ribavirin||79699||79699|101905| 565306|A02BX1302|Galieve Cool Mint|mixtúra|||300|ml|1|glerfl|dreifa|A02BX13|01.12.2010||L|||0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa||||300|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||| 565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|||0|0|B|0|UCB|0|0|0|100|DKK|11243|16359|lyfalmen||||100|0|50,0000|Vistor hf|U.C.B|Olsalazín||11243||11243|16359| 565982|H01BA0401|Glypressin|stl|0,1|mg/ml|8,5|ml|5|lykjur|lausn|H01BA04|01.08.2012||R|||0|0|0|1|FEL|0|0|0|100|DKK|35331|46223|lyfsjukr||||42|0|3,5500|Vistor hf|Ferring Lćgemidler A/S|Terlípressín||35331||35331|46223| 566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|||0|0|*|0|ALC|0|0|0|100|USD|1388|2878|lyfalmen|V0444|2194||5|0|25,0000|K.Pétursson hf|Alcon|Brinzólamíđ||1388||1388|2878| 567016|R06AD0201|Phenergan|mixtúra|1|mg/ml|100|ml|1|glas||R06AD02|01.10.1995|31.07.2012|R|||0|0|E|0|SNO|0|0|1|100|NOK|2326|4161|lyfalmen||||100|0|4,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||2326||2326|4161| 567028|L01XE0701|Tyverb|filmhtfl|250|mg|84|stk|1|glas||L01XE07|01.02.2012||R|||0|1|0|1|GGL|0|0|0|100|GBP|210697|266307|lyfsjukr||||84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Labatinibum||210697||210697|266307| 567460|C01CA2407|Jext|stl|150|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|||0|0|B|0|ALK|0|0|1|100|DKK|5650|8708|lyfalmen||||1|0|0,3000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5650|8708| 567503|N05AX0801|Risperdal|töflur|1|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|||0|0|*|0|JAS|0|1|0|100|SEK|3447|5694|lyfalmen|V0291|3373||60|0|12,0000|Vistor hf|Janssen-Cilag AB|Risperídón||3447||3447|5694| 567511|N05AX0801|Risperdal|töflur|2|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|||0|0|*|0|JAS|0|1|0|100|SEK|6976|10522|lyfalmen|V0292|5566||60|0|24,0000|Vistor hf|Janssen-Cilag AB|Risperídón||6976||6976|10522| 567529|N05AX0801|Risperdal|töflur|3|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|||0|0|*|0|JAS|0|1|0|100|SEK|10196|14927|lyfalmen|V0293|8178||60|0|36,0000|Vistor hf|Janssen-Cilag AB|Risperídón||10196||10196|14927| 567537|N05AX0801|Risperdal|töflur|4|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|||0|0|*|0|JAS|0|1|0|100|SEK|13390|19350|lyfalmen|V0294|10467||60|0|48,0000|Vistor hf|Janssen-Cilag AB|Risperídón||13390||13390|19350| 567545|R01AC0201|Livostin|nefúđi|0,5|mg/úđask|15|ml|1|glas||R01AC02|01.06.1998||L|||0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa||||15|0|12,5000|Vistor hf|McNeil Sweden AB|Levókabastín|||||| 567946|A02BX1302|Galieve Cool Mint|mixtúra|||10|ml|24|skammt|dreifa|A02BX13|01.12.2010||L|||0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa||||240|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||| 568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|||0|0|0|0|GSK|0|0|1|100|GBP|1115|2504|lyfalmen||||3|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Mupirocin||1115||1115|2504| 568840|C08CA0201|Feldil|forđatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|||0|0|B|0|ACA|0|0|0|100|XEU|1369|2852|lyfalmen|V0058|2852||100|0|100,0000|Actavis Group hf|Actavis hf|Felódipín||1369||1369|2852| 568865|C08CA0201|Feldil|forđatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|||0|0|B|0|ACA|0|0|0|100|XEU|2168|3945|lyfalmen|V0059|3945||100|0|200,0000|Actavis Group hf|Actavis hf|Felódipín||2168||2168|3945| 569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|||0|0|0|1|NOH|0|0|0|100|DKK|16732|22881|lyfsjukr||||5|0|18,1800|Vistor hf|Novartis Healthcare A/S-|Baklófen||16732||16732|22881| 569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|||0|0|0|1|NOH|0|0|0|100|DKK|19239|26027|lyfsjukr||||20|0|18,1800|Vistor hf|Novartis Healthcare A/S-|Baklófen||19239||19239|26027| 571524|A02BX1303|Galieve Peppermint|tuggutfl|||24|stk|1|ţpakki|dreifa|A02BX13|01.12.2010||L|||0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa||||24|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||| 572422|L04AD0201|Advagraf|forđahlk|5|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|||0|1|*|0|APE|0|0|0|100|XEU|81830|105242|lyfalmen||||50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||81830||81830|105242| 572612|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|||0|0|0|0|APC|0|0|0|100|XEU|12529|8675|lyfalmen|V0253|7520||100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||5626||5626|8675| 572768|B02BC1001|Tisseel Duo Quick|vefjalím|||0,5|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|||0|0|0|1|BAX|0|0|0|100|SEK|164108|207838|lyfsjukr||||5|0||Icepharma hf|Baxter|Fíbrínógen manna||164108||164108|207838| 572776|B02BC1001|Tisseel Duo Quick|vefjalím|||1|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|||0|0|0|1|BAX|0|0|0|100|SEK|194725|246262|lyfsjukr||||10|0||Icepharma hf|Baxter|Fíbrínógen manna||194725||194725|246262| 572784|B02BC1001|Tisseel Duo Quick|vefjalím|||2|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|||0|0|0|1|BAX|0|0|0|100|SEK|410056|516503|lyfsjukr||||20|0||Icepharma hf|Baxter|Fíbrínógen manna||410056||410056|516503| 572798|A02BX1303|Galieve Peppermint|tuggutfl|||48|stk|1|ţpakki|dreifa|A02BX13|01.12.2010||L|||0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa||||48|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||| 573065|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|98|stk|1|glas||A02BC05|01.08.2011||R|||0|0|E|0|LYF|0|0|0|100|IKR|9783|5012|lyfalmen|V0011|5012||98|0|65,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||2948||2948|5012| 573120|N03AX0903|Lamotrin|dreifit.|100|mg|98|stk|1|ţpakki||N03AX09|01.12.2010||R|||0|0|E|0|ACA|0|0|0|100|IKR|5300|4615|lyfalmen|V0245|4615||98|0|32,6700|Actavis Group hf|Actavis hf|Lamótrigín||2658||2658|4615| 573177|S01ED5110|Duotrav|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|||0|0|*|0|ALC|0|0|0|100|USD|3561|5850|lyfalmen|V0464|5105||2|0|25,0000|K.Pétursson hf|Alcon|Tímólól í blöndum||3561||3561|5850| 573287|G03CA0306|Evorel|forđapl|25|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|||0|0|E|0|JAS|0|0|0|100|SEK|3325|5527|lyfalmen|V0129|5527||26|0|45,5000|Vistor hf|Janssen-Cilag AB|Estradíól||3325||3325|5527| 573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|94060|119928|lyfsjukr||||1|0||Icepharma hf|Roche|Trastuzumab||94060||94060|119928| 573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.10.1995||R|||0|0|0|1|AZA|0|0|0|100|SEK|24573|32722|lyfsjukr||||5000|0|2,5000|Vistor hf|AstraZeneca AB|Meropenem||24573||24573|32722| 573642|J01DH0201|Meronem|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.10.1995||R|||0|0|0|1|AZA|0|0|0|100|SEK|41607|54099|lyfsjukr||||10|0|5,0000|Vistor hf|AstraZeneca AB|Meropenem||41607||41607|54099| 573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|ţpakki||M01AB05|01.01.1996||R|||0|0|E|0|NOH|0|0|1|100|IKR|2756|2659|lyfalmen|V0189|2116||100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1228||1228|2659| 575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|ţpakki||N06AB06|01.10.1995||R|||0|0|0|0|PER|0|1|0|100|DKK|2408|2076|lyfalmen|V0151|1972||28|0|28,0000|Icepharma hf|Pfizer ApS|Sertralín||802||802|2076| 575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|ţpakki||N06AB06|01.10.1995||R|||0|0|B|0|PER|0|1|0|100|DKK|7502|6779|lyfalmen|V0322|4247||98|0|98,0000|Icepharma hf|Pfizer ApS|Sertralín||4240||4240|6779| 575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|ţpakki||N06AB06|01.03.2001||R|||0|0|0|0|PER|0|1|0|100|DKK|4441|2076|lyfalmen|V0152|1972||28|0|56,0000|Icepharma hf|Pfizer ApS|Sertralín||802||802|2076| 575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|ţpakki||N06AB06|01.03.2001||R|||0|0|B|0|PER|0|1|0|100|DKK|13296|6779|lyfalmen|V0323|6307||98|0|196,0000|Icepharma hf|Pfizer ApS|Sertralín||4240||4240|6779| 575472|P03AX0301|Prioderm|hársápa|10|mg/ml|40|g|1|túpa||P03AX03|01.04.1994||L|||0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa||||40|0||Icepharma hf|Norpharma |Malatíón|||||| 575506|C01EB1001|Adenocor|stl|3|mg/ml|2|ml|6|hgl||C01EB10|01.11.2007||R|||0|0|0|1|SAA|0|0|0|100|NOK|6993|10093|lyfsjukr||||12|0|2,4000|Vistor hf|Sanofi - Aventis|Adenósín||6993||6993|10093| 576032|N03AX0903|Lamotrin|dreifit.|25|mg|42|stk|1|ţpakki||N03AX09|01.12.2010||R|||0|0|E|0|ACA|0|0|0|100|IKR|1150|1789|lyfalmen|V0243|1662||42|0|3,5000|Actavis Group hf|Actavis hf|Lamótrigín||592||592|1789| 578259|A04AA0104|Ondansetron Billev|filmhtfl|8|mg|10|stk|1|ţpakki||A04AA01|01.05.2012||R|||0|0|E|0|MYL|0|0|0|100|SEK|3797|5009|lyfalmen|V0384|4764||10|0|5,0000|Actavis Group PTC ehf|Mylan AB|Ondansetrón||2946||2946|5009| 578654|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|ţpakki|50+500 mg|QP52AA51|01.07.2011||R|||0|0|0|0|ICE|0|0|0|100|USD|5707|9956|vetorma||||20|0||Icepharma hf|Icepharma hf|||5707||5707|9956| 579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|||0|0|B|0|AZD|0|0|0|100|SEK|1324|2790|lyfalmen||||10|0|0,3300|Vistor hf|AstraZeneca A/S DK|Terbútalín||1324||1324|2790| 579421|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|28|stk|1|ţpakki||A02BC05|01.08.2011||R|||0|0|0|0|LYF|0|0|0|100|IKR|4499|2114|lyfalmen|V0005|1797||28|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||830||830|2114| 579854|L04AX0305|Methotrexate Pfizer|töflur|2,5|mg|30|stk|1|glas||L04AX03|01.01.1994||R|||0|0|*|0|PER|0|0|0|100|DKK|687|1919|lyfalmen||||30|0|30,0000|Icepharma hf|Pfizer ApS|Metótrexat||687||687|1919| 580190|N06AB1005|Escitalopram LYFIS|filmhtfl|5|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|||0|0|B|0|LYF|0|1|0|100|XEU|2703|2519|lyfalmen|V0324|2519||100|0|50,0000|LYFIS ehf|LYFIS ehf|Escítalópram||1126||1126|2519| 580227|A10BX0202|Repaglinid Krka (LYFIS)|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|||0|0|*|0|LYF|0|0|0|100|XEU|2837|2871|lyfalmen|V0462|2871||90|0|11,2500|LYFIS ehf|LYFIS ehf|Repaglíníđ||1383||1383|2871| 581328|C10AA0505|Atorvastatin Bluefish|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA05|01.10.2012||R|||0|0|0|0|BLP|0|0|0|100|XEU|2740|2754|lyfalmen|V0113|2649||100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Atorvastatín||1298||1298|2754| 581806|A10BX0202|Repaglinid Krka (LYFIS)|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|||0|0|*|0|LYF|0|0|0|100|XEU|3273|3241|lyfalmen|V0472|3241||90|0|45,0000|LYFIS ehf|LYFIS ehf|Repaglíníđ||1654||1654|3241| 581890|QN02AF0103|Torphasol vet.|stl|10|mg/ml|20|ml|1|hgl||QN02AF01|01.02.2011||R|||0|0|0|0|ANI|1|0|0|100|XEU|14013|27080|vetalmen||||20|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||14013||14013|27080| 581969|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.07.2011||R|||0|0|*|0|ALC|0|0|0|100|USD|2317|4148|lyfalmen||||2|0|25,0000|K.Pétursson hf|Alcon|Cýklópentólat||2317||2317|4148| 582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|||0|1|0|1|ELI|0|0|0|100|XEU|27379|36243|lyfsjukr||||1|0|9,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||27379||27379|36243| 582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|||0|1|0|1|ELI|0|0|0|100|XEU|52837|68193|lyfsjukr||||1|0|18,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||52837||52837|68193| 582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|||0|1|0|1|ELI|0|0|0|100|XEU|105673|134502|lyfsjukr||||1|0|36,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||105673||105673|134502| 582213|R01AA0503|Nezeril|nefúđi|0,1|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|||0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa||||8|0|1,8750|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||| 582221|V08AB0201|Omnipaque|stl|140|mg J/ml|200|ml|10|plastf||V08AB02|01.04.2011||R|||0|0|0|1|GEH|0|0|0|100|NOK|66980|85942|lyfsjukr||||2000|0||Icepharma hf|GE Healthcare AS|Jóhexól||66980||66980|85942| 582247|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.02.1999||R|||0|0|0|0|PAL|1|0|0|100|DKK|4835|8434|vetorma||||50|0||Icepharma hf|Pfizer Oy Animal Health|Doramectinum||4835||4835|8434| 582262|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.02.1999||R|||0|0|0|0|PAL|1|0|0|100|DKK|18218|31780|vetorma||||200|0||Icepharma hf|Pfizer Oy Animal Health|Doramectinum||18218||18218|31780| 582451|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|56|stk|1|ţpakki||A02BC05|01.11.2011||R|||0|0|0|0|POF|0|0|0|100|XEU|4438|3741|lyfalmen|V0011|2864||56|0|37,3300|Portfarma ehf|Portfarma|Esómeprazól||2019||2019|3741| 582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|45039|58406|lyfsjukr||||1000|0||Icepharma hf|GE Healthcare AS|Jóhexól||45039||45039|58406| 582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|102466|130477|lyfsjukr||||3000|0||Icepharma hf|GE Healthcare AS|Jóhexól||102466||102466|130477| 582783|C07AB0205|Seloken|töflur|100|mg|28|stk|1|ţpakki||C07AB02|01.12.2001||R|||0|0|B|0|AZD|0|0|0|100|SEK|838|2125|lyfalmen||||28|0|18,6667|Vistor hf|AstraZeneca A/S DK|Metóprólól||838||838|2125| 582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|49649|64192|lyfsjukr||||1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||49649||49649|64192| 582990|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.05.2011||R|||0|1|0|1|EMA|0|0|0|100|SEK|54760|70606|lyfsjukr||||2|0|18,0000|Icepharma hf|E. Merck AB|Sómatrópín||54760||54760|70606| 583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|98733|125792|lyfsjukr||||2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||98733||98733|125792| 583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|ţpakki||C07AA07|01.01.1994||R|||0|0|B|0|MYL|0|0|0|100|SEK|1128|2522|lyfalmen||||100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||1128||1128|2522| 583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|117847|149780|lyfsjukr||||3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||117847||117847|149780| 583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|53811|69415|lyfsjukr||||1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||53811||53811|69415| 583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|110849|140998|lyfsjukr||||2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||110849||110849|140998| 583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|121172|153953|lyfsjukr||||3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||121172||121172|153953| 583849|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Excel umbúđir|B05BB01|01.11.2002||R|||0|0|0|1|FRP|0|0|0|100|DKK|3701|5341|lyfsjukr||||5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||3701||3701|5341| 584029|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|9|plpok|Excel umbúđir|B05BA03|01.11.2002||R|||0|0|0|1|FRP|0|0|0|100|DKK|2242|3236|lyfsjukr||||9000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2242||2242|3236| 584133|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|||0|1|0|1|SCP|0|0|0|100|DKK|18011|24486|lyfsjukr||||1|0|9,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||18011||18011|24486| 584292|N06AG0201|Aurorix|töflur|300|mg|30|stk|1|ţpakki||N06AG02|01.07.1995||R|||0|0|B|0|MAS|0|1|0|100|SEK|1899|3577|lyfalmen||||30|0|30,0000|Vistor hf|Meda AS|Móklóbemíđ||1899||1899|3577| 585646|B01AB0101|Heparin Leo|stl|25000|ae/ml|2|ml|10|hgl||B01AB01|01.11.1981|31.07.2012|R|||0|0|0|1|LEP|0|0|0|100|DKK|10163|14637|lyfsjukr||||20|0|50,0000|Vistor hf|LEO Pharma A/S|Heparín||10163||10163|14637| 585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|||0|0|0|1|LEP|0|0|0|100|DKK|4450|6422|lyfsjukr||||25|0|12,5000|Vistor hf|LEO Pharma A/S|Heparín||4450||4450|6422| 585869|J07BC0201|Havrix|bóluefni|1440|ein/ml|1|ml|1|dćla|einnota dćla|J07BC02|01.07.1994||R|||0|0|0|0|GSK|0|0|0|100|GBP|4518|7159|lyfalmen||||1|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||4518||4518|7159| 585975|C07AB0312|Atenolol LYFIS|filmhtfl|25|mg|100|stk|1|ţpakki||C07AB03|01.05.2012||R|||0|0|B|0|LYF|0|0|0|100|XEU|456|1597|lyfalmen|V0541|1597||100|0|33,3300|LYFIS ehf|LYFIS ehf|Atenólól||452||452|1597| 586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|||0|0|*|0|NOH|0|0|0|100|DKK|31625|42235|lyfalmen||||50|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||31625||31625|42235| 586206|D07AB0201|Locoid|smyrsli|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|||0|0|B|0|ASP|0|0|1|100|XEU|1687|3287|lyfalmen||||100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1687||1687|3287| 586223|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|||0|0|0|1|BRA|0|0|0|100|XEU|13762|19154|lyfsjukr||||800|0|10,0000|Actavis Group hf|Braun|Gentamícín||13762||13762|19154| 586241|J01GB0101|Tobi Podhaler|innönddu|28|mg|224|stk|1|ţpakki|hart hylki+innönd.tćki|J01GB01|01.04.2012||R|||0|1|0|1|NOE|0|0|0|100|DKK|367723|463375|lyfsjukr||||224|0|20,9100|Vistor hf|Novartis Europharm Ltd|Tobramýcín||367723||367723|463375| 587641|C09DA0602|Candpress Comp|töflur|28,5|mg|100|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.01.2012||R|||0|0|0|0|AGP|0|0|0|100|XEU|9822|13738|lyfalmen|V0095|13738||100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan og ţvagrćsilyf||9327||9327|13738| 588395|N03AX2101|Trobalt|filmhtfl|50|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|4703|7412|lyfalmen||||84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||4703||4703|7412| 588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|ţpakki||J01FF01|01.10.1995||R|||0|0|0|0|PER|0|0|1|100|DKK|2124|3884|lyfalmen|V0461|3883||20|0|5,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2124||2124|3884| 588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|ţpakki||B01AC05|01.04.1995||R|||0|0|E|0|SNO|0|0|0|100|NOK|9718|14273|lyfalmen||||100|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Tíklópídín||9718||9718|14273| 588772|H05BA0103|Miacalcic Nasal|nefúđi|200|ae/sk|2|ml|1|úđagl|14 skammt|H05BA01|01.03.2002|30.09.2012|R|||0|0|E|0|NOH|0|0|0|100|DKK|8236|12245|lyfalmen||||2|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||8236||8236|12245| 589358|QP54AA0501|Stronghold vet.|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.04.2004||R|||0|0|0|0|PFA|1|0|0|100|XEU|5909|10308|vetorma||||3|0||Icepharma hf|Pfizer Animal Health|Selamectinum||5909||5909|10308| 589366|QP54AA0501|Stronghold vet.|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|||0|0|0|0|PFA|1|0|0|100|XEU|2290|3995|vetorma||||1|0||Icepharma hf|Pfizer Animal Health|Selamectinum||2290||2290|3995| 589374|QP54AA0501|Stronghold vet.|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.04.2004||R|||0|0|0|0|PFA|1|0|0|100|XEU|5701|9945|vetorma||||6|0||Icepharma hf|Pfizer Animal Health|Selamectinum||5701||5701|9945| 589382|QP54AA0501|Stronghold vet.|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|||0|0|0|0|PFA|1|0|0|100|XEU|3079|5371|vetorma||||1|0||Icepharma hf|Pfizer Animal Health|Selamectinum||3079||3079|5371| 589390|QP54AA0501|Stronghold vet.|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.04.2004||R|||0|0|0|0|PFA|1|0|0|100|XEU|3198|5579|vetorma||||2|0||Icepharma hf|Pfizer Animal Health|Selamectinum||3198||3198|5579| 589408|QP54AA0501|Stronghold vet.|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.04.2004||R|||0|0|0|0|PFA|1|0|0|100|DKK|3082|5376|vetorma||||2|0||Icepharma hf|Pfizer Animal Health|Selamectinum||3082||3082|5376| 590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|||0|0|0|0|BAE|0|0|1|100|IKR|||lyflausa||||20|0||Icepharma hf|Bayer AB|Klótrímazól|||||| 590562|C01DA1403|Ismo|forđatfl|60|mg|98|stk|1|glas||C01DA14|01.10.1999||R|||0|0|B|0|ACA|0|0|0|100|XEU|1971|3675|lyfalmen|V0041|3674||98|0|147,0000|Actavis Group hf|Actavis hf|Ísósorbíđ mónónítrat||1971||1971|3675| 590752|N05AF0102|Fluanxol Depot|stl|100|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1979||R|||0|0|*|0|LBK|0|1|0|100|DKK|22251|30470|lyfalmen||||10|0|250,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||22251||22251|30470| 590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|||0|0|0|1|BOI|0|0|0|100|DKK|174740|221181|lyfsjukr||||1|0|0,7500|Vistor hf|Boehringer Ingelheim|Tenekteplasi||174740||174740|221181| 591260|N06DA0302|Exelon (Lyfjaver)|forđapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|||0|0|E|0|LVR|0|0|0|100|DKK|14708|21004|lyfalmen|V0347|21004||30|0|14,5300|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||14708||14708|21004| 592378|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|500|ml|1|glas||D08AC02|01.10.1976||L|||0|0|0|0|REM|0|0|0|100|IKR|||lyflausa||||500|0||Vistor hf|Regent Medical Overseas Limited|Klórhexidín|||||| 592977|L01XE1201|Caprelsa|filmhtfl|300|mg|30|stk|1|ţpakki||L01XE12|01.07.2012||R|||0|1|0|1|AZA|0|0|0|100|SEK|814809|1024468|lyfsjukr||||30|0||Vistor hf|AstraZeneca AB|Vandetaníb||814809||814809|1024468| 593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|||0|0|E|0|ROC|0|0|0|100|DKK|502|1666|lyfalmen|V0238|732||50|0|3,1250|Icepharma hf|Roche|Klónazepam||502||502|1666| 593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|||0|0|E|0|ROC|0|0|0|100|DKK|889|2195|lyfalmen|V0238|2195||150|0|9,3750|Icepharma hf|Roche|Klónazepam||889||889|2195| 593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|||0|0|E|0|ROC|0|0|0|100|DKK|1311|2772|lyfalmen||||100|0|25,0000|Icepharma hf|Roche|Klónazepam||1311||1311|2772| 593654|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.11.2011||L|||0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa||||204|0|27,2000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||| 594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|||0|0|B|0|MAB|0|0|1|100|SEK|21321|29303|lyfalmen||||12|0|32,0000|Vistor hf|Meda AB|Tríamcínólón||21321||21321|29303| 594408|C10AA0504|Atorvastatin Portfarma|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|||0|0|0|0|POF|0|0|0|100|IKR|7867|5541|lyfalmen|V0114|4946||100|0|200,0000|Portfarma ehf|Portfarma|Atorvastatín||3335||3335|5541| 594713|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|1|spr||QP52AF02|01.07.1995||L|||0|0|0|0|PAL|0|0|0|100|DKK|328|572|vetorma||||10|0||Icepharma hf|Pfizer Oy Animal Health|||||328|572| 594721|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|10|spr||QP52AF02|01.07.1995||L|||0|0|0|0|PAL|0|0|0|100|DKK|2728|4759|vetorma||||100|0||Icepharma hf|Pfizer Oy Animal Health|||||2728|4759| 595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|||0|0|0|1|NOH|0|0|0|100|DKK|5792|8359|lyfsjukr||||5|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||5792||5792|8359| 595991|J07BB0201|Fluarix|bóluefni|||0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1994||R|||0|0|0|0|GSK|0|0|0|100|GBP|631|1842|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsađir mótefnavakar||631||631|1842| 596023|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|250|ml|1|glas||D08AC02|01.06.1982||L|||0|0|0|0|REM|0|0|0|100|IKR|||lyflausa||||250|0||Vistor hf|Regent Medical Overseas Limited|Klórhexidín|||||| 596085|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|62994|80940|lyfsjukr||||2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||||62994|80940| 596881|N05CM1801|Dexdor|irţ|100|mcg/ml|2|ml|5|lykjur|lausn|N05CM18|01.03.2012||R|||0|1|0|1|ORC|0|0|0|100|DKK|18825|25508|lyfsjukr||||10|0||Vistor hf|Orion Corporation|Dexmedetómid||18825||18825|25508| 597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|ţpakki||J01FF01|01.06.1979||R|||0|0|0|0|PER|0|0|1|100|DKK|2269|4083|lyfalmen||||24|0|3,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2269||2269|4083| 597433|L01XC1101|Yervoy|stţ|5|mg/ml|10|ml|1|hgl|lausn|L01XC11|01.05.2012||R|||0|1|0|1|BMS|0|0|0|100|DKK|663377|834421|lyfsjukr||||10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||663377||663377|834421| 597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|||0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa||||30|0||Vistor hf|McNeil Sweden AB|Ekónazól|||||| 598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|||0|0|0|0|SNO|0|0|1|100|NOK|459|1607|lyfalmen||||150|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||459||459|1607| 598499|M01AE0112|ibuxin rapid|filmhtfl|400|mg|30|stk|1|ţpakki||M01AE01|01.09.2012||L|||0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa||||30|0|10,0000|LYFIS ehf|ratiopharm GmbH|Íbúprófen|||||| 692098|N06BA0104|Amfetamin Glostrup|töflur|5|mg|100|stk|1|glas||N06BA01|01.07.2011||R|||1|0|0|0|PCO|0|0|0|100|DKK|3996|6445|lyfalmen||||100|1|33,3300|Distica|Distica - óskráđ lyf|Amfetamín||||3996|6445| 916827|A03FA0301|Motilium|töflur|10|mg|100|stk|1|glas||A03FA03|01.05.1998||R|||0|0|0|0|PCO|0|0|1|100|SEK|2835|4857|lyfalmen||||100|1|33,3333|Distica|Distica - óskráđ lyf|Dómíperídón||2835||2835|4857| 923351|S01XA2006|Lacri - Lube|augnsm|||3,5|g|1|túpa||S01XA20|01.01.1998||R|||0|0|0|0|PCO|0|0|0|100|IKR|480|1636|lyfalmen||||4|1||Distica|Distica - óskráđ lyf|Gervitár og ađrar óvirkar samsetningar||480||480|1636| 938483|M04AC0101|Colchicine|töflur|0,5|mg|100|stk|1|glas||M04AC01|01.01.1998||R|||0|0|0|0|LDR|0|0|0|100|GBP|6288|9581|lyfalmen||||100|1|50,0000|Parlogis hf|Parlogis - óskráđ lyf|Kolkisín||6288||6288|9581| 938780|C09AA0104|Captopril|hylki|1|mg|100|stk|1|glas||C09AA01|01.01.2000||R|||0|0|0|0|LDR|0|0|0|100|GBP|18064|25215|lyfalmen||||100|1|2,0000|Parlogis hf|Parlogis - óskráđ lyf|Kaptópríl||18064||18064|25215| 940313|G03BA0302|Testosteron|vefjatfl|100|mg|1|stk|1|pakki||G03BA03|01.04.1998||R|||0|0|0|0|PCO|0|0|0|100|GBP|2947|5010|lyfalmen||||1|1|33,3300|Distica|Distica - óskráđ lyf|Testósterón||2947||2947|5010| 944505|H02AB1005|Cortisonacetat|töflur|5|mg|100|stk|1|glas||H02AB10|01.12.2002||R|||0|0|0|0|PCO|0|0|1|100|DKK|5250|8161|lyfalmen||||100|1|13,3300|Distica|Distica - óskráđ lyf|Kortisón||5250||5250|8161| 944852|A06AX0102|Glycerol infant|eţ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|||0|0|0|0|LDR|0|0|0|100|IKR|342|1447|lyfalmen||||12|1||Parlogis hf|Parlogis - óskráđ lyf|Glýceról||342||342|1447| 944985|A06AX0103|Glycerol adult|eţ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|||0|0|0|0|LDR|0|0|0|100|IKR|664|1887|lyfalmen||||12|1||Parlogis hf|Parlogis - óskráđ lyf|Glýceról||664||664|1887| 945850|R06AD0202|Atosil|stl|25|mg/ml|2|ml|5|lykjur||R06AD02|01.03.2001||R|||0|0|0|0|PCO|0|0|1|100|IKR|2293|4116|lyfalmen||||10|1|10,0000|Distica|Distica - óskráđ lyf|Prómetazín||2293||2293|4116| 947715|H02AB1004|Cortisone Acetat|töflur|25|mg|100|stk|1|glas||H02AB10|01.01.1998||R|||0|0|0|0|LDR|0|0|1|100|IKR|5033|7864|lyfalmen||||100|1|66,6667|Parlogis hf|Parlogis - óskráđ lyf|Kortisón||5033||5033|7864| 948242|H02AB0203|Dexamethason|töflur|0,5|mg|100|stk|1|pakki||H02AB02|01.04.2005||R|||0|0|0|0|LDR|0|0|1|100|IKR|1990|3701|lyfalmen||||100|1|33,3300|Parlogis hf|Parlogis - óskráđ lyf|Dexametasón||1990||1990|3701| 951592|H02AB0907|Hydrocortison|töflur|1|mg|100|stk|1|glas||H02AB09|01.08.2009||R|||0|0|0|0|PCO|0|0|1|100|DKK|5250|8161|lyfalmen||||100|1|3,3300|Distica|Distica - óskráđ lyf|Hýdrókortisón||5250||5250|8161| 954421|C03CA0109|Furosemid|mixtúra|10|mg/ml|60|ml|1|glas||C03CA01|01.08.2009||R|||0|0|0|0|LDR|0|0|0|100|IKR|1870|3537|lyfalmen||||60|1||Parlogis hf|Parlogis - óskráđ lyf|Fúrósemíđ||||1870|3537| 954504|C07AA0510|Syprol|mixtúra|2|mg/ml|150|ml|1|fl||C07AA05|01.08.2009||R|||0|0|0|0|LDR|0|0|0|100|IKR|5690|8763|lyfalmen||||150|1||Parlogis hf|Parlogis - óskráđ lyf|Própranólól||||5690|8763| 961393|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|glas||A04AD05|01.01.1998||R|||0|0|0|0|LDR|0|0|1|100|IKR|1960|3660|lyfalmen||||20|1|20,0000|Parlogis hf|Parlogis - óskráđ lyf|Metópímazín||1960||1960|3660| 961591|H02AB0906|Hydrocortisone|töflur|10|mg|20|stk|1|glas||H02AB09|01.08.2009||R|||0|0|0|0|LDR|0|0|1|100|IKR|1850|3510|lyfalmen||||20|1|6,6700|Parlogis hf|Parlogis - óskráđ lyf|Hýdrókortisón||1850||1850|3510| 961658|H02AB0905|Hydrocortisone|töflur|20|mg|25|stk|1|glas||H02AB09|01.01.2009||R|||0|0|0|0|LDR|0|0|1|100|IKR|4320|6888|lyfalmen||||25|1|16,7000|Parlogis hf|Parlogis - óskráđ lyf|Hýdrókortisón||4320||4320|6888| 962466|H02AB0203|Dexamethason|töflur|4|mg|100|stk|1|glas||H02AB02|01.08.2009||R|||0|0|0|0|LDR|0|0|1|100|IKR|3451|5700|lyfalmen||||100|1|266,6600|Parlogis hf|Parlogis - óskráđ lyf|Dexametasón||||3451|5700| 962945|R06AB0201|Polaramin|töflur|2|mg|30|stk|1|ţpakki||R06AB02|01.11.2009||R|||0|0|0|0|LDR|0|0|0|100|IKR|2360|4207|lyfalmen||||30|1|10,0000|Parlogis hf|Parlogis - óskráđ lyf|Dexklórfeníramín||2360||2360|4207| 965767|A03AA0703|Dicykloverin Syrup|mixtúra|2|mg/ml|120|ml|1|glas||A03AA07|01.08.2011||R|||0|1|0|0|LDR|0|0|0|100|IKR|8480|12579|lyfalmen||||120|1|3,0000|Parlogis hf|Parlogis - óskráđ lyf|Dícýklóverín||8480||8480|12579| 967333|N05AH0408|Quetiapin Bluefish|filmhtfl|25|mg|60|stk|1|ţpakki||N05AH04|01.09.2012||R|||0|0|*|0|BLP|0|1|0|100|IKR|1200|2073|lyfalmen|V0284|1712||60|0|3,7500|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||800||800|2073| 967341|N05AH0408|Quetiapin Bluefish|filmhtfl|100|mg|60|stk|1|ţpakki||N05AH04|01.09.2012||R|||0|0|*|0|BLP|0|1|0|100|IKR|6800|7408|lyfalmen|V0285|7408||60|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||4700||4700|7408| 967359|N05AH0408|Quetiapin Bluefish|filmhtfl|200|mg|60|stk|1|ţpakki||N05AH04|01.09.2012||R|||0|0|*|0|BLP|0|1|0|100|IKR|12500|14795|lyfalmen|V0286|14795||60|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||10100||10100|14795| 967367|N05AH0408|Quetiapin Bluefish|filmhtfl|300|mg|60|stk|1|ţpakki||N05AH04|01.09.2012||R|||0|0|0|0|BLP|0|1|0|100|IKR|25000|33920|lyfalmen|V0287|33920||60|0|45,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||25000||25000|33920|